data_1hic_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hic _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 107.775 -1.195 . . . . 2.5499999999999998 107.775 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.6 p -123.7 168.47 12.64 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.995 -0.743 . . . . 1.8600000000000001 108.995 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -65.85 170.46 5.37 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.215 0.606 . . . . 2.1099999999999999 109.718 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.19 143.38 28.01 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.502 -0.749 . . . . 1.0900000000000001 111.266 171.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 p -97.85 -22.78 16.17 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.179 1.177 . . . . 2.2200000000000002 114.179 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -133.32 160.84 36.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.343 0.974 . . . . 2.5699999999999998 109.197 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -75.89 154.81 35.78 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.52000000000000002 110.292 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.54 22.77 66.44 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.313 -0.715 . . . . 0.54000000000000004 111.313 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -108.15 147.67 30.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.907 0.883 . . . . 2.52 109.944 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -115.17 176.85 4.88 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.758 0.823 . . . . 1.28 110.979 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.57 42.93 4.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.783 0.833 . . . . 3.1400000000000001 111.316 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.4 p -148.44 155.43 41.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.666 0.786 . . . . 1.46 109.201 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.4 mt -69.98 133.81 47.67 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.723 0.809 . . . . 1.7 109.548 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 t -143.14 -63.06 0.41 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.44 -0.948 . . . . 1.03 108.44 -168.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -85.01 87.79 7.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.544 0.688 . . . . 3.6400000000000001 109.97 161.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.64 -136.33 51.21 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.582 -1.407 . . . . 0.56999999999999995 109.582 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.7 t -77.5 4.92 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 117.95 0.875 . . . . 1.49 112.445 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -86.21 125.35 33.49 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 119.754 1.161 . . . . 2.2599999999999998 108.095 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.3 t -74.17 140.12 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.785 0.834 . . . . 3.3700000000000001 108.939 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.4 t -73.67 90.38 1.81 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.714 0.769 . . . . 0.52000000000000002 109.165 169.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.96 156.98 1.91 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.948 2.213 . . . . 1.3100000000000001 113.786 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -53.78 144.38 18.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.484 -0.421 . . . . 4.1399999999999997 111.626 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.47 -2.42 72.24 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.581 -0.566 . . . . 1.01 112.572 -174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -122.75 153.5 39.39 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.489 1.516 . . . . 1.8799999999999999 107.839 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 156.15 48.34 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.07 0.85 . . . . 3.6299999999999999 112.044 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.6 t -102.1 127.17 49.12 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.437 -2.061 . . . . 0.69999999999999996 105.437 -170.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mp -94.11 114.15 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 103.678 -2.712 . . . . 3.0299999999999998 103.678 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 105.972 -1.862 . . . . 3.21 105.972 165.529 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 m120 . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 109.099 -0.704 . . . . 2.0499999999999998 109.099 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -126.35 113.55 17.06 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.751 0.82 . . . . 3.3500000000000001 110.809 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -91.77 119.68 31.81 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.811 -0.811 . . . . 0.46999999999999997 108.811 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -128.41 152.35 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-N 118.275 0.489 . . . . 2.3300000000000001 109.852 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -64.48 159.41 21.57 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.798 0.439 . . . . 2.7400000000000002 110.925 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.39 -103.98 0.26 Allowed Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.099 -1.601 . . . . 2.6899999999999999 109.099 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.55 160.31 8.96 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.671 1.588 . . . . 3.8900000000000001 107.126 168.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.64 166.8 38.14 Favored Glycine 0 N--CA 1.467 0.713 0 N-CA-C 110.531 -1.027 . . . . 1.26 110.531 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.7 m -76.44 140.8 68.93 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.948 0.899 . . . . 2.5299999999999998 110.09 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.03 131.65 13.33 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.29 1.327 . . . . 1.05 111.527 173.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.6 tttt . . . . . 0 CA--C 1.552 1.051 0 C-N-CA 124.117 0.967 . . . . 3.6000000000000001 111.681 177.611 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 108.477 -0.934 . . . . 2.3300000000000001 108.477 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.9 p -140.82 162.48 35.34 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.038 1.335 . . . . 2.8399999999999999 109.382 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.56 162.39 27.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.309 1.044 . . . . 1.99 112.296 -173.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.3 m -87.28 162.04 17.63 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.357 -0.979 . . . . 0.95999999999999996 108.357 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -123.93 13.22 9.13 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.887 -0.578 . . . . 1.95 112.443 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -176.79 163.8 2.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.516 1.526 . . . . 2.6499999999999999 109.395 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -79.28 161.28 26.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.568 0.747 . . . . 0.58999999999999997 111.306 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.85 7.77 59.6 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.282 1.896 . . . . 0.62 113.289 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.12 -178.3 5.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.518 0.727 . . . . 2.9199999999999999 109.234 -175.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -166.53 -179.5 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 119.612 1.097 . . . . 0.93999999999999995 109.199 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tp 68.69 31.84 4.42 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.229 0.612 . . . . 3.8300000000000001 109.876 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.84 161.22 41.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.964 1.306 . . . . 1.22 108.635 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -74.27 104.68 5.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.534 -1.654 . . . . 1.8500000000000001 106.534 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -89.93 -63.92 1.21 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.993 -1.114 . . . . 1.3200000000000001 107.993 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -96.74 125.93 41.55 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.229 1.411 . . . . 4.6299999999999999 108.997 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.33 -127.76 6.76 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.714 0.673 . . . . 0.90000000000000002 112.003 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.5 t -96.42 14.32 24.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.65 0.78 . . . . 1.95 111.281 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -88.41 113.87 24.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.764 0.793 . . . . 3.02 109.026 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.37 125.88 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.546 -0.752 . . . . 3.0699999999999998 109.977 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -97.3 72.34 2.41 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.783 -0.821 . . . . 0.90000000000000002 108.783 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.78 -174.21 12.51 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 122.168 0.871 . . . . 1.78 114.873 -171.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -50.19 143.83 7.92 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.477 -1.014 . . . . 4.1500000000000004 111.343 166.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.0 -8.16 71.5 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 123.797 0.713 . . . . 1.0700000000000001 111.673 -167.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -132.11 162.76 30.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.24 1.416 . . . . 1.8899999999999999 109.44 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.04 135.7 36.14 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 127.676 2.39 . . . . 3.6400000000000001 108.486 -174.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 t -94.45 142.81 27.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.581 1.152 . . . . 0.93999999999999995 109.058 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.9 mm -124.0 117.0 49.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.769 -1.937 . . . . 2.4500000000000002 105.769 172.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.321 0 C-N-CA 124.786 1.234 . . . . 3.7000000000000002 109.815 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m120 . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 119.467 -0.301 . . . . 2.0800000000000001 111.347 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -142.21 127.55 18.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.617 0.767 . . . . 4.0999999999999996 109.217 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.9 t -96.35 105.43 17.5 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.679 0.672 . . . . 0.55000000000000004 109.544 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -95.99 174.75 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.351 1.06 . . . . 1.6499999999999999 109.577 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.1 166.76 18.44 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.842 0.857 . . . . 3.21 111.272 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.69 121.74 3.58 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 109.87 -1.292 . . . . 2.3300000000000001 109.87 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -51.36 123.15 9.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.656 1.182 . . . . 3.2599999999999998 112.68 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.43 -168.11 32.72 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.575 1.083 . . . . 1.6799999999999999 112.916 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.5 m -85.15 124.19 72.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.282 1.033 . . . . 2.77 110.378 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -74.73 135.0 19.01 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-N 120.95 1.375 . . . . 1.1599999999999999 111.427 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.4 tttm . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 123.488 0.715 . . . . 3.3700000000000001 111.753 178.41 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 108.695 -0.854 . . . . 3.2400000000000002 108.695 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -120.15 166.43 13.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.9 1.28 . . . . 1.9399999999999999 110.139 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.69 163.26 26.02 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.674 1.19 . . . . 1.6799999999999999 112.257 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.4 m -86.07 143.96 27.8 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.084 -0.71 . . . . 1.24 109.084 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -115.56 15.08 16.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.257 0.623 . . . . 1.77 111.815 -172.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.12 145.8 0.64 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.63 1.572 . . . . 3.5299999999999998 109.645 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -70.52 151.49 45.02 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 120.862 0.363 . . . . 0.47999999999999998 110.643 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.45 0.17 89.91 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.551 -0.62 . . . . 0.60999999999999999 111.551 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -98.19 168.7 10.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.06 0.944 . . . . 2.52 109.845 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -148.15 -170.9 3.7 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.921 -0.487 . . . . 1.1599999999999999 110.606 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 mp 60.31 37.67 20.15 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.734 0.778 . . . . 3.3500000000000001 110.128 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.4 p -150.21 147.49 27.76 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.959 1.303 . . . . 0.93000000000000005 108.845 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 mt -63.02 113.51 3.15 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 126.896 2.078 . . . . 1.6599999999999999 108.409 -176.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.5 t -109.94 -63.72 1.34 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.854 -1.536 . . . . 0.57999999999999996 106.854 -170.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -98.11 97.83 9.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.354 1.062 . . . . 3.46 108.327 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.46 -136.2 39.3 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.924 -1.271 . . . . 0.56999999999999995 109.924 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.05 -3.84 55.49 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.541 0.736 . . . . 1.5 112.293 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -78.08 117.92 19.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.915 -0.772 . . . . 2.0600000000000001 108.915 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p -73.31 139.44 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.102 0.561 . . . . 2.6499999999999999 109.495 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.4 t -74.14 96.93 2.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.099 -0.704 . . . . 0.42999999999999999 109.099 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.25 169.1 8.09 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.155 0.883 . . . . 0.93999999999999995 113.69 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.08 147.1 40.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.499 -1.0 . . . . 4.2800000000000002 111.273 173.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.62 81.77 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.578 -0.609 . . . . 0.71999999999999997 111.578 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -142.58 161.52 37.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.068 2.147 . . . . 2.2799999999999998 109.122 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -139.75 138.89 36.29 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.402 2.281 . . . . 2.9199999999999999 109.715 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -90.41 120.31 31.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.59 1.556 . . . . 0.48999999999999999 108.582 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.5 117.32 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 107.082 -1.451 . . . . 2.6000000000000001 107.082 170.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 N--CA 1.455 -0.219 0 O-C-N 123.845 0.716 . . . . 3.27 109.292 172.373 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 108.463 -0.94 . . . . 2.4300000000000002 108.463 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -126.13 123.58 38.62 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.242 0.617 . . . . 4.2000000000000002 110.53 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -92.88 88.59 6.25 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.266 0.626 . . . . 0.65000000000000002 109.536 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 m -85.55 168.08 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 C-N-CA 123.303 0.641 . . . . 1.5700000000000001 109.362 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.21 171.16 14.99 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.48 -0.762 . . . . 3.1899999999999999 112.01 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.55 132.03 7.16 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 108.496 -1.842 . . . . 2.1299999999999999 108.496 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.76 142.7 55.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.011 1.406 . . . . 3.6800000000000002 110.901 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -139.5 164.28 25.99 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.569 -1.412 . . . . 1.03 109.569 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.0 m -75.63 142.61 74.14 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.509 1.124 . . . . 3.02 109.757 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.48 151.83 42.78 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.541 2.16 . . . . 1.3700000000000001 111.652 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.37 0 C-N-CA 122.928 0.491 . . . . 3.75 111.825 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 109.963 -0.384 . . . . 2.0600000000000001 109.963 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.4 p -144.95 165.99 26.56 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.146 1.379 . . . . 2.6299999999999999 109.275 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.02 166.57 20.66 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.785 0.72 . . . . 2.3399999999999999 112.049 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -88.14 157.68 18.76 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 108.226 -1.028 . . . . 0.96999999999999997 108.226 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.6 p -103.4 -39.0 6.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.813 0.845 . . . . 2.4199999999999999 110.88 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.6 161.0 35.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.282 1.033 . . . . 2.5899999999999999 110.179 -175.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -70.05 150.55 46.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.932 0.872 . . . . 0.57999999999999996 110.944 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.45 10.67 85.58 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.212 1.387 . . . . 0.42999999999999999 113.249 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -77.04 179.92 5.95 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.927 0.863 . . . . 2.6499999999999999 110.213 172.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -158.05 -176.71 6.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.504 1.522 . . . . 0.91000000000000003 107.999 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp 67.43 36.1 3.99 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.052 1.341 . . . . 3.6400000000000001 111.398 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.25 159.02 38.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.504 2.722 . . . . 1.1699999999999999 107.987 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 mt -70.09 116.2 10.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.331 -1.729 . . . . 1.6399999999999999 106.331 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -95.23 -64.43 1.06 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.847 -1.168 . . . . 1.3 107.847 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -109.59 120.16 41.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.288 1.435 . . . . 3.3399999999999999 108.072 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 53.58 -128.72 39.87 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.416 -1.074 . . . . 0.83999999999999997 110.416 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 t -98.25 15.7 23.69 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.202 0.601 . . . . 1.8500000000000001 111.241 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -88.28 118.13 27.68 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.226 -1.027 . . . . 2.8300000000000001 108.226 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.03 116.39 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.809 0.844 . . . . 3.2400000000000002 110.65 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.9 t -89.92 78.45 6.77 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.351 -0.981 . . . . 0.66000000000000003 108.351 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.72 -172.5 25.52 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 123.417 0.532 . . . . 1.5600000000000001 114.362 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -56.82 144.98 31.0 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 121.417 -1.049 . . . . 5.4400000000000004 111.065 168.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.97 -7.66 81.27 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.196 0.903 . . . . 1.0800000000000001 111.285 -168.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -125.82 171.2 10.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.448 1.099 . . . . 2.1499999999999999 109.227 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -142.67 139.28 31.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.639 1.175 . . . . 3.6600000000000001 107.889 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.2 t -95.59 143.88 26.51 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 123.852 0.861 . . . . 0.82999999999999996 109.477 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.6 mm -118.84 118.3 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 127.206 2.202 . . . . 2.3599999999999999 106.709 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 126.308 1.843 . . . . 3.1600000000000001 107.706 169.497 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 . . . . . 0 C--O 1.225 -0.223 0 N-CA-C 109.659 -0.497 . . . . 1.79 109.659 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -139.71 126.79 21.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.287 1.035 . . . . 4.1100000000000003 111.415 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.7 t -95.63 108.23 20.49 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.768 1.227 . . . . 0.46000000000000002 109.812 174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.8 m -94.55 166.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.889 0.876 . . . . 1.8799999999999999 108.931 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.8 t -79.65 156.78 27.45 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.378 -0.826 . . . . 2.9100000000000001 108.796 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.32 -113.05 0.62 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.633 -1.387 . . . . 2.8300000000000001 109.633 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -170.21 147.35 3.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.805 2.042 . . . . 4.5700000000000003 106.666 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.57 177.01 24.25 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 118.938 0.79 . . . . 0.95999999999999996 111.384 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.8 m -86.11 131.5 46.4 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.81 -0.614 . . . . 2.27 109.404 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.36 140.87 59.8 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.266 1.311 . . . . 0.92000000000000004 110.101 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 118.673 -0.68 . . . . 4.0199999999999996 110.459 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 109.186 -0.672 . . . . 2.3399999999999999 109.186 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.6 p -121.89 171.57 8.82 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.882 0.873 . . . . 2.21 110.943 171.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.13 163.26 5.0 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.789 0.835 . . . . 2.0099999999999998 112.367 172.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.53 163.22 18.53 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.223 1.009 . . . . 1.1100000000000001 110.823 172.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.9 p -129.44 15.28 6.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.757 0.823 . . . . 2.1000000000000001 112.642 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.29 154.28 24.97 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.351 0.978 . . . . 3.2999999999999998 110.147 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -82.45 136.92 34.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.339 0.655 . . . . 0.55000000000000004 110.742 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.69 19.35 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.721 -0.551 . . . . 0.40999999999999998 111.721 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.25 145.36 47.93 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.046 0.538 . . . . 2.3999999999999999 110.717 -168.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -117.84 -178.63 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.893 0.877 . . . . 1.1799999999999999 110.471 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp 62.08 49.29 4.59 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.14 0.971 . . . . 2.9700000000000002 110.565 174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -160.77 160.33 31.15 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.409 1.084 . . . . 1.26 108.313 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.7 mt -75.38 113.86 13.25 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.29 1.036 . . . . 1.5700000000000001 108.971 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -116.41 -64.07 1.36 Allowed 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.196 -1.038 . . . . 0.67000000000000004 108.196 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.58 91.27 6.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.248 -1.39 . . . . 3.0899999999999999 107.248 171.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.21 -132.0 52.33 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.347 -1.101 . . . . 0.51000000000000001 110.347 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.6 t -83.08 5.3 22.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.987 0.893 . . . . 1.3500000000000001 112.158 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -89.5 123.52 33.69 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.243 0.928 . . . . 3.77 108.563 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.48 137.04 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.086 0.554 . . . . 2.5899999999999999 110.19 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.7 t -75.95 92.28 3.11 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.282 -0.636 . . . . 0.63 109.282 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.24 156.73 8.33 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.752 1.168 . . . . 1.1000000000000001 112.599 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -51.86 155.28 1.8 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.743 -0.857 . . . . 4.7300000000000004 112.722 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.72 1.4 89.25 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.028 0.823 . . . . 0.76000000000000001 113.357 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.26 156.81 48.35 Favored 'General case' 0 N--CA 1.448 -0.571 1 C-N-CA 131.998 4.119 . . . . 3.6200000000000001 108.578 179.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.95 154.27 48.3 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.719 1.608 . . . . 3.5600000000000001 110.588 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.5 t -95.23 128.53 42.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.598 1.559 . . . . 0.46999999999999997 108.809 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.3 mm -101.51 114.61 41.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.772 -1.936 . . . . 2.48 105.772 170.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 124.196 0.998 . . . . 3.0800000000000001 109.104 172.33 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 118.272 -0.87 . . . . 2.52 110.386 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -135.65 124.74 24.38 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 118.725 -0.655 . . . . 4.5499999999999998 111.922 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.4 t -92.99 101.71 14.05 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.734 1.152 . . . . 0.37 109.144 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -104.39 158.59 5.38 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 C-N-CA 123.567 0.747 . . . . 1.8999999999999999 109.065 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.16 176.04 4.8 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 119.864 -0.734 . . . . 2.73 111.207 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.3 129.48 6.31 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 108.097 -2.001 . . . . 2.1299999999999999 108.097 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.37 132.62 48.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.022 -0.733 . . . . 2.9500000000000002 109.022 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.99 -159.21 10.19 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.968 -1.653 . . . . 1.03 108.968 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.89 142.5 26.34 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.36 0.664 . . . . 2.1600000000000001 110.145 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.06 138.98 31.95 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.418 2.079 . . . . 0.82999999999999996 110.696 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 tttm . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 118.794 -0.622 . . . . 3.2000000000000002 111.066 179.194 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 110.045 -0.354 . . . . 2.6400000000000001 110.045 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.0 p -142.6 169.04 18.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.935 1.294 . . . . 1.8400000000000001 109.678 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.63 171.0 12.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.193 0.451 . . . . 1.79 110.469 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.4 m -85.63 153.92 22.04 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.595 -0.891 . . . . 1.23 108.595 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 p -103.11 -34.37 8.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.317 1.047 . . . . 2.6000000000000001 111.632 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -133.54 162.65 31.34 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.501 1.12 . . . . 3.0499999999999998 109.549 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.61 138.06 35.4 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.843 0.457 . . . . 0.71999999999999997 110.856 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.67 26.26 13.6 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.929 -0.868 . . . . 0.46000000000000002 110.929 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.15 151.66 43.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.364 0.666 . . . . 2.48 110.679 -172.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -124.31 -179.74 4.58 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.706 0.802 . . . . 1.3700000000000001 111.08 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.3 mt 60.46 49.76 6.5 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.871 1.268 . . . . 3.3199999999999998 110.603 -171.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -157.98 147.44 19.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.118 0.567 . . . . 0.90000000000000002 110.066 174.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.1 mt -64.27 129.64 40.72 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 125.976 1.711 . . . . 1.6200000000000001 108.208 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.9 t -131.14 -63.76 0.84 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 106.462 -1.681 . . . . 0.93999999999999995 106.462 -168.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.56 92.44 6.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.39 -1.707 . . . . 3.2999999999999998 106.39 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.1 -133.53 39.81 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.28 -1.128 . . . . 0.73999999999999999 110.28 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 t -84.73 0.1 51.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.886 0.475 . . . . 1.3500000000000001 111.216 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -80.75 119.34 23.22 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.845 -1.169 . . . . 1.9399999999999999 107.845 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.46 137.15 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.712 -0.847 . . . . 2.6699999999999999 108.712 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.4 t -73.63 95.84 2.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.161 -1.052 . . . . 0.51000000000000001 108.161 170.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.42 168.89 33.93 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.059 0.838 . . . . 0.85999999999999999 112.975 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -57.68 153.6 13.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.02 0.928 . . . . 4.46 111.732 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.67 -5.91 76.16 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.844 0.735 . . . . 0.70999999999999996 112.224 -172.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.96 169.14 17.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.044 2.538 . . . . 1.8 106.732 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 pttt -151.3 148.77 28.57 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.665 1.186 . . . . 2.79 108.658 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.7 t -104.06 132.2 50.56 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.1 1.36 . . . . 0.70999999999999996 109.242 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.0 128.0 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.2 -1.407 . . . . 2.4500000000000002 107.2 173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.342 0.256 0 N-CA-C 108.908 -0.775 . . . . 3.1899999999999999 108.908 173.756 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.6 m120 . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 109.203 -0.666 . . . . 2.5800000000000001 109.203 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -133.63 113.18 12.1 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 119.215 -0.422 . . . . 3.2000000000000002 110.893 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.1 t -94.65 108.05 20.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.042 -0.725 . . . . 0.37 109.042 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.38 154.04 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.826 -0.805 . . . . 1.8600000000000001 108.826 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -69.72 163.63 25.27 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.972 -0.455 . . . . 2.8700000000000001 111.292 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.62 127.36 4.57 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.243 -1.943 . . . . 2.1299999999999999 108.243 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -47.86 146.98 2.16 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.243 1.022 . . . . 4.3799999999999999 110.729 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.49 175.09 27.01 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.501 -1.839 . . . . 0.97999999999999998 108.501 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.9 m -73.64 136.83 77.39 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.286 0.634 . . . . 2.5499999999999998 109.583 177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.76 139.35 33.49 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.13 1.886 . . . . 0.96999999999999997 109.507 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.2 tttt . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 119.13 -0.462 . . . . 3.9399999999999999 110.857 -178.788 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 109.002 -0.74 . . . . 2.0699999999999998 109.002 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 p -143.76 170.68 15.41 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.557 1.543 . . . . 2.4700000000000002 107.823 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.52 163.37 27.01 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.658 0.783 . . . . 2.0299999999999998 112.295 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.54 167.33 17.47 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.89 0.476 . . . . 1.3500000000000001 111.666 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -120.01 -41.03 2.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.88 1.272 . . . . 2.0099999999999998 112.776 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -110.01 161.03 15.91 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.207 0.912 . . . . 2.7400000000000002 110.873 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.33 148.36 29.42 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 121.384 0.611 . . . . 0.52000000000000002 111.303 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.46 3.71 90.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 115.838 -0.619 . . . . 0.41999999999999998 112.154 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.54 170.07 15.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.345 -1.354 . . . . 2.4100000000000001 107.345 171.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -153.2 -171.91 4.07 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.318 -0.864 . . . . 0.93999999999999995 109.892 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tp 59.79 53.61 4.76 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.682 1.593 . . . . 3.27 110.654 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.7 p -166.83 160.82 14.9 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 126.649 1.98 . . . . 1.03 107.036 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.5 141.31 51.98 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.452 0.701 . . . . 1.6499999999999999 109.557 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.3 t -142.07 -64.15 0.43 Allowed 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 118.226 -1.39 . . . . 0.68999999999999995 108.702 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -92.83 91.73 7.59 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.597 -1.26 . . . . 3.2599999999999998 107.597 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.5 -130.48 51.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.366 -1.494 . . . . 0.63 109.366 -175.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 t -87.13 12.15 12.25 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 117.176 0.488 . . . . 1.5700000000000001 111.867 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -87.04 125.06 33.86 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.084 -1.01 . . . . 1.9299999999999999 109.422 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.0 t -75.61 123.18 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.193 -1.04 . . . . 3.1400000000000001 108.193 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.6 t -76.27 85.82 3.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.856 -0.794 . . . . 0.56999999999999995 108.856 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.02 -175.41 9.17 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 115.147 0.819 . . . . 1.0800000000000001 115.147 -170.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.5 148.71 22.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.955 -0.732 . . . . 5.2699999999999996 109.748 165.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.65 4.01 90.27 Favored Glycine 0 CA--C 1.538 1.527 0 N-CA-C 111.427 -0.669 . . . . 1.1100000000000001 111.427 -170.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -137.38 174.48 10.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.405 1.103 . . . . 1.97 109.571 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.46 133.35 18.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.953 1.301 . . . . 3.6699999999999999 109.914 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -102.82 118.09 36.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.668 -0.864 . . . . 0.56999999999999995 108.668 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.76 122.35 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.146 -1.798 . . . . 2.5699999999999998 106.146 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 CA--C 1.53 0.2 0 C-N-CA 123.253 0.621 . . . . 3.6200000000000001 109.623 172.173 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 118.888 -0.577 . . . . 3.0 110.086 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -134.01 120.08 19.8 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.564 -0.731 . . . . 3.1000000000000001 110.685 -176.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 50.6 t -101.59 107.08 18.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.707 1.139 . . . . 0.45000000000000001 110.086 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 m -102.85 162.18 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 121.66 -0.65 . . . . 1.9199999999999999 109.364 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -75.04 150.98 38.74 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.157 -0.683 . . . . 2.9399999999999999 109.157 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.15 -116.5 0.8 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.585 -1.406 . . . . 2.8399999999999999 109.585 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -167.19 142.42 4.05 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.943 1.297 . . . . 4.04 108.699 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.8 170.52 30.6 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.425 1.488 . . . . 0.87 109.906 -169.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -98.24 138.21 20.86 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 117.684 0.742 . . . . 2.4900000000000002 110.08 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.64 143.16 61.18 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.873 1.715 . . . . 1.04 110.317 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.1 tttp . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 118.994 -0.527 . . . . 3.8500000000000001 110.83 178.563 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 109.889 -0.412 . . . . 1.8999999999999999 109.889 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.8 p -138.17 164.68 28.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.733 1.213 . . . . 2.0499999999999998 108.642 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -75.33 162.75 28.14 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.56 -0.734 . . . . 2.2599999999999998 110.917 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.4 m -83.33 140.71 32.28 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.65 1.114 . . . . 1.2 108.614 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -109.59 -11.53 14.77 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.051 0.76 . . . . 1.99 113.051 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.44 145.8 34.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.87 1.668 . . . . 3.8599999999999999 109.769 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -73.7 158.3 34.94 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.335 1.064 . . . . 0.59999999999999998 111.373 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.94 15.04 81.2 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.835 -1.075 . . . . 0.56000000000000005 111.405 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -123.09 156.95 33.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.02 0.928 . . . . 2.8100000000000001 109.106 -172.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -135.94 -167.68 2.08 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.941 0.896 . . . . 1.53 110.275 -173.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 64.46 38.66 7.41 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.96 0.8 . . . . 3.1099999999999999 110.235 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -158.0 154.31 27.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.71 0.804 . . . . 1.0 109.655 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -64.95 119.55 10.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.338 -1.727 . . . . 1.6100000000000001 106.338 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.7 t -118.79 -63.62 1.38 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.261 -1.385 . . . . 0.56000000000000005 107.261 -173.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -98.51 101.62 13.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.481 1.112 . . . . 4.0099999999999998 109.01 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.81 -138.64 49.27 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.725 -0.95 . . . . 0.60999999999999999 110.725 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -83.4 1.83 39.52 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 122.188 -0.596 . . . . 1.5600000000000001 111.287 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -84.19 116.7 23.07 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.059 -1.46 . . . . 2.0899999999999999 107.059 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.86 136.77 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.906 -0.776 . . . . 2.79 108.906 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.6 t -73.5 93.98 2.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.046 -1.094 . . . . 0.52000000000000002 108.046 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.97 171.96 16.48 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 122.071 0.817 . . . . 0.84999999999999998 113.425 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.19 138.27 57.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.459 1.104 . . . . 5.3600000000000003 112.463 172.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.93 10.3 62.94 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 110.988 -0.845 . . . . 0.78000000000000003 110.988 -172.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -140.11 163.5 32.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.537 1.935 . . . . 2.0299999999999998 108.487 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.91 137.61 36.63 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.28 1.832 . . . . 3.29 109.344 176.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -90.63 128.41 36.6 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.615 1.166 . . . . 0.46000000000000002 108.736 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.7 mm -110.08 111.2 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.469 -1.678 . . . . 2.6699999999999999 106.469 172.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 N--CA 1.463 0.19 0 C-N-CA 123.846 0.858 . . . . 3.4399999999999999 110.091 177.833 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 119.279 -0.391 . . . . 2.1800000000000002 110.449 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -135.91 107.07 6.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.065 0.946 . . . . 3.9199999999999999 109.363 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.6 t -82.64 93.66 7.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.604 0.638 . . . . 0.42999999999999999 109.572 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 m -89.65 164.0 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.465 0.706 . . . . 1.5800000000000001 109.722 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 t -73.74 167.09 22.1 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.981 -0.449 . . . . 3.0499999999999998 110.783 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.79 137.47 8.33 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.551 -1.42 . . . . 2.1299999999999999 109.551 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.5 146.62 54.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.787 1.294 . . . . 3.2999999999999998 109.899 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.08 -171.41 13.48 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.535 1.064 . . . . 1.27 111.157 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -72.42 131.55 84.69 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.907 1.683 . . . . 2.1800000000000002 112.322 168.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.9 146.43 20.61 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.763 2.976 . . . . 1.01 110.471 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 123.48 0.712 . . . . 3.7200000000000002 109.813 -178.879 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 109.549 -0.537 . . . . 2.3500000000000001 109.549 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.2 p -147.58 163.13 37.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.061 1.744 . . . . 1.9099999999999999 108.327 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -80.29 159.19 25.92 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.013 0.824 . . . . 2.1400000000000001 111.16 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.6 m -84.2 155.59 22.45 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.588 1.085 . . . . 0.97999999999999998 108.152 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -114.71 -15.02 11.97 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.702 1.001 . . . . 2.04 113.702 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -144.71 152.18 40.02 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.769 0.828 . . . . 2.5099999999999998 109.282 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -76.89 144.08 39.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.094 0.473 . . . . 0.70999999999999996 109.997 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 4.36 76.75 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.931 -0.927 . . . . 0.41999999999999998 112.424 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.78 173.94 7.99 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.383 1.091 . . . . 2.5699999999999998 108.867 171.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.0 p30 -151.31 -172.61 4.26 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.814 0.846 . . . . 1.1699999999999999 109.816 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 66.56 44.16 2.36 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 122.119 0.962 . . . . 3.04 110.037 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -161.2 152.29 18.61 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.722 2.009 . . . . 1.1200000000000001 108.603 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.5 mt -59.52 134.44 57.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.865 1.266 . . . . 1.6499999999999999 107.706 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -131.9 -68.4 0.64 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.543 -1.651 . . . . 0.55000000000000004 106.543 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -90.36 89.94 7.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.065 -1.087 . . . . 3.1299999999999999 108.065 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.47 -131.65 52.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.102 -1.599 . . . . 0.71999999999999997 109.102 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.0 t -79.59 6.35 10.76 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.441 -0.79 . . . . 1.6299999999999999 112.488 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -84.33 118.72 24.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.844 -1.169 . . . . 2.3300000000000001 107.844 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.4 p -72.12 129.02 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.803 -0.814 . . . . 2.4900000000000002 108.803 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.1 t -76.44 85.79 3.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.405 -0.961 . . . . 0.41999999999999998 108.405 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.25 157.95 17.61 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.448 1.499 . . . . 0.91000000000000003 113.448 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.67 137.35 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.287 1.035 . . . . 4.3499999999999996 111.57 174.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.1 -34.34 4.73 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 110.924 -0.87 . . . . 0.98999999999999999 110.924 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -84.54 166.45 17.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.937 -0.764 . . . . 2.6699999999999999 108.937 173.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -139.95 128.17 22.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.026 1.73 . . . . 3.9100000000000001 107.722 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.9 t -86.95 135.45 33.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.237 -0.653 . . . . 0.59999999999999998 109.237 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.1 mm -112.19 123.18 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 104.703 -2.332 . . . . 2.5299999999999998 104.703 167.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 108.698 -0.853 . . . . 3.1200000000000001 108.698 167.546 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.3 m120 . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 119.738 -0.172 . . . . 2.1400000000000001 111.458 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -140.79 124.44 16.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.03 0.932 . . . . 3.5699999999999998 108.953 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.8 t -103.2 98.98 8.82 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.162 0.985 . . . . 0.46999999999999997 109.24 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -102.51 179.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.357 0.663 . . . . 1.75 109.382 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.67 140.45 34.93 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.248 -0.649 . . . . 3.3799999999999999 109.248 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.57 -24.6 0.18 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.167 -1.016 . . . . 2.7999999999999998 114.323 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 68.49 144.95 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.846 1.658 . . . . 2.7999999999999998 110.71 -171.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.43 -172.03 24.14 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.96 -1.256 . . . . 1.1499999999999999 109.96 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 m -73.12 135.5 79.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.122 0.969 . . . . 2.6499999999999999 111.116 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.99 143.6 36.66 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.754 1.636 . . . . 0.79000000000000004 110.06 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 111.814 0.301 . . . . 3.3199999999999998 111.814 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 109.478 -0.564 . . . . 2.4900000000000002 109.478 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.8 p -143.84 164.58 30.14 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.089 0.956 . . . . 1.98 109.275 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.91 165.68 24.69 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.092 0.557 . . . . 2.1200000000000001 110.679 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.3 m -86.84 142.62 27.94 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.011 -1.107 . . . . 1.29 108.011 -175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 p -106.53 -16.27 14.57 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.664 0.386 . . . . 2.0600000000000001 111.167 -172.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -147.71 153.47 39.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.485 1.514 . . . . 2.4399999999999999 109.289 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -71.14 157.8 37.54 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 121.037 0.446 . . . . 0.58999999999999997 110.968 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.71 5.24 86.19 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.538 -0.625 . . . . 0.53000000000000003 111.538 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.75 164.86 12.22 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.665 0.786 . . . . 2.3700000000000001 109.755 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -147.57 -176.98 5.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.364 -0.606 . . . . 1.46 109.364 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 mt 65.51 35.18 7.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.544 1.538 . . . . 3.4900000000000002 110.259 -174.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.34 151.86 37.25 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.165 -0.68 . . . . 0.92000000000000004 109.165 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.8 mt -72.31 108.12 5.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.323 1.449 . . . . 1.6399999999999999 107.291 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.5 t -106.94 -63.36 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.034 -0.728 . . . . 0.54000000000000004 109.034 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -95.02 98.95 11.05 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.925 1.29 . . . . 3.8999999999999999 108.767 169.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.16 -134.11 52.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.67 -0.972 . . . . 0.46999999999999997 110.67 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.6 t -82.75 -3.0 55.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 117.476 0.638 . . . . 1.8400000000000001 111.073 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.08 122.43 23.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.042 -1.036 . . . . 2.8599999999999999 108.34 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.7 126.61 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.563 -0.903 . . . . 4.1299999999999999 108.563 -173.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.5 t -76.43 90.97 3.27 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.022 -0.423 . . . . 0.63 109.867 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.65 161.44 22.58 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 121.451 -0.781 . . . . 0.95999999999999996 113.166 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -50.71 154.13 1.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.802 0.841 . . . . 4.4400000000000004 111.934 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.52 -19.32 44.89 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.123 -0.791 . . . . 1.1299999999999999 111.123 -173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -119.62 166.49 13.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.22 2.208 . . . . 1.8600000000000001 109.716 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 141.06 27.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.454 1.502 . . . . 3.5099999999999998 110.313 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.6 t -88.1 122.57 31.83 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.341 2.256 . . . . 0.44 108.735 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.56 123.48 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.082 -1.451 . . . . 2.6499999999999999 107.082 172.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.548 0.898 0 CA-C-N 119.934 1.243 . . . . 3.1499999999999999 110.969 -179.005 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 CA--C 1.542 0.639 0 N-CA-C 113.974 1.102 . . . . 2.02 113.974 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.67 115.09 3.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.75 0.82 . . . . 4.6200000000000001 112.924 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -88.02 110.98 21.02 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.938 1.295 . . . . 0.68000000000000005 110.547 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.25 155.06 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.119 0.968 . . . . 2.0099999999999998 109.586 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -64.84 148.96 50.32 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.406 0.283 . . . . 2.6000000000000001 110.487 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.44 50.41 0.06 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.464 1.03 . . . . 2.9199999999999999 111.638 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 42.11 83.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.461 2.304 . . . . 5.3399999999999999 114.829 171.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.72 174.8 44.9 Favored Glycine 0 C--N 1.338 0.673 0 O-C-N 121.477 -0.765 . . . . 1.5900000000000001 112.632 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.2 m -96.85 134.88 22.49 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.683 1.193 . . . . 3.1000000000000001 109.503 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.6 152.43 78.2 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.551 1.501 . . . . 1.0 110.836 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 118.677 -0.677 . . . . 3.75 110.928 174.773 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 110.37 -0.233 . . . . 2.7599999999999998 110.37 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -148.42 170.85 17.08 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.505 1.522 . . . . 1.8100000000000001 108.125 -175.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -78.36 166.62 22.45 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 118.721 0.691 . . . . 2.0899999999999999 111.056 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -84.46 170.89 13.05 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 107.503 -1.295 . . . . 1.0700000000000001 107.503 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 p -134.45 -39.21 0.82 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.877 -0.602 . . . . 2.3700000000000001 111.093 -170.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -116.98 147.78 42.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.556 1.143 . . . . 2.79 109.992 173.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -74.9 139.38 43.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.826 0.45 . . . . 0.65000000000000002 110.255 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.69 -2.69 58.78 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.937 -0.465 . . . . 0.65000000000000002 111.937 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -94.97 174.24 7.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.369 1.068 . . . . 2.5600000000000001 109.265 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -150.18 -173.32 4.4 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.146 -0.971 . . . . 1.4399999999999999 110.591 176.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 71.38 38.5 1.03 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.618 1.567 . . . . 3.7200000000000002 111.982 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.88 153.49 31.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.223 2.609 . . . . 1.05 109.545 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 mt -64.05 127.7 32.56 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.899 1.68 . . . . 1.6599999999999999 107.917 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.5 t -120.69 -63.98 1.29 Allowed 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.831 -1.174 . . . . 0.53000000000000003 107.831 -169.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -105.46 106.06 16.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.453 -1.249 . . . . 4.9199999999999999 107.678 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.2 -136.98 50.47 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.337 -1.105 . . . . 0.62 110.337 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 -3.99 58.47 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.869 0.868 . . . . 1.6100000000000001 112.525 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -75.26 118.32 18.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.356 -0.979 . . . . 2.1000000000000001 108.356 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.0 p -72.78 139.26 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.46 -0.57 . . . . 2.6299999999999999 109.46 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.55 97.13 4.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.954 -1.128 . . . . 0.57999999999999996 107.954 170.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.71 165.86 32.41 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.096 0.855 . . . . 0.84999999999999998 112.866 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.89 153.49 20.87 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.673 -0.898 . . . . 5.1900000000000004 111.803 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.34 -0.5 83.49 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 111.555 -0.618 . . . . 0.67000000000000004 111.555 -172.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -136.29 171.23 14.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.066 2.146 . . . . 1.8500000000000001 108.081 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -142.7 144.66 32.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.315 1.446 . . . . 3.2200000000000002 109.484 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -96.88 125.74 41.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.794 1.238 . . . . 0.5 108.211 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.5 mm -97.25 120.37 46.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.794 -2.298 . . . . 2.0699999999999998 104.794 171.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 109.166 -0.679 . . . . 3.1000000000000001 109.166 169.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 119.614 -0.231 . . . . 2.5499999999999998 110.73 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -143.92 132.91 22.77 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 118.891 -0.576 . . . . 3.8399999999999999 110.777 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.6 t -97.3 94.98 7.39 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 118.972 0.805 . . . . 0.45000000000000001 108.982 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 m -88.25 166.88 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 C-N-CA 123.525 0.73 . . . . 1.8500000000000001 109.353 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 t -81.23 -173.14 4.16 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.909 1.338 . . . . 2.9399999999999999 111.8 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.89 133.74 6.57 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.562 -1.815 . . . . 1.97 108.562 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -56.2 137.59 51.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 117.622 0.711 . . . . 4.2300000000000004 111.003 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.68 172.94 26.23 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.52 -1.032 . . . . 1.1100000000000001 110.52 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.0 m -84.07 138.74 39.64 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 123.954 0.901 . . . . 3.0299999999999998 110.559 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -74.35 147.9 37.69 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.342 2.028 . . . . 0.96999999999999997 111.392 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.5 tttt . . . . . 0 CA--C 1.534 0.351 0 C-N-CA 123.192 0.597 . . . . 3.5 110.962 176.485 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 109.719 -0.474 . . . . 3.6299999999999999 109.719 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.9 p -146.98 169.21 19.68 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.218 -1.401 . . . . 1.8999999999999999 107.218 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.99 165.85 5.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.948 0.404 . . . . 1.8500000000000001 111.589 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.16 151.72 25.58 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.231 0.539 . . . . 1.0700000000000001 111.933 163.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -117.97 -30.65 5.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.32 1.848 . . . . 2.3199999999999998 111.705 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.89 155.25 23.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.47 1.108 . . . . 3.3799999999999999 110.036 173.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -79.16 147.6 32.62 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 122.869 0.468 . . . . 0.58999999999999997 110.383 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.51 27.11 21.12 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.04 -0.824 . . . . 0.48999999999999999 111.04 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.46 144.63 51.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.137 0.575 . . . . 2.4300000000000002 110.331 -171.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -114.78 -177.31 3.1 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.066 1.346 . . . . 1.3999999999999999 109.689 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.2 mt 52.2 57.69 6.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.121 0.968 . . . . 3.2400000000000002 111.197 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -163.53 156.57 18.62 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.52 1.128 . . . . 1.22 108.183 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -72.1 130.09 40.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.803 -1.184 . . . . 1.77 107.803 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.7 t -127.66 -62.93 1.05 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.14 -0.689 . . . . 0.56999999999999995 109.14 -168.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -100.34 108.29 20.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.929 1.292 . . . . 4.2199999999999998 109.323 164.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.5 -143.58 47.22 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.391 -0.818 . . . . 0.81000000000000005 111.321 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 t -83.99 5.95 23.78 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.089 0.444 . . . . 1.75 110.691 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -85.65 119.77 26.36 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.646 -1.242 . . . . 2.0499999999999998 107.646 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.93 139.64 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.408 -0.59 . . . . 2.7000000000000002 109.408 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.3 t -73.22 85.8 1.41 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.089 0.947 . . . . 0.52000000000000002 109.813 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.87 157.0 1.84 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.348 1.927 . . . . 1.0700000000000001 113.141 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -58.91 151.03 22.68 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.901 0.48 . . . . 4.04 111.187 -175.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.32 -10.99 64.51 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.608 -0.551 . . . . 0.81999999999999995 112.626 -173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -122.01 160.6 24.59 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.5 1.92 . . . . 2.1099999999999999 108.028 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.04 150.0 43.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.739 1.215 . . . . 2.9700000000000002 109.358 177.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.1 t -97.59 123.41 41.48 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 125.094 1.358 . . . . 0.54000000000000004 107.895 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.2 120.12 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.769 -1.567 . . . . 2.46 106.769 175.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.523 -0.072 0 C-N-CA 126.784 2.034 . . . . 3.2400000000000002 110.19 178.801 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 114.649 1.352 . . . . 1.8500000000000001 114.649 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.72 121.13 7.9 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 124.067 0.947 . . . . 3.1699999999999999 111.477 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.3 t -92.31 103.3 15.76 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.27 -0.641 . . . . 0.40000000000000002 109.27 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -111.73 159.87 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.905 0.882 . . . . 1.78 109.599 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.0 149.06 51.16 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.836 0.351 . . . . 2.9300000000000002 110.394 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.26 114.74 1.76 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.259 -1.936 . . . . 2.29 108.259 -174.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -55.94 121.81 10.16 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.313 -0.625 . . . . 3.2400000000000002 109.313 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.13 -172.96 16.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.055 1.312 . . . . 0.90000000000000002 110.214 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 t -96.94 147.36 32.81 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.108 -0.948 . . . . 2.6000000000000001 109.531 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.96 141.61 24.16 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.292 1.995 . . . . 0.90000000000000002 112.394 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 119.528 -0.272 . . . . 3.3500000000000001 111.294 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 109.22 -0.659 . . . . 2.2599999999999998 109.22 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.1 p -137.83 166.91 22.86 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.635 1.574 . . . . 2.1699999999999999 108.273 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.88 162.84 21.46 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.412 0.285 . . . . 1.77 111.456 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.7 m -83.71 163.96 19.91 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.255 0.55 . . . . 1.54 111.454 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -123.08 -2.78 8.61 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.42 1.088 . . . . 2.1899999999999999 112.442 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -139.59 136.17 34.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.908 0.883 . . . . 4.7000000000000002 109.89 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -60.71 141.67 56.62 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 121.63 -0.669 . . . . 0.53000000000000003 110.109 174.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.54 -11.01 72.16 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.817 -0.435 . . . . 0.73999999999999999 112.02 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -72.55 168.72 17.99 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 118.057 0.928 . . . . 2.4500000000000002 111.194 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -149.29 174.58 12.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.941 0.896 . . . . 1.01 110.249 171.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 74.73 53.36 0.08 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.732 1.213 . . . . 3.0699999999999998 108.81 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -174.49 162.86 3.55 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.111 1.765 . . . . 1.02 107.173 -169.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.6 mt -79.33 145.53 33.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.716 0.806 . . . . 1.75 109.692 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.5 t -139.21 -63.24 0.52 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.506 -0.77 . . . . 0.72999999999999998 109.756 -168.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -103.01 109.8 21.48 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.179 -1.045 . . . . 3.5600000000000001 108.179 165.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.45 -125.37 37.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.577 -1.009 . . . . 0.68999999999999995 110.577 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.5 t -98.34 9.11 43.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.54 0.736 . . . . 1.26 111.436 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -80.98 119.93 24.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.059 -1.089 . . . . 2.3799999999999999 108.059 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.7 p -79.88 120.02 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.84 -0.8 . . . . 2.73 108.84 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.7 t -78.65 77.3 5.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.982 -1.118 . . . . 0.82999999999999996 107.982 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.43 176.9 44.31 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.036 0.351 . . . . 1.51 113.407 -170.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -48.31 146.31 2.86 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.418 0.687 . . . . 5.7999999999999998 110.77 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.58 -20.75 33.01 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.009 -0.884 . . . . 0.75 111.54 -166.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -124.52 171.2 10.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.065 1.433 . . . . 3.3900000000000001 109.962 -177.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.74 137.46 29.81 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.604 1.962 . . . . 3.98 110.49 176.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.5 t -89.15 118.45 28.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.656 0.782 . . . . 0.52000000000000002 109.15 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.48 130.04 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.716 -1.587 . . . . 2.6499999999999999 106.716 170.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 C--N 1.34 0.178 0 C-N-CA 124.035 0.934 . . . . 4.2199999999999998 111.627 -179.809 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 m120 . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 114.233 1.197 . . . . 2.5699999999999998 114.233 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -136.41 110.9 8.54 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.742 1.217 . . . . 3.9100000000000001 109.728 -173.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.72 100.8 11.13 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.61 0.764 . . . . 0.54000000000000004 109.13 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -96.55 167.01 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 C-N-CA 122.968 0.507 . . . . 1.77 109.72 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.38 159.67 14.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.649 0.78 . . . . 3.46 110.374 -171.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.04 45.07 1.31 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.646 1.117 . . . . 2.6299999999999999 112.637 169.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 58.5 144.9 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 129.554 3.142 . . . . 3.1499999999999999 116.602 171.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.07 -179.85 25.3 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.799 1.19 . . . . 0.93999999999999995 111.647 -168.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 m -95.38 130.68 31.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.935 . . . . 2.6499999999999999 110.943 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.52 135.41 42.26 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 CA-C-N 120.714 1.291 . . . . 1.3 110.327 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 tttm . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 119.066 -0.492 . . . . 3.6699999999999999 111.011 176.54 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 109.311 -0.625 . . . . 2.6699999999999999 109.311 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.8 p -124.22 167.2 14.61 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.156 0.983 . . . . 1.9199999999999999 109.913 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.47 168.19 2.94 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.316 0.647 . . . . 1.6699999999999999 111.464 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.0 m -83.91 150.86 25.42 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 108.204 -1.035 . . . . 1.25 108.204 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -108.94 -20.84 12.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.656 0.783 . . . . 2.4500000000000002 111.412 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -144.57 147.85 33.68 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.232 1.413 . . . . 2.6000000000000001 109.225 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -68.77 159.7 31.83 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.764 0.826 . . . . 0.71999999999999997 110.849 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.68 14.88 80.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.829 -0.908 . . . . 0.48999999999999999 110.829 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -119.27 158.4 26.12 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 123.411 0.685 . . . . 2.48 110.125 -170.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -135.63 -176.46 4.29 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.449 0.7 . . . . 0.96999999999999997 110.402 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 tp 66.79 39.76 3.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.158 0.983 . . . . 3.5499999999999998 109.704 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.4 p -154.61 153.45 31.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.339 1.455 . . . . 0.91000000000000003 108.156 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.5 mt -76.38 108.67 9.49 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 125.396 1.478 . . . . 1.6499999999999999 108.004 -174.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -107.32 -63.17 1.32 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.449 0.699 . . . . 0.60999999999999999 109.41 -170.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -91.51 98.63 11.79 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.666 0.786 . . . . 2.8999999999999999 109.841 168.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.8 -130.69 50.01 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.247 -1.141 . . . . 0.46999999999999997 110.247 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.88 4.97 42.65 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.217 0.509 . . . . 1.6799999999999999 111.039 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -79.89 120.12 23.68 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 120.922 -1.111 . . . . 2.3500000000000001 108.058 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.9 t -83.78 124.85 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.315 -0.994 . . . . 3.7000000000000002 108.315 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.8 t -76.53 86.9 3.24 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.956 -0.757 . . . . 0.46000000000000002 108.956 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.65 172.29 19.4 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 121.659 -0.651 . . . . 1.02 113.151 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.07 152.21 4.32 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.73 -0.865 . . . . 4.6500000000000004 112.249 174.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.93 -5.73 83.1 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.969 0.795 . . . . 0.68000000000000005 111.787 -174.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -132.36 157.64 43.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.963 2.505 . . . . 1.97 108.048 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -141.51 152.33 44.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.363 1.465 . . . . 3.5 109.042 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.4 t -99.42 130.18 45.67 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.771 2.029 . . . . 0.40999999999999998 108.91 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.5 mm -102.72 107.48 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.4 -1.704 . . . . 2.5 106.4 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.4 mt . . . . . 0 C--N 1.343 0.304 0 C-N-CA 125.387 1.475 . . . . 3.21 110.375 178.69 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 114.083 1.142 . . . . 2.4100000000000001 114.083 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -128.27 133.3 48.76 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.153 0.981 . . . . 3.4300000000000002 110.328 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.5 t -100.85 105.02 16.27 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.636 -0.876 . . . . 0.46999999999999997 108.636 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -110.3 172.82 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 109.329 -0.619 . . . . 1.98 109.329 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 t -67.16 177.99 1.61 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.272 1.034 . . . . 3.1499999999999999 111.949 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.41 124.03 4.76 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.853 -2.099 . . . . 2.27 107.853 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.4 134.05 40.26 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.469 -0.567 . . . . 3.71 109.469 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.8 165.86 15.37 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 108.528 -1.829 . . . . 0.94999999999999996 108.528 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -76.01 149.94 83.01 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 108.581 -0.896 . . . . 2.8100000000000001 108.581 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -78.08 157.48 30.37 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.275 1.983 . . . . 0.78000000000000003 111.506 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 tttm . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 119.096 -0.478 . . . . 3.9100000000000001 111.069 175.485 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.291 -0.633 . . . . 2.5600000000000001 109.291 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 p -147.9 165.83 29.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.606 1.562 . . . . 1.6399999999999999 107.652 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -64.22 160.47 18.48 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.393 0.616 . . . . 1.6599999999999999 111.975 -176.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -83.2 152.66 25.12 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.501 -0.772 . . . . 1.0600000000000001 112.317 165.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.7 p -132.6 23.77 4.35 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.82 1.248 . . . . 2.3799999999999999 111.319 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.08 159.66 11.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.116 0.966 . . . . 3.1800000000000002 109.419 175.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -85.49 146.34 26.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.909 0.484 . . . . 0.60999999999999999 111.164 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.69 28.01 17.69 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.011 -0.541 . . . . 0.57999999999999996 111.854 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.92 158.12 39.7 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.674 -0.679 . . . . 3.3399999999999999 110.569 -165.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -138.33 -179.81 6.01 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.694 1.134 . . . . 1.3300000000000001 111.822 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 62.74 36.7 13.1 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.677 0.751 . . . . 3.1299999999999999 111.049 173.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.9 p -149.45 161.04 42.89 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.572 1.549 . . . . 1.1399999999999999 107.605 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.78 130.94 40.97 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.177 -1.046 . . . . 1.6499999999999999 108.177 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.9 t -127.64 -63.64 1.02 Allowed 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 106.938 -1.505 . . . . 0.54000000000000004 106.938 -174.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.59 98.26 11.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.944 -0.761 . . . . 3.46 108.944 172.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.78 -135.26 52.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.87 -1.292 . . . . 0.56999999999999995 109.87 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 t -85.52 9.99 14.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.715 0.757 . . . . 1.4399999999999999 112.225 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -90.64 124.85 35.39 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.655 -0.869 . . . . 2.4300000000000002 108.655 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.3 139.17 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.999 -0.371 . . . . 2.7599999999999998 109.999 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.7 t -75.09 91.21 2.54 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.532 -0.914 . . . . 0.62 108.532 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.68 158.26 1.43 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.158 1.837 . . . . 1.3700000000000001 113.971 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -56.99 144.72 32.93 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.77 -0.841 . . . . 4.3499999999999996 111.404 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.74 -5.08 79.57 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.105 0.86 . . . . 0.73999999999999999 111.967 -171.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -125.48 166.87 15.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.169 1.788 . . . . 2.2400000000000002 109.238 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -145.84 153.57 41.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.02 -1.104 . . . . 3.5899999999999999 108.02 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.8 t -98.55 128.89 45.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.691 1.596 . . . . 0.46999999999999997 107.041 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mt -101.05 124.65 54.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.456 -1.683 . . . . 3.1800000000000002 106.456 166.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 106.551 -1.648 . . . . 3.73 106.551 167.633 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 111.776 0.287 . . . . 2.2000000000000002 111.776 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -148.04 109.54 4.39 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.31 0.644 . . . . 4.1399999999999997 111.542 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.1 t -90.05 114.44 26.32 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 124.641 1.176 . . . . 0.40999999999999998 109.466 174.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.86 161.65 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.825 -0.806 . . . . 2.27 108.825 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -61.58 148.0 43.74 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.784 -0.572 . . . . 3.1000000000000001 110.226 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.77 -31.85 0.27 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.151 -0.805 . . . . 2.6800000000000002 113.623 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 72.06 83.51 0.13 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.293 1.437 . . . . 3.7200000000000002 111.356 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.38 -178.01 52.17 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.152 -0.477 . . . . 1.74 112.184 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.0 m -87.89 147.72 41.7 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.215 1.006 . . . . 3.7799999999999998 108.652 171.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.61 143.5 24.23 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.111 1.874 . . . . 1.49 111.54 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tttm . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 123.464 0.705 . . . . 3.75 111.129 179.067 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.106 -1.072 . . . . 2.3100000000000001 108.106 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 p -147.03 173.44 12.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.466 1.907 . . . . 2.5299999999999998 106.221 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.03 168.5 8.17 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.939 0.4 . . . . 1.95 111.034 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.3 m -82.86 156.14 23.75 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.714 0.768 . . . . 1.29 110.759 159.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -110.53 -11.05 14.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.244 -1.344 . . . . 1.6699999999999999 111.259 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -147.79 136.28 21.64 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 107.171 -1.418 . . . . 3.3599999999999999 107.171 -166.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -64.7 150.35 47.39 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.45 0.568 . . . . 0.55000000000000004 110.021 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.04 -1.27 62.9 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.046 -0.597 . . . . 0.65000000000000002 112.149 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -99.79 147.43 25.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 117.657 0.729 . . . . 2.4500000000000002 112.676 -171.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -115.19 -176.13 2.84 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.485 1.114 . . . . 1.4299999999999999 110.664 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 59.14 53.74 5.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 122.379 1.085 . . . . 3.5499999999999998 110.361 172.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.0 p -169.33 159.43 8.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.189 -1.411 . . . . 1.1599999999999999 107.189 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.64 143.81 46.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.78 -0.822 . . . . 1.8 108.78 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.8 t -138.89 -63.2 0.53 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.509 -0.922 . . . . 0.59999999999999998 108.509 -172.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -93.29 97.49 10.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.696 -0.853 . . . . 2.96 108.696 169.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.94 -132.64 52.55 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.925 -1.27 . . . . 0.68000000000000005 109.925 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.4 t -87.28 14.68 7.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.732 0.766 . . . . 1.3700000000000001 112.168 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -88.22 124.61 34.02 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.185 0.902 . . . . 2.3100000000000001 109.377 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.0 t -71.66 133.23 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.209 1.004 . . . . 3.4399999999999999 109.518 175.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.5 t -74.15 91.87 2.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.992 -0.744 . . . . 0.63 108.992 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.66 152.58 1.84 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.327 1.918 . . . . 1.54 114.188 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -49.43 139.1 12.35 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.479 0.712 . . . . 5.46 110.732 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.94 -3.3 87.28 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.411 -0.661 . . . . 0.96999999999999997 112.71 -174.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -123.05 167.79 13.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.965 1.306 . . . . 1.8300000000000001 108.318 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.04 154.99 42.47 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.357 1.063 . . . . 3.6400000000000001 110.653 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.8 t -105.83 127.79 53.33 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 106.846 -1.539 . . . . 0.59999999999999998 106.846 -172.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.5 mm -98.11 107.37 20.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 105.698 -1.964 . . . . 2.4300000000000002 105.698 173.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.231 0.129 0 C-N-CA 124.849 1.259 . . . . 3.0800000000000001 108.815 -179.259 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 111.968 0.358 . . . . 1.72 111.968 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -118.7 127.26 53.4 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 131.306 3.842 . . . . 4.1900000000000004 109.359 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -101.42 111.26 23.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.692 1.587 . . . . 0.55000000000000004 110.15 172.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.4 m -114.22 155.57 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.038 0.935 . . . . 2.0699999999999998 111.202 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.01 168.54 15.85 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.793 0.806 . . . . 3.4900000000000002 111.229 -169.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.61 45.96 1.47 Allowed Glycine 0 CA--C 1.524 0.605 0 O-C-N 120.842 -1.162 . . . . 2.9500000000000002 111.38 162.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 73.68 154.97 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.586 2.354 . . . . 3.48 111.108 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.77 158.27 31.09 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.129 -1.588 . . . . 1.3100000000000001 109.129 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -92.56 146.91 33.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 117.544 0.672 . . . . 3.23 109.436 -174.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.41 154.56 65.06 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-N 121.035 1.405 . . . . 1.6499999999999999 110.659 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 124.354 1.062 . . . . 3.5899999999999999 109.592 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 CA--C 1.544 0.714 0 N-CA-C 108.527 -0.916 . . . . 3.5099999999999998 108.527 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.1 p -101.63 165.93 10.97 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 124.106 0.963 . . . . 2.5 109.579 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.11 156.98 38.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.907 0.776 . . . . 2.23 110.955 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.7 m -84.81 150.87 24.74 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 117.855 -1.538 . . . . 1.1499999999999999 109.226 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -132.34 6.06 4.13 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.73 0.641 . . . . 2.6600000000000001 112.73 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.404 ' CD ' HE22 ' A' ' 11' ' ' GLN . 0.7 OUTLIER -150.53 136.33 18.28 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.58 1.552 . . . . 3.6800000000000002 106.812 -169.388 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -71.83 139.4 48.89 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 118.65 0.659 . . . . 1.3200000000000001 110.353 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.68 67.53 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.733 -0.547 . . . . 0.56999999999999995 111.733 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.404 HE22 ' CD ' ' A' ' 8' ' ' GLU . 30.5 tt0 -97.13 164.07 12.66 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 123.297 0.639 . . . . 2.5600000000000001 109.742 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -148.41 -175.37 4.89 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.223 0.609 . . . . 1.26 109.587 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 58.61 37.03 25.4 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.516 0.674 . . . . 3.5099999999999998 109.481 -174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -148.81 145.6 27.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.6 1.16 . . . . 1.0700000000000001 109.269 175.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 mt -57.68 108.88 0.62 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.411 2.284 . . . . 1.6899999999999999 108.637 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.1 t -99.18 -63.15 1.15 Allowed 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.443 -1.688 . . . . 0.62 106.443 -174.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -109.79 99.08 8.28 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.035 1.334 . . . . 3.8300000000000001 109.452 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.82 -145.73 38.84 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.617 -1.393 . . . . 0.80000000000000004 109.617 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.02 -0.7 45.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.512 0.725 . . . . 2.21 110.687 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -82.25 118.82 23.41 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.197 -1.408 . . . . 2.1000000000000001 107.197 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.18 146.94 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 110.289 -0.263 . . . . 2.7599999999999998 110.289 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 t -73.16 95.79 2.13 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.789 0.804 . . . . 0.51000000000000001 109.285 167.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.57 157.42 2.19 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 127.632 2.539 . . . . 1.4399999999999999 113.137 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.38 144.94 56.8 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.051 -0.676 . . . . 4.0599999999999996 110.667 -177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.5 0.41 84.45 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.323 0.487 . . . . 0.76000000000000001 112.156 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.66 161.2 30.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.063 2.145 . . . . 2.1600000000000001 108.596 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -136.63 156.64 48.27 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.881 1.672 . . . . 3.73 111.49 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.5 t -103.42 119.43 38.88 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.232 -1.766 . . . . 0.53000000000000003 106.232 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mp -88.3 109.36 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 104.883 -2.266 . . . . 2.4199999999999999 104.883 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 107.766 -1.198 . . . . 3.2999999999999998 107.766 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 110.003 -0.369 . . . . 2.1699999999999999 110.003 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.44 110.21 14.82 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.471 1.108 . . . . 3.48 110.409 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.3 t -84.53 98.11 9.94 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.277 -0.638 . . . . 0.35999999999999999 109.277 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.48 168.56 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.734 -0.839 . . . . 2.0 108.734 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 t -67.29 171.06 6.26 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.037 -1.039 . . . . 3.6200000000000001 111.51 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.05 140.79 7.57 Favored Glycine 0 C--O 1.223 -0.581 0 N-CA-C 109.106 -1.598 . . . . 2.27 109.106 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.39 112.74 14.46 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.326 -1.102 . . . . 3.73 108.976 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.94 174.76 23.59 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.264 0.935 . . . . 1.0700000000000001 111.536 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -94.5 138.08 22.45 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 109.115 -0.698 . . . . 2.7200000000000002 109.115 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.72 142.11 42.92 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 121.862 1.708 . . . . 1.25 109.586 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 tttp . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 118.985 -0.531 . . . . 4.1799999999999997 111.737 -177.945 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.335 -0.617 . . . . 1.8999999999999999 109.335 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 p -134.39 163.9 28.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.296 1.438 . . . . 1.98 108.719 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.64 161.49 29.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.351 0.596 . . . . 1.8700000000000001 111.91 -176.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 11' ' ' GLN . 1.3 m -83.82 173.73 11.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.652 0.781 . . . . 1.6499999999999999 111.765 171.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -141.35 28.0 1.87 Allowed 'General case' 0 C--N 1.345 0.404 0 CA-C-O 118.733 -0.651 . . . . 2.0699999999999998 112.733 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -165.14 160.78 19.05 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.995 -1.113 . . . . 2.7599999999999998 107.995 170.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.29 153.82 26.88 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.866 0.867 . . . . 0.65000000000000002 111.363 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' ' CG ' ' A' ' 27' ' ' LYS . . . 75.37 15.32 81.25 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.154 0.883 . . . . 0.46000000000000002 111.751 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 1.9 mt-30 -92.18 171.4 9.1 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.412 0.685 . . . . 2.4199999999999999 109.158 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -154.94 179.6 8.97 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.089 0.859 . . . . 0.89000000000000001 110.394 170.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.56 55.84 1.68 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.544 1.538 . . . . 3.25 111.103 178.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.4 p -173.83 163.91 4.21 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.415 1.886 . . . . 0.90000000000000002 106.532 -172.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.0 mt -71.93 144.18 49.03 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.918 -0.771 . . . . 1.6200000000000001 108.918 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.0 t -142.31 -64.57 0.42 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.393 -0.595 . . . . 0.64000000000000001 109.393 -172.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -94.32 98.96 11.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.156 -1.424 . . . . 2.9700000000000002 107.156 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.69 -128.6 32.98 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.094 -1.203 . . . . 0.71999999999999997 110.094 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 t -88.32 5.98 39.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 117.134 0.467 . . . . 1.5800000000000001 111.823 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -83.61 124.34 30.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.129 -0.982 . . . . 3.0699999999999998 108.484 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.08 132.68 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.533 0.733 . . . . 2.7200000000000002 109.26 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.7 t -87.55 92.19 9.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.486 -1.301 . . . . 0.48999999999999999 107.486 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.73 -172.71 9.94 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.501 1.048 . . . . 0.95999999999999996 114.797 -168.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -61.63 145.46 52.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.856 -0.791 . . . . 4.5800000000000001 109.321 168.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.51 10.3 86.02 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.159 -0.776 . . . . 1.0800000000000001 111.159 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -135.2 167.92 20.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.474 1.11 . . . . 2.21 108.126 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 13.9 ttmt -145.46 132.32 20.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.744 1.218 . . . . 3.4300000000000002 108.205 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -92.0 123.77 35.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.215 1.006 . . . . 0.64000000000000001 109.293 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.9 mm -107.71 111.56 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 106.417 -1.697 . . . . 3.0099999999999998 106.417 169.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.2 mt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.771 -0.455 . . . . 3.52 109.771 169.293 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 118.876 -0.583 . . . . 3.2999999999999998 111.371 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -142.11 124.18 15.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.269 1.428 . . . . 3.8999999999999999 110.165 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.4 t -97.81 102.22 13.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.454 1.025 . . . . 0.46999999999999997 109.881 174.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.8 m -91.47 162.7 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.195 0.598 . . . . 1.6799999999999999 109.916 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 t -79.71 152.8 29.69 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.778 -0.823 . . . . 2.8399999999999999 108.778 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.75 -114.58 0.76 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.706 -1.358 . . . . 2.71 109.706 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -162.8 156.84 20.72 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.335 1.454 . . . . 4.4900000000000002 107.816 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.8 170.37 30.6 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.703 -0.959 . . . . 0.90000000000000002 110.703 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 t -81.04 140.28 49.76 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 117.366 0.583 . . . . 3.48 109.86 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.31 154.75 56.32 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.057 1.838 . . . . 1.3700000000000001 111.673 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.539 0.545 0 C-N-CA 123.085 0.554 . . . . 4.4900000000000002 110.054 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 108.504 -0.924 . . . . 3.4700000000000002 108.504 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 79.0 p -143.31 173.22 11.79 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.679 1.192 . . . . 2.3799999999999999 108.683 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.71 162.2 8.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.503 0.668 . . . . 2.1000000000000001 112.391 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -83.64 165.91 18.59 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 115.65 -0.704 . . . . 1.3500000000000001 111.4 169.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -126.68 9.0 6.99 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.512 0.725 . . . . 1.76 112.592 -174.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -156.98 161.89 39.59 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.514 1.125 . . . . 2.8100000000000001 109.007 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -81.91 157.69 24.24 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 122.767 0.427 . . . . 0.70999999999999996 110.439 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.26 21.94 69.09 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 119.696 -1.24 . . . . 0.56000000000000005 110.328 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -110.64 165.92 11.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.523 0.729 . . . . 2.3700000000000001 109.14 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -144.23 -179.3 6.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.745 1.157 . . . . 1.0700000000000001 110.612 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mt 58.46 54.84 5.26 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.62 1.168 . . . . 3.4399999999999999 111.388 175.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.6 p -165.01 164.96 20.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.427 1.091 . . . . 1.0600000000000001 108.172 -175.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.2 mt -75.4 120.82 21.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.073 -1.084 . . . . 1.6799999999999999 108.073 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.1 t -123.07 -63.43 1.26 Allowed 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 108.109 -1.071 . . . . 0.56000000000000005 108.109 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -90.82 88.9 7.25 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.715 1.206 . . . . 3.0600000000000001 109.338 168.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.32 -135.21 42.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.393 -1.483 . . . . 0.56000000000000005 109.393 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -81.78 -6.06 58.73 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.046 0.923 . . . . 1.6599999999999999 111.604 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -76.51 123.98 26.88 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.184 -0.948 . . . . 2.29 108.662 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.8 t -83.2 136.87 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.156 -0.683 . . . . 3.5 109.156 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.5 t -77.96 94.36 4.59 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.907 -0.496 . . . . 0.65000000000000002 110.869 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.24 165.66 9.18 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.239 0.923 . . . . 1.01 114.156 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -57.34 151.53 15.97 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.876 -1.367 . . . . 4.4199999999999999 113.249 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.36 0.32 86.72 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.07 1.319 . . . . 0.75 111.305 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -130.91 161.47 31.79 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.072 2.549 . . . . 2.1099999999999999 108.642 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 145.83 33.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.641 1.176 . . . . 3.6099999999999999 108.307 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.72 126.42 40.97 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.134 2.174 . . . . 0.47999999999999998 108.688 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.3 mp -97.81 114.19 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 106.168 -1.789 . . . . 3.0499999999999998 106.168 170.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 CA--C 1.531 0.235 0 C-N-CA 124.828 1.251 . . . . 3.2400000000000002 109.038 177.495 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 113.622 0.971 . . . . 1.76 113.622 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.73 105.58 1.62 Allowed 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.518 1.127 . . . . 4.2000000000000002 111.78 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.2 t -80.99 100.31 8.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 125.071 1.348 . . . . 0.67000000000000004 109.325 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -107.72 176.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.772 0.829 . . . . 1.96 108.879 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.04 178.38 5.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.79 -0.569 . . . . 2.9199999999999999 110.286 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.83 155.4 31.77 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.826 -1.71 . . . . 2.1899999999999999 108.826 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -81.3 165.67 21.19 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 117.458 0.629 . . . . 3.48 109.918 -171.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.91 -179.13 38.01 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.355 -1.498 . . . . 1.3300000000000001 109.355 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -93.19 148.79 36.33 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 117.416 0.608 . . . . 3.0 110.165 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -73.66 173.3 14.14 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.552 1.501 . . . . 1.1000000000000001 111.137 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 123.887 0.875 . . . . 3.1400000000000001 108.95 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 . . . . . 0 CA--C 1.542 0.647 0 N-CA-C 109.193 -0.669 . . . . 2.3799999999999999 109.193 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.9 p -127.3 166.43 17.81 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.965 0.906 . . . . 2.1299999999999999 108.917 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.87 164.96 25.11 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.365 0.984 . . . . 2.29 109.684 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -82.48 157.13 23.73 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.113 -1.035 . . . . 1.0900000000000001 109.397 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.1 p -121.64 -18.24 7.23 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.02 0.748 . . . . 1.8500000000000001 113.02 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.24 155.08 43.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.998 1.719 . . . . 2.46 107.182 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -69.79 150.65 46.65 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.305 0.957 . . . . 0.66000000000000003 109.888 173.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.66 -1.13 71.35 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.741 -0.477 . . . . 0.64000000000000001 112.348 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -91.72 163.3 14.13 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.292 0.637 . . . . 2.4399999999999999 110.544 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -150.52 -178.96 6.85 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.553 -0.717 . . . . 1.3999999999999999 109.288 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mp 62.23 38.49 13.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.512 1.125 . . . . 3.2799999999999998 110.398 -167.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -149.16 152.26 35.77 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.922 0.889 . . . . 1.05 110.232 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.8 mt -66.02 135.23 54.38 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.28 1.432 . . . . 1.6100000000000001 107.67 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.9 t -140.84 -63.94 0.46 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.283 -1.377 . . . . 0.68999999999999995 107.283 -168.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.42 89.15 7.89 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.184 -1.043 . . . . 3.27 108.184 168.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.75 -128.92 48.11 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.532 -1.427 . . . . 0.52000000000000002 109.532 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 t -84.23 9.77 12.04 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.954 0.877 . . . . 1.6200000000000001 112.432 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -91.33 117.99 30.13 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.797 1.181 . . . . 2.6299999999999999 107.831 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.48 128.74 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.842 -0.617 . . . . 2.4700000000000002 109.453 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.0 t -72.83 85.23 1.23 Allowed 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.347 0.594 . . . . 0.48999999999999999 109.913 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.27 167.62 9.58 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 126.331 1.92 . . . . 0.92000000000000004 114.049 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -55.6 152.44 9.2 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.307 -1.702 . . . . 4.4000000000000004 112.019 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.02 12.0 84.58 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.338 0.97 . . . . 0.89000000000000001 112.827 -173.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -138.7 170.1 16.6 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.67 3.188 . . . . 3.7999999999999998 108.934 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.34 136.7 14.04 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.544 1.538 . . . . 3.02 109.524 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.4 t -94.48 126.52 39.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.211 -1.403 . . . . 0.45000000000000001 107.211 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.6 mm -101.43 113.53 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.925 -1.509 . . . . 3.02 106.925 170.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 N--CA 1.45 -0.436 0 C-N-CA 125.503 1.521 . . . . 3.3700000000000001 107.723 175.34 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 119.069 -0.491 . . . . 2.6400000000000001 110.431 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -135.08 123.77 23.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.425 1.89 . . . . 5.1200000000000001 111.346 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 39.0 t -95.81 101.99 13.74 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.603 1.961 . . . . 0.37 110.246 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.83 158.7 3.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 123.927 0.891 . . . . 1.8100000000000001 110.099 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.41 167.71 16.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.832 -0.543 . . . . 3.6899999999999999 110.226 176.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.97 -110.8 0.83 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.691 -1.763 . . . . 2.7599999999999998 108.691 170.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -156.7 165.31 36.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.067 -1.827 . . . . 3.0099999999999998 106.067 171.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.62 168.32 38.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.366 -1.494 . . . . 1.1399999999999999 109.366 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.9 t -82.78 132.77 50.49 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.268 -0.642 . . . . 3.23 109.268 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.77 132.22 18.29 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.273 1.315 . . . . 0.90000000000000002 110.252 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 tttm . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 118.774 -0.632 . . . . 3.1400000000000001 110.008 174.376 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 67.4 t . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 106.058 -1.831 . . . . 4.6799999999999997 106.058 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.9 t -110.69 127.66 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.668 -1.604 . . . . 3.6000000000000001 106.668 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -109.41 176.49 5.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.138 1.375 . . . . 2.5499999999999998 107.775 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.6 p -123.7 168.47 12.64 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.995 -0.743 . . . . 1.8600000000000001 108.995 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -65.85 170.46 5.37 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.215 0.606 . . . . 2.1099999999999999 109.718 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.19 143.38 28.01 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.502 -0.749 . . . . 1.0900000000000001 111.266 171.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 p -97.85 -22.78 16.17 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.179 1.177 . . . . 2.2200000000000002 114.179 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -133.32 160.84 36.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.343 0.974 . . . . 2.5699999999999998 109.197 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -75.89 154.81 35.78 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.52000000000000002 110.292 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.54 22.77 66.44 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.313 -0.715 . . . . 0.54000000000000004 111.313 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -108.15 147.67 30.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.907 0.883 . . . . 2.52 109.944 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -115.17 176.85 4.88 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.758 0.823 . . . . 1.28 110.979 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.57 42.93 4.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.783 0.833 . . . . 3.1400000000000001 111.316 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.4 p -148.44 155.43 41.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.666 0.786 . . . . 1.46 109.201 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.4 mt -69.98 133.81 47.67 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.723 0.809 . . . . 1.7 109.548 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 t -143.14 -63.06 0.41 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.44 -0.948 . . . . 1.03 108.44 -168.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -85.01 87.79 7.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.544 0.688 . . . . 3.6400000000000001 109.97 161.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.64 -136.33 51.21 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.582 -1.407 . . . . 0.56999999999999995 109.582 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.7 t -77.5 4.92 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 117.95 0.875 . . . . 1.49 112.445 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -86.21 125.35 33.49 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 119.754 1.161 . . . . 2.2599999999999998 108.095 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.3 t -74.17 140.12 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.785 0.834 . . . . 3.3700000000000001 108.939 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.4 t -73.67 90.38 1.81 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.714 0.769 . . . . 0.52000000000000002 109.165 169.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.96 156.98 1.91 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.948 2.213 . . . . 1.3100000000000001 113.786 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -53.78 144.38 18.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.484 -0.421 . . . . 4.1399999999999997 111.626 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.47 -2.42 72.24 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.581 -0.566 . . . . 1.01 112.572 -174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -122.75 153.5 39.39 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.489 1.516 . . . . 1.8799999999999999 107.839 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 156.15 48.34 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.07 0.85 . . . . 3.6299999999999999 112.044 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.6 t -102.1 127.17 49.12 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.437 -2.061 . . . . 0.69999999999999996 105.437 -170.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mp -94.11 114.15 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 103.678 -2.712 . . . . 3.0299999999999998 103.678 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -65.53 130.74 44.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.972 -1.862 . . . . 3.21 105.972 165.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -53.18 151.89 8.98 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.958 -0.912 . . . . 2.6000000000000001 111.018 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.8 m -128.72 42.63 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.942 1.46 . . . . 5.5899999999999999 114.942 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 153.09 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.217 0.451 . . . . 5.3600000000000003 112.217 -141.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.05 -8.16 8.73 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.373 -1.455 . . . . 2.8100000000000001 113.901 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -63.46 155.61 28.66 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.731 1.265 . . . . 3.4199999999999999 113.065 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -95.19 167.47 11.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 114.535 -1.211 . . . . 5.0599999999999996 109.188 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -59.47 123.62 17.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.281 1.032 . . . . 2.0499999999999998 109.099 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -126.35 113.55 17.06 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.751 0.82 . . . . 3.3500000000000001 110.809 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -91.77 119.68 31.81 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.811 -0.811 . . . . 0.46999999999999997 108.811 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -128.41 152.35 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-N 118.275 0.489 . . . . 2.3300000000000001 109.852 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -64.48 159.41 21.57 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.798 0.439 . . . . 2.7400000000000002 110.925 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.39 -103.98 0.26 Allowed Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.099 -1.601 . . . . 2.6899999999999999 109.099 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.55 160.31 8.96 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.671 1.588 . . . . 3.8900000000000001 107.126 168.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.64 166.8 38.14 Favored Glycine 0 N--CA 1.467 0.713 0 N-CA-C 110.531 -1.027 . . . . 1.26 110.531 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.7 m -76.44 140.8 68.93 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.948 0.899 . . . . 2.5299999999999998 110.09 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.03 131.65 13.33 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.29 1.327 . . . . 1.05 111.527 173.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -58.68 118.6 29.95 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.117 0.967 . . . . 3.6000000000000001 111.681 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.6 160.61 31.51 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.293 3.329 . . . . 1.4299999999999999 112.127 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -82.45 102.83 11.57 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 120.869 -1.145 . . . . 6.6200000000000001 112.159 -166.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.7 m 61.19 144.58 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.266 0.839 . . . . 4.4800000000000004 113.266 -150.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 . . . . . 0 C--N 1.343 0.322 0 N-CA-C 106.696 -1.594 . . . . 13.06 106.696 166.275 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 108.621 -0.881 . . . . 5.6200000000000001 108.621 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 82.2 t -86.16 149.94 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.354 -1.35 . . . . 3.3300000000000001 107.354 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -138.86 163.33 32.55 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.132 1.373 . . . . 2.3300000000000001 108.477 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.9 p -140.82 162.48 35.34 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.038 1.335 . . . . 2.8399999999999999 109.382 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.56 162.39 27.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.309 1.044 . . . . 1.99 112.296 -173.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.3 m -87.28 162.04 17.63 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.357 -0.979 . . . . 0.95999999999999996 108.357 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -123.93 13.22 9.13 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.887 -0.578 . . . . 1.95 112.443 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -176.79 163.8 2.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.516 1.526 . . . . 2.6499999999999999 109.395 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -79.28 161.28 26.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.568 0.747 . . . . 0.58999999999999997 111.306 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.85 7.77 59.6 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.282 1.896 . . . . 0.62 113.289 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.12 -178.3 5.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.518 0.727 . . . . 2.9199999999999999 109.234 -175.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -166.53 -179.5 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 119.612 1.097 . . . . 0.93999999999999995 109.199 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tp 68.69 31.84 4.42 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.229 0.612 . . . . 3.8300000000000001 109.876 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.84 161.22 41.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.964 1.306 . . . . 1.22 108.635 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -74.27 104.68 5.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.534 -1.654 . . . . 1.8500000000000001 106.534 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -89.93 -63.92 1.21 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.993 -1.114 . . . . 1.3200000000000001 107.993 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -96.74 125.93 41.55 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.229 1.411 . . . . 4.6299999999999999 108.997 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.33 -127.76 6.76 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.714 0.673 . . . . 0.90000000000000002 112.003 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.5 t -96.42 14.32 24.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.65 0.78 . . . . 1.95 111.281 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -88.41 113.87 24.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.764 0.793 . . . . 3.02 109.026 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.37 125.88 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.546 -0.752 . . . . 3.0699999999999998 109.977 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -97.3 72.34 2.41 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.783 -0.821 . . . . 0.90000000000000002 108.783 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.78 -174.21 12.51 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 122.168 0.871 . . . . 1.78 114.873 -171.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -50.19 143.83 7.92 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.477 -1.014 . . . . 4.1500000000000004 111.343 166.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.0 -8.16 71.5 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 123.797 0.713 . . . . 1.0700000000000001 111.673 -167.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -132.11 162.76 30.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.24 1.416 . . . . 1.8899999999999999 109.44 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.04 135.7 36.14 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 127.676 2.39 . . . . 3.6400000000000001 108.486 -174.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 t -94.45 142.81 27.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.581 1.152 . . . . 0.93999999999999995 109.058 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.9 mm -124.0 117.0 49.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.769 -1.937 . . . . 2.4500000000000002 105.769 172.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 63.46 1.72 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.786 1.234 . . . . 3.7000000000000002 109.815 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.24 -168.96 37.06 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 121.892 0.718 . . . . 3.2000000000000002 113.84 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -144.04 69.42 1.28 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 105.983 -1.858 . . . . 4.1299999999999999 105.983 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.88 30.84 5.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.505 1.522 . . . . 5.4100000000000001 111.974 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.58 -56.19 0.19 Allowed Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.298 -0.721 . . . . 2.5600000000000001 111.298 -170.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.41 155.89 27.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.777 0.788 . . . . 3.4199999999999999 111.385 167.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -85.1 175.54 8.94 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.174 1.79 . . . . 5.5099999999999998 108.354 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -46.18 143.69 2.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.034 0.934 . . . . 2.0800000000000001 111.347 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -142.21 127.55 18.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.617 0.767 . . . . 4.0999999999999996 109.217 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.9 t -96.35 105.43 17.5 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.679 0.672 . . . . 0.55000000000000004 109.544 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -95.99 174.75 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.351 1.06 . . . . 1.6499999999999999 109.577 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.1 166.76 18.44 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.842 0.857 . . . . 3.21 111.272 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.69 121.74 3.58 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 109.87 -1.292 . . . . 2.3300000000000001 109.87 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -51.36 123.15 9.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.656 1.182 . . . . 3.2599999999999998 112.68 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.43 -168.11 32.72 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.575 1.083 . . . . 1.6799999999999999 112.916 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.5 m -85.15 124.19 72.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.282 1.033 . . . . 2.77 110.378 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -74.73 135.0 19.01 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-N 120.95 1.375 . . . . 1.1599999999999999 111.427 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -46.99 111.65 1.66 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.488 0.715 . . . . 3.3700000000000001 111.753 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.01 115.53 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.884 1.723 . . . . 2.0600000000000001 109.959 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -79.41 121.02 24.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.119 -0.697 . . . . 6.04 109.119 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.5 m -86.38 177.15 7.54 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.104 0.962 . . . . 5.6900000000000004 110.206 169.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 117.461 -1.257 . . . . 10.789999999999999 110.86 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 106.591 -1.633 . . . . 4.46 106.591 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.1 122.65 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.79 -1.559 . . . . 4.9299999999999997 106.79 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -96.79 -173.94 2.86 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.31 1.444 . . . . 3.2400000000000002 108.695 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -120.15 166.43 13.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.9 1.28 . . . . 1.9399999999999999 110.139 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.69 163.26 26.02 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.674 1.19 . . . . 1.6799999999999999 112.257 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.4 m -86.07 143.96 27.8 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.084 -0.71 . . . . 1.24 109.084 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -115.56 15.08 16.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.257 0.623 . . . . 1.77 111.815 -172.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.12 145.8 0.64 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.63 1.572 . . . . 3.5299999999999998 109.645 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -70.52 151.49 45.02 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 120.862 0.363 . . . . 0.47999999999999998 110.643 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.45 0.17 89.91 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.551 -0.62 . . . . 0.60999999999999999 111.551 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -98.19 168.7 10.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.06 0.944 . . . . 2.52 109.845 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -148.15 -170.9 3.7 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.921 -0.487 . . . . 1.1599999999999999 110.606 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 mp 60.31 37.67 20.15 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.734 0.778 . . . . 3.3500000000000001 110.128 -176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.4 p -150.21 147.49 27.76 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.959 1.303 . . . . 0.93000000000000005 108.845 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 mt -63.02 113.51 3.15 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 126.896 2.078 . . . . 1.6599999999999999 108.409 -176.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.5 t -109.94 -63.72 1.34 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.854 -1.536 . . . . 0.57999999999999996 106.854 -170.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -98.11 97.83 9.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.354 1.062 . . . . 3.46 108.327 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.46 -136.2 39.3 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.924 -1.271 . . . . 0.56999999999999995 109.924 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.05 -3.84 55.49 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.541 0.736 . . . . 1.5 112.293 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -78.08 117.92 19.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.915 -0.772 . . . . 2.0600000000000001 108.915 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p -73.31 139.44 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.102 0.561 . . . . 2.6499999999999999 109.495 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.4 t -74.14 96.93 2.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.099 -0.704 . . . . 0.42999999999999999 109.099 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.25 169.1 8.09 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.155 0.883 . . . . 0.93999999999999995 113.69 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.08 147.1 40.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.499 -1.0 . . . . 4.2800000000000002 111.273 173.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.62 81.77 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.578 -0.609 . . . . 0.71999999999999997 111.578 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -142.58 161.52 37.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.068 2.147 . . . . 2.2799999999999998 109.122 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -139.75 138.89 36.29 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.402 2.281 . . . . 2.9199999999999999 109.715 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -90.41 120.31 31.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.59 1.556 . . . . 0.48999999999999999 108.582 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 mp -94.5 117.32 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 107.082 -1.451 . . . . 2.6000000000000001 107.082 170.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.47 137.54 58.14 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 123.845 0.716 . . . . 3.27 109.292 172.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -53.09 134.62 40.69 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.5 -0.773 . . . . 2.8799999999999999 112.741 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 p -101.35 69.96 1.29 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.75 1.62 . . . . 4.6699999999999999 108.448 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 45.0 33.61 1.07 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.085 1.354 . . . . 5.46 113.048 176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.41 -72.48 0.05 OUTLIER Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.02 -1.632 . . . . 3.5099999999999998 109.02 -173.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -62.35 154.32 28.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.534 0.683 . . . . 3.3999999999999999 111.224 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -95.81 174.51 6.92 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.148 2.579 . . . . 6.7599999999999998 108.434 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -52.9 121.01 6.48 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.463 -0.94 . . . . 2.4300000000000002 108.463 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -126.13 123.58 38.62 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.242 0.617 . . . . 4.2000000000000002 110.53 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -92.88 88.59 6.25 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.266 0.626 . . . . 0.65000000000000002 109.536 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 m -85.55 168.08 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 C-N-CA 123.303 0.641 . . . . 1.5700000000000001 109.362 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.21 171.16 14.99 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.48 -0.762 . . . . 3.1899999999999999 112.01 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.55 132.03 7.16 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 108.496 -1.842 . . . . 2.1299999999999999 108.496 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.76 142.7 55.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.011 1.406 . . . . 3.6800000000000002 110.901 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -139.5 164.28 25.99 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.569 -1.412 . . . . 1.03 109.569 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.0 m -75.63 142.61 74.14 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.509 1.124 . . . . 3.02 109.757 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.48 151.83 42.78 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.541 2.16 . . . . 1.3700000000000001 111.652 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.9 110.11 2.08 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 122.928 0.491 . . . . 3.75 111.825 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -72.27 128.43 13.77 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 N-CA-C 107.282 -1.853 . . . . 1.76 107.282 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -48.87 158.04 0.35 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.17 0.988 . . . . 6.0099999999999998 111.215 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 m -150.28 67.11 0.96 Allowed 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.638 -0.663 . . . . 5.0199999999999996 109.743 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.248 0 C-N-CA 124.911 1.284 . . . . 10.17 110.587 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.7 t . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 106.726 -1.583 . . . . 5.0700000000000003 106.726 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 73.9 t -92.12 155.99 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.432 1.093 . . . . 3.0600000000000001 108.5 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -133.26 170.54 15.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.356 1.463 . . . . 2.0600000000000001 109.963 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.4 p -144.95 165.99 26.56 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.146 1.379 . . . . 2.6299999999999999 109.275 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.02 166.57 20.66 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.785 0.72 . . . . 2.3399999999999999 112.049 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -88.14 157.68 18.76 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 108.226 -1.028 . . . . 0.96999999999999997 108.226 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.6 p -103.4 -39.0 6.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.813 0.845 . . . . 2.4199999999999999 110.88 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.6 161.0 35.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.282 1.033 . . . . 2.5899999999999999 110.179 -175.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -70.05 150.55 46.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.932 0.872 . . . . 0.57999999999999996 110.944 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.45 10.67 85.58 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.212 1.387 . . . . 0.42999999999999999 113.249 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -77.04 179.92 5.95 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.927 0.863 . . . . 2.6499999999999999 110.213 172.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -158.05 -176.71 6.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.504 1.522 . . . . 0.91000000000000003 107.999 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp 67.43 36.1 3.99 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.052 1.341 . . . . 3.6400000000000001 111.398 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.25 159.02 38.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.504 2.722 . . . . 1.1699999999999999 107.987 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 mt -70.09 116.2 10.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.331 -1.729 . . . . 1.6399999999999999 106.331 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -95.23 -64.43 1.06 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.847 -1.168 . . . . 1.3 107.847 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -109.59 120.16 41.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.288 1.435 . . . . 3.3399999999999999 108.072 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 53.58 -128.72 39.87 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.416 -1.074 . . . . 0.83999999999999997 110.416 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 t -98.25 15.7 23.69 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.202 0.601 . . . . 1.8500000000000001 111.241 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -88.28 118.13 27.68 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.226 -1.027 . . . . 2.8300000000000001 108.226 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.03 116.39 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.809 0.844 . . . . 3.2400000000000002 110.65 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.9 t -89.92 78.45 6.77 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.351 -0.981 . . . . 0.66000000000000003 108.351 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.72 -172.5 25.52 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 123.417 0.532 . . . . 1.5600000000000001 114.362 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -56.82 144.98 31.0 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 121.417 -1.049 . . . . 5.4400000000000004 111.065 168.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.97 -7.66 81.27 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.196 0.903 . . . . 1.0800000000000001 111.285 -168.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -125.82 171.2 10.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.448 1.099 . . . . 2.1499999999999999 109.227 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -142.67 139.28 31.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.639 1.175 . . . . 3.6600000000000001 107.889 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.2 t -95.59 143.88 26.51 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 123.852 0.861 . . . . 0.82999999999999996 109.477 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.6 mm -118.84 118.3 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 127.206 2.202 . . . . 2.3599999999999999 106.709 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.24 129.36 34.88 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.308 1.843 . . . . 3.1600000000000001 107.706 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.03 170.06 47.93 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.68 -0.968 . . . . 3.4199999999999999 110.68 170.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.5 m -144.34 43.22 1.41 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.41 1.105 . . . . 6.8200000000000003 112.609 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 170.27 37.04 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.34 0.591 . . . . 5.4699999999999998 112.566 -150.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.81 1.23 37.76 Favored Glycine 0 CA--C 1.539 1.544 0 O-C-N 120.828 -1.17 . . . . 5.1200000000000001 114.106 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.5 169.11 18.86 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.612 2.365 . . . . 5.0700000000000003 111.842 173.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -95.12 168.33 10.83 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.385 1.474 . . . . 5.7599999999999998 110.09 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -81.28 153.1 27.27 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.101 0.961 . . . . 1.79 109.659 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -139.71 126.79 21.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.287 1.035 . . . . 4.1100000000000003 111.415 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.7 t -95.63 108.23 20.49 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.768 1.227 . . . . 0.46000000000000002 109.812 174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.8 m -94.55 166.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.889 0.876 . . . . 1.8799999999999999 108.931 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.8 t -79.65 156.78 27.45 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.378 -0.826 . . . . 2.9100000000000001 108.796 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.32 -113.05 0.62 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.633 -1.387 . . . . 2.8300000000000001 109.633 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -170.21 147.35 3.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.805 2.042 . . . . 4.5700000000000003 106.666 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.57 177.01 24.25 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 118.938 0.79 . . . . 0.95999999999999996 111.384 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.8 m -86.11 131.5 46.4 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.81 -0.614 . . . . 2.27 109.404 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.36 140.87 59.8 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.266 1.311 . . . . 0.92000000000000004 110.101 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.66 117.99 12.14 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 118.673 -0.68 . . . . 4.0199999999999996 110.459 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.6 149.29 84.14 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.525 -1.375 . . . . 1.49 108.525 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -64.79 152.9 41.53 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.529 1.132 . . . . 7.3499999999999996 110.896 166.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.3 m 65.45 168.8 0.2 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.679 1.192 . . . . 4.7000000000000002 111.467 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 117.267 -1.349 . . . . 9.9900000000000002 111.821 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 75.7 t . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.55 -1.278 . . . . 4.29 107.55 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.3 t -92.15 111.65 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.323 -1.362 . . . . 5.46 107.323 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -79.63 -173.12 3.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.333 2.653 . . . . 2.3399999999999999 109.186 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.6 p -121.89 171.57 8.82 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.882 0.873 . . . . 2.21 110.943 171.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.13 163.26 5.0 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.789 0.835 . . . . 2.0099999999999998 112.367 172.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.53 163.22 18.53 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.223 1.009 . . . . 1.1100000000000001 110.823 172.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.9 p -129.44 15.28 6.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.757 0.823 . . . . 2.1000000000000001 112.642 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.29 154.28 24.97 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.351 0.978 . . . . 3.2999999999999998 110.147 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -82.45 136.92 34.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.339 0.655 . . . . 0.55000000000000004 110.742 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.69 19.35 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.721 -0.551 . . . . 0.40999999999999998 111.721 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.25 145.36 47.93 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.046 0.538 . . . . 2.3999999999999999 110.717 -168.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -117.84 -178.63 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.893 0.877 . . . . 1.1799999999999999 110.471 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp 62.08 49.29 4.59 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.14 0.971 . . . . 2.9700000000000002 110.565 174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -160.77 160.33 31.15 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.409 1.084 . . . . 1.26 108.313 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.7 mt -75.38 113.86 13.25 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.29 1.036 . . . . 1.5700000000000001 108.971 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -116.41 -64.07 1.36 Allowed 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.196 -1.038 . . . . 0.67000000000000004 108.196 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.58 91.27 6.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.248 -1.39 . . . . 3.0899999999999999 107.248 171.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.21 -132.0 52.33 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.347 -1.101 . . . . 0.51000000000000001 110.347 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.6 t -83.08 5.3 22.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.987 0.893 . . . . 1.3500000000000001 112.158 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -89.5 123.52 33.69 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.243 0.928 . . . . 3.77 108.563 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.48 137.04 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.086 0.554 . . . . 2.5899999999999999 110.19 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.7 t -75.95 92.28 3.11 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.282 -0.636 . . . . 0.63 109.282 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.24 156.73 8.33 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.752 1.168 . . . . 1.1000000000000001 112.599 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -51.86 155.28 1.8 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.743 -0.857 . . . . 4.7300000000000004 112.722 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.72 1.4 89.25 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.028 0.823 . . . . 0.76000000000000001 113.357 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.26 156.81 48.35 Favored 'General case' 0 N--CA 1.448 -0.571 1 C-N-CA 131.998 4.119 . . . . 3.6200000000000001 108.578 179.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.95 154.27 48.3 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.719 1.608 . . . . 3.5600000000000001 110.588 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.5 t -95.23 128.53 42.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.598 1.559 . . . . 0.46999999999999997 108.809 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.3 mm -101.51 114.61 41.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.772 -1.936 . . . . 2.48 105.772 170.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp -63.4 142.39 58.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.196 0.998 . . . . 3.0800000000000001 109.104 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.66 134.43 30.26 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.307 -0.86 . . . . 2.7200000000000002 112.762 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -99.83 68.52 1.52 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.722 -1.214 . . . . 4.3300000000000001 107.722 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 43.55 35.31 0.95 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.545 1.538 . . . . 5.5199999999999996 113.195 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.09 -72.6 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.419 -1.872 . . . . 2.9199999999999999 108.419 -172.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -66.83 159.99 26.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.329 0.652 . . . . 3.9500000000000002 110.003 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.5 176.37 6.06 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.011 1.324 . . . . 5.5099999999999998 108.453 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -54.17 129.86 36.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.272 -0.87 . . . . 2.52 110.386 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -135.65 124.74 24.38 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 118.725 -0.655 . . . . 4.5499999999999998 111.922 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.4 t -92.99 101.71 14.05 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.734 1.152 . . . . 0.37 109.144 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -104.39 158.59 5.38 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 C-N-CA 123.567 0.747 . . . . 1.8999999999999999 109.065 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.16 176.04 4.8 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 119.864 -0.734 . . . . 2.73 111.207 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.3 129.48 6.31 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 108.097 -2.001 . . . . 2.1299999999999999 108.097 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.37 132.62 48.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.022 -0.733 . . . . 2.9500000000000002 109.022 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.99 -159.21 10.19 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.968 -1.653 . . . . 1.03 108.968 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.89 142.5 26.34 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.36 0.664 . . . . 2.1600000000000001 110.145 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.06 138.98 31.95 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.418 2.079 . . . . 0.82999999999999996 110.696 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -55.32 121.23 36.11 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.794 -0.622 . . . . 3.2000000000000002 111.066 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.4 124.72 13.78 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 N-CA-C 107.798 -1.654 . . . . 1.8600000000000001 107.798 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -70.33 154.78 41.52 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.227 1.011 . . . . 7.0099999999999998 108.29 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m 67.23 91.16 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.899 0.88 . . . . 4.6600000000000001 110.13 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 104.9 -2.259 . . . . 12.35 104.9 178.294 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.967 0.413 . . . . 4.4299999999999997 110.278 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.8 t -74.86 129.72 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.111 -1.07 . . . . 3.5 108.111 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -107.7 172.16 6.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.703 1.201 . . . . 2.6400000000000001 110.045 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.0 p -142.6 169.04 18.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.935 1.294 . . . . 1.8400000000000001 109.678 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.63 171.0 12.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.193 0.451 . . . . 1.79 110.469 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.4 m -85.63 153.92 22.04 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.595 -0.891 . . . . 1.23 108.595 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 p -103.11 -34.37 8.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.317 1.047 . . . . 2.6000000000000001 111.632 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -133.54 162.65 31.34 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.501 1.12 . . . . 3.0499999999999998 109.549 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.61 138.06 35.4 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.843 0.457 . . . . 0.71999999999999997 110.856 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.67 26.26 13.6 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.929 -0.868 . . . . 0.46000000000000002 110.929 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.15 151.66 43.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.364 0.666 . . . . 2.48 110.679 -172.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -124.31 -179.74 4.58 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.706 0.802 . . . . 1.3700000000000001 111.08 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.3 mt 60.46 49.76 6.5 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.871 1.268 . . . . 3.3199999999999998 110.603 -171.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -157.98 147.44 19.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.118 0.567 . . . . 0.90000000000000002 110.066 174.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.1 mt -64.27 129.64 40.72 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 125.976 1.711 . . . . 1.6200000000000001 108.208 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.9 t -131.14 -63.76 0.84 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 106.462 -1.681 . . . . 0.93999999999999995 106.462 -168.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.56 92.44 6.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.39 -1.707 . . . . 3.2999999999999998 106.39 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.1 -133.53 39.81 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.28 -1.128 . . . . 0.73999999999999999 110.28 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 t -84.73 0.1 51.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.886 0.475 . . . . 1.3500000000000001 111.216 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -80.75 119.34 23.22 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.845 -1.169 . . . . 1.9399999999999999 107.845 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.46 137.15 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.712 -0.847 . . . . 2.6699999999999999 108.712 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.4 t -73.63 95.84 2.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.161 -1.052 . . . . 0.51000000000000001 108.161 170.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.42 168.89 33.93 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.059 0.838 . . . . 0.85999999999999999 112.975 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -57.68 153.6 13.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.02 0.928 . . . . 4.46 111.732 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.67 -5.91 76.16 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.844 0.735 . . . . 0.70999999999999996 112.224 -172.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.96 169.14 17.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.044 2.538 . . . . 1.8 106.732 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 pttt -151.3 148.77 28.57 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.665 1.186 . . . . 2.79 108.658 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.7 t -104.06 132.2 50.56 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.1 1.36 . . . . 0.70999999999999996 109.242 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mp -102.0 128.0 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.2 -1.407 . . . . 2.4500000000000002 107.2 173.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.69 143.5 57.51 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.908 -0.775 . . . . 3.1899999999999999 108.908 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.22 133.13 37.97 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 116.014 -0.539 . . . . 3.0 112.465 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 t -83.72 65.4 8.51 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.121 0.968 . . . . 4.6399999999999997 108.444 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 43.86 41.59 3.93 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.561 1.545 . . . . 6.2800000000000002 112.155 175.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.62 -66.26 0.06 OUTLIER Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.528 -1.429 . . . . 2.5299999999999998 109.528 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 mp0 -63.46 159.78 17.71 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.649 0.737 . . . . 3.54 110.975 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -95.22 175.01 6.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.398 1.079 . . . . 4.4400000000000004 108.758 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -50.85 133.6 26.35 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.447 1.099 . . . . 2.5800000000000001 109.203 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -133.63 113.18 12.1 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 119.215 -0.422 . . . . 3.2000000000000002 110.893 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.1 t -94.65 108.05 20.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.042 -0.725 . . . . 0.37 109.042 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.38 154.04 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.826 -0.805 . . . . 1.8600000000000001 108.826 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -69.72 163.63 25.27 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.972 -0.455 . . . . 2.8700000000000001 111.292 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.62 127.36 4.57 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.243 -1.943 . . . . 2.1299999999999999 108.243 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -47.86 146.98 2.16 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.243 1.022 . . . . 4.3799999999999999 110.729 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.49 175.09 27.01 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.501 -1.839 . . . . 0.97999999999999998 108.501 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.9 m -73.64 136.83 77.39 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.286 0.634 . . . . 2.5499999999999998 109.583 177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.76 139.35 33.49 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.13 1.886 . . . . 0.96999999999999997 109.507 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -56.66 115.14 9.31 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 119.13 -0.462 . . . . 3.9399999999999999 110.857 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.44 166.66 27.06 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.355 2.037 . . . . 1.6399999999999999 109.507 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -82.09 157.8 23.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.915 0.886 . . . . 6.6299999999999999 110.265 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 p -101.33 -60.72 1.48 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.168 0.987 . . . . 4.4900000000000002 109.726 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.8 p80 . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 105.905 -1.887 . . . . 9.4199999999999999 105.905 173.192 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 106.52 -1.659 . . . . 5.5300000000000002 106.52 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 75.2 t -114.29 154.51 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 107.193 -1.41 . . . . 3.2999999999999998 107.193 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -129.83 161.06 31.62 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.02 1.328 . . . . 2.0699999999999998 109.002 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 p -143.76 170.68 15.41 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.557 1.543 . . . . 2.4700000000000002 107.823 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.52 163.37 27.01 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.658 0.783 . . . . 2.0299999999999998 112.295 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.54 167.33 17.47 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.89 0.476 . . . . 1.3500000000000001 111.666 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -120.01 -41.03 2.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.88 1.272 . . . . 2.0099999999999998 112.776 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -110.01 161.03 15.91 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.207 0.912 . . . . 2.7400000000000002 110.873 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.33 148.36 29.42 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 121.384 0.611 . . . . 0.52000000000000002 111.303 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.46 3.71 90.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 115.838 -0.619 . . . . 0.41999999999999998 112.154 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.54 170.07 15.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.345 -1.354 . . . . 2.4100000000000001 107.345 171.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -153.2 -171.91 4.07 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.318 -0.864 . . . . 0.93999999999999995 109.892 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tp 59.79 53.61 4.76 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.682 1.593 . . . . 3.27 110.654 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.7 p -166.83 160.82 14.9 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 126.649 1.98 . . . . 1.03 107.036 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.5 141.31 51.98 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.452 0.701 . . . . 1.6499999999999999 109.557 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.3 t -142.07 -64.15 0.43 Allowed 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 118.226 -1.39 . . . . 0.68999999999999995 108.702 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -92.83 91.73 7.59 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.597 -1.26 . . . . 3.2599999999999998 107.597 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.5 -130.48 51.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.366 -1.494 . . . . 0.63 109.366 -175.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 t -87.13 12.15 12.25 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 117.176 0.488 . . . . 1.5700000000000001 111.867 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -87.04 125.06 33.86 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.084 -1.01 . . . . 1.9299999999999999 109.422 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.0 t -75.61 123.18 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.193 -1.04 . . . . 3.1400000000000001 108.193 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.6 t -76.27 85.82 3.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.856 -0.794 . . . . 0.56999999999999995 108.856 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.02 -175.41 9.17 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 115.147 0.819 . . . . 1.0800000000000001 115.147 -170.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.5 148.71 22.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.955 -0.732 . . . . 5.2699999999999996 109.748 165.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.65 4.01 90.27 Favored Glycine 0 CA--C 1.538 1.527 0 N-CA-C 111.427 -0.669 . . . . 1.1100000000000001 111.427 -170.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -137.38 174.48 10.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.405 1.103 . . . . 1.97 109.571 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.46 133.35 18.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.953 1.301 . . . . 3.6699999999999999 109.914 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -102.82 118.09 36.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.668 -0.864 . . . . 0.56999999999999995 108.668 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 mp -101.76 122.35 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.146 -1.798 . . . . 2.5699999999999998 106.146 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.32 146.59 53.95 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.253 0.621 . . . . 3.6200000000000001 109.623 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.35 169.47 23.7 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.563 0.601 . . . . 2.6699999999999999 111.873 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -142.55 93.28 2.5 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.137 -0.69 . . . . 4.54 109.137 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.7 t0 95.75 73.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 128.989 2.916 . . . . 7.3300000000000001 109.897 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.6 58.67 9.61 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.47 -0.786 . . . . 5.2000000000000002 112.186 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -133.55 171.04 14.64 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.484 1.114 . . . . 5.1600000000000001 110.803 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -95.95 171.91 8.33 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.067 1.347 . . . . 5.6699999999999999 110.054 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -79.85 151.67 30.1 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.155 0.982 . . . . 3.0 110.086 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -134.01 120.08 19.8 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.564 -0.731 . . . . 3.1000000000000001 110.685 -176.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 50.6 t -101.59 107.08 18.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.707 1.139 . . . . 0.45000000000000001 110.086 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 m -102.85 162.18 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 121.66 -0.65 . . . . 1.9199999999999999 109.364 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -75.04 150.98 38.74 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.157 -0.683 . . . . 2.9399999999999999 109.157 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.15 -116.5 0.8 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.585 -1.406 . . . . 2.8399999999999999 109.585 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -167.19 142.42 4.05 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.943 1.297 . . . . 4.04 108.699 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.8 170.52 30.6 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.425 1.488 . . . . 0.87 109.906 -169.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -98.24 138.21 20.86 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 117.684 0.742 . . . . 2.4900000000000002 110.08 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.64 143.16 61.18 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.873 1.715 . . . . 1.04 110.317 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -56.08 118.17 19.64 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 118.994 -0.527 . . . . 3.8500000000000001 110.83 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -74.75 154.03 43.5 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 121.566 1.511 . . . . 1.98 109.176 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -56.63 159.88 3.6 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.916 0.886 . . . . 7.3600000000000003 111.643 171.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -81.68 -50.67 9.03 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.821 1.248 . . . . 5.5599999999999996 111.337 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 124.511 1.125 . . . . 9.6500000000000004 109.422 179.006 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 107.97 -1.122 . . . . 5.4699999999999998 107.97 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.6 t -82.37 137.75 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.049 -1.093 . . . . 4.21 108.049 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -106.94 158.28 17.14 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.659 1.183 . . . . 1.8999999999999999 109.889 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.8 p -138.17 164.68 28.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.733 1.213 . . . . 2.0499999999999998 108.642 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -75.33 162.75 28.14 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.56 -0.734 . . . . 2.2599999999999998 110.917 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.4 m -83.33 140.71 32.28 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.65 1.114 . . . . 1.2 108.614 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -109.59 -11.53 14.77 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.051 0.76 . . . . 1.99 113.051 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.44 145.8 34.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.87 1.668 . . . . 3.8599999999999999 109.769 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -73.7 158.3 34.94 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.335 1.064 . . . . 0.59999999999999998 111.373 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.94 15.04 81.2 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.835 -1.075 . . . . 0.56000000000000005 111.405 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -123.09 156.95 33.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.02 0.928 . . . . 2.8100000000000001 109.106 -172.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -135.94 -167.68 2.08 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.941 0.896 . . . . 1.53 110.275 -173.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 64.46 38.66 7.41 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.96 0.8 . . . . 3.1099999999999999 110.235 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -158.0 154.31 27.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.71 0.804 . . . . 1.0 109.655 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -64.95 119.55 10.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.338 -1.727 . . . . 1.6100000000000001 106.338 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.7 t -118.79 -63.62 1.38 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.261 -1.385 . . . . 0.56000000000000005 107.261 -173.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -98.51 101.62 13.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.481 1.112 . . . . 4.0099999999999998 109.01 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.81 -138.64 49.27 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.725 -0.95 . . . . 0.60999999999999999 110.725 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -83.4 1.83 39.52 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 122.188 -0.596 . . . . 1.5600000000000001 111.287 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -84.19 116.7 23.07 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.059 -1.46 . . . . 2.0899999999999999 107.059 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.2 p -69.86 136.77 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.906 -0.776 . . . . 2.79 108.906 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.6 t -73.5 93.98 2.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.046 -1.094 . . . . 0.52000000000000002 108.046 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.97 171.96 16.48 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 122.071 0.817 . . . . 0.84999999999999998 113.425 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.19 138.27 57.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.459 1.104 . . . . 5.3600000000000003 112.463 172.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.93 10.3 62.94 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 110.988 -0.845 . . . . 0.78000000000000003 110.988 -172.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -140.11 163.5 32.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.537 1.935 . . . . 2.0299999999999998 108.487 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.91 137.61 36.63 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.28 1.832 . . . . 3.29 109.344 176.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -90.63 128.41 36.6 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.615 1.166 . . . . 0.46000000000000002 108.736 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.7 mm -110.08 111.2 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.469 -1.678 . . . . 2.6699999999999999 106.469 172.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.21 63.84 1.94 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.846 0.858 . . . . 3.4399999999999999 110.091 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 43.85 -135.11 5.64 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.21 -0.905 . . . . 2.98 113.79 -172.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.5 m -157.45 72.31 0.67 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.15 1.38 . . . . 3.8500000000000001 107.453 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 53.44 41.69 32.08 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.385 1.074 . . . . 7.9000000000000004 111.867 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.1 -49.7 0.25 Allowed Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.266 -0.896 . . . . 3.0299999999999998 112.134 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -63.56 163.13 11.66 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.414 0.626 . . . . 3.8100000000000001 111.096 170.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.14 175.51 6.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.668 1.187 . . . . 5.2400000000000002 110.013 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.68 135.42 57.62 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.777 1.631 . . . . 2.1800000000000002 110.449 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -135.91 107.07 6.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.065 0.946 . . . . 3.9199999999999999 109.363 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.6 t -82.64 93.66 7.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.604 0.638 . . . . 0.42999999999999999 109.572 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 m -89.65 164.0 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.465 0.706 . . . . 1.5800000000000001 109.722 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 t -73.74 167.09 22.1 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.981 -0.449 . . . . 3.0499999999999998 110.783 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.79 137.47 8.33 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.551 -1.42 . . . . 2.1299999999999999 109.551 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.5 146.62 54.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.787 1.294 . . . . 3.2999999999999998 109.899 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.08 -171.41 13.48 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.535 1.064 . . . . 1.27 111.157 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -72.42 131.55 84.69 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.907 1.683 . . . . 2.1800000000000002 112.322 168.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.9 146.43 20.61 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.763 2.976 . . . . 1.01 110.471 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -76.19 118.81 74.0 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 123.48 0.712 . . . . 3.7200000000000002 109.813 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.69 139.96 28.72 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 N-CA-C 107.938 -1.601 . . . . 1.8600000000000001 107.938 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -66.28 154.62 39.45 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 121.803 -0.561 . . . . 8.2799999999999994 109.658 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.8 t -71.52 -40.76 69.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.53 0.332 . . . . 5.0300000000000002 111.751 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 118.243 -0.884 . . . . 11.18 110.485 178.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 108.883 -0.784 . . . . 7.8700000000000001 108.883 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.06 89.82 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.476 -1.305 . . . . 6.1200000000000001 107.476 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -143.18 166.58 24.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.049 0.94 . . . . 2.3500000000000001 109.549 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.2 p -147.58 163.13 37.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.061 1.744 . . . . 1.9099999999999999 108.327 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -80.29 159.19 25.92 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.013 0.824 . . . . 2.1400000000000001 111.16 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.6 m -84.2 155.59 22.45 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.588 1.085 . . . . 0.97999999999999998 108.152 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -114.71 -15.02 11.97 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.702 1.001 . . . . 2.04 113.702 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -144.71 152.18 40.02 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.769 0.828 . . . . 2.5099999999999998 109.282 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -76.89 144.08 39.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.094 0.473 . . . . 0.70999999999999996 109.997 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 4.36 76.75 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.931 -0.927 . . . . 0.41999999999999998 112.424 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.78 173.94 7.99 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.383 1.091 . . . . 2.5699999999999998 108.867 171.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.0 p30 -151.31 -172.61 4.26 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.814 0.846 . . . . 1.1699999999999999 109.816 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 66.56 44.16 2.36 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 122.119 0.962 . . . . 3.04 110.037 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -161.2 152.29 18.61 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.722 2.009 . . . . 1.1200000000000001 108.603 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.5 mt -59.52 134.44 57.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.865 1.266 . . . . 1.6499999999999999 107.706 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -131.9 -68.4 0.64 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.543 -1.651 . . . . 0.55000000000000004 106.543 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -90.36 89.94 7.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.065 -1.087 . . . . 3.1299999999999999 108.065 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.47 -131.65 52.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.102 -1.599 . . . . 0.71999999999999997 109.102 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.0 t -79.59 6.35 10.76 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.441 -0.79 . . . . 1.6299999999999999 112.488 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -84.33 118.72 24.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.844 -1.169 . . . . 2.3300000000000001 107.844 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.4 p -72.12 129.02 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.803 -0.814 . . . . 2.4900000000000002 108.803 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.1 t -76.44 85.79 3.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.405 -0.961 . . . . 0.41999999999999998 108.405 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.25 157.95 17.61 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.448 1.499 . . . . 0.91000000000000003 113.448 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.67 137.35 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.287 1.035 . . . . 4.3499999999999996 111.57 174.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.1 -34.34 4.73 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 110.924 -0.87 . . . . 0.98999999999999999 110.924 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -84.54 166.45 17.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.937 -0.764 . . . . 2.6699999999999999 108.937 173.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -139.95 128.17 22.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.026 1.73 . . . . 3.9100000000000001 107.722 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.9 t -86.95 135.45 33.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.237 -0.653 . . . . 0.59999999999999998 109.237 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.1 mm -112.19 123.18 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 104.703 -2.332 . . . . 2.5299999999999998 104.703 167.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.42 149.97 43.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.698 -0.853 . . . . 3.1200000000000001 108.698 167.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.85 149.76 43.5 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 121.92 0.733 . . . . 3.25 112.163 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.8 p -86.28 69.91 10.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.431 2.693 . . . . 4.7599999999999998 108.649 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 46.89 40.3 8.89 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.836 1.255 . . . . 7.9000000000000004 112.508 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.28 -59.9 0.07 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.337 -1.505 . . . . 3.4100000000000001 109.337 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.49 164.36 14.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.468 0.651 . . . . 3.0800000000000001 110.438 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -96.6 174.3 6.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.594 1.157 . . . . 5.75 108.318 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.87 149.06 37.34 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.358 0.663 . . . . 2.1400000000000001 111.458 173.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -140.79 124.44 16.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.03 0.932 . . . . 3.5699999999999998 108.953 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.8 t -103.2 98.98 8.82 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.162 0.985 . . . . 0.46999999999999997 109.24 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -102.51 179.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.357 0.663 . . . . 1.75 109.382 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.67 140.45 34.93 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.248 -0.649 . . . . 3.3799999999999999 109.248 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.57 -24.6 0.18 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.167 -1.016 . . . . 2.7999999999999998 114.323 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 68.49 144.95 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.846 1.658 . . . . 2.7999999999999998 110.71 -171.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.43 -172.03 24.14 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.96 -1.256 . . . . 1.1499999999999999 109.96 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 m -73.12 135.5 79.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.122 0.969 . . . . 2.6499999999999999 111.116 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.99 143.6 36.66 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.754 1.636 . . . . 0.79000000000000004 110.06 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.12 153.37 9.38 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 111.814 0.301 . . . . 3.3199999999999998 111.814 173.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.74 151.56 57.77 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.21 1.94 . . . . 2.8399999999999999 108.913 174.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -93.14 122.21 35.3 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.768 1.227 . . . . 6.5199999999999996 108.633 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 t 74.09 151.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.733 1.613 . . . . 6.5 110.326 -171.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 . . . . . 0 CA--C 1.541 0.623 0 C-N-CA 124.589 1.156 . . . . 8.9600000000000009 110.341 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.815 -0.439 . . . . 7.21 109.815 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 85.8 t -116.69 106.37 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 106.56 -1.645 . . . . 3.1600000000000001 106.56 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -108.71 -174.22 2.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.37 1.068 . . . . 2.4900000000000002 109.478 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.8 p -143.84 164.58 30.14 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.089 0.956 . . . . 1.98 109.275 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.91 165.68 24.69 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.092 0.557 . . . . 2.1200000000000001 110.679 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.3 m -86.84 142.62 27.94 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.011 -1.107 . . . . 1.29 108.011 -175.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 p -106.53 -16.27 14.57 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.664 0.386 . . . . 2.0600000000000001 111.167 -172.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -147.71 153.47 39.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.485 1.514 . . . . 2.4399999999999999 109.289 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -71.14 157.8 37.54 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 121.037 0.446 . . . . 0.58999999999999997 110.968 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.71 5.24 86.19 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.538 -0.625 . . . . 0.53000000000000003 111.538 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.75 164.86 12.22 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.665 0.786 . . . . 2.3700000000000001 109.755 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -147.57 -176.98 5.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.364 -0.606 . . . . 1.46 109.364 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 mt 65.51 35.18 7.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.544 1.538 . . . . 3.4900000000000002 110.259 -174.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.34 151.86 37.25 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.165 -0.68 . . . . 0.92000000000000004 109.165 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.8 mt -72.31 108.12 5.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.323 1.449 . . . . 1.6399999999999999 107.291 -174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.5 t -106.94 -63.36 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.034 -0.728 . . . . 0.54000000000000004 109.034 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -95.02 98.95 11.05 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.925 1.29 . . . . 3.8999999999999999 108.767 169.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.16 -134.11 52.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.67 -0.972 . . . . 0.46999999999999997 110.67 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.6 t -82.75 -3.0 55.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 117.476 0.638 . . . . 1.8400000000000001 111.073 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.08 122.43 23.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.042 -1.036 . . . . 2.8599999999999999 108.34 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.7 126.61 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.563 -0.903 . . . . 4.1299999999999999 108.563 -173.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.5 t -76.43 90.97 3.27 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.022 -0.423 . . . . 0.63 109.867 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.65 161.44 22.58 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 121.451 -0.781 . . . . 0.95999999999999996 113.166 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -50.71 154.13 1.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.802 0.841 . . . . 4.4400000000000004 111.934 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.52 -19.32 44.89 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.123 -0.791 . . . . 1.1299999999999999 111.123 -173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -119.62 166.49 13.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.22 2.208 . . . . 1.8600000000000001 109.716 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 141.06 27.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.454 1.502 . . . . 3.5099999999999998 110.313 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.6 t -88.1 122.57 31.83 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.341 2.256 . . . . 0.44 108.735 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 mp -100.56 123.48 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.082 -1.451 . . . . 2.6499999999999999 107.082 172.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 mp -74.71 63.28 1.13 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.934 1.243 . . . . 3.1499999999999999 110.969 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.77 162.4 0.3 Allowed Glycine 0 CA--C 1.547 2.036 0 CA-C-O 118.249 -1.306 . . . . 3.0699999999999998 113.541 -164.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 p -143.67 42.09 1.46 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 118.091 2.626 . . . . 4.6799999999999997 118.091 150.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 p30 160.09 28.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.416 1.007 . . . . 8.0 113.571 -144.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.57 1.69 86.92 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 120.898 -1.126 . . . . 3.3999999999999999 113.598 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.4 172.44 8.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.52 1.152 . . . . 3.8100000000000001 109.529 174.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -87.69 176.89 7.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.368 2.667 . . . . 5.8399999999999999 109.561 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -44.1 146.01 0.69 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.055 1.342 . . . . 2.02 113.974 168.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.67 115.09 3.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.75 0.82 . . . . 4.6200000000000001 112.924 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -88.02 110.98 21.02 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.938 1.295 . . . . 0.68000000000000005 110.547 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.25 155.06 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.119 0.968 . . . . 2.0099999999999998 109.586 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -64.84 148.96 50.32 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.406 0.283 . . . . 2.6000000000000001 110.487 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.44 50.41 0.06 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.464 1.03 . . . . 2.9199999999999999 111.638 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 42.11 83.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.461 2.304 . . . . 5.3399999999999999 114.829 171.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.72 174.8 44.9 Favored Glycine 0 C--N 1.338 0.673 0 O-C-N 121.477 -0.765 . . . . 1.5900000000000001 112.632 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.2 m -96.85 134.88 22.49 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.683 1.193 . . . . 3.1000000000000001 109.503 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.6 152.43 78.2 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.551 1.501 . . . . 1.0 110.836 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp -78.59 112.19 24.81 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.677 -0.677 . . . . 3.75 110.928 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.36 149.5 50.85 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.317 1.345 . . . . 2.21 109.483 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.14 164.48 22.34 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.719 0.808 . . . . 6.5999999999999996 109.306 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 99.8 p -102.17 159.3 15.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.371 1.068 . . . . 4.0700000000000003 109.199 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 127.103 2.161 . . . . 7.9699999999999998 113.434 177.798 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 77.6 t . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 107.32 -1.363 . . . . 5.5 107.32 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.16 145.21 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 107.905 -1.146 . . . . 3.6400000000000001 107.905 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -118.9 164.89 14.77 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.735 1.214 . . . . 2.7599999999999998 110.37 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -148.42 170.85 17.08 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.505 1.522 . . . . 1.8100000000000001 108.125 -175.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -78.36 166.62 22.45 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 118.721 0.691 . . . . 2.0899999999999999 111.056 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -84.46 170.89 13.05 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 107.503 -1.295 . . . . 1.0700000000000001 107.503 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 p -134.45 -39.21 0.82 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.877 -0.602 . . . . 2.3700000000000001 111.093 -170.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -116.98 147.78 42.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.556 1.143 . . . . 2.79 109.992 173.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -74.9 139.38 43.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.826 0.45 . . . . 0.65000000000000002 110.255 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.69 -2.69 58.78 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.937 -0.465 . . . . 0.65000000000000002 111.937 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -94.97 174.24 7.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.369 1.068 . . . . 2.5600000000000001 109.265 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -150.18 -173.32 4.4 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.146 -0.971 . . . . 1.4399999999999999 110.591 176.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 71.38 38.5 1.03 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.618 1.567 . . . . 3.7200000000000002 111.982 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.88 153.49 31.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.223 2.609 . . . . 1.05 109.545 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 mt -64.05 127.7 32.56 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.899 1.68 . . . . 1.6599999999999999 107.917 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.5 t -120.69 -63.98 1.29 Allowed 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.831 -1.174 . . . . 0.53000000000000003 107.831 -169.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -105.46 106.06 16.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.453 -1.249 . . . . 4.9199999999999999 107.678 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.2 -136.98 50.47 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.337 -1.105 . . . . 0.62 110.337 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 -3.99 58.47 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.869 0.868 . . . . 1.6100000000000001 112.525 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -75.26 118.32 18.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.356 -0.979 . . . . 2.1000000000000001 108.356 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.0 p -72.78 139.26 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.46 -0.57 . . . . 2.6299999999999999 109.46 175.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.55 97.13 4.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.954 -1.128 . . . . 0.57999999999999996 107.954 170.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.71 165.86 32.41 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.096 0.855 . . . . 0.84999999999999998 112.866 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.89 153.49 20.87 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.673 -0.898 . . . . 5.1900000000000004 111.803 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.34 -0.5 83.49 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 111.555 -0.618 . . . . 0.67000000000000004 111.555 -172.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -136.29 171.23 14.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.066 2.146 . . . . 1.8500000000000001 108.081 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -142.7 144.66 32.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.315 1.446 . . . . 3.2200000000000002 109.484 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -96.88 125.74 41.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.794 1.238 . . . . 0.5 108.211 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.5 mm -97.25 120.37 46.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.794 -2.298 . . . . 2.0699999999999998 104.794 171.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.47 146.36 52.0 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.166 -0.679 . . . . 3.1000000000000001 109.166 169.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.08 134.89 52.22 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.531 -1.213 . . . . 3.25 111.506 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.83 67.67 1.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.818 -1.179 . . . . 4.6900000000000004 107.818 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 45.26 35.13 1.65 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.599 1.16 . . . . 6.5800000000000001 113.601 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.41 -61.19 0.05 OUTLIER Glycine 0 C--N 1.347 1.154 0 O-C-N 120.87 -1.144 . . . . 2.5099999999999998 110.956 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -69.26 154.18 42.46 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 117.488 0.644 . . . . 4.3099999999999996 110.082 165.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -94.24 174.49 7.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.203 1.801 . . . . 4.8799999999999999 109.235 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -57.74 140.41 51.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.614 -0.231 . . . . 2.5499999999999998 110.73 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -143.92 132.91 22.77 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 118.891 -0.576 . . . . 3.8399999999999999 110.777 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.6 t -97.3 94.98 7.39 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 118.972 0.805 . . . . 0.45000000000000001 108.982 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 m -88.25 166.88 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 C-N-CA 123.525 0.73 . . . . 1.8500000000000001 109.353 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 t -81.23 -173.14 4.16 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.909 1.338 . . . . 2.9399999999999999 111.8 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.89 133.74 6.57 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.562 -1.815 . . . . 1.97 108.562 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -56.2 137.59 51.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 117.622 0.711 . . . . 4.2300000000000004 111.003 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.68 172.94 26.23 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.52 -1.032 . . . . 1.1100000000000001 110.52 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.0 m -84.07 138.74 39.64 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 123.954 0.901 . . . . 3.0299999999999998 110.559 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -74.35 147.9 37.69 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.342 2.028 . . . . 0.96999999999999997 111.392 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -60.53 124.93 80.96 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.192 0.597 . . . . 3.5 110.962 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -66.46 157.13 62.04 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.172 1.915 . . . . 1.3500000000000001 109.486 171.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -51.16 155.41 1.33 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.039 0.535 . . . . 6.5999999999999996 111.959 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 t -137.96 157.63 45.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.473 -1.306 . . . . 5.2999999999999998 107.473 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 105.866 -1.901 . . . . 8.2400000000000002 105.866 -177.545 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 106.906 -1.516 . . . . 6.6699999999999999 106.906 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.5 t -86.01 129.49 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.221 -1.029 . . . . 3.8599999999999999 108.221 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -94.48 165.11 12.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.087 0.955 . . . . 3.6299999999999999 109.719 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.9 p -146.98 169.21 19.68 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.218 -1.401 . . . . 1.8999999999999999 107.218 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.99 165.85 5.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.948 0.404 . . . . 1.8500000000000001 111.589 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.16 151.72 25.58 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.231 0.539 . . . . 1.0700000000000001 111.933 163.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -117.97 -30.65 5.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.32 1.848 . . . . 2.3199999999999998 111.705 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.89 155.25 23.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.47 1.108 . . . . 3.3799999999999999 110.036 173.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -79.16 147.6 32.62 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 122.869 0.468 . . . . 0.58999999999999997 110.383 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.51 27.11 21.12 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.04 -0.824 . . . . 0.48999999999999999 111.04 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.46 144.63 51.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.137 0.575 . . . . 2.4300000000000002 110.331 -171.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -114.78 -177.31 3.1 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.066 1.346 . . . . 1.3999999999999999 109.689 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.2 mt 52.2 57.69 6.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.121 0.968 . . . . 3.2400000000000002 111.197 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -163.53 156.57 18.62 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.52 1.128 . . . . 1.22 108.183 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -72.1 130.09 40.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.803 -1.184 . . . . 1.77 107.803 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.7 t -127.66 -62.93 1.05 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.14 -0.689 . . . . 0.56999999999999995 109.14 -168.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -100.34 108.29 20.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.929 1.292 . . . . 4.2199999999999998 109.323 164.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.5 -143.58 47.22 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.391 -0.818 . . . . 0.81000000000000005 111.321 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 t -83.99 5.95 23.78 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.089 0.444 . . . . 1.75 110.691 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -85.65 119.77 26.36 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.646 -1.242 . . . . 2.0499999999999998 107.646 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.93 139.64 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.408 -0.59 . . . . 2.7000000000000002 109.408 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.3 t -73.22 85.8 1.41 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.089 0.947 . . . . 0.52000000000000002 109.813 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.87 157.0 1.84 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.348 1.927 . . . . 1.0700000000000001 113.141 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -58.91 151.03 22.68 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.901 0.48 . . . . 4.04 111.187 -175.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.32 -10.99 64.51 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.608 -0.551 . . . . 0.81999999999999995 112.626 -173.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -122.01 160.6 24.59 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.5 1.92 . . . . 2.1099999999999999 108.028 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.04 150.0 43.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.739 1.215 . . . . 2.9700000000000002 109.358 177.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.1 t -97.59 123.41 41.48 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 125.094 1.358 . . . . 0.54000000000000004 107.895 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 mp -96.2 120.12 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.769 -1.567 . . . . 2.46 106.769 175.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.92 64.78 0.51 Allowed 'General case' 0 CA--C 1.523 -0.072 0 C-N-CA 126.784 2.034 . . . . 3.2400000000000002 110.19 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.17 169.54 9.56 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.972 -1.013 . . . . 3.0699999999999998 111.851 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.5 60.5 1.33 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.165 -1.42 . . . . 4.9900000000000002 107.165 178.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 58.11 24.68 11.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.657 1.183 . . . . 6.4900000000000002 111.62 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.12 -53.22 0.17 Allowed Glycine 0 CA--C 1.533 1.174 0 O-C-N 121.765 -0.585 . . . . 3.3599999999999999 111.747 -171.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -62.89 163.74 9.13 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.906 0.882 . . . . 3.4900000000000002 110.828 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -94.56 177.26 5.99 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.201 2.2 . . . . 4.6600000000000001 109.084 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -42.29 130.57 3.74 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.649 1.352 . . . . 1.8500000000000001 114.649 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.72 121.13 7.9 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 124.067 0.947 . . . . 3.1699999999999999 111.477 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.3 t -92.31 103.3 15.76 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.27 -0.641 . . . . 0.40000000000000002 109.27 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -111.73 159.87 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.905 0.882 . . . . 1.78 109.599 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.0 149.06 51.16 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.836 0.351 . . . . 2.9300000000000002 110.394 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.26 114.74 1.76 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.259 -1.936 . . . . 2.29 108.259 -174.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -55.94 121.81 10.16 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.313 -0.625 . . . . 3.2400000000000002 109.313 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.13 -172.96 16.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.055 1.312 . . . . 0.90000000000000002 110.214 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 t -96.94 147.36 32.81 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.108 -0.948 . . . . 2.6000000000000001 109.531 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.96 141.61 24.16 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.292 1.995 . . . . 0.90000000000000002 112.394 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.12 137.47 27.63 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.528 -0.272 . . . . 3.3500000000000001 111.294 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.99 132.91 31.6 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 N-CA-C 108.281 -1.469 . . . . 2.0800000000000001 108.281 172.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.35 161.41 30.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.376 1.07 . . . . 7.0999999999999996 109.74 173.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.3 p -139.23 82.5 1.89 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.666 -1.235 . . . . 5.3099999999999996 107.666 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.3 m80 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 106.613 -1.625 . . . . 12.31 106.613 172.146 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 106.138 -1.801 . . . . 5.4299999999999997 106.138 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.8 t -134.42 126.48 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 106.231 -1.766 . . . . 3.3300000000000001 106.231 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -113.52 170.54 8.17 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.114 1.366 . . . . 2.2599999999999998 109.22 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.1 p -137.83 166.91 22.86 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.635 1.574 . . . . 2.1699999999999999 108.273 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.88 162.84 21.46 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.412 0.285 . . . . 1.77 111.456 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.7 m -83.71 163.96 19.91 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.255 0.55 . . . . 1.54 111.454 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -123.08 -2.78 8.61 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.42 1.088 . . . . 2.1899999999999999 112.442 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -139.59 136.17 34.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.908 0.883 . . . . 4.7000000000000002 109.89 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -60.71 141.67 56.62 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 121.63 -0.669 . . . . 0.53000000000000003 110.109 174.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.54 -11.01 72.16 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.817 -0.435 . . . . 0.73999999999999999 112.02 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -72.55 168.72 17.99 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 118.057 0.928 . . . . 2.4500000000000002 111.194 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -149.29 174.58 12.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.941 0.896 . . . . 1.01 110.249 171.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 74.73 53.36 0.08 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.732 1.213 . . . . 3.0699999999999998 108.81 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -174.49 162.86 3.55 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.111 1.765 . . . . 1.02 107.173 -169.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.6 mt -79.33 145.53 33.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.716 0.806 . . . . 1.75 109.692 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.5 t -139.21 -63.24 0.52 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.506 -0.77 . . . . 0.72999999999999998 109.756 -168.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -103.01 109.8 21.48 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.179 -1.045 . . . . 3.5600000000000001 108.179 165.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.45 -125.37 37.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.577 -1.009 . . . . 0.68999999999999995 110.577 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.5 t -98.34 9.11 43.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.54 0.736 . . . . 1.26 111.436 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -80.98 119.93 24.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.059 -1.089 . . . . 2.3799999999999999 108.059 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.7 p -79.88 120.02 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.84 -0.8 . . . . 2.73 108.84 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.7 t -78.65 77.3 5.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.982 -1.118 . . . . 0.82999999999999996 107.982 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.43 176.9 44.31 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.036 0.351 . . . . 1.51 113.407 -170.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -48.31 146.31 2.86 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.418 0.687 . . . . 5.7999999999999998 110.77 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.58 -20.75 33.01 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.009 -0.884 . . . . 0.75 111.54 -166.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -124.52 171.2 10.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.065 1.433 . . . . 3.3900000000000001 109.962 -177.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.74 137.46 29.81 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.604 1.962 . . . . 3.98 110.49 176.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.5 t -89.15 118.45 28.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.656 0.782 . . . . 0.52000000000000002 109.15 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.48 130.04 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.716 -1.587 . . . . 2.6499999999999999 106.716 170.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.6 mt -74.6 65.08 1.26 Allowed 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.035 0.934 . . . . 4.2199999999999998 111.627 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.02 174.06 29.77 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.518 -0.764 . . . . 3.4900000000000002 112.011 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.52 93.59 2.63 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.282 -1.377 . . . . 5.5599999999999996 107.282 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.0 t0 38.74 67.39 0.43 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.462 1.905 . . . . 5.5499999999999998 111.56 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.03 -31.42 7.68 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.511 -1.222 . . . . 2.6699999999999999 113.02 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -63.96 142.95 58.22 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.707 1.753 . . . . 4.5599999999999996 109.91 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -66.8 174.1 3.14 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.583 1.153 . . . . 4.9199999999999999 111.127 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -43.05 138.45 2.1 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.881 2.072 . . . . 2.5699999999999998 114.233 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -136.41 110.9 8.54 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.742 1.217 . . . . 3.9100000000000001 109.728 -173.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.72 100.8 11.13 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.61 0.764 . . . . 0.54000000000000004 109.13 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -96.55 167.01 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 C-N-CA 122.968 0.507 . . . . 1.77 109.72 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.38 159.67 14.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.649 0.78 . . . . 3.46 110.374 -171.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.04 45.07 1.31 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.646 1.117 . . . . 2.6299999999999999 112.637 169.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 58.5 144.9 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 129.554 3.142 . . . . 3.1499999999999999 116.602 171.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.07 -179.85 25.3 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.799 1.19 . . . . 0.93999999999999995 111.647 -168.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 m -95.38 130.68 31.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.935 . . . . 2.6499999999999999 110.943 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.52 135.41 42.26 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 CA-C-N 120.714 1.291 . . . . 1.3 110.327 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -64.55 131.86 95.22 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 119.066 -0.492 . . . . 3.6699999999999999 111.011 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.56 171.02 18.98 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.599 2.199 . . . . 1.72 111.657 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.24 151.53 0.24 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.71 2.004 . . . . 8.9100000000000001 114.251 -176.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.4 m -158.66 171.24 20.47 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.664 -1.606 . . . . 4.8799999999999999 106.664 164.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 107.116 -1.438 . . . . 9.2899999999999991 107.116 151.209 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 121.034 0.445 . . . . 9.5500000000000007 110.452 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.5 t -111.53 82.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 106.867 -1.531 . . . . 4.3899999999999997 106.867 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -143.08 178.48 7.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.05 0.94 . . . . 2.6699999999999999 109.311 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.8 p -124.22 167.2 14.61 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.156 0.983 . . . . 1.9199999999999999 109.913 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.47 168.19 2.94 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.316 0.647 . . . . 1.6699999999999999 111.464 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.0 m -83.91 150.86 25.42 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 108.204 -1.035 . . . . 1.25 108.204 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -108.94 -20.84 12.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.656 0.783 . . . . 2.4500000000000002 111.412 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -144.57 147.85 33.68 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.232 1.413 . . . . 2.6000000000000001 109.225 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -68.77 159.7 31.83 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.764 0.826 . . . . 0.71999999999999997 110.849 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.68 14.88 80.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.829 -0.908 . . . . 0.48999999999999999 110.829 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -119.27 158.4 26.12 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 123.411 0.685 . . . . 2.48 110.125 -170.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -135.63 -176.46 4.29 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.449 0.7 . . . . 0.96999999999999997 110.402 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 tp 66.79 39.76 3.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.158 0.983 . . . . 3.5499999999999998 109.704 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.4 p -154.61 153.45 31.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.339 1.455 . . . . 0.91000000000000003 108.156 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.5 mt -76.38 108.67 9.49 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 125.396 1.478 . . . . 1.6499999999999999 108.004 -174.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -107.32 -63.17 1.32 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.449 0.699 . . . . 0.60999999999999999 109.41 -170.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -91.51 98.63 11.79 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.666 0.786 . . . . 2.8999999999999999 109.841 168.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.8 -130.69 50.01 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.247 -1.141 . . . . 0.46999999999999997 110.247 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.88 4.97 42.65 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.217 0.509 . . . . 1.6799999999999999 111.039 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -79.89 120.12 23.68 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 120.922 -1.111 . . . . 2.3500000000000001 108.058 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.9 t -83.78 124.85 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.315 -0.994 . . . . 3.7000000000000002 108.315 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.8 t -76.53 86.9 3.24 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.956 -0.757 . . . . 0.46000000000000002 108.956 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.65 172.29 19.4 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 121.659 -0.651 . . . . 1.02 113.151 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.07 152.21 4.32 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.73 -0.865 . . . . 4.6500000000000004 112.249 174.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.93 -5.73 83.1 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.969 0.795 . . . . 0.68000000000000005 111.787 -174.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -132.36 157.64 43.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.963 2.505 . . . . 1.97 108.048 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -141.51 152.33 44.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.363 1.465 . . . . 3.5 109.042 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.4 t -99.42 130.18 45.67 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.771 2.029 . . . . 0.40999999999999998 108.91 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.5 mm -102.72 107.48 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.4 -1.704 . . . . 2.5 106.4 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 34.4 mt -69.73 73.91 0.41 Allowed 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.387 1.475 . . . . 3.21 110.375 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.05 146.49 2.87 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.066 -1.214 . . . . 2.7999999999999998 110.066 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.44 58.13 1.39 Allowed 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 108.739 -0.838 . . . . 5.2699999999999996 108.739 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 49.63 28.02 2.41 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.479 1.512 . . . . 5.8499999999999996 111.832 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.88 -72.41 0.14 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.433 -1.467 . . . . 4.6200000000000001 109.433 -165.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -63.5 158.16 21.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 117.967 0.884 . . . . 3.6600000000000001 110.199 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -86.91 177.64 7.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.902 2.481 . . . . 4.9100000000000001 109.641 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -42.0 110.13 0.16 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.365 1.866 . . . . 2.4100000000000001 114.083 166.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -128.27 133.3 48.76 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.153 0.981 . . . . 3.4300000000000002 110.328 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.5 t -100.85 105.02 16.27 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.636 -0.876 . . . . 0.46999999999999997 108.636 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -110.3 172.82 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 109.329 -0.619 . . . . 1.98 109.329 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 t -67.16 177.99 1.61 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.272 1.034 . . . . 3.1499999999999999 111.949 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.41 124.03 4.76 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.853 -2.099 . . . . 2.27 107.853 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.4 134.05 40.26 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.469 -0.567 . . . . 3.71 109.469 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.8 165.86 15.37 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 108.528 -1.829 . . . . 0.94999999999999996 108.528 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -76.01 149.94 83.01 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 108.581 -0.896 . . . . 2.8100000000000001 108.581 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -78.08 157.48 30.37 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.275 1.983 . . . . 0.78000000000000003 111.506 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -61.55 132.51 93.01 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 119.096 -0.478 . . . . 3.9100000000000001 111.069 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.1 131.81 34.03 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.49 1.46 . . . . 2.0600000000000001 108.973 170.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -50.25 144.64 7.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.675 0.79 . . . . 6.96 110.838 174.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.0 m 67.48 -75.64 0.06 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.559 0.744 . . . . 4.5599999999999996 109.81 -174.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 117.597 -1.192 . . . . 11.52 109.64 -177.511 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 107.233 -1.395 . . . . 5.25 107.233 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 73.3 t -85.19 114.91 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.931 -1.507 . . . . 4.5099999999999998 106.931 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -124.71 161.76 25.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.425 1.09 . . . . 2.5600000000000001 109.291 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 p -147.9 165.83 29.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.606 1.562 . . . . 1.6399999999999999 107.652 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -64.22 160.47 18.48 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.393 0.616 . . . . 1.6599999999999999 111.975 -176.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -83.2 152.66 25.12 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.501 -0.772 . . . . 1.0600000000000001 112.317 165.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.7 p -132.6 23.77 4.35 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.82 1.248 . . . . 2.3799999999999999 111.319 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.08 159.66 11.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.116 0.966 . . . . 3.1800000000000002 109.419 175.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -85.49 146.34 26.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.909 0.484 . . . . 0.60999999999999999 111.164 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.69 28.01 17.69 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.011 -0.541 . . . . 0.57999999999999996 111.854 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.92 158.12 39.7 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.674 -0.679 . . . . 3.3399999999999999 110.569 -165.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -138.33 -179.81 6.01 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.694 1.134 . . . . 1.3300000000000001 111.822 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 62.74 36.7 13.1 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.677 0.751 . . . . 3.1299999999999999 111.049 173.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.9 p -149.45 161.04 42.89 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.572 1.549 . . . . 1.1399999999999999 107.605 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.78 130.94 40.97 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.177 -1.046 . . . . 1.6499999999999999 108.177 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.9 t -127.64 -63.64 1.02 Allowed 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 106.938 -1.505 . . . . 0.54000000000000004 106.938 -174.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.59 98.26 11.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.944 -0.761 . . . . 3.46 108.944 172.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.78 -135.26 52.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.87 -1.292 . . . . 0.56999999999999995 109.87 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 t -85.52 9.99 14.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.715 0.757 . . . . 1.4399999999999999 112.225 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -90.64 124.85 35.39 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.655 -0.869 . . . . 2.4300000000000002 108.655 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.3 139.17 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.999 -0.371 . . . . 2.7599999999999998 109.999 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.7 t -75.09 91.21 2.54 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.532 -0.914 . . . . 0.62 108.532 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.68 158.26 1.43 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.158 1.837 . . . . 1.3700000000000001 113.971 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -56.99 144.72 32.93 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.77 -0.841 . . . . 4.3499999999999996 111.404 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.74 -5.08 79.57 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.105 0.86 . . . . 0.73999999999999999 111.967 -171.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -125.48 166.87 15.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.169 1.788 . . . . 2.2400000000000002 109.238 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -145.84 153.57 41.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.02 -1.104 . . . . 3.5899999999999999 108.02 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.8 t -98.55 128.89 45.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.691 1.596 . . . . 0.46999999999999997 107.041 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mt -101.05 124.65 54.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.456 -1.683 . . . . 3.1800000000000002 106.456 166.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.01 129.95 39.24 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 106.551 -1.648 . . . . 3.73 106.551 167.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -48.02 146.56 4.95 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 117.861 -1.522 . . . . 2.4300000000000002 112.112 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.0 t -124.33 42.49 3.24 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.95 1.875 . . . . 4.75 113.826 -171.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.0 p30 152.89 28.42 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.689 0.996 . . . . 5.6200000000000001 113.689 -140.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.53 14.31 77.54 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.47 -1.394 . . . . 2.6899999999999999 114.127 173.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.19 169.96 12.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.736 1.215 . . . . 3.5099999999999998 110.216 173.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -91.37 176.44 6.56 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.628 1.171 . . . . 4.54 109.908 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -55.82 150.41 13.06 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.613 0.765 . . . . 2.2000000000000002 111.776 173.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -148.04 109.54 4.39 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.31 0.644 . . . . 4.1399999999999997 111.542 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.1 t -90.05 114.44 26.32 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 124.641 1.176 . . . . 0.40999999999999998 109.466 174.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.86 161.65 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.825 -0.806 . . . . 2.27 108.825 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -61.58 148.0 43.74 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.784 -0.572 . . . . 3.1000000000000001 110.226 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.77 -31.85 0.27 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.151 -0.805 . . . . 2.6800000000000002 113.623 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 72.06 83.51 0.13 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.293 1.437 . . . . 3.7200000000000002 111.356 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.38 -178.01 52.17 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.152 -0.477 . . . . 1.74 112.184 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.0 m -87.89 147.72 41.7 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.215 1.006 . . . . 3.7799999999999998 108.652 171.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.61 143.5 24.23 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.111 1.874 . . . . 1.49 111.54 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -50.52 130.22 26.36 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 123.464 0.705 . . . . 3.75 111.129 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.32 149.52 75.53 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.788 1.659 . . . . 1.51 110.342 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -59.9 153.63 20.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.998 0.428 . . . . 6.4100000000000001 110.525 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.5 p -172.93 -64.77 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.617 -0.883 . . . . 4.0 108.617 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.324 0 CA-C-N 114.774 -1.103 . . . . 11.289999999999999 109.35 171.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 107.618 -1.252 . . . . 5.5499999999999998 107.618 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.19 150.02 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 106.828 -1.545 . . . . 3.75 106.828 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -125.3 157.96 35.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.571 1.148 . . . . 2.3100000000000001 108.106 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 p -147.03 173.44 12.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.466 1.907 . . . . 2.5299999999999998 106.221 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.03 168.5 8.17 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.939 0.4 . . . . 1.95 111.034 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.3 m -82.86 156.14 23.75 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.714 0.768 . . . . 1.29 110.759 159.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -110.53 -11.05 14.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.244 -1.344 . . . . 1.6699999999999999 111.259 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -147.79 136.28 21.64 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 107.171 -1.418 . . . . 3.3599999999999999 107.171 -166.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -64.7 150.35 47.39 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.45 0.568 . . . . 0.55000000000000004 110.021 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.04 -1.27 62.9 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.046 -0.597 . . . . 0.65000000000000002 112.149 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -99.79 147.43 25.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 117.657 0.729 . . . . 2.4500000000000002 112.676 -171.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -115.19 -176.13 2.84 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.485 1.114 . . . . 1.4299999999999999 110.664 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 59.14 53.74 5.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 122.379 1.085 . . . . 3.5499999999999998 110.361 172.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.0 p -169.33 159.43 8.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.189 -1.411 . . . . 1.1599999999999999 107.189 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.64 143.81 46.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.78 -0.822 . . . . 1.8 108.78 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.8 t -138.89 -63.2 0.53 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.509 -0.922 . . . . 0.59999999999999998 108.509 -172.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -93.29 97.49 10.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.696 -0.853 . . . . 2.96 108.696 169.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.94 -132.64 52.55 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.925 -1.27 . . . . 0.68000000000000005 109.925 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.4 t -87.28 14.68 7.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.732 0.766 . . . . 1.3700000000000001 112.168 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -88.22 124.61 34.02 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.185 0.902 . . . . 2.3100000000000001 109.377 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.0 t -71.66 133.23 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.209 1.004 . . . . 3.4399999999999999 109.518 175.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.5 t -74.15 91.87 2.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.992 -0.744 . . . . 0.63 108.992 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.66 152.58 1.84 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.327 1.918 . . . . 1.54 114.188 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -49.43 139.1 12.35 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.479 0.712 . . . . 5.46 110.732 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.94 -3.3 87.28 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.411 -0.661 . . . . 0.96999999999999997 112.71 -174.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -123.05 167.79 13.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.965 1.306 . . . . 1.8300000000000001 108.318 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.04 154.99 42.47 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.357 1.063 . . . . 3.6400000000000001 110.653 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.8 t -105.83 127.79 53.33 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 106.846 -1.539 . . . . 0.59999999999999998 106.846 -172.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.5 mm -98.11 107.37 20.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 105.698 -1.964 . . . . 2.4300000000000002 105.698 173.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -71.14 92.99 1.02 Allowed 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.849 1.259 . . . . 3.0800000000000001 108.815 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.45 175.58 4.35 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.489 -1.044 . . . . 2.9700000000000002 110.489 -175.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -176.38 94.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 103.898 -2.63 . . . . 4.8499999999999996 103.898 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 54.77 43.19 30.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.889 0.876 . . . . 6.2199999999999998 112.141 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.96 6.91 58.96 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.097 1.332 . . . . 2.4300000000000002 113.734 176.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.4 173.26 11.16 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 122.791 1.281 . . . . 2.8599999999999999 110.971 172.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.41 177.01 8.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.277 2.631 . . . . 5.1500000000000004 109.287 171.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -63.45 125.35 23.9 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 111.968 0.358 . . . . 1.72 111.968 162.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -118.7 127.26 53.4 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 131.306 3.842 . . . . 4.1900000000000004 109.359 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -101.42 111.26 23.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.692 1.587 . . . . 0.55000000000000004 110.15 172.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.4 m -114.22 155.57 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.038 0.935 . . . . 2.0699999999999998 111.202 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.01 168.54 15.85 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.793 0.806 . . . . 3.4900000000000002 111.229 -169.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.61 45.96 1.47 Allowed Glycine 0 CA--C 1.524 0.605 0 O-C-N 120.842 -1.162 . . . . 2.9500000000000002 111.38 162.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 73.68 154.97 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.586 2.354 . . . . 3.48 111.108 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.77 158.27 31.09 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.129 -1.588 . . . . 1.3100000000000001 109.129 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -92.56 146.91 33.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 117.544 0.672 . . . . 3.23 109.436 -174.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.41 154.56 65.06 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-N 121.035 1.405 . . . . 1.6499999999999999 110.659 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 106.86 38.1 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.354 1.062 . . . . 3.5899999999999999 109.592 176.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -80.48 139.63 12.97 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.743 2.296 . . . . 1.8700000000000001 110.19 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -86.34 160.55 19.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.73 0.812 . . . . 8.6799999999999997 109.346 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.8 m 63.64 162.15 0.11 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.196 1.798 . . . . 5.1799999999999997 112.176 -172.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 . . . . . 0 N--CA 1.45 -0.442 0 C-N-CA 127.62 2.368 . . . . 12.08 105.233 174.248 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 106.427 -1.694 . . . . 5.6699999999999999 106.427 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.7 t -86.03 123.42 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.783 -1.562 . . . . 4.5099999999999998 106.783 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -85.82 169.49 13.29 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.181 0.992 . . . . 3.5099999999999998 108.527 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.1 p -101.63 165.93 10.97 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 124.106 0.963 . . . . 2.5 109.579 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.11 156.98 38.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.907 0.776 . . . . 2.23 110.955 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.7 m -84.81 150.87 24.74 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 117.855 -1.538 . . . . 1.1499999999999999 109.226 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -132.34 6.06 4.13 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.73 0.641 . . . . 2.6600000000000001 112.73 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.404 ' CD ' HE22 ' A' ' 11' ' ' GLN . 0.7 OUTLIER -150.53 136.33 18.28 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.58 1.552 . . . . 3.6800000000000002 106.812 -169.388 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -71.83 139.4 48.89 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 118.65 0.659 . . . . 1.3200000000000001 110.353 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.68 67.53 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.733 -0.547 . . . . 0.56999999999999995 111.733 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.404 HE22 ' CD ' ' A' ' 8' ' ' GLU . 30.5 tt0 -97.13 164.07 12.66 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 123.297 0.639 . . . . 2.5600000000000001 109.742 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -148.41 -175.37 4.89 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.223 0.609 . . . . 1.26 109.587 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 58.61 37.03 25.4 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.516 0.674 . . . . 3.5099999999999998 109.481 -174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -148.81 145.6 27.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.6 1.16 . . . . 1.0700000000000001 109.269 175.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 mt -57.68 108.88 0.62 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.411 2.284 . . . . 1.6899999999999999 108.637 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.1 t -99.18 -63.15 1.15 Allowed 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.443 -1.688 . . . . 0.62 106.443 -174.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -109.79 99.08 8.28 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.035 1.334 . . . . 3.8300000000000001 109.452 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.82 -145.73 38.84 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.617 -1.393 . . . . 0.80000000000000004 109.617 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.02 -0.7 45.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.512 0.725 . . . . 2.21 110.687 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -82.25 118.82 23.41 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.197 -1.408 . . . . 2.1000000000000001 107.197 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.18 146.94 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 110.289 -0.263 . . . . 2.7599999999999998 110.289 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 t -73.16 95.79 2.13 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.789 0.804 . . . . 0.51000000000000001 109.285 167.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.57 157.42 2.19 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 127.632 2.539 . . . . 1.4399999999999999 113.137 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.38 144.94 56.8 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.051 -0.676 . . . . 4.0599999999999996 110.667 -177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.5 0.41 84.45 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.323 0.487 . . . . 0.76000000000000001 112.156 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.66 161.2 30.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.063 2.145 . . . . 2.1600000000000001 108.596 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -136.63 156.64 48.27 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.881 1.672 . . . . 3.73 111.49 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.5 t -103.42 119.43 38.88 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.232 -1.766 . . . . 0.53000000000000003 106.232 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mp -88.3 109.36 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 104.883 -2.266 . . . . 2.4199999999999999 104.883 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.39 132.97 55.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.766 -1.198 . . . . 3.2999999999999998 107.766 175.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.29 137.88 49.53 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.06 -0.816 . . . . 2.8500000000000001 111.06 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 m -130.23 43.2 3.16 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.082 -0.485 . . . . 5.5899999999999999 111.955 -174.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 164.07 49.72 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.89 1.676 . . . . 4.75 109.105 -173.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.77 0.34 13.0 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 120.306 -1.496 . . . . 3.3900000000000001 113.926 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -68.18 160.23 29.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 117.525 0.662 . . . . 3.8900000000000001 110.828 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.95 166.19 12.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.271 -0.64 . . . . 5.8499999999999996 109.271 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -58.72 127.39 31.94 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.895 0.878 . . . . 2.1699999999999999 110.003 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.44 110.21 14.82 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.471 1.108 . . . . 3.48 110.409 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.3 t -84.53 98.11 9.94 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.277 -0.638 . . . . 0.35999999999999999 109.277 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.48 168.56 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.734 -0.839 . . . . 2.0 108.734 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 t -67.29 171.06 6.26 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.037 -1.039 . . . . 3.6200000000000001 111.51 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.05 140.79 7.57 Favored Glycine 0 C--O 1.223 -0.581 0 N-CA-C 109.106 -1.598 . . . . 2.27 109.106 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.39 112.74 14.46 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.326 -1.102 . . . . 3.73 108.976 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.94 174.76 23.59 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.264 0.935 . . . . 1.0700000000000001 111.536 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -94.5 138.08 22.45 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 109.115 -0.698 . . . . 2.7200000000000002 109.115 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.72 142.11 42.92 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 121.862 1.708 . . . . 1.25 109.586 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -50.77 108.23 0.99 Allowed Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.985 -0.531 . . . . 4.1799999999999997 111.737 -177.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -77.71 170.79 18.51 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.014 1.809 . . . . 2.0899999999999999 110.143 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -60.68 160.66 8.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.856 1.312 . . . . 5.7000000000000002 111.649 173.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 m -151.62 124.58 8.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.613 -1.995 . . . . 5.8300000000000001 105.613 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 105.346 -2.094 . . . . 9.8100000000000005 105.346 179.516 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 71.7 t . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 106.557 -1.645 . . . . 4.9299999999999997 106.557 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.2 t -136.63 118.89 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.638 -1.986 . . . . 3.3599999999999999 105.638 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -89.65 163.04 15.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.335 -0.617 . . . . 1.8999999999999999 109.335 175.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 p -134.39 163.9 28.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.296 1.438 . . . . 1.98 108.719 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.64 161.49 29.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.351 0.596 . . . . 1.8700000000000001 111.91 -176.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 11' ' ' GLN . 1.3 m -83.82 173.73 11.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.652 0.781 . . . . 1.6499999999999999 111.765 171.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -141.35 28.0 1.87 Allowed 'General case' 0 C--N 1.345 0.404 0 CA-C-O 118.733 -0.651 . . . . 2.0699999999999998 112.733 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -165.14 160.78 19.05 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.995 -1.113 . . . . 2.7599999999999998 107.995 170.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.29 153.82 26.88 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.866 0.867 . . . . 0.65000000000000002 111.363 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' ' CG ' ' A' ' 27' ' ' LYS . . . 75.37 15.32 81.25 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.154 0.883 . . . . 0.46000000000000002 111.751 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 1.9 mt-30 -92.18 171.4 9.1 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.412 0.685 . . . . 2.4199999999999999 109.158 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -154.94 179.6 8.97 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.089 0.859 . . . . 0.89000000000000001 110.394 170.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.56 55.84 1.68 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.544 1.538 . . . . 3.25 111.103 178.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.4 p -173.83 163.91 4.21 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.415 1.886 . . . . 0.90000000000000002 106.532 -172.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.0 mt -71.93 144.18 49.03 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.918 -0.771 . . . . 1.6200000000000001 108.918 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.0 t -142.31 -64.57 0.42 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.393 -0.595 . . . . 0.64000000000000001 109.393 -172.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -94.32 98.96 11.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.156 -1.424 . . . . 2.9700000000000002 107.156 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.69 -128.6 32.98 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.094 -1.203 . . . . 0.71999999999999997 110.094 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 t -88.32 5.98 39.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 117.134 0.467 . . . . 1.5800000000000001 111.823 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -83.61 124.34 30.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.129 -0.982 . . . . 3.0699999999999998 108.484 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.08 132.68 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.533 0.733 . . . . 2.7200000000000002 109.26 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.7 t -87.55 92.19 9.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.486 -1.301 . . . . 0.48999999999999999 107.486 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.73 -172.71 9.94 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.501 1.048 . . . . 0.95999999999999996 114.797 -168.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -61.63 145.46 52.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.856 -0.791 . . . . 4.5800000000000001 109.321 168.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.51 10.3 86.02 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.159 -0.776 . . . . 1.0800000000000001 111.159 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -135.2 167.92 20.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.474 1.11 . . . . 2.21 108.126 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 13.9 ttmt -145.46 132.32 20.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.744 1.218 . . . . 3.4300000000000002 108.205 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -92.0 123.77 35.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.215 1.006 . . . . 0.64000000000000001 109.293 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.9 mm -107.71 111.56 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 106.417 -1.697 . . . . 3.0099999999999998 106.417 169.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.98 166.21 16.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.771 -0.455 . . . . 3.52 109.771 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.62 134.13 4.46 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.803 0.716 . . . . 2.3399999999999999 112.798 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 m -144.29 98.5 3.22 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.444 -2.058 . . . . 4.3600000000000003 105.444 -175.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t0 78.05 61.76 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.907 2.083 . . . . 5.8099999999999996 110.73 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.53 29.88 74.87 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.818 0.723 . . . . 2.7599999999999998 113.452 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -104.53 173.87 6.12 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.653 1.981 . . . . 3.9199999999999999 110.606 173.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -96.27 176.86 5.91 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.251 2.62 . . . . 4.25 109.073 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -72.62 144.21 47.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.876 -0.583 . . . . 3.2999999999999998 111.371 172.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -142.11 124.18 15.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.269 1.428 . . . . 3.8999999999999999 110.165 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.4 t -97.81 102.22 13.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.454 1.025 . . . . 0.46999999999999997 109.881 174.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.8 m -91.47 162.7 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.195 0.598 . . . . 1.6799999999999999 109.916 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 t -79.71 152.8 29.69 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.778 -0.823 . . . . 2.8399999999999999 108.778 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.75 -114.58 0.76 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.706 -1.358 . . . . 2.71 109.706 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -162.8 156.84 20.72 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.335 1.454 . . . . 4.4900000000000002 107.816 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.8 170.37 30.6 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.703 -0.959 . . . . 0.90000000000000002 110.703 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 t -81.04 140.28 49.76 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 117.366 0.583 . . . . 3.48 109.86 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.31 154.75 56.32 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.057 1.838 . . . . 1.3700000000000001 111.673 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.97 133.88 47.61 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.085 0.554 . . . . 4.4900000000000002 110.054 171.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.31 153.18 35.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.741 2.294 . . . . 2.1400000000000001 109.756 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -90.36 141.29 28.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.752 0.821 . . . . 7.0700000000000003 109.511 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.1 m 67.86 174.46 0.27 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.302 1.441 . . . . 5.1500000000000004 111.894 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 118.376 -0.821 . . . . 9.25 110.532 170.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 106.924 -1.51 . . . . 5.4299999999999997 106.924 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.8 t -124.83 141.94 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 106.576 -1.639 . . . . 3.71 106.576 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -117.2 160.1 21.59 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.313 1.445 . . . . 3.4700000000000002 108.504 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 79.0 p -143.31 173.22 11.79 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.679 1.192 . . . . 2.3799999999999999 108.683 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.71 162.2 8.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.503 0.668 . . . . 2.1000000000000001 112.391 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -83.64 165.91 18.59 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 115.65 -0.704 . . . . 1.3500000000000001 111.4 169.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -126.68 9.0 6.99 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.512 0.725 . . . . 1.76 112.592 -174.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -156.98 161.89 39.59 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.514 1.125 . . . . 2.8100000000000001 109.007 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -81.91 157.69 24.24 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 122.767 0.427 . . . . 0.70999999999999996 110.439 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.26 21.94 69.09 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 119.696 -1.24 . . . . 0.56000000000000005 110.328 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -110.64 165.92 11.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.523 0.729 . . . . 2.3700000000000001 109.14 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -144.23 -179.3 6.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.745 1.157 . . . . 1.0700000000000001 110.612 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 mt 58.46 54.84 5.26 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.62 1.168 . . . . 3.4399999999999999 111.388 175.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.6 p -165.01 164.96 20.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.427 1.091 . . . . 1.0600000000000001 108.172 -175.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.2 mt -75.4 120.82 21.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.073 -1.084 . . . . 1.6799999999999999 108.073 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.1 t -123.07 -63.43 1.26 Allowed 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 108.109 -1.071 . . . . 0.56000000000000005 108.109 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -90.82 88.9 7.25 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.715 1.206 . . . . 3.0600000000000001 109.338 168.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.32 -135.21 42.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.393 -1.483 . . . . 0.56000000000000005 109.393 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -81.78 -6.06 58.73 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.046 0.923 . . . . 1.6599999999999999 111.604 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -76.51 123.98 26.88 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.184 -0.948 . . . . 2.29 108.662 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.8 t -83.2 136.87 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.156 -0.683 . . . . 3.5 109.156 -176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.5 t -77.96 94.36 4.59 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.907 -0.496 . . . . 0.65000000000000002 110.869 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.24 165.66 9.18 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.239 0.923 . . . . 1.01 114.156 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -57.34 151.53 15.97 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.876 -1.367 . . . . 4.4199999999999999 113.249 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.36 0.32 86.72 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.07 1.319 . . . . 0.75 111.305 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -130.91 161.47 31.79 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.072 2.549 . . . . 2.1099999999999999 108.642 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 145.83 33.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.641 1.176 . . . . 3.6099999999999999 108.307 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.72 126.42 40.97 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.134 2.174 . . . . 0.47999999999999998 108.688 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.3 mp -97.81 114.19 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 106.168 -1.789 . . . . 3.0499999999999998 106.168 170.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -73.0 76.41 1.19 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.828 1.251 . . . . 3.2400000000000002 109.038 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.27 150.18 4.61 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.119 -0.793 . . . . 3.0099999999999998 111.119 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.0 p -147.88 64.22 1.11 Allowed 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.993 -0.71 . . . . 5.5300000000000002 110.024 -175.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.0 t0 87.38 61.49 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.688 1.995 . . . . 6.0499999999999998 109.715 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.98 -12.61 10.98 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.341 -0.849 . . . . 2.7799999999999998 113.989 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -61.98 161.92 9.95 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 123.016 1.388 . . . . 3.52 110.752 164.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -86.55 177.55 7.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.681 2.392 . . . . 6.0599999999999996 108.436 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -43.25 149.64 0.23 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.622 0.971 . . . . 1.76 113.622 164.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.73 105.58 1.62 Allowed 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.518 1.127 . . . . 4.2000000000000002 111.78 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.2 t -80.99 100.31 8.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 125.071 1.348 . . . . 0.67000000000000004 109.325 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -107.72 176.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.772 0.829 . . . . 1.96 108.879 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.04 178.38 5.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.79 -0.569 . . . . 2.9199999999999999 110.286 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.83 155.4 31.77 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.826 -1.71 . . . . 2.1899999999999999 108.826 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -81.3 165.67 21.19 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 117.458 0.629 . . . . 3.48 109.918 -171.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.91 -179.13 38.01 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.355 -1.498 . . . . 1.3300000000000001 109.355 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -93.19 148.79 36.33 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 117.416 0.608 . . . . 3.0 110.165 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -73.66 173.3 14.14 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.552 1.501 . . . . 1.1000000000000001 111.137 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 132.09 21.22 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.887 0.875 . . . . 3.1400000000000001 108.95 177.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.4 149.89 57.32 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.384 1.39 . . . . 2.1400000000000001 110.802 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -72.38 154.87 40.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.148 0.979 . . . . 7.0199999999999996 109.938 174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.56 158.73 17.3 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.614 1.166 . . . . 5.4100000000000001 108.294 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 106.35 -1.722 . . . . 12.07 106.35 178.414 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 104.931 -2.248 . . . . 5.0999999999999996 104.931 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.6 t -97.85 147.51 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.174 -1.047 . . . . 4.1500000000000004 108.174 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -108.55 -176.17 2.97 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.94 1.296 . . . . 2.3799999999999999 109.193 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.9 p -127.3 166.43 17.81 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.965 0.906 . . . . 2.1299999999999999 108.917 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.87 164.96 25.11 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.365 0.984 . . . . 2.29 109.684 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -82.48 157.13 23.73 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.113 -1.035 . . . . 1.0900000000000001 109.397 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.1 p -121.64 -18.24 7.23 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.02 0.748 . . . . 1.8500000000000001 113.02 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.24 155.08 43.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.998 1.719 . . . . 2.46 107.182 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -69.79 150.65 46.65 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.305 0.957 . . . . 0.66000000000000003 109.888 173.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.66 -1.13 71.35 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.741 -0.477 . . . . 0.64000000000000001 112.348 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -91.72 163.3 14.13 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.292 0.637 . . . . 2.4399999999999999 110.544 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -150.52 -178.96 6.85 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.553 -0.717 . . . . 1.3999999999999999 109.288 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mp 62.23 38.49 13.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.512 1.125 . . . . 3.2799999999999998 110.398 -167.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -149.16 152.26 35.77 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.922 0.889 . . . . 1.05 110.232 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.8 mt -66.02 135.23 54.38 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.28 1.432 . . . . 1.6100000000000001 107.67 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.9 t -140.84 -63.94 0.46 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.283 -1.377 . . . . 0.68999999999999995 107.283 -168.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.42 89.15 7.89 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.184 -1.043 . . . . 3.27 108.184 168.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.75 -128.92 48.11 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.532 -1.427 . . . . 0.52000000000000002 109.532 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 t -84.23 9.77 12.04 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.954 0.877 . . . . 1.6200000000000001 112.432 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -91.33 117.99 30.13 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.797 1.181 . . . . 2.6299999999999999 107.831 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.48 128.74 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.842 -0.617 . . . . 2.4700000000000002 109.453 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.0 t -72.83 85.23 1.23 Allowed 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.347 0.594 . . . . 0.48999999999999999 109.913 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.27 167.62 9.58 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 126.331 1.92 . . . . 0.92000000000000004 114.049 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -55.6 152.44 9.2 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.307 -1.702 . . . . 4.4000000000000004 112.019 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.02 12.0 84.58 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.338 0.97 . . . . 0.89000000000000001 112.827 -173.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -138.7 170.1 16.6 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.67 3.188 . . . . 3.7999999999999998 108.934 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.34 136.7 14.04 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.544 1.538 . . . . 3.02 109.524 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.4 t -94.48 126.52 39.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.211 -1.403 . . . . 0.45000000000000001 107.211 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.6 mm -101.43 113.53 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.925 -1.509 . . . . 3.02 106.925 170.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mt -89.07 85.69 6.74 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.503 1.521 . . . . 3.3700000000000001 107.723 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.0 135.09 6.24 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.224 -0.75 . . . . 3.4199999999999999 111.224 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.06 99.45 2.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 104.65 -2.352 . . . . 5.6699999999999999 104.65 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 42.82 47.7 4.81 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.523 1.154 . . . . 8.0500000000000007 112.745 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.72 34.31 25.25 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.487 1.518 . . . . 3.8100000000000001 112.951 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -97.66 169.65 9.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 123.017 1.389 . . . . 3.9700000000000002 112.405 169.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -85.11 177.99 7.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.663 2.385 . . . . 4.0800000000000001 109.212 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -62.38 127.14 29.91 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.283 0.633 . . . . 2.6400000000000001 110.431 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -135.08 123.77 23.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.425 1.89 . . . . 5.1200000000000001 111.346 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 39.0 t -95.81 101.99 13.74 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.603 1.961 . . . . 0.37 110.246 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.83 158.7 3.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 123.927 0.891 . . . . 1.8100000000000001 110.099 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.41 167.71 16.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.832 -0.543 . . . . 3.6899999999999999 110.226 176.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.97 -110.8 0.83 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.691 -1.763 . . . . 2.7599999999999998 108.691 170.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -156.7 165.31 36.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.067 -1.827 . . . . 3.0099999999999998 106.067 171.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.62 168.32 38.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.366 -1.494 . . . . 1.1399999999999999 109.366 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.9 t -82.78 132.77 50.49 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.268 -0.642 . . . . 3.23 109.268 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.77 132.22 18.29 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.273 1.315 . . . . 0.90000000000000002 110.252 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -55.31 119.25 22.37 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.774 -0.632 . . . . 3.1400000000000001 110.008 174.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.3 146.78 40.85 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.287 1.325 . . . . 1.8500000000000001 108.851 172.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -92.69 153.1 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.316 1.046 . . . . 7.0899999999999999 109.618 169.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.4 m -163.58 -41.57 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.385 1.074 . . . . 4.9500000000000002 110.575 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.5 p80 . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 125.211 1.404 . . . . 10.289999999999999 112.682 -176.018 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 107.775 -1.195 . . . . 2.55 107.775 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.6 p -123.7 168.47 12.64 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.995 -0.743 . . . . 0.89 108.995 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -65.85 170.46 5.37 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.215 0.606 . . . . 2.11 109.718 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.19 143.38 28.01 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.502 -0.749 . . . . 1.09 111.266 171.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.484 HG23 ' HE3' ' A' ' 47' ' ' LYS . 10.2 p -97.85 -22.78 16.17 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.179 1.177 . . . . 1.29 114.179 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -133.32 160.84 36.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.343 0.974 . . . . 2.57 109.197 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -75.89 154.81 35.78 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.5 110.292 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.54 22.77 66.44 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.313 -0.715 . . . . 0.54 111.313 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -108.15 147.67 30.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.907 0.883 . . . . 2.15 109.944 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -115.17 176.85 4.88 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.758 0.823 . . . . 1.04 110.979 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.57 42.93 4.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.783 0.833 . . . . 2.17 111.316 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.4 p -148.44 155.43 41.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.666 0.786 . . . . 1.46 109.201 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.4 mt -69.98 133.81 47.67 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.723 0.809 . . . . 0.59 109.548 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 t -143.14 -63.06 0.41 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.44 -0.948 . . . . 1.03 108.44 -168.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -85.01 87.79 7.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.544 0.688 . . . . 3.64 109.97 161.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.64 -136.33 51.21 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.582 -1.407 . . . . 0.52 109.582 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.7 t -77.5 4.92 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 117.95 0.875 . . . . 0.77 112.445 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -86.21 125.35 33.49 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 119.754 1.161 . . . . 1.78 108.095 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.3 t -74.17 140.12 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.785 0.834 . . . . 2.07 108.939 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.4 t -73.67 90.38 1.81 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.714 0.769 . . . . 0.52 109.165 169.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.96 156.98 1.91 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.948 2.213 . . . . 1.02 113.786 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -53.78 144.38 18.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.484 -0.421 . . . . 3.4 111.626 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.47 -2.42 72.24 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.581 -0.566 . . . . 0.93 112.572 -174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -122.75 153.5 39.39 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.489 1.516 . . . . 1.66 107.839 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 156.15 48.34 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.07 0.85 . . . . 2.41 112.044 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.6 t -102.1 127.17 49.12 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.437 -2.061 . . . . 0.65 105.437 -170.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.511 ' N ' HD12 ' A' ' 29' ' ' ILE . 2.1 mp -94.11 114.15 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 103.678 -2.712 . . . . 1.62 103.678 170.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 105.972 -1.862 . . . . 2.05 105.972 165.529 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 m120 . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 109.099 -0.704 . . . . 2.05 109.099 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -126.35 113.55 17.06 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.751 0.82 . . . . 2.6 110.809 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -91.77 119.68 31.81 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.811 -0.811 . . . . 0.47 108.811 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -128.41 152.35 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-N 118.275 0.489 . . . . 0.74 109.852 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -64.48 159.41 21.57 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.798 0.439 . . . . 2.11 110.925 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.39 -103.98 0.26 Allowed Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.099 -1.601 . . . . 2.69 109.099 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.55 160.31 8.96 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.671 1.588 . . . . 3.89 107.126 168.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.64 166.8 38.14 Favored Glycine 0 N--CA 1.467 0.713 0 N-CA-C 110.531 -1.027 . . . . 0.83 110.531 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.7 m -76.44 140.8 68.93 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.948 0.899 . . . . 1.68 110.09 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.03 131.65 13.33 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.29 1.327 . . . . 0.87 111.527 173.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HE3' HG23 ' A' ' 7' ' ' THR . 44.6 tttt . . . . . 0 CA--C 1.552 1.051 0 C-N-CA 124.117 0.967 . . . . 2.65 111.681 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 108.477 -0.934 . . . . 2.06 108.477 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.9 p -140.82 162.48 35.34 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.038 1.335 . . . . 1.43 109.382 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.56 162.39 27.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.309 1.044 . . . . 1.99 112.296 -173.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.3 m -87.28 162.04 17.63 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.357 -0.979 . . . . 0.96 108.357 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -123.93 13.22 9.13 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.887 -0.578 . . . . 1.1 112.443 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -176.79 163.8 2.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.516 1.526 . . . . 2.65 109.395 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -79.28 161.28 26.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.568 0.747 . . . . 0.57 111.306 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.85 7.77 59.6 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.282 1.896 . . . . 0.48 113.289 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.12 -178.3 5.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.518 0.727 . . . . 2.92 109.234 -175.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -166.53 -179.5 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 119.612 1.097 . . . . 0.91 109.199 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tp 68.69 31.84 4.42 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.229 0.612 . . . . 2.81 109.876 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.84 161.22 41.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.964 1.306 . . . . 1.22 108.635 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -74.27 104.68 5.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.534 -1.654 . . . . 0.68 106.534 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -89.93 -63.92 1.21 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.993 -1.114 . . . . 1.32 107.993 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -96.74 125.93 41.55 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.229 1.411 . . . . 4.63 108.997 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.33 -127.76 6.76 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.714 0.673 . . . . 0.86 112.003 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.5 t -96.42 14.32 24.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.65 0.78 . . . . 1.09 111.281 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -88.41 113.87 24.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.764 0.793 . . . . 3.02 109.026 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.37 125.88 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.546 -0.752 . . . . 1.78 109.977 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -97.3 72.34 2.41 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.783 -0.821 . . . . 0.9 108.783 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.78 -174.21 12.51 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 122.168 0.871 . . . . 1.37 114.873 -171.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -50.19 143.83 7.92 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.477 -1.014 . . . . 3.45 111.343 166.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.0 -8.16 71.5 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 123.797 0.713 . . . . 1.07 111.673 -167.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -132.11 162.76 30.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.24 1.416 . . . . 1.69 109.44 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.04 135.7 36.14 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 127.676 2.39 . . . . 2.61 108.486 -174.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 t -94.45 142.81 27.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.581 1.152 . . . . 0.94 109.058 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.9 mm -124.0 117.0 49.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.769 -1.937 . . . . 1.19 105.769 172.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.321 0 C-N-CA 124.786 1.234 . . . . 2.58 109.815 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.532 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 119.467 -0.301 . . . . 2.08 111.347 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -142.21 127.55 18.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.617 0.767 . . . . 3.29 109.217 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.9 t -96.35 105.43 17.5 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.679 0.672 . . . . 0.43 109.544 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -95.99 174.75 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.351 1.06 . . . . 0.74 109.577 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.1 166.76 18.44 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.842 0.857 . . . . 2.31 111.272 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.69 121.74 3.58 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 109.87 -1.292 . . . . 2.33 109.87 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -51.36 123.15 9.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.656 1.182 . . . . 3.21 112.68 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.43 -168.11 32.72 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.575 1.083 . . . . 1.04 112.916 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.5 m -85.15 124.19 72.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.282 1.033 . . . . 1.98 110.378 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -74.73 135.0 19.01 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-N 120.95 1.375 . . . . 0.83 111.427 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.4 tttm . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 123.488 0.715 . . . . 2.63 111.753 178.41 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 108.695 -0.854 . . . . 2.28 108.695 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -120.15 166.43 13.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.9 1.28 . . . . 0.99 110.139 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.69 163.26 26.02 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.674 1.19 . . . . 1.68 112.257 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.4 m -86.07 143.96 27.8 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.084 -0.71 . . . . 1.24 109.084 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -115.56 15.08 16.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.257 0.623 . . . . 1.45 111.815 -172.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.12 145.8 0.64 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.63 1.572 . . . . 3.53 109.645 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -70.52 151.49 45.02 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 120.862 0.363 . . . . 0.37 110.643 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.45 0.17 89.91 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.551 -0.62 . . . . 0.61 111.551 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -98.19 168.7 10.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.06 0.944 . . . . 2.52 109.845 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -148.15 -170.9 3.7 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.921 -0.487 . . . . 0.93 110.606 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.448 HD22 ' HB3' ' A' ' 46' ' ' PRO . 2.3 mp 60.31 37.67 20.15 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.734 0.778 . . . . 2.19 110.128 -176.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.4 p -150.21 147.49 27.76 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.959 1.303 . . . . 0.93 108.845 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 mt -63.02 113.51 3.15 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 126.896 2.078 . . . . 0.69 108.409 -176.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.5 t -109.94 -63.72 1.34 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.854 -1.536 . . . . 0.58 106.854 -170.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -98.11 97.83 9.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.354 1.062 . . . . 3.46 108.327 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.46 -136.2 39.3 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.924 -1.271 . . . . 0.51 109.924 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.05 -3.84 55.49 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.541 0.736 . . . . 1.11 112.293 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -78.08 117.92 19.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.915 -0.772 . . . . 1.53 108.915 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p -73.31 139.44 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.102 0.561 . . . . 1.73 109.495 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.4 t -74.14 96.93 2.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.099 -0.704 . . . . 0.43 109.099 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.25 169.1 8.09 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.155 0.883 . . . . 0.71 113.69 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.08 147.1 40.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.499 -1.0 . . . . 3.58 111.273 173.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.62 81.77 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.578 -0.609 . . . . 0.72 111.578 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -142.58 161.52 37.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.068 2.147 . . . . 1.47 109.122 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -139.75 138.89 36.29 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.402 2.281 . . . . 2.05 109.715 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -90.41 120.31 31.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.59 1.556 . . . . 0.49 108.582 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.9 mp -94.5 117.32 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 107.082 -1.451 . . . . 1.35 107.082 170.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 N--CA 1.455 -0.219 0 O-C-N 123.845 0.716 . . . . 2.25 109.292 172.373 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 108.463 -0.94 . . . . 2.43 108.463 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -126.13 123.58 38.62 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.242 0.617 . . . . 3.03 110.53 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -92.88 88.59 6.25 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.266 0.626 . . . . 0.65 109.536 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 m -85.55 168.08 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 C-N-CA 123.303 0.641 . . . . 0.63 109.362 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.21 171.16 14.99 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.48 -0.762 . . . . 2.34 112.01 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.55 132.03 7.16 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 108.496 -1.842 . . . . 2.13 108.496 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.76 142.7 55.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.011 1.406 . . . . 3.68 110.901 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -139.5 164.28 25.99 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.569 -1.412 . . . . 1.03 109.569 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.0 m -75.63 142.61 74.14 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.509 1.124 . . . . 1.95 109.757 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.448 ' HB3' HD22 ' A' ' 13' ' ' LEU . 56.0 Cg_endo -74.48 151.83 42.78 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.541 2.16 . . . . 1.16 111.652 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.37 0 C-N-CA 122.928 0.491 . . . . 2.81 111.825 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 109.963 -0.384 . . . . 1.86 109.963 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.4 p -144.95 165.99 26.56 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.146 1.379 . . . . 1.22 109.275 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.02 166.57 20.66 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.785 0.72 . . . . 2.34 112.049 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -88.14 157.68 18.76 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 108.226 -1.028 . . . . 0.97 108.226 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.6 p -103.4 -39.0 6.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.813 0.845 . . . . 1.38 110.88 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.6 161.0 35.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.282 1.033 . . . . 2.59 110.179 -175.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -70.05 150.55 46.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.932 0.872 . . . . 0.4 110.944 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.45 10.67 85.58 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.212 1.387 . . . . 0.39 113.249 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -77.04 179.92 5.95 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.927 0.863 . . . . 2.65 110.213 172.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -158.05 -176.71 6.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.504 1.522 . . . . 0.73 107.999 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp 67.43 36.1 3.99 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.052 1.341 . . . . 2.65 111.398 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.25 159.02 38.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.504 2.722 . . . . 1.17 107.987 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 mt -70.09 116.2 10.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.331 -1.729 . . . . 0.56 106.331 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -95.23 -64.43 1.06 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.847 -1.168 . . . . 1.3 107.847 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -109.59 120.16 41.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.288 1.435 . . . . 2.8 108.072 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 53.58 -128.72 39.87 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.416 -1.074 . . . . 0.82 110.416 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 t -98.25 15.7 23.69 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.202 0.601 . . . . 1.0 111.241 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -88.28 118.13 27.68 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.226 -1.027 . . . . 2.28 108.226 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.03 116.39 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.809 0.844 . . . . 2.07 110.65 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.9 t -89.92 78.45 6.77 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.351 -0.981 . . . . 0.66 108.351 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.72 -172.5 25.52 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 123.417 0.532 . . . . 1.18 114.362 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -56.82 144.98 31.0 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 121.417 -1.049 . . . . 4.61 111.065 168.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.97 -7.66 81.27 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.196 0.903 . . . . 1.08 111.285 -168.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -125.82 171.2 10.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.448 1.099 . . . . 2.15 109.227 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -142.67 139.28 31.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.639 1.175 . . . . 2.75 107.889 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.2 t -95.59 143.88 26.51 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 123.852 0.861 . . . . 0.83 109.477 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.6 mm -118.84 118.3 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 127.206 2.202 . . . . 1.24 106.709 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 126.308 1.843 . . . . 2.15 107.706 169.497 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 . . . . . 0 C--O 1.225 -0.223 0 N-CA-C 109.659 -0.497 . . . . 1.79 109.659 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -139.71 126.79 21.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.287 1.035 . . . . 3.34 111.415 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.7 t -95.63 108.23 20.49 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.768 1.227 . . . . 0.46 109.812 174.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.8 m -94.55 166.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.889 0.876 . . . . 0.78 108.931 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.8 t -79.65 156.78 27.45 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.378 -0.826 . . . . 1.79 108.796 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.32 -113.05 0.62 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.633 -1.387 . . . . 2.83 109.633 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -170.21 147.35 3.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.805 2.042 . . . . 4.57 106.666 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.57 177.01 24.25 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 118.938 0.79 . . . . 0.73 111.384 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.8 m -86.11 131.5 46.4 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.81 -0.614 . . . . 1.69 109.404 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.36 140.87 59.8 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.266 1.311 . . . . 0.8 110.101 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 118.673 -0.68 . . . . 3.09 110.459 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 109.186 -0.672 . . . . 1.95 109.186 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.6 p -121.89 171.57 8.82 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.882 0.873 . . . . 0.98 110.943 171.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.13 163.26 5.0 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.789 0.835 . . . . 2.01 112.367 172.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.53 163.22 18.53 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.223 1.009 . . . . 1.11 110.823 172.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.9 p -129.44 15.28 6.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.757 0.823 . . . . 1.1 112.642 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.29 154.28 24.97 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.351 0.978 . . . . 3.3 110.147 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -82.45 136.92 34.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.339 0.655 . . . . 0.55 110.742 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.69 19.35 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.721 -0.551 . . . . 0.41 111.721 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.25 145.36 47.93 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.046 0.538 . . . . 2.4 110.717 -168.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -117.84 -178.63 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.893 0.877 . . . . 0.93 110.471 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp 62.08 49.29 4.59 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.14 0.971 . . . . 2.07 110.565 174.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -160.77 160.33 31.15 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.409 1.084 . . . . 1.26 108.313 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.7 mt -75.38 113.86 13.25 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.29 1.036 . . . . 0.69 108.971 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -116.41 -64.07 1.36 Allowed 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.196 -1.038 . . . . 0.67 108.196 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.58 91.27 6.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.248 -1.39 . . . . 3.09 107.248 171.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.21 -132.0 52.33 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.347 -1.101 . . . . 0.42 110.347 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.6 t -83.08 5.3 22.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.987 0.893 . . . . 0.6 112.158 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -89.5 123.52 33.69 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.243 0.928 . . . . 2.4 108.563 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.48 137.04 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.086 0.554 . . . . 1.49 110.19 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.7 t -75.95 92.28 3.11 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.282 -0.636 . . . . 0.63 109.282 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.24 156.73 8.33 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.752 1.168 . . . . 0.89 112.599 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -51.86 155.28 1.8 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.743 -0.857 . . . . 3.81 112.722 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.72 1.4 89.25 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.028 0.823 . . . . 0.76 113.357 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -135.26 156.81 48.35 Favored 'General case' 0 N--CA 1.448 -0.571 1 C-N-CA 131.998 4.119 . . . . 2.16 108.578 179.211 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.95 154.27 48.3 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.719 1.608 . . . . 2.57 110.588 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.5 t -95.23 128.53 42.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.598 1.559 . . . . 0.43 108.809 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.3 mm -101.51 114.61 41.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.772 -1.936 . . . . 1.44 105.772 170.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 124.196 0.998 . . . . 2.07 109.104 172.33 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 118.272 -0.87 . . . . 2.52 110.386 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -135.65 124.74 24.38 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 118.725 -0.655 . . . . 3.48 111.922 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.4 t -92.99 101.71 14.05 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.734 1.152 . . . . 0.33 109.144 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -104.39 158.59 5.38 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 C-N-CA 123.567 0.747 . . . . 0.58 109.065 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -71.16 176.04 4.8 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 119.864 -0.734 . . . . 1.96 111.207 -179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.3 129.48 6.31 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 108.097 -2.001 . . . . 2.13 108.097 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.37 132.62 48.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.022 -0.733 . . . . 2.95 109.022 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.99 -159.21 10.19 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.968 -1.653 . . . . 1.03 108.968 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.89 142.5 26.34 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.36 0.664 . . . . 1.54 110.145 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.06 138.98 31.95 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.418 2.079 . . . . 0.73 110.696 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 tttm . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 118.794 -0.622 . . . . 2.38 111.066 179.194 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 110.045 -0.354 . . . . 1.76 110.045 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.0 p -142.6 169.04 18.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.935 1.294 . . . . 0.97 109.678 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.63 171.0 12.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.193 0.451 . . . . 1.79 110.469 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.4 m -85.63 153.92 22.04 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.595 -0.891 . . . . 1.23 108.595 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 p -103.11 -34.37 8.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.317 1.047 . . . . 1.49 111.632 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -133.54 162.65 31.34 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.501 1.12 . . . . 3.05 109.549 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.61 138.06 35.4 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.843 0.457 . . . . 0.58 110.856 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.67 26.26 13.6 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.929 -0.868 . . . . 0.4 110.929 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.15 151.66 43.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.364 0.666 . . . . 2.48 110.679 -172.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -124.31 -179.74 4.58 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.706 0.802 . . . . 1.1 111.08 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.3 mt 60.46 49.76 6.5 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.871 1.268 . . . . 2.16 110.603 -171.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -157.98 147.44 19.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.118 0.567 . . . . 0.9 110.066 174.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.1 mt -64.27 129.64 40.72 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 125.976 1.711 . . . . 0.64 108.208 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.9 t -131.14 -63.76 0.84 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 106.462 -1.681 . . . . 0.94 106.462 -168.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.56 92.44 6.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.39 -1.707 . . . . 3.3 106.39 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.1 -133.53 39.81 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.28 -1.128 . . . . 0.7 110.28 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 t -84.73 0.1 51.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.886 0.475 . . . . 0.77 111.216 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -80.75 119.34 23.22 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.845 -1.169 . . . . 1.86 107.845 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.46 137.15 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.712 -0.847 . . . . 1.73 108.712 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.4 t -73.63 95.84 2.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.161 -1.052 . . . . 0.51 108.161 170.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.42 168.89 33.93 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.059 0.838 . . . . 0.68 112.975 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -57.68 153.6 13.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.02 0.928 . . . . 3.76 111.732 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.67 -5.91 76.16 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.844 0.735 . . . . 0.71 112.224 -172.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.96 169.14 17.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.044 2.538 . . . . 1.51 106.732 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 pttt -151.3 148.77 28.57 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.665 1.186 . . . . 1.97 108.658 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.7 t -104.06 132.2 50.56 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.1 1.36 . . . . 0.59 109.242 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.475 ' N ' HD12 ' A' ' 29' ' ' ILE . 2.9 mp -102.0 128.0 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.2 -1.407 . . . . 1.33 107.2 173.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.342 0.256 0 N-CA-C 108.908 -0.775 . . . . 2.17 108.908 173.756 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.6 m120 . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 109.203 -0.666 . . . . 2.58 109.203 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -133.63 113.18 12.1 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 119.215 -0.422 . . . . 3.2 110.893 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.1 t -94.65 108.05 20.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.042 -0.725 . . . . 0.37 109.042 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.38 154.04 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.826 -0.805 . . . . 0.57 108.826 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -69.72 163.63 25.27 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.972 -0.455 . . . . 1.9 111.292 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.62 127.36 4.57 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.243 -1.943 . . . . 2.13 108.243 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -47.86 146.98 2.16 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.243 1.022 . . . . 4.38 110.729 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.49 175.09 27.01 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.501 -1.839 . . . . 0.71 108.501 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.9 m -73.64 136.83 77.39 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.286 0.634 . . . . 1.63 109.583 177.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.76 139.35 33.49 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.13 1.886 . . . . 0.85 109.507 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.2 tttt . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 119.13 -0.462 . . . . 2.75 110.857 -178.788 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 109.002 -0.74 . . . . 2.03 109.002 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 p -143.76 170.68 15.41 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.557 1.543 . . . . 1.23 107.823 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.52 163.37 27.01 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.658 0.783 . . . . 2.03 112.295 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.54 167.33 17.47 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.89 0.476 . . . . 1.35 111.666 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -120.01 -41.03 2.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.88 1.272 . . . . 1.36 112.776 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -110.01 161.03 15.91 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.207 0.912 . . . . 2.74 110.873 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.33 148.36 29.42 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 121.384 0.611 . . . . 0.42 111.303 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.46 3.71 90.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 115.838 -0.619 . . . . 0.42 112.154 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.54 170.07 15.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.345 -1.354 . . . . 2.41 107.345 171.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -153.2 -171.91 4.07 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.318 -0.864 . . . . 0.72 109.892 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tp 59.79 53.61 4.76 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.682 1.593 . . . . 2.21 110.654 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.7 p -166.83 160.82 14.9 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 126.649 1.98 . . . . 1.03 107.036 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.5 141.31 51.98 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.452 0.701 . . . . 0.66 109.557 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.3 t -142.07 -64.15 0.43 Allowed 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 118.226 -1.39 . . . . 0.69 108.702 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -92.83 91.73 7.59 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.597 -1.26 . . . . 3.26 107.597 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.5 -130.48 51.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.366 -1.494 . . . . 0.58 109.366 -175.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 t -87.13 12.15 12.25 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 117.176 0.488 . . . . 0.61 111.867 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -87.04 125.06 33.86 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.084 -1.01 . . . . 1.9 109.422 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.0 t -75.61 123.18 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.193 -1.04 . . . . 1.95 108.193 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.6 t -76.27 85.82 3.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.856 -0.794 . . . . 0.57 108.856 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.02 -175.41 9.17 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 115.147 0.819 . . . . 0.84 115.147 -170.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.5 148.71 22.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.955 -0.732 . . . . 4.36 109.748 165.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.65 4.01 90.27 Favored Glycine 0 CA--C 1.538 1.527 0 N-CA-C 111.427 -0.669 . . . . 1.11 111.427 -170.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -137.38 174.48 10.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.405 1.103 . . . . 1.7 109.571 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.46 133.35 18.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.953 1.301 . . . . 2.68 109.914 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -102.82 118.09 36.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.668 -0.864 . . . . 0.57 108.668 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 29' ' ' ILE . 2.5 mp -101.76 122.35 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.146 -1.798 . . . . 1.45 106.146 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 CA--C 1.53 0.2 0 C-N-CA 123.253 0.621 . . . . 2.39 109.623 172.173 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 118.888 -0.577 . . . . 3.0 110.086 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -134.01 120.08 19.8 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.564 -0.731 . . . . 2.98 110.685 -176.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 50.6 t -101.59 107.08 18.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.707 1.139 . . . . 0.44 110.086 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 m -102.85 162.18 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 121.66 -0.65 . . . . 0.6 109.364 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -75.04 150.98 38.74 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.157 -0.683 . . . . 1.91 109.157 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.15 -116.5 0.8 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.585 -1.406 . . . . 2.84 109.585 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -167.19 142.42 4.05 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.943 1.297 . . . . 4.04 108.699 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.8 170.52 30.6 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.425 1.488 . . . . 0.61 109.906 -169.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -98.24 138.21 20.86 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 117.684 0.742 . . . . 2.1 110.08 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.64 143.16 61.18 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.873 1.715 . . . . 0.87 110.317 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.1 tttp . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 118.994 -0.527 . . . . 2.99 110.83 178.563 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.613 ' CE1' HG21 ' A' ' 21' ' ' VAL . 13.4 m-85 . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 109.889 -0.412 . . . . 1.82 109.889 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.8 p -138.17 164.68 28.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.733 1.213 . . . . 1.01 108.642 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -75.33 162.75 28.14 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.56 -0.734 . . . . 2.26 110.917 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.4 m -83.33 140.71 32.28 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.65 1.114 . . . . 1.2 108.614 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -109.59 -11.53 14.77 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.051 0.76 . . . . 1.03 113.051 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.44 145.8 34.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.87 1.668 . . . . 3.86 109.769 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -73.7 158.3 34.94 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.335 1.064 . . . . 0.5 111.373 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.94 15.04 81.2 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.835 -1.075 . . . . 0.56 111.405 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -123.09 156.95 33.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.02 0.928 . . . . 2.81 109.106 -172.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -135.94 -167.68 2.08 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.941 0.896 . . . . 1.2 110.275 -173.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 64.46 38.66 7.41 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.96 0.8 . . . . 2.05 110.235 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -158.0 154.31 27.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.71 0.804 . . . . 1.0 109.655 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -64.95 119.55 10.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.338 -1.727 . . . . 0.54 106.338 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.7 t -118.79 -63.62 1.38 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.261 -1.385 . . . . 0.56 107.261 -173.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -98.51 101.62 13.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.481 1.112 . . . . 4.01 109.01 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.81 -138.64 49.27 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.725 -0.95 . . . . 0.5 110.725 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -83.4 1.83 39.52 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 122.188 -0.596 . . . . 0.6 111.287 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -84.19 116.7 23.07 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.059 -1.46 . . . . 1.52 107.059 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.613 HG21 ' CE1' ' A' ' 3' ' ' TYR . 8.2 p -69.86 136.77 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.906 -0.776 . . . . 1.68 108.906 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.6 t -73.5 93.98 2.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.046 -1.094 . . . . 0.52 108.046 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.97 171.96 16.48 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 122.071 0.817 . . . . 0.67 113.425 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.19 138.27 57.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.459 1.104 . . . . 4.48 112.463 172.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.93 10.3 62.94 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 110.988 -0.845 . . . . 0.78 110.988 -172.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -140.11 163.5 32.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.537 1.935 . . . . 1.47 108.487 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.91 137.61 36.63 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.28 1.832 . . . . 2.37 109.344 176.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -90.63 128.41 36.6 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.615 1.166 . . . . 0.42 108.736 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.7 mm -110.08 111.2 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.469 -1.678 . . . . 1.49 106.469 172.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 N--CA 1.463 0.19 0 C-N-CA 123.846 0.858 . . . . 2.28 110.091 177.833 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.622 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 119.279 -0.391 . . . . 2.18 110.449 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -135.91 107.07 6.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.065 0.946 . . . . 3.11 109.363 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.6 t -82.64 93.66 7.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.604 0.638 . . . . 0.36 109.572 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 m -89.65 164.0 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.465 0.706 . . . . 0.73 109.722 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 t -73.74 167.09 22.1 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.981 -0.449 . . . . 1.93 110.783 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.79 137.47 8.33 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.551 -1.42 . . . . 2.13 109.551 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.5 146.62 54.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.787 1.294 . . . . 3.3 109.899 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.08 -171.41 13.48 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.535 1.064 . . . . 0.99 111.157 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -72.42 131.55 84.69 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.907 1.683 . . . . 1.65 112.322 168.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.9 146.43 20.61 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.763 2.976 . . . . 0.86 110.471 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.2 tmtt? . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 123.48 0.712 . . . . 2.78 109.813 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 109.549 -0.537 . . . . 1.6 109.549 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.2 p -147.58 163.13 37.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.061 1.744 . . . . 0.94 108.327 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -80.29 159.19 25.92 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.013 0.824 . . . . 2.14 111.16 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.6 m -84.2 155.59 22.45 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.588 1.085 . . . . 0.98 108.152 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -114.71 -15.02 11.97 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.702 1.001 . . . . 0.83 113.702 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -144.71 152.18 40.02 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.769 0.828 . . . . 2.51 109.282 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -76.89 144.08 39.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.094 0.473 . . . . 0.54 109.997 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 4.36 76.75 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.931 -0.927 . . . . 0.42 112.424 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -89.78 173.94 7.99 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.383 1.091 . . . . 2.57 108.867 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.0 p30 -151.31 -172.61 4.26 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.814 0.846 . . . . 0.99 109.816 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 66.56 44.16 2.36 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 122.119 0.962 . . . . 2.01 110.037 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -161.2 152.29 18.61 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.722 2.009 . . . . 1.12 108.603 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.5 mt -59.52 134.44 57.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.865 1.266 . . . . 0.65 107.706 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -131.9 -68.4 0.64 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.543 -1.651 . . . . 0.55 106.543 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -90.36 89.94 7.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.065 -1.087 . . . . 3.13 108.065 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.47 -131.65 52.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.102 -1.599 . . . . 0.59 109.102 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.0 t -79.59 6.35 10.76 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.441 -0.79 . . . . 0.75 112.488 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -84.33 118.72 24.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.844 -1.169 . . . . 1.61 107.844 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.4 p -72.12 129.02 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.803 -0.814 . . . . 1.44 108.803 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.1 t -76.44 85.79 3.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.405 -0.961 . . . . 0.42 108.405 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.25 157.95 17.61 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.448 1.499 . . . . 0.72 113.448 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.67 137.35 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.287 1.035 . . . . 4.35 111.57 174.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.1 -34.34 4.73 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 110.924 -0.87 . . . . 0.99 110.924 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -84.54 166.45 17.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.937 -0.764 . . . . 1.78 108.937 173.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -139.95 128.17 22.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.026 1.73 . . . . 2.98 107.722 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.9 t -86.95 135.45 33.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.237 -0.653 . . . . 0.6 109.237 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.1 mm -112.19 123.18 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 104.703 -2.332 . . . . 1.35 104.703 167.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 108.698 -0.853 . . . . 2.08 108.698 167.546 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.3 m120 . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 119.738 -0.172 . . . . 2.14 111.458 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -140.79 124.44 16.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.03 0.932 . . . . 2.67 108.953 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.8 t -103.2 98.98 8.82 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.162 0.985 . . . . 0.41 109.24 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -102.51 179.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.357 0.663 . . . . 0.57 109.382 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.67 140.45 34.93 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.248 -0.649 . . . . 2.23 109.248 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.57 -24.6 0.18 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.167 -1.016 . . . . 2.8 114.323 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 68.49 144.95 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.846 1.658 . . . . 2.8 110.71 -171.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.43 -172.03 24.14 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.96 -1.256 . . . . 0.87 109.96 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 m -73.12 135.5 79.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.122 0.969 . . . . 1.68 111.116 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.99 143.6 36.66 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.754 1.636 . . . . 0.67 110.06 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 111.814 0.301 . . . . 2.29 111.814 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.433 ' HB2' HD21 ' A' ' 15' ' ' LEU . 66.2 m-85 . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 109.478 -0.564 . . . . 1.86 109.478 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.8 p -143.84 164.58 30.14 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.089 0.956 . . . . 0.86 109.275 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.91 165.68 24.69 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.092 0.557 . . . . 2.12 110.679 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.3 m -86.84 142.62 27.94 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.011 -1.107 . . . . 1.29 108.011 -175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 p -106.53 -16.27 14.57 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.664 0.386 . . . . 1.05 111.167 -172.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -147.71 153.47 39.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.485 1.514 . . . . 2.44 109.289 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -71.14 157.8 37.54 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 121.037 0.446 . . . . 0.59 110.968 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.71 5.24 86.19 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.538 -0.625 . . . . 0.53 111.538 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.75 164.86 12.22 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.665 0.786 . . . . 2.37 109.755 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -147.57 -176.98 5.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.364 -0.606 . . . . 1.2 109.364 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 13' ' ' LEU . 5.4 mt 65.51 35.18 7.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.544 1.538 . . . . 2.5 110.259 -174.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.34 151.86 37.25 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.165 -0.68 . . . . 0.92 109.165 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 3' ' ' TYR . 28.8 mt -72.31 108.12 5.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.323 1.449 . . . . 0.93 107.291 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.5 t -106.94 -63.36 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.034 -0.728 . . . . 0.54 109.034 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -95.02 98.95 11.05 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.925 1.29 . . . . 3.9 108.767 169.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.16 -134.11 52.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.67 -0.972 . . . . 0.41 110.67 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.6 t -82.75 -3.0 55.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 117.476 0.638 . . . . 0.77 111.073 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.08 122.43 23.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.042 -1.036 . . . . 1.77 108.34 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.7 126.61 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.563 -0.903 . . . . 2.79 108.563 -173.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.5 t -76.43 90.97 3.27 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.022 -0.423 . . . . 0.63 109.867 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.65 161.44 22.58 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 121.451 -0.781 . . . . 0.76 113.166 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -50.71 154.13 1.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.802 0.841 . . . . 3.71 111.934 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.52 -19.32 44.89 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.123 -0.791 . . . . 1.13 111.123 -173.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -119.62 166.49 13.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.22 2.208 . . . . 1.53 109.716 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 141.06 27.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.454 1.502 . . . . 1.96 110.313 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.6 t -88.1 122.57 31.83 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.341 2.256 . . . . 0.44 108.735 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.9 mp -100.56 123.48 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.082 -1.451 . . . . 1.47 107.082 172.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.548 0.898 0 CA-C-N 119.934 1.243 . . . . 2.05 110.969 -179.005 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 CA--C 1.542 0.639 0 N-CA-C 113.974 1.102 . . . . 2.02 113.974 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.67 115.09 3.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.75 0.82 . . . . 3.75 112.924 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -88.02 110.98 21.02 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.938 1.295 . . . . 0.58 110.547 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.25 155.06 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.119 0.968 . . . . 1.08 109.586 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -64.84 148.96 50.32 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.406 0.283 . . . . 2.22 110.487 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.44 50.41 0.06 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.464 1.03 . . . . 2.92 111.638 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 42.11 83.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.461 2.304 . . . . 5.34 114.829 171.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.72 174.8 44.9 Favored Glycine 0 C--N 1.338 0.673 0 O-C-N 121.477 -0.765 . . . . 0.94 112.632 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.2 m -96.85 134.88 22.49 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.683 1.193 . . . . 2.06 109.503 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.6 152.43 78.2 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.551 1.501 . . . . 0.88 110.836 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 118.677 -0.677 . . . . 2.57 110.928 174.773 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CE1' HG21 ' A' ' 21' ' ' VAL . 17.4 m-85 . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 110.37 -0.233 . . . . 1.88 110.37 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -148.42 170.85 17.08 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.505 1.522 . . . . 0.76 108.125 -175.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -78.36 166.62 22.45 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 118.721 0.691 . . . . 2.09 111.056 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -84.46 170.89 13.05 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 107.503 -1.295 . . . . 1.07 107.503 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 p -134.45 -39.21 0.82 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.877 -0.602 . . . . 1.03 111.093 -170.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -116.98 147.78 42.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.556 1.143 . . . . 2.79 109.992 173.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -74.9 139.38 43.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.826 0.45 . . . . 0.61 110.255 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.69 -2.69 58.78 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.937 -0.465 . . . . 0.65 111.937 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -94.97 174.24 7.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.369 1.068 . . . . 2.56 109.265 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -150.18 -173.32 4.4 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.146 -0.971 . . . . 1.11 110.591 176.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 71.38 38.5 1.03 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.618 1.567 . . . . 2.34 111.982 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.88 153.49 31.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.223 2.609 . . . . 1.05 109.545 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 mt -64.05 127.7 32.56 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.899 1.68 . . . . 0.49 107.917 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.5 t -120.69 -63.98 1.29 Allowed 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.831 -1.174 . . . . 0.53 107.831 -169.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -105.46 106.06 16.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.453 -1.249 . . . . 4.92 107.678 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.2 -136.98 50.47 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.337 -1.105 . . . . 0.52 110.337 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 -3.99 58.47 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.869 0.868 . . . . 1.31 112.525 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -75.26 118.32 18.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.356 -0.979 . . . . 1.55 108.356 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' A' ' 3' ' ' TYR . 5.0 p -72.78 139.26 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.46 -0.57 . . . . 1.64 109.46 175.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.55 97.13 4.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.954 -1.128 . . . . 0.58 107.954 170.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.71 165.86 32.41 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.096 0.855 . . . . 0.68 112.866 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.89 153.49 20.87 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.673 -0.898 . . . . 4.41 111.803 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.34 -0.5 83.49 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 111.555 -0.618 . . . . 0.67 111.555 -172.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -136.29 171.23 14.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.066 2.146 . . . . 1.41 108.081 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -142.7 144.66 32.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.315 1.446 . . . . 2.17 109.484 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -96.88 125.74 41.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.794 1.238 . . . . 0.5 108.211 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.5 mm -97.25 120.37 46.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.794 -2.298 . . . . 1.05 104.794 171.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 109.166 -0.679 . . . . 2.11 109.166 169.99 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 119.614 -0.231 . . . . 1.94 110.73 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -143.92 132.91 22.77 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 118.891 -0.576 . . . . 2.91 110.777 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.6 t -97.3 94.98 7.39 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 118.972 0.805 . . . . 0.45 108.982 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 m -88.25 166.88 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 C-N-CA 123.525 0.73 . . . . 0.7 109.353 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 t -81.23 -173.14 4.16 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.909 1.338 . . . . 1.93 111.8 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.89 133.74 6.57 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.562 -1.815 . . . . 1.97 108.562 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -56.2 137.59 51.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 117.622 0.711 . . . . 4.23 111.003 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.68 172.94 26.23 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.52 -1.032 . . . . 0.88 110.52 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.0 m -84.07 138.74 39.64 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 123.954 0.901 . . . . 1.75 110.559 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -74.35 147.9 37.69 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.342 2.028 . . . . 0.86 111.392 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.5 tttt . . . . . 0 CA--C 1.534 0.351 0 C-N-CA 123.192 0.597 . . . . 2.33 110.962 176.485 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 109.719 -0.474 . . . . 2.61 109.719 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.9 p -146.98 169.21 19.68 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.218 -1.401 . . . . 1.03 107.218 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.99 165.85 5.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.948 0.404 . . . . 1.85 111.589 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.16 151.72 25.58 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.231 0.539 . . . . 1.07 111.933 163.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -117.97 -30.65 5.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.32 1.848 . . . . 1.16 111.705 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.89 155.25 23.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.47 1.108 . . . . 3.38 110.036 173.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -79.16 147.6 32.62 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 122.869 0.468 . . . . 0.43 110.383 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.51 27.11 21.12 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.04 -0.824 . . . . 0.49 111.04 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -127.46 144.63 51.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.137 0.575 . . . . 2.33 110.331 -171.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -114.78 -177.31 3.1 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.066 1.346 . . . . 1.09 109.689 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 13' ' ' LEU . 15.2 mt 52.2 57.69 6.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.121 0.968 . . . . 2.2 111.197 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -163.53 156.57 18.62 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.52 1.128 . . . . 1.22 108.183 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -72.1 130.09 40.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.803 -1.184 . . . . 0.51 107.803 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.7 t -127.66 -62.93 1.05 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.14 -0.689 . . . . 0.57 109.14 -168.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -100.34 108.29 20.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.929 1.292 . . . . 4.22 109.323 164.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.5 -143.58 47.22 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.391 -0.818 . . . . 0.66 111.321 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 t -83.99 5.95 23.78 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.089 0.444 . . . . 0.95 110.691 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -85.65 119.77 26.36 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.646 -1.242 . . . . 1.73 107.646 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.93 139.64 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.408 -0.59 . . . . 1.67 109.408 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.3 t -73.22 85.8 1.41 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.089 0.947 . . . . 0.52 109.813 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.87 157.0 1.84 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.348 1.927 . . . . 0.85 113.141 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -58.91 151.03 22.68 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.901 0.48 . . . . 3.3 111.187 -175.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.32 -10.99 64.51 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.608 -0.551 . . . . 0.82 112.626 -173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -122.01 160.6 24.59 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.5 1.92 . . . . 2.03 108.028 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.04 150.0 43.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.739 1.215 . . . . 2.09 109.358 177.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.1 t -97.59 123.41 41.48 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 125.094 1.358 . . . . 0.5 107.895 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.4 mp -96.2 120.12 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.769 -1.567 . . . . 1.34 106.769 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.523 -0.072 0 C-N-CA 126.784 2.034 . . . . 2.1 110.19 178.801 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 114.649 1.352 . . . . 1.85 114.649 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.72 121.13 7.9 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 124.067 0.947 . . . . 3.17 111.477 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.3 t -92.31 103.3 15.76 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.27 -0.641 . . . . 0.35 109.27 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -111.73 159.87 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.905 0.882 . . . . 0.64 109.599 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.0 149.06 51.16 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.836 0.351 . . . . 2.26 110.394 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.26 114.74 1.76 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.259 -1.936 . . . . 2.29 108.259 -174.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -55.94 121.81 10.16 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.313 -0.625 . . . . 3.24 109.313 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.13 -172.96 16.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.055 1.312 . . . . 0.6 110.214 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 t -96.94 147.36 32.81 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.108 -0.948 . . . . 2.0 109.531 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.96 141.61 24.16 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.292 1.995 . . . . 0.75 112.394 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 119.528 -0.272 . . . . 2.35 111.294 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 109.22 -0.659 . . . . 1.57 109.22 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.1 p -137.83 166.91 22.86 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.635 1.574 . . . . 1.22 108.273 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.88 162.84 21.46 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.412 0.285 . . . . 1.77 111.456 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.7 m -83.71 163.96 19.91 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.255 0.55 . . . . 1.54 111.454 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -123.08 -2.78 8.61 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.42 1.088 . . . . 1.0 112.442 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -139.59 136.17 34.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.908 0.883 . . . . 4.7 109.89 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -60.71 141.67 56.62 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 121.63 -0.669 . . . . 0.37 110.109 174.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.54 -11.01 72.16 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.817 -0.435 . . . . 0.74 112.02 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -72.55 168.72 17.99 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 118.057 0.928 . . . . 2.45 111.194 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -149.29 174.58 12.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.941 0.896 . . . . 0.78 110.249 171.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 74.73 53.36 0.08 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.732 1.213 . . . . 1.99 108.81 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -174.49 162.86 3.55 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.111 1.765 . . . . 1.02 107.173 -169.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.6 mt -79.33 145.53 33.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.716 0.806 . . . . 0.77 109.692 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.5 t -139.21 -63.24 0.52 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.506 -0.77 . . . . 0.73 109.756 -168.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -103.01 109.8 21.48 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.179 -1.045 . . . . 3.56 108.179 165.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.45 -125.37 37.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.577 -1.009 . . . . 0.58 110.577 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.5 t -98.34 9.11 43.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.54 0.736 . . . . 0.84 111.436 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -80.98 119.93 24.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.059 -1.089 . . . . 1.79 108.059 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.7 p -79.88 120.02 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.84 -0.8 . . . . 1.49 108.84 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.7 t -78.65 77.3 5.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.982 -1.118 . . . . 0.83 107.982 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.43 176.9 44.31 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.036 0.351 . . . . 1.09 113.407 -170.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -48.31 146.31 2.86 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.418 0.687 . . . . 4.65 110.77 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.58 -20.75 33.01 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.009 -0.884 . . . . 0.65 111.54 -166.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -124.52 171.2 10.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.065 1.433 . . . . 2.01 109.962 -177.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.74 137.46 29.81 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.604 1.962 . . . . 2.57 110.49 176.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.5 t -89.15 118.45 28.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.656 0.782 . . . . 0.52 109.15 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.48 130.04 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.716 -1.587 . . . . 1.35 106.716 170.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 C--N 1.34 0.178 0 C-N-CA 124.035 0.934 . . . . 2.95 111.627 -179.809 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 m120 . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 114.233 1.197 . . . . 1.87 114.233 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -136.41 110.9 8.54 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.742 1.217 . . . . 3.15 109.728 -173.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.72 100.8 11.13 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.61 0.764 . . . . 0.5 109.13 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -96.55 167.01 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 C-N-CA 122.968 0.507 . . . . 0.9 109.72 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.38 159.67 14.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.649 0.78 . . . . 2.42 110.374 -171.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.04 45.07 1.31 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.646 1.117 . . . . 2.63 112.637 169.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 58.5 144.9 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 129.554 3.142 . . . . 3.15 116.602 171.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.07 -179.85 25.3 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.799 1.19 . . . . 0.69 111.647 -168.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 m -95.38 130.68 31.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.935 . . . . 2.37 110.943 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.52 135.41 42.26 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 CA-C-N 120.714 1.291 . . . . 1.09 110.327 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 tttm . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 119.066 -0.492 . . . . 2.48 111.011 176.54 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 109.311 -0.625 . . . . 2.15 109.311 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.8 p -124.22 167.2 14.61 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.156 0.983 . . . . 0.91 109.913 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.47 168.19 2.94 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.316 0.647 . . . . 1.67 111.464 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.44 ' HB2' HD21 ' A' ' 30' ' ' LEU . 65.0 m -83.91 150.86 25.42 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 108.204 -1.035 . . . . 1.25 108.204 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -108.94 -20.84 12.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.656 0.783 . . . . 1.52 111.412 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -144.57 147.85 33.68 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.232 1.413 . . . . 2.6 109.225 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -68.77 159.7 31.83 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.764 0.826 . . . . 0.61 110.849 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.68 14.88 80.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.829 -0.908 . . . . 0.49 110.829 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -119.27 158.4 26.12 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 123.411 0.685 . . . . 2.34 110.125 -170.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -135.63 -176.46 4.29 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.449 0.7 . . . . 0.75 110.402 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 13' ' ' LEU . 5.4 tp 66.79 39.76 3.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.158 0.983 . . . . 2.37 109.704 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.4 p -154.61 153.45 31.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.339 1.455 . . . . 0.91 108.156 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.511 ' CD2' HG22 ' A' ' 21' ' ' VAL . 76.5 mt -76.38 108.67 9.49 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 125.396 1.478 . . . . 0.85 108.004 -174.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -107.32 -63.17 1.32 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.449 0.699 . . . . 0.54 109.41 -170.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -91.51 98.63 11.79 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.666 0.786 . . . . 2.9 109.841 168.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.8 -130.69 50.01 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.247 -1.141 . . . . 0.41 110.247 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.88 4.97 42.65 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.217 0.509 . . . . 0.61 111.039 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -79.89 120.12 23.68 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 120.922 -1.111 . . . . 1.67 108.058 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.511 HG22 ' CD2' ' A' ' 15' ' ' LEU . 4.9 t -83.78 124.85 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.315 -0.994 . . . . 2.59 108.315 -175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.8 t -76.53 86.9 3.24 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.956 -0.757 . . . . 0.46 108.956 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.65 172.29 19.4 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 121.659 -0.651 . . . . 0.78 113.151 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.07 152.21 4.32 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.73 -0.865 . . . . 4.0 112.249 174.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.93 -5.73 83.1 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.969 0.795 . . . . 0.68 111.787 -174.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -132.36 157.64 43.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.963 2.505 . . . . 1.28 108.048 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -141.51 152.33 44.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.363 1.465 . . . . 2.31 109.042 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.4 t -99.42 130.18 45.67 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.771 2.029 . . . . 0.41 108.91 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.5 mm -102.72 107.48 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.4 -1.704 . . . . 1.28 106.4 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 6' ' ' CYS . 34.4 mt . . . . . 0 C--N 1.343 0.304 0 C-N-CA 125.387 1.475 . . . . 2.18 110.375 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.65 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 114.083 1.142 . . . . 2.41 114.083 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -128.27 133.3 48.76 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.153 0.981 . . . . 2.58 110.328 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.5 t -100.85 105.02 16.27 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.636 -0.876 . . . . 0.46 108.636 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -110.3 172.82 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 109.329 -0.619 . . . . 0.78 109.329 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 t -67.16 177.99 1.61 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.272 1.034 . . . . 2.03 111.949 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.41 124.03 4.76 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.853 -2.099 . . . . 2.27 107.853 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.4 134.05 40.26 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.469 -0.567 . . . . 3.71 109.469 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.8 165.86 15.37 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 108.528 -1.829 . . . . 0.65 108.528 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -76.01 149.94 83.01 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 108.581 -0.896 . . . . 1.73 108.581 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -78.08 157.48 30.37 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.275 1.983 . . . . 0.71 111.506 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 tttm . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 119.096 -0.478 . . . . 3.22 111.069 175.485 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.291 -0.633 . . . . 1.8 109.291 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 p -147.9 165.83 29.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.606 1.562 . . . . 0.78 107.652 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -64.22 160.47 18.48 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.393 0.616 . . . . 1.66 111.975 -176.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -83.2 152.66 25.12 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.501 -0.772 . . . . 1.06 112.317 165.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.7 p -132.6 23.77 4.35 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.82 1.248 . . . . 1.39 111.319 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.08 159.66 11.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.116 0.966 . . . . 3.18 109.419 175.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -85.49 146.34 26.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.909 0.484 . . . . 0.5 111.164 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.69 28.01 17.69 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.011 -0.541 . . . . 0.58 111.854 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.92 158.12 39.7 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.674 -0.679 . . . . 3.34 110.569 -165.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -138.33 -179.81 6.01 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.694 1.134 . . . . 1.02 111.822 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 62.74 36.7 13.1 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.677 0.751 . . . . 2.23 111.049 173.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.9 p -149.45 161.04 42.89 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.572 1.549 . . . . 1.14 107.605 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.78 130.94 40.97 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.177 -1.046 . . . . 0.65 108.177 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.9 t -127.64 -63.64 1.02 Allowed 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 106.938 -1.505 . . . . 0.54 106.938 -174.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.59 98.26 11.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.944 -0.761 . . . . 3.46 108.944 172.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.78 -135.26 52.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.87 -1.292 . . . . 0.51 109.87 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 t -85.52 9.99 14.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.715 0.757 . . . . 0.82 112.225 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -90.64 124.85 35.39 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.655 -0.869 . . . . 1.68 108.655 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.3 139.17 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.999 -0.371 . . . . 1.7 109.999 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.7 t -75.09 91.21 2.54 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.532 -0.914 . . . . 0.62 108.532 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.68 158.26 1.43 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.158 1.837 . . . . 1.08 113.971 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -56.99 144.72 32.93 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.77 -0.841 . . . . 3.49 111.404 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.74 -5.08 79.57 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.105 0.86 . . . . 0.74 111.967 -171.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -125.48 166.87 15.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.169 1.788 . . . . 1.48 109.238 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -145.84 153.57 41.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.02 -1.104 . . . . 2.62 108.02 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.8 t -98.55 128.89 45.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.691 1.596 . . . . 0.45 107.041 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mt -101.05 124.65 54.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.456 -1.683 . . . . 2.14 106.456 166.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 106.551 -1.648 . . . . 2.5 106.551 167.633 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 111.776 0.287 . . . . 2.2 111.776 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -148.04 109.54 4.39 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.31 0.644 . . . . 3.26 111.542 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.1 t -90.05 114.44 26.32 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 124.641 1.176 . . . . 0.41 109.466 174.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.86 161.65 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.825 -0.806 . . . . 0.77 108.825 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -61.58 148.0 43.74 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.784 -0.572 . . . . 2.35 110.226 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.77 -31.85 0.27 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.151 -0.805 . . . . 2.68 113.623 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 72.06 83.51 0.13 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.293 1.437 . . . . 3.72 111.356 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.38 -178.01 52.17 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.152 -0.477 . . . . 0.93 112.184 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.0 m -87.89 147.72 41.7 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.215 1.006 . . . . 2.35 108.652 171.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.61 143.5 24.23 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.111 1.874 . . . . 1.22 111.54 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tttm . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 123.464 0.705 . . . . 2.67 111.129 179.067 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.106 -1.072 . . . . 1.96 108.106 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 p -147.03 173.44 12.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.466 1.907 . . . . 1.19 106.221 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.03 168.5 8.17 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.939 0.4 . . . . 1.95 111.034 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.3 m -82.86 156.14 23.75 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.714 0.768 . . . . 1.29 110.759 159.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -110.53 -11.05 14.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.244 -1.344 . . . . 0.84 111.259 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -147.79 136.28 21.64 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 107.171 -1.418 . . . . 3.36 107.171 -166.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -64.7 150.35 47.39 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.45 0.568 . . . . 0.49 110.021 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.04 -1.27 62.9 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.046 -0.597 . . . . 0.46 112.149 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -99.79 147.43 25.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 117.657 0.729 . . . . 2.4 112.676 -171.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -115.19 -176.13 2.84 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.485 1.114 . . . . 1.17 110.664 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 59.14 53.74 5.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 122.379 1.085 . . . . 2.36 110.361 172.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.0 p -169.33 159.43 8.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.189 -1.411 . . . . 1.16 107.189 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.64 143.81 46.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.78 -0.822 . . . . 0.74 108.78 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.8 t -138.89 -63.2 0.53 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.509 -0.922 . . . . 0.57 108.509 -172.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -93.29 97.49 10.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.696 -0.853 . . . . 2.96 108.696 169.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.94 -132.64 52.55 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.925 -1.27 . . . . 0.54 109.925 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.4 t -87.28 14.68 7.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.732 0.766 . . . . 0.66 112.168 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -88.22 124.61 34.02 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.185 0.902 . . . . 1.49 109.377 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.0 t -71.66 133.23 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.209 1.004 . . . . 2.06 109.518 175.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.5 t -74.15 91.87 2.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.992 -0.744 . . . . 0.63 108.992 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.66 152.58 1.84 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.327 1.918 . . . . 1.18 114.188 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -49.43 139.1 12.35 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.479 0.712 . . . . 4.83 110.732 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.94 -3.3 87.28 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.411 -0.661 . . . . 0.97 112.71 -174.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -123.05 167.79 13.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.965 1.306 . . . . 1.55 108.318 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HE3' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -146.04 154.99 42.47 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.357 1.063 . . . . 2.7 110.653 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.8 t -105.83 127.79 53.33 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 106.846 -1.539 . . . . 0.52 106.846 -172.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.5 mm -98.11 107.37 20.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 105.698 -1.964 . . . . 1.3 105.698 173.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.231 0.129 0 C-N-CA 124.849 1.259 . . . . 2.13 108.815 -179.259 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 111.968 0.358 . . . . 1.72 111.968 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -118.7 127.26 53.4 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 131.306 3.842 . . . . 4.19 109.359 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -101.42 111.26 23.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.692 1.587 . . . . 0.47 110.15 172.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG23 ' HE3' ' A' ' 27' ' ' LYS . 31.4 m -114.22 155.57 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.038 0.935 . . . . 0.81 111.202 -174.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.01 168.54 15.85 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.793 0.806 . . . . 2.41 111.229 -169.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.61 45.96 1.47 Allowed Glycine 0 CA--C 1.524 0.605 0 O-C-N 120.842 -1.162 . . . . 2.95 111.38 162.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 73.68 154.97 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.586 2.354 . . . . 3.48 111.108 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.77 158.27 31.09 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.129 -1.588 . . . . 0.67 109.129 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -92.56 146.91 33.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 117.544 0.672 . . . . 1.97 109.436 -174.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.41 154.56 65.06 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-N 121.035 1.405 . . . . 1.4 110.659 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 124.354 1.062 . . . . 2.61 109.592 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 CA--C 1.544 0.714 0 N-CA-C 108.527 -0.916 . . . . 2.62 108.527 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.1 p -101.63 165.93 10.97 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 124.106 0.963 . . . . 1.33 109.579 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.11 156.98 38.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.907 0.776 . . . . 2.23 110.955 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.456 ' C ' HD21 ' A' ' 30' ' ' LEU . 75.7 m -84.81 150.87 24.74 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 117.855 -1.538 . . . . 1.15 109.226 178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -132.34 6.06 4.13 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.73 0.641 . . . . 1.45 112.73 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.53 136.33 18.28 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.58 1.552 . . . . 3.68 106.812 -169.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -71.83 139.4 48.89 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 118.65 0.659 . . . . 0.77 110.353 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.68 67.53 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.733 -0.547 . . . . 0.48 111.733 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -97.13 164.07 12.66 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 123.297 0.639 . . . . 2.56 109.742 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -148.41 -175.37 4.89 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.223 0.609 . . . . 0.96 109.587 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 58.61 37.03 25.4 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.516 0.674 . . . . 2.3 109.481 -174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -148.81 145.6 27.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.6 1.16 . . . . 1.07 109.269 175.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 mt -57.68 108.88 0.62 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.411 2.284 . . . . 0.69 108.637 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.1 t -99.18 -63.15 1.15 Allowed 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.443 -1.688 . . . . 0.62 106.443 -174.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -109.79 99.08 8.28 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.035 1.334 . . . . 3.83 109.452 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.82 -145.73 38.84 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.617 -1.393 . . . . 0.66 109.617 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.02 -0.7 45.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.512 0.725 . . . . 1.02 110.687 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -82.25 118.82 23.41 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.197 -1.408 . . . . 1.62 107.197 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.18 146.94 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 110.289 -0.263 . . . . 1.8 110.289 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 t -73.16 95.79 2.13 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.789 0.804 . . . . 0.51 109.285 167.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.57 157.42 2.19 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 127.632 2.539 . . . . 1.09 113.137 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.38 144.94 56.8 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.051 -0.676 . . . . 3.89 110.667 -177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.5 0.41 84.45 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.323 0.487 . . . . 0.76 112.156 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.66 161.2 30.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.063 2.145 . . . . 1.44 108.596 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -136.63 156.64 48.27 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.881 1.672 . . . . 2.71 111.49 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.5 t -103.42 119.43 38.88 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.232 -1.766 . . . . 0.5 106.232 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.537 HD13 HG22 ' A' ' 40' ' ' VAL . 1.3 mp -88.3 109.36 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 104.883 -2.266 . . . . 1.29 104.883 174.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.456 HD21 ' C ' ' A' ' 6' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 107.766 -1.198 . . . . 2.03 107.766 175.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 110.003 -0.369 . . . . 2.17 110.003 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.44 110.21 14.82 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.471 1.108 . . . . 2.73 110.409 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.3 t -84.53 98.11 9.94 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.277 -0.638 . . . . 0.33 109.277 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.537 HG22 HD13 ' A' ' 29' ' ' ILE . 3.2 m -100.48 168.56 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.734 -0.839 . . . . 0.66 108.734 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 t -67.29 171.06 6.26 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.037 -1.039 . . . . 2.56 111.51 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.05 140.79 7.57 Favored Glycine 0 C--O 1.223 -0.581 0 N-CA-C 109.106 -1.598 . . . . 2.27 109.106 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.39 112.74 14.46 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.326 -1.102 . . . . 3.73 108.976 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.94 174.76 23.59 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.264 0.935 . . . . 0.72 111.536 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -94.5 138.08 22.45 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 109.115 -0.698 . . . . 2.3 109.115 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.72 142.11 42.92 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 121.862 1.708 . . . . 1.1 109.586 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 tttp . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 118.985 -0.531 . . . . 3.29 111.737 -177.945 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.335 -0.617 . . . . 1.53 109.335 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 p -134.39 163.9 28.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.296 1.438 . . . . 1.16 108.719 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.64 161.49 29.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.351 0.596 . . . . 1.87 111.91 -176.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 11' ' ' GLN . 1.3 m -83.82 173.73 11.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.652 0.781 . . . . 1.65 111.765 171.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -141.35 28.0 1.87 Allowed 'General case' 0 C--N 1.345 0.404 0 CA-C-O 118.733 -0.651 . . . . 1.58 112.733 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -165.14 160.78 19.05 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.995 -1.113 . . . . 2.76 107.995 170.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.29 153.82 26.88 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.866 0.867 . . . . 0.48 111.363 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.512 ' HA2' ' CG ' ' A' ' 27' ' ' LYS . . . 75.37 15.32 81.25 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.154 0.883 . . . . 0.46 111.751 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.43 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 1.9 mt-30 -92.18 171.4 9.1 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.412 0.685 . . . . 2.42 109.158 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -154.94 179.6 8.97 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.089 0.859 . . . . 0.71 110.394 170.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 63.56 55.84 1.68 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.544 1.538 . . . . 2.13 111.103 178.326 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.4 p -173.83 163.91 4.21 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.415 1.886 . . . . 0.9 106.532 -172.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.0 mt -71.93 144.18 49.03 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.918 -0.771 . . . . 1.01 108.918 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.0 t -142.31 -64.57 0.42 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.393 -0.595 . . . . 0.64 109.393 -172.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -94.32 98.96 11.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.156 -1.424 . . . . 2.97 107.156 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.69 -128.6 32.98 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.094 -1.203 . . . . 0.62 110.094 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 t -88.32 5.98 39.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 117.134 0.467 . . . . 0.67 111.823 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -83.61 124.34 30.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.129 -0.982 . . . . 2.14 108.484 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.08 132.68 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.533 0.733 . . . . 1.53 109.26 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.7 t -87.55 92.19 9.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.486 -1.301 . . . . 0.49 107.486 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.73 -172.71 9.94 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.501 1.048 . . . . 0.81 114.797 -168.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -61.63 145.46 52.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.856 -0.791 . . . . 3.91 109.321 168.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.51 10.3 86.02 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.159 -0.776 . . . . 1.08 111.159 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -135.2 167.92 20.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.474 1.11 . . . . 2.21 108.126 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.512 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 13.9 ttmt -145.46 132.32 20.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.744 1.218 . . . . 2.22 108.205 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -92.0 123.77 35.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.215 1.006 . . . . 0.62 109.293 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.9 mm -107.71 111.56 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 106.417 -1.697 . . . . 1.7 106.417 169.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.2 mt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.771 -0.455 . . . . 2.34 109.771 169.293 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 118.876 -0.583 . . . . 3.3 111.371 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -142.11 124.18 15.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.269 1.428 . . . . 2.99 110.165 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.4 t -97.81 102.22 13.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.454 1.025 . . . . 0.37 109.881 174.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.8 m -91.47 162.7 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.195 0.598 . . . . 0.74 109.916 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 t -79.71 152.8 29.69 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.778 -0.823 . . . . 1.9 108.778 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.75 -114.58 0.76 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.706 -1.358 . . . . 2.71 109.706 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -162.8 156.84 20.72 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.335 1.454 . . . . 4.49 107.816 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.8 170.37 30.6 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.703 -0.959 . . . . 0.78 110.703 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 t -81.04 140.28 49.76 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 117.366 0.583 . . . . 2.16 109.86 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.31 154.75 56.32 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.057 1.838 . . . . 1.12 111.673 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.539 0.545 0 C-N-CA 123.085 0.554 . . . . 3.45 110.054 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 108.504 -0.924 . . . . 2.55 108.504 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 79.0 p -143.31 173.22 11.79 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.679 1.192 . . . . 1.36 108.683 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.71 162.2 8.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.503 0.668 . . . . 2.1 112.391 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -83.64 165.91 18.59 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 115.65 -0.704 . . . . 1.35 111.4 169.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -126.68 9.0 6.99 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.512 0.725 . . . . 1.02 112.592 -174.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -156.98 161.89 39.59 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.514 1.125 . . . . 2.81 109.007 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -81.91 157.69 24.24 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 122.767 0.427 . . . . 0.53 110.439 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.26 21.94 69.09 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 119.696 -1.24 . . . . 0.56 110.328 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -110.64 165.92 11.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.523 0.729 . . . . 2.26 109.14 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -144.23 -179.3 6.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.745 1.157 . . . . 0.81 110.612 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 13' ' ' LEU . 1.2 mt 58.46 54.84 5.26 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.62 1.168 . . . . 2.55 111.388 175.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.6 p -165.01 164.96 20.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.427 1.091 . . . . 1.06 108.172 -175.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.552 ' CD2' HG22 ' A' ' 21' ' ' VAL . 22.2 mt -75.4 120.82 21.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.073 -1.084 . . . . 0.49 108.073 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.1 t -123.07 -63.43 1.26 Allowed 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 108.109 -1.071 . . . . 0.56 108.109 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -90.82 88.9 7.25 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.715 1.206 . . . . 3.06 109.338 168.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.32 -135.21 42.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.393 -1.483 . . . . 0.48 109.393 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -81.78 -6.06 58.73 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.046 0.923 . . . . 0.73 111.604 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -76.51 123.98 26.88 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.184 -0.948 . . . . 1.59 108.662 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.552 HG22 ' CD2' ' A' ' 15' ' ' LEU . 6.8 t -83.2 136.87 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.156 -0.683 . . . . 2.32 109.156 -176.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.5 t -77.96 94.36 4.59 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.907 -0.496 . . . . 0.65 110.869 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.24 165.66 9.18 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.239 0.923 . . . . 0.83 114.156 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -57.34 151.53 15.97 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.876 -1.367 . . . . 3.63 113.249 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.36 0.32 86.72 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.07 1.319 . . . . 0.75 111.305 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -130.91 161.47 31.79 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.072 2.549 . . . . 1.34 108.642 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 145.83 33.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.641 1.176 . . . . 2.55 108.307 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.72 126.42 40.97 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.134 2.174 . . . . 0.45 108.688 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 29' ' ' ILE . 2.3 mp -97.81 114.19 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 106.168 -1.789 . . . . 1.66 106.168 170.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 CA--C 1.531 0.235 0 C-N-CA 124.828 1.251 . . . . 2.23 109.038 177.495 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 113.622 0.971 . . . . 1.76 113.622 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.73 105.58 1.62 Allowed 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.518 1.127 . . . . 3.21 111.78 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.2 t -80.99 100.31 8.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 125.071 1.348 . . . . 0.5 109.325 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -107.72 176.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.772 0.829 . . . . 0.81 108.879 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.04 178.38 5.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.79 -0.569 . . . . 2.31 110.286 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.83 155.4 31.77 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.826 -1.71 . . . . 2.19 108.826 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -81.3 165.67 21.19 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 117.458 0.629 . . . . 3.48 109.918 -171.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.91 -179.13 38.01 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.355 -1.498 . . . . 0.97 109.355 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -93.19 148.79 36.33 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 117.416 0.608 . . . . 1.94 110.165 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -73.66 173.3 14.14 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.552 1.501 . . . . 1.1 111.137 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 123.887 0.875 . . . . 2.23 108.95 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 . . . . . 0 CA--C 1.542 0.647 0 N-CA-C 109.193 -0.669 . . . . 2.34 109.193 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.9 p -127.3 166.43 17.81 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.965 0.906 . . . . 0.93 108.917 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.87 164.96 25.11 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.365 0.984 . . . . 2.29 109.684 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -82.48 157.13 23.73 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.113 -1.035 . . . . 1.09 109.397 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.1 p -121.64 -18.24 7.23 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.02 0.748 . . . . 1.0 113.02 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.24 155.08 43.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.998 1.719 . . . . 2.46 107.182 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -69.79 150.65 46.65 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.305 0.957 . . . . 0.46 109.888 173.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.66 -1.13 71.35 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.741 -0.477 . . . . 0.47 112.348 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -91.72 163.3 14.13 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.292 0.637 . . . . 2.44 110.544 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -150.52 -178.96 6.85 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.553 -0.717 . . . . 1.09 109.288 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mp 62.23 38.49 13.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.512 1.125 . . . . 2.22 110.398 -167.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -149.16 152.26 35.77 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.922 0.889 . . . . 1.05 110.232 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.8 mt -66.02 135.23 54.38 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.28 1.432 . . . . 0.51 107.67 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.9 t -140.84 -63.94 0.46 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.283 -1.377 . . . . 0.69 107.283 -168.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.42 89.15 7.89 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.184 -1.043 . . . . 3.27 108.184 168.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.75 -128.92 48.11 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.532 -1.427 . . . . 0.44 109.532 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 t -84.23 9.77 12.04 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.954 0.877 . . . . 0.74 112.432 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -91.33 117.99 30.13 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.797 1.181 . . . . 1.73 107.831 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.48 128.74 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.842 -0.617 . . . . 1.56 109.453 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.0 t -72.83 85.23 1.23 Allowed 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.347 0.594 . . . . 0.49 109.913 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.27 167.62 9.58 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 126.331 1.92 . . . . 0.75 114.049 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -55.6 152.44 9.2 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.307 -1.702 . . . . 3.96 112.019 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.02 12.0 84.58 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.338 0.97 . . . . 0.89 112.827 -173.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -138.7 170.1 16.6 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.67 3.188 . . . . 2.36 108.934 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.34 136.7 14.04 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.544 1.538 . . . . 1.98 109.524 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.4 t -94.48 126.52 39.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.211 -1.403 . . . . 0.43 107.211 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.6 mm -101.43 113.53 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.925 -1.509 . . . . 1.76 106.925 170.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 N--CA 1.45 -0.436 0 C-N-CA 125.503 1.521 . . . . 2.23 107.723 175.34 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 119.069 -0.491 . . . . 2.64 110.431 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -135.08 123.77 23.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.425 1.89 . . . . 4.29 111.346 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 39.0 t -95.81 101.99 13.74 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.603 1.961 . . . . 0.37 110.246 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.83 158.7 3.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 123.927 0.891 . . . . 0.61 110.099 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.41 167.71 16.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.832 -0.543 . . . . 2.57 110.226 176.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.97 -110.8 0.83 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.691 -1.763 . . . . 2.76 108.691 170.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -156.7 165.31 36.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.067 -1.827 . . . . 2.84 106.067 171.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.62 168.32 38.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.366 -1.494 . . . . 0.66 109.366 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.9 t -82.78 132.77 50.49 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.268 -0.642 . . . . 2.16 109.268 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.77 132.22 18.29 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.273 1.315 . . . . 0.76 110.252 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 tttm . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 118.774 -0.632 . . . . 2.22 110.008 174.376 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 67.4 t . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 106.058 -1.831 . . . . 3.88 106.058 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.9 t -110.69 127.66 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.668 -1.604 . . . . 2.73 106.668 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -109.41 176.49 5.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.138 1.375 . . . . 2.55 107.775 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.6 p -123.7 168.47 12.64 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.995 -0.743 . . . . 0.89 108.995 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -65.85 170.46 5.37 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.215 0.606 . . . . 2.11 109.718 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.19 143.38 28.01 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.502 -0.749 . . . . 1.09 111.266 171.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.484 HG23 ' HE3' ' A' ' 47' ' ' LYS . 10.2 p -97.85 -22.78 16.17 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.179 1.177 . . . . 1.29 114.179 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -133.32 160.84 36.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.343 0.974 . . . . 2.57 109.197 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -75.89 154.81 35.78 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.5 110.292 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.54 22.77 66.44 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.313 -0.715 . . . . 0.54 111.313 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -108.15 147.67 30.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.907 0.883 . . . . 2.15 109.944 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -115.17 176.85 4.88 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.758 0.823 . . . . 1.04 110.979 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.57 42.93 4.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.783 0.833 . . . . 2.17 111.316 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.4 p -148.44 155.43 41.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.666 0.786 . . . . 1.46 109.201 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.4 mt -69.98 133.81 47.67 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.723 0.809 . . . . 0.59 109.548 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 t -143.14 -63.06 0.41 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.44 -0.948 . . . . 1.03 108.44 -168.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -85.01 87.79 7.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.544 0.688 . . . . 3.64 109.97 161.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.64 -136.33 51.21 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.582 -1.407 . . . . 0.52 109.582 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.7 t -77.5 4.92 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 117.95 0.875 . . . . 0.77 112.445 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -86.21 125.35 33.49 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 119.754 1.161 . . . . 1.78 108.095 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.3 t -74.17 140.12 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.785 0.834 . . . . 2.07 108.939 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.4 t -73.67 90.38 1.81 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.714 0.769 . . . . 0.52 109.165 169.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.96 156.98 1.91 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.948 2.213 . . . . 1.02 113.786 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -53.78 144.38 18.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.484 -0.421 . . . . 3.4 111.626 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.47 -2.42 72.24 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.581 -0.566 . . . . 0.93 112.572 -174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -122.75 153.5 39.39 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.489 1.516 . . . . 1.66 107.839 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 156.15 48.34 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.07 0.85 . . . . 2.41 112.044 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.6 t -102.1 127.17 49.12 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.437 -2.061 . . . . 0.65 105.437 -170.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.511 ' N ' HD12 ' A' ' 29' ' ' ILE . 2.1 mp -94.11 114.15 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 103.678 -2.712 . . . . 1.62 103.678 170.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -65.53 130.74 44.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.972 -1.862 . . . . 2.05 105.972 165.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -53.18 151.89 8.98 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.958 -0.912 . . . . 2.6 111.018 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.8 m -128.72 42.63 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.942 1.46 . . . . 4.61 114.942 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 153.09 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.217 0.451 . . . . 5.36 112.217 -141.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.05 -8.16 8.73 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.373 -1.455 . . . . 2.39 113.901 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -63.46 155.61 28.66 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.731 1.265 . . . . 3.42 113.065 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -95.19 167.47 11.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 114.535 -1.211 . . . . 4.37 109.188 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -59.47 123.62 17.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.281 1.032 . . . . 2.05 109.099 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -126.35 113.55 17.06 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.751 0.82 . . . . 2.6 110.809 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -91.77 119.68 31.81 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.811 -0.811 . . . . 0.47 108.811 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -128.41 152.35 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-N 118.275 0.489 . . . . 0.74 109.852 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -64.48 159.41 21.57 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.798 0.439 . . . . 2.11 110.925 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.39 -103.98 0.26 Allowed Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.099 -1.601 . . . . 2.69 109.099 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.55 160.31 8.96 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.671 1.588 . . . . 3.89 107.126 168.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.64 166.8 38.14 Favored Glycine 0 N--CA 1.467 0.713 0 N-CA-C 110.531 -1.027 . . . . 0.83 110.531 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.7 m -76.44 140.8 68.93 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.948 0.899 . . . . 1.68 110.09 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.03 131.65 13.33 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.29 1.327 . . . . 0.87 111.527 173.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HE3' HG23 ' A' ' 7' ' ' THR . 44.6 tttt -58.68 118.6 29.95 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.117 0.967 . . . . 2.65 111.681 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.6 160.61 31.51 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.293 3.329 . . . . 1.19 112.127 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -82.45 102.83 11.57 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 120.869 -1.145 . . . . 5.44 112.159 -166.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.7 m 61.19 144.58 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.266 0.839 . . . . 4.48 113.266 -150.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 . . . . . 0 C--N 1.343 0.322 0 N-CA-C 106.696 -1.594 . . . . 11.9 106.696 166.275 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 108.621 -0.881 . . . . 4.69 108.621 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 82.2 t -86.16 149.94 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.354 -1.35 . . . . 2.62 107.354 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -138.86 163.33 32.55 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.132 1.373 . . . . 2.06 108.477 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.9 p -140.82 162.48 35.34 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.038 1.335 . . . . 1.43 109.382 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.56 162.39 27.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.309 1.044 . . . . 1.99 112.296 -173.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.3 m -87.28 162.04 17.63 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.357 -0.979 . . . . 0.96 108.357 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -123.93 13.22 9.13 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.887 -0.578 . . . . 1.1 112.443 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -176.79 163.8 2.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.516 1.526 . . . . 2.65 109.395 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -79.28 161.28 26.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.568 0.747 . . . . 0.57 111.306 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.85 7.77 59.6 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.282 1.896 . . . . 0.48 113.289 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.12 -178.3 5.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.518 0.727 . . . . 2.92 109.234 -175.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -166.53 -179.5 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 119.612 1.097 . . . . 0.91 109.199 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tp 68.69 31.84 4.42 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.229 0.612 . . . . 2.81 109.876 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.84 161.22 41.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.964 1.306 . . . . 1.22 108.635 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -74.27 104.68 5.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.534 -1.654 . . . . 0.68 106.534 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -89.93 -63.92 1.21 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.993 -1.114 . . . . 1.32 107.993 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -96.74 125.93 41.55 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.229 1.411 . . . . 4.63 108.997 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.33 -127.76 6.76 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.714 0.673 . . . . 0.86 112.003 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.5 t -96.42 14.32 24.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.65 0.78 . . . . 1.09 111.281 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -88.41 113.87 24.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.764 0.793 . . . . 3.02 109.026 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.37 125.88 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.546 -0.752 . . . . 1.78 109.977 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -97.3 72.34 2.41 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.783 -0.821 . . . . 0.9 108.783 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.78 -174.21 12.51 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 122.168 0.871 . . . . 1.37 114.873 -171.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -50.19 143.83 7.92 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.477 -1.014 . . . . 3.45 111.343 166.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.0 -8.16 71.5 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 123.797 0.713 . . . . 1.07 111.673 -167.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -132.11 162.76 30.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.24 1.416 . . . . 1.69 109.44 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.04 135.7 36.14 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 127.676 2.39 . . . . 2.61 108.486 -174.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 t -94.45 142.81 27.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.581 1.152 . . . . 0.94 109.058 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.9 mm -124.0 117.0 49.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.769 -1.937 . . . . 1.19 105.769 172.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 63.46 1.72 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.786 1.234 . . . . 2.58 109.815 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.24 -168.96 37.06 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 121.892 0.718 . . . . 3.2 113.84 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -144.04 69.42 1.28 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 105.983 -1.858 . . . . 3.79 105.983 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.88 30.84 5.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.505 1.522 . . . . 5.41 111.974 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.58 -56.19 0.19 Allowed Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.298 -0.721 . . . . 2.17 111.298 -170.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.41 155.89 27.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.777 0.788 . . . . 3.42 111.385 167.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -85.1 175.54 8.94 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.174 1.79 . . . . 4.78 108.354 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -46.18 143.69 2.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.034 0.934 . . . . 2.08 111.347 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -142.21 127.55 18.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.617 0.767 . . . . 3.29 109.217 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.9 t -96.35 105.43 17.5 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.679 0.672 . . . . 0.43 109.544 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -95.99 174.75 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.351 1.06 . . . . 0.74 109.577 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.1 166.76 18.44 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.842 0.857 . . . . 2.31 111.272 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.69 121.74 3.58 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 109.87 -1.292 . . . . 2.33 109.87 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -51.36 123.15 9.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.656 1.182 . . . . 3.21 112.68 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.43 -168.11 32.72 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.575 1.083 . . . . 1.04 112.916 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.5 m -85.15 124.19 72.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.282 1.033 . . . . 1.98 110.378 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -74.73 135.0 19.01 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-N 120.95 1.375 . . . . 0.83 111.427 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -46.99 111.65 1.66 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.488 0.715 . . . . 2.63 111.753 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.01 115.53 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.884 1.723 . . . . 2.06 109.959 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -79.41 121.02 24.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.119 -0.697 . . . . 5.01 109.119 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.5 m -86.38 177.15 7.54 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.104 0.962 . . . . 5.69 110.206 169.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 117.461 -1.257 . . . . 10.06 110.86 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 106.591 -1.633 . . . . 3.76 106.591 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.1 122.65 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.79 -1.559 . . . . 3.68 106.79 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -96.79 -173.94 2.86 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.31 1.444 . . . . 2.28 108.695 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -120.15 166.43 13.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.9 1.28 . . . . 0.99 110.139 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.69 163.26 26.02 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.674 1.19 . . . . 1.68 112.257 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.4 m -86.07 143.96 27.8 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.084 -0.71 . . . . 1.24 109.084 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -115.56 15.08 16.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.257 0.623 . . . . 1.45 111.815 -172.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.12 145.8 0.64 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.63 1.572 . . . . 3.53 109.645 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -70.52 151.49 45.02 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 120.862 0.363 . . . . 0.37 110.643 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.45 0.17 89.91 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.551 -0.62 . . . . 0.61 111.551 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -98.19 168.7 10.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.06 0.944 . . . . 2.52 109.845 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -148.15 -170.9 3.7 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.921 -0.487 . . . . 0.93 110.606 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.448 HD22 ' HB3' ' A' ' 46' ' ' PRO . 2.3 mp 60.31 37.67 20.15 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.734 0.778 . . . . 2.19 110.128 -176.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.4 p -150.21 147.49 27.76 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.959 1.303 . . . . 0.93 108.845 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 mt -63.02 113.51 3.15 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 126.896 2.078 . . . . 0.69 108.409 -176.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.5 t -109.94 -63.72 1.34 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.854 -1.536 . . . . 0.58 106.854 -170.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -98.11 97.83 9.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.354 1.062 . . . . 3.46 108.327 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.46 -136.2 39.3 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.924 -1.271 . . . . 0.51 109.924 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.05 -3.84 55.49 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.541 0.736 . . . . 1.11 112.293 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -78.08 117.92 19.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.915 -0.772 . . . . 1.53 108.915 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p -73.31 139.44 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.102 0.561 . . . . 1.73 109.495 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.4 t -74.14 96.93 2.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.099 -0.704 . . . . 0.43 109.099 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.25 169.1 8.09 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.155 0.883 . . . . 0.71 113.69 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.08 147.1 40.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.499 -1.0 . . . . 3.58 111.273 173.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.62 81.77 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.578 -0.609 . . . . 0.72 111.578 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -142.58 161.52 37.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.068 2.147 . . . . 1.47 109.122 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -139.75 138.89 36.29 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.402 2.281 . . . . 2.05 109.715 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -90.41 120.31 31.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.59 1.556 . . . . 0.49 108.582 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.9 mp -94.5 117.32 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 107.082 -1.451 . . . . 1.35 107.082 170.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.47 137.54 58.14 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 123.845 0.716 . . . . 2.25 109.292 172.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -53.09 134.62 40.69 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.5 -0.773 . . . . 2.88 112.741 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 p -101.35 69.96 1.29 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.75 1.62 . . . . 3.78 108.448 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 45.0 33.61 1.07 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.085 1.354 . . . . 5.01 113.048 176.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.41 -72.48 0.05 OUTLIER Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.02 -1.632 . . . . 2.85 109.02 -173.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -62.35 154.32 28.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.534 0.683 . . . . 3.4 111.224 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -95.81 174.51 6.92 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.148 2.579 . . . . 5.87 108.434 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -52.9 121.01 6.48 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.463 -0.94 . . . . 2.43 108.463 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -126.13 123.58 38.62 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.242 0.617 . . . . 3.03 110.53 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -92.88 88.59 6.25 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.266 0.626 . . . . 0.65 109.536 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 m -85.55 168.08 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 C-N-CA 123.303 0.641 . . . . 0.63 109.362 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.21 171.16 14.99 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.48 -0.762 . . . . 2.34 112.01 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.55 132.03 7.16 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 108.496 -1.842 . . . . 2.13 108.496 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.76 142.7 55.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.011 1.406 . . . . 3.68 110.901 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -139.5 164.28 25.99 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.569 -1.412 . . . . 1.03 109.569 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.0 m -75.63 142.61 74.14 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.509 1.124 . . . . 1.95 109.757 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.448 ' HB3' HD22 ' A' ' 13' ' ' LEU . 56.0 Cg_endo -74.48 151.83 42.78 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.541 2.16 . . . . 1.16 111.652 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.9 110.11 2.08 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 122.928 0.491 . . . . 2.81 111.825 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -72.27 128.43 13.77 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 N-CA-C 107.282 -1.853 . . . . 1.57 107.282 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -48.87 158.04 0.35 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.17 0.988 . . . . 5.21 111.215 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 m -150.28 67.11 0.96 Allowed 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.638 -0.663 . . . . 5.02 109.743 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.248 0 C-N-CA 124.911 1.284 . . . . 8.9 110.587 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.7 t . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 106.726 -1.583 . . . . 4.36 106.726 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 73.9 t -92.12 155.99 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.432 1.093 . . . . 2.3 108.5 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -133.26 170.54 15.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.356 1.463 . . . . 1.86 109.963 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.4 p -144.95 165.99 26.56 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.146 1.379 . . . . 1.22 109.275 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.02 166.57 20.66 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.785 0.72 . . . . 2.34 112.049 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -88.14 157.68 18.76 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 108.226 -1.028 . . . . 0.97 108.226 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.6 p -103.4 -39.0 6.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.813 0.845 . . . . 1.38 110.88 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.6 161.0 35.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.282 1.033 . . . . 2.59 110.179 -175.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -70.05 150.55 46.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.932 0.872 . . . . 0.4 110.944 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.45 10.67 85.58 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.212 1.387 . . . . 0.39 113.249 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -77.04 179.92 5.95 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.927 0.863 . . . . 2.65 110.213 172.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -158.05 -176.71 6.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.504 1.522 . . . . 0.73 107.999 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp 67.43 36.1 3.99 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.052 1.341 . . . . 2.65 111.398 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.25 159.02 38.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.504 2.722 . . . . 1.17 107.987 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 mt -70.09 116.2 10.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.331 -1.729 . . . . 0.56 106.331 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -95.23 -64.43 1.06 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.847 -1.168 . . . . 1.3 107.847 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -109.59 120.16 41.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.288 1.435 . . . . 2.8 108.072 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 53.58 -128.72 39.87 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.416 -1.074 . . . . 0.82 110.416 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 t -98.25 15.7 23.69 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.202 0.601 . . . . 1.0 111.241 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -88.28 118.13 27.68 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.226 -1.027 . . . . 2.28 108.226 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.03 116.39 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.809 0.844 . . . . 2.07 110.65 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.9 t -89.92 78.45 6.77 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.351 -0.981 . . . . 0.66 108.351 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.72 -172.5 25.52 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 123.417 0.532 . . . . 1.18 114.362 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -56.82 144.98 31.0 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 121.417 -1.049 . . . . 4.61 111.065 168.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.97 -7.66 81.27 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.196 0.903 . . . . 1.08 111.285 -168.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -125.82 171.2 10.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.448 1.099 . . . . 2.15 109.227 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -142.67 139.28 31.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.639 1.175 . . . . 2.75 107.889 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.2 t -95.59 143.88 26.51 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 123.852 0.861 . . . . 0.83 109.477 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.6 mm -118.84 118.3 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 127.206 2.202 . . . . 1.24 106.709 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.24 129.36 34.88 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.308 1.843 . . . . 2.15 107.706 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.03 170.06 47.93 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.68 -0.968 . . . . 3.42 110.68 170.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.5 m -144.34 43.22 1.41 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.41 1.105 . . . . 6.26 112.609 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 170.27 37.04 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.34 0.591 . . . . 5.47 112.566 -150.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.81 1.23 37.76 Favored Glycine 0 CA--C 1.539 1.544 0 O-C-N 120.828 -1.17 . . . . 4.48 114.106 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.5 169.11 18.86 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.612 2.365 . . . . 5.07 111.842 173.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -95.12 168.33 10.83 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.385 1.474 . . . . 5.05 110.09 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -81.28 153.1 27.27 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.101 0.961 . . . . 1.79 109.659 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -139.71 126.79 21.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.287 1.035 . . . . 3.34 111.415 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.7 t -95.63 108.23 20.49 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.768 1.227 . . . . 0.46 109.812 174.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.8 m -94.55 166.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.889 0.876 . . . . 0.78 108.931 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.8 t -79.65 156.78 27.45 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.378 -0.826 . . . . 1.79 108.796 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.32 -113.05 0.62 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.633 -1.387 . . . . 2.83 109.633 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -170.21 147.35 3.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.805 2.042 . . . . 4.57 106.666 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.57 177.01 24.25 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 118.938 0.79 . . . . 0.73 111.384 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.8 m -86.11 131.5 46.4 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.81 -0.614 . . . . 1.69 109.404 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.36 140.87 59.8 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.266 1.311 . . . . 0.8 110.101 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.66 117.99 12.14 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 118.673 -0.68 . . . . 3.09 110.459 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.6 149.29 84.14 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.525 -1.375 . . . . 1.27 108.525 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -64.79 152.9 41.53 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.529 1.132 . . . . 6.19 110.896 166.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.3 m 65.45 168.8 0.2 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.679 1.192 . . . . 4.7 111.467 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 117.267 -1.349 . . . . 9.58 111.821 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 75.7 t . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.55 -1.278 . . . . 3.58 107.55 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.3 t -92.15 111.65 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.323 -1.362 . . . . 4.57 107.323 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -79.63 -173.12 3.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.333 2.653 . . . . 1.95 109.186 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.6 p -121.89 171.57 8.82 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.882 0.873 . . . . 0.98 110.943 171.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.13 163.26 5.0 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.789 0.835 . . . . 2.01 112.367 172.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.53 163.22 18.53 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.223 1.009 . . . . 1.11 110.823 172.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.9 p -129.44 15.28 6.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.757 0.823 . . . . 1.1 112.642 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.29 154.28 24.97 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.351 0.978 . . . . 3.3 110.147 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -82.45 136.92 34.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.339 0.655 . . . . 0.55 110.742 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.69 19.35 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.721 -0.551 . . . . 0.41 111.721 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.25 145.36 47.93 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.046 0.538 . . . . 2.4 110.717 -168.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -117.84 -178.63 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.893 0.877 . . . . 0.93 110.471 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp 62.08 49.29 4.59 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.14 0.971 . . . . 2.07 110.565 174.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -160.77 160.33 31.15 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.409 1.084 . . . . 1.26 108.313 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.7 mt -75.38 113.86 13.25 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.29 1.036 . . . . 0.69 108.971 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -116.41 -64.07 1.36 Allowed 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.196 -1.038 . . . . 0.67 108.196 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.58 91.27 6.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.248 -1.39 . . . . 3.09 107.248 171.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.21 -132.0 52.33 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.347 -1.101 . . . . 0.42 110.347 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.6 t -83.08 5.3 22.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.987 0.893 . . . . 0.6 112.158 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -89.5 123.52 33.69 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.243 0.928 . . . . 2.4 108.563 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.48 137.04 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.086 0.554 . . . . 1.49 110.19 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.7 t -75.95 92.28 3.11 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.282 -0.636 . . . . 0.63 109.282 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.24 156.73 8.33 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.752 1.168 . . . . 0.89 112.599 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -51.86 155.28 1.8 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.743 -0.857 . . . . 3.81 112.722 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.72 1.4 89.25 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.028 0.823 . . . . 0.76 113.357 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -135.26 156.81 48.35 Favored 'General case' 0 N--CA 1.448 -0.571 1 C-N-CA 131.998 4.119 . . . . 2.16 108.578 179.211 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.95 154.27 48.3 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.719 1.608 . . . . 2.57 110.588 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.5 t -95.23 128.53 42.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.598 1.559 . . . . 0.43 108.809 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.3 mm -101.51 114.61 41.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.772 -1.936 . . . . 1.44 105.772 170.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp -63.4 142.39 58.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.196 0.998 . . . . 2.07 109.104 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.66 134.43 30.26 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.307 -0.86 . . . . 2.72 112.762 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -99.83 68.52 1.52 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.722 -1.214 . . . . 3.69 107.722 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 43.55 35.31 0.95 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.545 1.538 . . . . 5.03 113.195 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.09 -72.6 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.419 -1.872 . . . . 2.33 108.419 -172.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -66.83 159.99 26.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.329 0.652 . . . . 3.95 110.003 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.5 176.37 6.06 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.011 1.324 . . . . 4.74 108.453 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -54.17 129.86 36.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.272 -0.87 . . . . 2.52 110.386 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -135.65 124.74 24.38 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 118.725 -0.655 . . . . 3.48 111.922 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.4 t -92.99 101.71 14.05 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.734 1.152 . . . . 0.33 109.144 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -104.39 158.59 5.38 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 C-N-CA 123.567 0.747 . . . . 0.58 109.065 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -71.16 176.04 4.8 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 119.864 -0.734 . . . . 1.96 111.207 -179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.3 129.48 6.31 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 108.097 -2.001 . . . . 2.13 108.097 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.37 132.62 48.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.022 -0.733 . . . . 2.95 109.022 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.99 -159.21 10.19 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.968 -1.653 . . . . 1.03 108.968 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.89 142.5 26.34 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.36 0.664 . . . . 1.54 110.145 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.06 138.98 31.95 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.418 2.079 . . . . 0.73 110.696 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -55.32 121.23 36.11 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.794 -0.622 . . . . 2.38 111.066 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.4 124.72 13.78 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 N-CA-C 107.798 -1.654 . . . . 1.65 107.798 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -70.33 154.78 41.52 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.227 1.011 . . . . 5.8 108.29 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m 67.23 91.16 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.899 0.88 . . . . 4.66 110.13 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 104.9 -2.259 . . . . 11.11 104.9 178.294 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.967 0.413 . . . . 3.72 110.278 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.8 t -74.86 129.72 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.111 -1.07 . . . . 2.52 108.111 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -107.7 172.16 6.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.703 1.201 . . . . 1.76 110.045 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.0 p -142.6 169.04 18.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.935 1.294 . . . . 0.97 109.678 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.63 171.0 12.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.193 0.451 . . . . 1.79 110.469 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.4 m -85.63 153.92 22.04 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.595 -0.891 . . . . 1.23 108.595 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 p -103.11 -34.37 8.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.317 1.047 . . . . 1.49 111.632 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -133.54 162.65 31.34 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.501 1.12 . . . . 3.05 109.549 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.61 138.06 35.4 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.843 0.457 . . . . 0.58 110.856 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.67 26.26 13.6 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.929 -0.868 . . . . 0.4 110.929 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.15 151.66 43.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.364 0.666 . . . . 2.48 110.679 -172.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -124.31 -179.74 4.58 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.706 0.802 . . . . 1.1 111.08 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.3 mt 60.46 49.76 6.5 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.871 1.268 . . . . 2.16 110.603 -171.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -157.98 147.44 19.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.118 0.567 . . . . 0.9 110.066 174.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.1 mt -64.27 129.64 40.72 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 125.976 1.711 . . . . 0.64 108.208 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.9 t -131.14 -63.76 0.84 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 106.462 -1.681 . . . . 0.94 106.462 -168.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.56 92.44 6.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.39 -1.707 . . . . 3.3 106.39 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.1 -133.53 39.81 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.28 -1.128 . . . . 0.7 110.28 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 t -84.73 0.1 51.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.886 0.475 . . . . 0.77 111.216 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -80.75 119.34 23.22 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.845 -1.169 . . . . 1.86 107.845 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.46 137.15 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.712 -0.847 . . . . 1.73 108.712 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.4 t -73.63 95.84 2.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.161 -1.052 . . . . 0.51 108.161 170.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.42 168.89 33.93 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.059 0.838 . . . . 0.68 112.975 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -57.68 153.6 13.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.02 0.928 . . . . 3.76 111.732 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.67 -5.91 76.16 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.844 0.735 . . . . 0.71 112.224 -172.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.96 169.14 17.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.044 2.538 . . . . 1.51 106.732 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 pttt -151.3 148.77 28.57 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.665 1.186 . . . . 1.97 108.658 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.7 t -104.06 132.2 50.56 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.1 1.36 . . . . 0.59 109.242 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.475 ' N ' HD12 ' A' ' 29' ' ' ILE . 2.9 mp -102.0 128.0 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.2 -1.407 . . . . 1.33 107.2 173.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.69 143.5 57.51 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.908 -0.775 . . . . 2.17 108.908 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.22 133.13 37.97 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 116.014 -0.539 . . . . 3.0 112.465 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 t -83.72 65.4 8.51 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.121 0.968 . . . . 3.8 108.444 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 43.86 41.59 3.93 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.561 1.545 . . . . 5.51 112.155 175.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.62 -66.26 0.06 OUTLIER Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.528 -1.429 . . . . 2.43 109.528 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 mp0 -63.46 159.78 17.71 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.649 0.737 . . . . 3.54 110.975 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -95.22 175.01 6.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.398 1.079 . . . . 3.73 108.758 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -50.85 133.6 26.35 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.447 1.099 . . . . 2.58 109.203 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -133.63 113.18 12.1 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 119.215 -0.422 . . . . 3.2 110.893 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.1 t -94.65 108.05 20.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.042 -0.725 . . . . 0.37 109.042 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.38 154.04 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.826 -0.805 . . . . 0.57 108.826 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -69.72 163.63 25.27 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.972 -0.455 . . . . 1.9 111.292 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.62 127.36 4.57 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.243 -1.943 . . . . 2.13 108.243 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -47.86 146.98 2.16 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.243 1.022 . . . . 4.38 110.729 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.49 175.09 27.01 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.501 -1.839 . . . . 0.71 108.501 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.9 m -73.64 136.83 77.39 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.286 0.634 . . . . 1.63 109.583 177.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.76 139.35 33.49 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.13 1.886 . . . . 0.85 109.507 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -56.66 115.14 9.31 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 119.13 -0.462 . . . . 2.75 110.857 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.44 166.66 27.06 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.355 2.037 . . . . 1.4 109.507 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -82.09 157.8 23.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.915 0.886 . . . . 5.35 110.265 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 p -101.33 -60.72 1.48 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.168 0.987 . . . . 4.3 109.726 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.8 p80 . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 105.905 -1.887 . . . . 8.18 105.905 173.192 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 106.52 -1.659 . . . . 4.6 106.52 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 75.2 t -114.29 154.51 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 107.193 -1.41 . . . . 2.5 107.193 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -129.83 161.06 31.62 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.02 1.328 . . . . 2.03 109.002 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 p -143.76 170.68 15.41 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.557 1.543 . . . . 1.23 107.823 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.52 163.37 27.01 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.658 0.783 . . . . 2.03 112.295 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.54 167.33 17.47 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.89 0.476 . . . . 1.35 111.666 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -120.01 -41.03 2.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.88 1.272 . . . . 1.36 112.776 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -110.01 161.03 15.91 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.207 0.912 . . . . 2.74 110.873 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.33 148.36 29.42 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 121.384 0.611 . . . . 0.42 111.303 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.46 3.71 90.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 115.838 -0.619 . . . . 0.42 112.154 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.54 170.07 15.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.345 -1.354 . . . . 2.41 107.345 171.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -153.2 -171.91 4.07 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.318 -0.864 . . . . 0.72 109.892 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tp 59.79 53.61 4.76 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.682 1.593 . . . . 2.21 110.654 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.7 p -166.83 160.82 14.9 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 126.649 1.98 . . . . 1.03 107.036 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.5 141.31 51.98 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.452 0.701 . . . . 0.66 109.557 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.3 t -142.07 -64.15 0.43 Allowed 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 118.226 -1.39 . . . . 0.69 108.702 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -92.83 91.73 7.59 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.597 -1.26 . . . . 3.26 107.597 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.5 -130.48 51.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.366 -1.494 . . . . 0.58 109.366 -175.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 t -87.13 12.15 12.25 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 117.176 0.488 . . . . 0.61 111.867 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -87.04 125.06 33.86 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.084 -1.01 . . . . 1.9 109.422 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.0 t -75.61 123.18 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.193 -1.04 . . . . 1.95 108.193 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.6 t -76.27 85.82 3.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.856 -0.794 . . . . 0.57 108.856 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.02 -175.41 9.17 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 115.147 0.819 . . . . 0.84 115.147 -170.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.5 148.71 22.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.955 -0.732 . . . . 4.36 109.748 165.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.65 4.01 90.27 Favored Glycine 0 CA--C 1.538 1.527 0 N-CA-C 111.427 -0.669 . . . . 1.11 111.427 -170.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -137.38 174.48 10.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.405 1.103 . . . . 1.7 109.571 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.46 133.35 18.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.953 1.301 . . . . 2.68 109.914 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -102.82 118.09 36.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.668 -0.864 . . . . 0.57 108.668 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 29' ' ' ILE . 2.5 mp -101.76 122.35 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.146 -1.798 . . . . 1.45 106.146 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.32 146.59 53.95 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.253 0.621 . . . . 2.39 109.623 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.35 169.47 23.7 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.563 0.601 . . . . 2.67 111.873 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -142.55 93.28 2.5 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.137 -0.69 . . . . 3.69 109.137 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.7 t0 95.75 73.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 128.989 2.916 . . . . 7.33 109.897 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.6 58.67 9.61 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.47 -0.786 . . . . 4.45 112.186 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -133.55 171.04 14.64 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.484 1.114 . . . . 4.44 110.803 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -95.95 171.91 8.33 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.067 1.347 . . . . 4.76 110.054 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -79.85 151.67 30.1 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.155 0.982 . . . . 3.0 110.086 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -134.01 120.08 19.8 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.564 -0.731 . . . . 2.98 110.685 -176.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 50.6 t -101.59 107.08 18.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.707 1.139 . . . . 0.44 110.086 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 m -102.85 162.18 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 121.66 -0.65 . . . . 0.6 109.364 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -75.04 150.98 38.74 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.157 -0.683 . . . . 1.91 109.157 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.15 -116.5 0.8 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.585 -1.406 . . . . 2.84 109.585 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -167.19 142.42 4.05 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.943 1.297 . . . . 4.04 108.699 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.8 170.52 30.6 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.425 1.488 . . . . 0.61 109.906 -169.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -98.24 138.21 20.86 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 117.684 0.742 . . . . 2.1 110.08 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.64 143.16 61.18 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.873 1.715 . . . . 0.87 110.317 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -56.08 118.17 19.64 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 118.994 -0.527 . . . . 2.99 110.83 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -74.75 154.03 43.5 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 121.566 1.511 . . . . 1.54 109.176 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -56.63 159.88 3.6 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.916 0.886 . . . . 6.51 111.643 171.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -81.68 -50.67 9.03 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.821 1.248 . . . . 5.56 111.337 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 124.511 1.125 . . . . 8.36 109.422 179.006 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 107.97 -1.122 . . . . 4.75 107.97 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.6 t -82.37 137.75 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.049 -1.093 . . . . 3.4 108.049 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.613 ' CE1' HG21 ' A' ' 21' ' ' VAL . 13.4 m-85 -106.94 158.28 17.14 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.659 1.183 . . . . 1.82 109.889 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.8 p -138.17 164.68 28.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.733 1.213 . . . . 1.01 108.642 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -75.33 162.75 28.14 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.56 -0.734 . . . . 2.26 110.917 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.4 m -83.33 140.71 32.28 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.65 1.114 . . . . 1.2 108.614 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -109.59 -11.53 14.77 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.051 0.76 . . . . 1.03 113.051 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.44 145.8 34.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.87 1.668 . . . . 3.86 109.769 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -73.7 158.3 34.94 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.335 1.064 . . . . 0.5 111.373 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.94 15.04 81.2 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.835 -1.075 . . . . 0.56 111.405 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -123.09 156.95 33.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.02 0.928 . . . . 2.81 109.106 -172.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -135.94 -167.68 2.08 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.941 0.896 . . . . 1.2 110.275 -173.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 64.46 38.66 7.41 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.96 0.8 . . . . 2.05 110.235 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -158.0 154.31 27.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.71 0.804 . . . . 1.0 109.655 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -64.95 119.55 10.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.338 -1.727 . . . . 0.54 106.338 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.7 t -118.79 -63.62 1.38 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.261 -1.385 . . . . 0.56 107.261 -173.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -98.51 101.62 13.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.481 1.112 . . . . 4.01 109.01 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.81 -138.64 49.27 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.725 -0.95 . . . . 0.5 110.725 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -83.4 1.83 39.52 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 122.188 -0.596 . . . . 0.6 111.287 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -84.19 116.7 23.07 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.059 -1.46 . . . . 1.52 107.059 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.613 HG21 ' CE1' ' A' ' 3' ' ' TYR . 8.2 p -69.86 136.77 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.906 -0.776 . . . . 1.68 108.906 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.6 t -73.5 93.98 2.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.046 -1.094 . . . . 0.52 108.046 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.97 171.96 16.48 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 122.071 0.817 . . . . 0.67 113.425 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.19 138.27 57.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.459 1.104 . . . . 4.48 112.463 172.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.93 10.3 62.94 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 110.988 -0.845 . . . . 0.78 110.988 -172.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -140.11 163.5 32.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.537 1.935 . . . . 1.47 108.487 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.91 137.61 36.63 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.28 1.832 . . . . 2.37 109.344 176.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -90.63 128.41 36.6 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.615 1.166 . . . . 0.42 108.736 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.7 mm -110.08 111.2 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.469 -1.678 . . . . 1.49 106.469 172.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.21 63.84 1.94 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.846 0.858 . . . . 2.28 110.091 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 43.85 -135.11 5.64 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.21 -0.905 . . . . 2.98 113.79 -172.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.5 m -157.45 72.31 0.67 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.15 1.38 . . . . 3.36 107.453 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 53.44 41.69 32.08 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.385 1.074 . . . . 7.9 111.867 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.1 -49.7 0.25 Allowed Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.266 -0.896 . . . . 2.99 112.134 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -63.56 163.13 11.66 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.414 0.626 . . . . 3.81 111.096 170.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.14 175.51 6.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.668 1.187 . . . . 4.43 110.013 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.68 135.42 57.62 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.777 1.631 . . . . 2.18 110.449 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -135.91 107.07 6.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.065 0.946 . . . . 3.11 109.363 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.6 t -82.64 93.66 7.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.604 0.638 . . . . 0.36 109.572 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 m -89.65 164.0 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.465 0.706 . . . . 0.73 109.722 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 t -73.74 167.09 22.1 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.981 -0.449 . . . . 1.93 110.783 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.79 137.47 8.33 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.551 -1.42 . . . . 2.13 109.551 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.5 146.62 54.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.787 1.294 . . . . 3.3 109.899 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.08 -171.41 13.48 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.535 1.064 . . . . 0.99 111.157 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -72.42 131.55 84.69 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.907 1.683 . . . . 1.65 112.322 168.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.9 146.43 20.61 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.763 2.976 . . . . 0.86 110.471 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.2 tmtt? -76.19 118.81 74.0 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 123.48 0.712 . . . . 2.78 109.813 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.69 139.96 28.72 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 N-CA-C 107.938 -1.601 . . . . 1.59 107.938 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -66.28 154.62 39.45 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 121.803 -0.561 . . . . 7.05 109.658 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.8 t -71.52 -40.76 69.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.53 0.332 . . . . 4.6 111.751 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 118.243 -0.884 . . . . 10.12 110.485 178.958 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 108.883 -0.784 . . . . 7.12 108.883 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.06 89.82 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.476 -1.305 . . . . 4.87 107.476 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -143.18 166.58 24.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.049 0.94 . . . . 1.6 109.549 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.2 p -147.58 163.13 37.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.061 1.744 . . . . 0.94 108.327 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -80.29 159.19 25.92 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.013 0.824 . . . . 2.14 111.16 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.6 m -84.2 155.59 22.45 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.588 1.085 . . . . 0.98 108.152 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -114.71 -15.02 11.97 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.702 1.001 . . . . 0.83 113.702 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -144.71 152.18 40.02 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.769 0.828 . . . . 2.51 109.282 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -76.89 144.08 39.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.094 0.473 . . . . 0.54 109.997 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 4.36 76.75 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.931 -0.927 . . . . 0.42 112.424 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -89.78 173.94 7.99 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.383 1.091 . . . . 2.57 108.867 171.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.0 p30 -151.31 -172.61 4.26 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.814 0.846 . . . . 0.99 109.816 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 66.56 44.16 2.36 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 122.119 0.962 . . . . 2.01 110.037 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -161.2 152.29 18.61 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.722 2.009 . . . . 1.12 108.603 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.5 mt -59.52 134.44 57.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.865 1.266 . . . . 0.65 107.706 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -131.9 -68.4 0.64 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.543 -1.651 . . . . 0.55 106.543 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -90.36 89.94 7.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.065 -1.087 . . . . 3.13 108.065 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.47 -131.65 52.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.102 -1.599 . . . . 0.59 109.102 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.0 t -79.59 6.35 10.76 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.441 -0.79 . . . . 0.75 112.488 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -84.33 118.72 24.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.844 -1.169 . . . . 1.61 107.844 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.4 p -72.12 129.02 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.803 -0.814 . . . . 1.44 108.803 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.1 t -76.44 85.79 3.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.405 -0.961 . . . . 0.42 108.405 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.25 157.95 17.61 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.448 1.499 . . . . 0.72 113.448 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.67 137.35 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.287 1.035 . . . . 4.35 111.57 174.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.1 -34.34 4.73 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 110.924 -0.87 . . . . 0.99 110.924 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -84.54 166.45 17.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.937 -0.764 . . . . 1.78 108.937 173.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -139.95 128.17 22.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.026 1.73 . . . . 2.98 107.722 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.9 t -86.95 135.45 33.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.237 -0.653 . . . . 0.6 109.237 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.1 mm -112.19 123.18 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 104.703 -2.332 . . . . 1.35 104.703 167.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.42 149.97 43.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.698 -0.853 . . . . 2.08 108.698 167.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.85 149.76 43.5 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 121.92 0.733 . . . . 3.25 112.163 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.8 p -86.28 69.91 10.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.431 2.693 . . . . 4.33 108.649 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 46.89 40.3 8.89 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.836 1.255 . . . . 6.97 112.508 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.28 -59.9 0.07 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.337 -1.505 . . . . 3.41 109.337 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.49 164.36 14.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.468 0.651 . . . . 3.08 110.438 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -96.6 174.3 6.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.594 1.157 . . . . 5.04 108.318 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.87 149.06 37.34 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.358 0.663 . . . . 2.14 111.458 173.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -140.79 124.44 16.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.03 0.932 . . . . 2.67 108.953 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.8 t -103.2 98.98 8.82 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.162 0.985 . . . . 0.41 109.24 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -102.51 179.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.357 0.663 . . . . 0.57 109.382 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.67 140.45 34.93 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.248 -0.649 . . . . 2.23 109.248 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.57 -24.6 0.18 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.167 -1.016 . . . . 2.8 114.323 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 68.49 144.95 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.846 1.658 . . . . 2.8 110.71 -171.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.43 -172.03 24.14 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.96 -1.256 . . . . 0.87 109.96 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 m -73.12 135.5 79.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.122 0.969 . . . . 1.68 111.116 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.99 143.6 36.66 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.754 1.636 . . . . 0.67 110.06 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.442 ' HG2' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -54.12 153.37 9.38 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 111.814 0.301 . . . . 2.29 111.814 173.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD2' ' HG2' ' A' ' 47' ' ' LYS . 57.8 Cg_endo -71.74 151.56 57.77 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.21 1.94 . . . . 2.35 108.913 174.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -93.14 122.21 35.3 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.768 1.227 . . . . 5.73 108.633 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 t 74.09 151.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.733 1.613 . . . . 5.51 110.326 -171.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 . . . . . 0 CA--C 1.541 0.623 0 C-N-CA 124.589 1.156 . . . . 7.75 110.341 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 3' ' ' TYR . 4.1 p . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.815 -0.439 . . . . 6.31 109.815 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 85.8 t -116.69 106.37 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 106.56 -1.645 . . . . 2.3 106.56 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.433 ' HB2' HD21 ' A' ' 15' ' ' LEU . 66.2 m-85 -108.71 -174.22 2.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.37 1.068 . . . . 1.86 109.478 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.8 p -143.84 164.58 30.14 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.089 0.956 . . . . 0.86 109.275 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.91 165.68 24.69 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.092 0.557 . . . . 2.12 110.679 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.3 m -86.84 142.62 27.94 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.011 -1.107 . . . . 1.29 108.011 -175.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 p -106.53 -16.27 14.57 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.664 0.386 . . . . 1.05 111.167 -172.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -147.71 153.47 39.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.485 1.514 . . . . 2.44 109.289 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -71.14 157.8 37.54 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 121.037 0.446 . . . . 0.59 110.968 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.71 5.24 86.19 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.538 -0.625 . . . . 0.53 111.538 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.75 164.86 12.22 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.665 0.786 . . . . 2.37 109.755 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -147.57 -176.98 5.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.364 -0.606 . . . . 1.2 109.364 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 13' ' ' LEU . 5.4 mt 65.51 35.18 7.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.544 1.538 . . . . 2.5 110.259 -174.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.34 151.86 37.25 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.165 -0.68 . . . . 0.92 109.165 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 3' ' ' TYR . 28.8 mt -72.31 108.12 5.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.323 1.449 . . . . 0.93 107.291 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.5 t -106.94 -63.36 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.034 -0.728 . . . . 0.54 109.034 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -95.02 98.95 11.05 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.925 1.29 . . . . 3.9 108.767 169.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.16 -134.11 52.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.67 -0.972 . . . . 0.41 110.67 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.6 t -82.75 -3.0 55.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 117.476 0.638 . . . . 0.77 111.073 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.08 122.43 23.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.042 -1.036 . . . . 1.77 108.34 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.7 126.61 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.563 -0.903 . . . . 2.79 108.563 -173.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.5 t -76.43 90.97 3.27 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.022 -0.423 . . . . 0.63 109.867 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.65 161.44 22.58 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 121.451 -0.781 . . . . 0.76 113.166 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -50.71 154.13 1.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.802 0.841 . . . . 3.71 111.934 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.52 -19.32 44.89 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.123 -0.791 . . . . 1.13 111.123 -173.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -119.62 166.49 13.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.22 2.208 . . . . 1.53 109.716 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 141.06 27.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.454 1.502 . . . . 1.96 110.313 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.6 t -88.1 122.57 31.83 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.341 2.256 . . . . 0.44 108.735 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.9 mp -100.56 123.48 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.082 -1.451 . . . . 1.47 107.082 172.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 mp -74.71 63.28 1.13 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.934 1.243 . . . . 2.05 110.969 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.77 162.4 0.3 Allowed Glycine 0 CA--C 1.547 2.036 0 CA-C-O 118.249 -1.306 . . . . 3.07 113.541 -164.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 p -143.67 42.09 1.46 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 118.091 2.626 . . . . 4.49 118.091 150.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 p30 160.09 28.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.416 1.007 . . . . 8.0 113.571 -144.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.57 1.69 86.92 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 120.898 -1.126 . . . . 3.4 113.598 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.4 172.44 8.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.52 1.152 . . . . 3.81 109.529 174.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -87.69 176.89 7.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.368 2.667 . . . . 4.98 109.561 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -44.1 146.01 0.69 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.055 1.342 . . . . 2.02 113.974 168.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.67 115.09 3.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.75 0.82 . . . . 3.75 112.924 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -88.02 110.98 21.02 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.938 1.295 . . . . 0.58 110.547 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.25 155.06 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.119 0.968 . . . . 1.08 109.586 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -64.84 148.96 50.32 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.406 0.283 . . . . 2.22 110.487 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.44 50.41 0.06 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.464 1.03 . . . . 2.92 111.638 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 42.11 83.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.461 2.304 . . . . 5.34 114.829 171.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.72 174.8 44.9 Favored Glycine 0 C--N 1.338 0.673 0 O-C-N 121.477 -0.765 . . . . 0.94 112.632 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.2 m -96.85 134.88 22.49 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.683 1.193 . . . . 2.06 109.503 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.6 152.43 78.2 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.551 1.501 . . . . 0.88 110.836 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp -78.59 112.19 24.81 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.677 -0.677 . . . . 2.57 110.928 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.36 149.5 50.85 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.317 1.345 . . . . 1.77 109.483 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.14 164.48 22.34 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.719 0.808 . . . . 5.44 109.306 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 99.8 p -102.17 159.3 15.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.371 1.068 . . . . 4.07 109.199 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 127.103 2.161 . . . . 7.72 113.434 177.798 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 77.6 t . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 107.32 -1.363 . . . . 4.63 107.32 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.16 145.21 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 107.905 -1.146 . . . . 2.65 107.905 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CE1' HG21 ' A' ' 21' ' ' VAL . 17.4 m-85 -118.9 164.89 14.77 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.735 1.214 . . . . 1.88 110.37 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -148.42 170.85 17.08 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.505 1.522 . . . . 0.76 108.125 -175.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -78.36 166.62 22.45 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 118.721 0.691 . . . . 2.09 111.056 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -84.46 170.89 13.05 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 107.503 -1.295 . . . . 1.07 107.503 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 p -134.45 -39.21 0.82 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.877 -0.602 . . . . 1.03 111.093 -170.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -116.98 147.78 42.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.556 1.143 . . . . 2.79 109.992 173.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -74.9 139.38 43.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.826 0.45 . . . . 0.61 110.255 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.69 -2.69 58.78 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.937 -0.465 . . . . 0.65 111.937 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -94.97 174.24 7.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.369 1.068 . . . . 2.56 109.265 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -150.18 -173.32 4.4 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.146 -0.971 . . . . 1.11 110.591 176.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 71.38 38.5 1.03 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.618 1.567 . . . . 2.34 111.982 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.88 153.49 31.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.223 2.609 . . . . 1.05 109.545 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 mt -64.05 127.7 32.56 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.899 1.68 . . . . 0.49 107.917 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.5 t -120.69 -63.98 1.29 Allowed 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.831 -1.174 . . . . 0.53 107.831 -169.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -105.46 106.06 16.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.453 -1.249 . . . . 4.92 107.678 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.2 -136.98 50.47 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.337 -1.105 . . . . 0.52 110.337 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 -3.99 58.47 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.869 0.868 . . . . 1.31 112.525 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -75.26 118.32 18.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.356 -0.979 . . . . 1.55 108.356 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' A' ' 3' ' ' TYR . 5.0 p -72.78 139.26 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.46 -0.57 . . . . 1.64 109.46 175.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.55 97.13 4.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.954 -1.128 . . . . 0.58 107.954 170.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.71 165.86 32.41 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.096 0.855 . . . . 0.68 112.866 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.89 153.49 20.87 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.673 -0.898 . . . . 4.41 111.803 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.34 -0.5 83.49 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 111.555 -0.618 . . . . 0.67 111.555 -172.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -136.29 171.23 14.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.066 2.146 . . . . 1.41 108.081 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -142.7 144.66 32.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.315 1.446 . . . . 2.17 109.484 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -96.88 125.74 41.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.794 1.238 . . . . 0.5 108.211 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.5 mm -97.25 120.37 46.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.794 -2.298 . . . . 1.05 104.794 171.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.47 146.36 52.0 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.166 -0.679 . . . . 2.11 109.166 169.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.08 134.89 52.22 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.531 -1.213 . . . . 3.25 111.506 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.83 67.67 1.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.818 -1.179 . . . . 4.35 107.818 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 45.26 35.13 1.65 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.599 1.16 . . . . 5.84 113.601 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.41 -61.19 0.05 OUTLIER Glycine 0 C--N 1.347 1.154 0 O-C-N 120.87 -1.144 . . . . 2.23 110.956 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -69.26 154.18 42.46 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 117.488 0.644 . . . . 4.31 110.082 165.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -94.24 174.49 7.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.203 1.801 . . . . 4.05 109.235 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -57.74 140.41 51.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.614 -0.231 . . . . 1.94 110.73 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -143.92 132.91 22.77 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 118.891 -0.576 . . . . 2.91 110.777 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.6 t -97.3 94.98 7.39 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 118.972 0.805 . . . . 0.45 108.982 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 m -88.25 166.88 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 C-N-CA 123.525 0.73 . . . . 0.7 109.353 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 t -81.23 -173.14 4.16 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.909 1.338 . . . . 1.93 111.8 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.89 133.74 6.57 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.562 -1.815 . . . . 1.97 108.562 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -56.2 137.59 51.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 117.622 0.711 . . . . 4.23 111.003 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.68 172.94 26.23 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.52 -1.032 . . . . 0.88 110.52 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.0 m -84.07 138.74 39.64 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 123.954 0.901 . . . . 1.75 110.559 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -74.35 147.9 37.69 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.342 2.028 . . . . 0.86 111.392 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -60.53 124.93 80.96 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.192 0.597 . . . . 2.33 110.962 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -66.46 157.13 62.04 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.172 1.915 . . . . 1.24 109.486 171.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -51.16 155.41 1.33 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.039 0.535 . . . . 5.55 111.959 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 t -137.96 157.63 45.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.473 -1.306 . . . . 4.88 107.473 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 105.866 -1.901 . . . . 7.12 105.866 -177.545 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 106.906 -1.516 . . . . 5.86 106.906 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.5 t -86.01 129.49 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.221 -1.029 . . . . 3.05 108.221 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -94.48 165.11 12.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.087 0.955 . . . . 2.61 109.719 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.9 p -146.98 169.21 19.68 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.218 -1.401 . . . . 1.03 107.218 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.99 165.85 5.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.948 0.404 . . . . 1.85 111.589 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.16 151.72 25.58 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.231 0.539 . . . . 1.07 111.933 163.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -117.97 -30.65 5.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.32 1.848 . . . . 1.16 111.705 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.89 155.25 23.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.47 1.108 . . . . 3.38 110.036 173.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -79.16 147.6 32.62 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 122.869 0.468 . . . . 0.43 110.383 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.51 27.11 21.12 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.04 -0.824 . . . . 0.49 111.04 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -127.46 144.63 51.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.137 0.575 . . . . 2.33 110.331 -171.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -114.78 -177.31 3.1 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.066 1.346 . . . . 1.09 109.689 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 13' ' ' LEU . 15.2 mt 52.2 57.69 6.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.121 0.968 . . . . 2.2 111.197 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -163.53 156.57 18.62 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.52 1.128 . . . . 1.22 108.183 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -72.1 130.09 40.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.803 -1.184 . . . . 0.51 107.803 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.7 t -127.66 -62.93 1.05 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.14 -0.689 . . . . 0.57 109.14 -168.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -100.34 108.29 20.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.929 1.292 . . . . 4.22 109.323 164.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.5 -143.58 47.22 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.391 -0.818 . . . . 0.66 111.321 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 t -83.99 5.95 23.78 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.089 0.444 . . . . 0.95 110.691 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -85.65 119.77 26.36 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.646 -1.242 . . . . 1.73 107.646 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.93 139.64 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.408 -0.59 . . . . 1.67 109.408 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.3 t -73.22 85.8 1.41 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.089 0.947 . . . . 0.52 109.813 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.87 157.0 1.84 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.348 1.927 . . . . 0.85 113.141 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -58.91 151.03 22.68 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.901 0.48 . . . . 3.3 111.187 -175.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.32 -10.99 64.51 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.608 -0.551 . . . . 0.82 112.626 -173.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -122.01 160.6 24.59 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.5 1.92 . . . . 2.03 108.028 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.04 150.0 43.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.739 1.215 . . . . 2.09 109.358 177.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.1 t -97.59 123.41 41.48 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 125.094 1.358 . . . . 0.5 107.895 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.4 mp -96.2 120.12 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.769 -1.567 . . . . 1.34 106.769 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.92 64.78 0.51 Allowed 'General case' 0 CA--C 1.523 -0.072 0 C-N-CA 126.784 2.034 . . . . 2.1 110.19 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.17 169.54 9.56 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.972 -1.013 . . . . 3.07 111.851 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.5 60.5 1.33 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.165 -1.42 . . . . 4.08 107.165 178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 58.11 24.68 11.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.657 1.183 . . . . 6.49 111.62 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.12 -53.22 0.17 Allowed Glycine 0 CA--C 1.533 1.174 0 O-C-N 121.765 -0.585 . . . . 2.94 111.747 -171.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -62.89 163.74 9.13 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.906 0.882 . . . . 3.49 110.828 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -94.56 177.26 5.99 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.201 2.2 . . . . 3.79 109.084 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -42.29 130.57 3.74 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.649 1.352 . . . . 1.85 114.649 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.72 121.13 7.9 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 124.067 0.947 . . . . 3.17 111.477 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.3 t -92.31 103.3 15.76 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.27 -0.641 . . . . 0.35 109.27 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -111.73 159.87 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.905 0.882 . . . . 0.64 109.599 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.0 149.06 51.16 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.836 0.351 . . . . 2.26 110.394 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.26 114.74 1.76 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.259 -1.936 . . . . 2.29 108.259 -174.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -55.94 121.81 10.16 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.313 -0.625 . . . . 3.24 109.313 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.13 -172.96 16.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.055 1.312 . . . . 0.6 110.214 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 t -96.94 147.36 32.81 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.108 -0.948 . . . . 2.0 109.531 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.96 141.61 24.16 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.292 1.995 . . . . 0.75 112.394 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.12 137.47 27.63 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.528 -0.272 . . . . 2.35 111.294 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.99 132.91 31.6 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 N-CA-C 108.281 -1.469 . . . . 1.71 108.281 172.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.35 161.41 30.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.376 1.07 . . . . 6.02 109.74 173.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.3 p -139.23 82.5 1.89 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.666 -1.235 . . . . 5.31 107.666 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.3 m80 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 106.613 -1.625 . . . . 11.9 106.613 172.146 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 106.138 -1.801 . . . . 4.52 106.138 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.8 t -134.42 126.48 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 106.231 -1.766 . . . . 2.7 106.231 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -113.52 170.54 8.17 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.114 1.366 . . . . 1.57 109.22 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.1 p -137.83 166.91 22.86 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.635 1.574 . . . . 1.22 108.273 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.88 162.84 21.46 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.412 0.285 . . . . 1.77 111.456 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.7 m -83.71 163.96 19.91 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.255 0.55 . . . . 1.54 111.454 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -123.08 -2.78 8.61 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.42 1.088 . . . . 1.0 112.442 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -139.59 136.17 34.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.908 0.883 . . . . 4.7 109.89 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -60.71 141.67 56.62 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 121.63 -0.669 . . . . 0.37 110.109 174.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.54 -11.01 72.16 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.817 -0.435 . . . . 0.74 112.02 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -72.55 168.72 17.99 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 118.057 0.928 . . . . 2.45 111.194 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -149.29 174.58 12.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.941 0.896 . . . . 0.78 110.249 171.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 74.73 53.36 0.08 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.732 1.213 . . . . 1.99 108.81 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -174.49 162.86 3.55 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.111 1.765 . . . . 1.02 107.173 -169.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.6 mt -79.33 145.53 33.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.716 0.806 . . . . 0.77 109.692 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.5 t -139.21 -63.24 0.52 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.506 -0.77 . . . . 0.73 109.756 -168.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -103.01 109.8 21.48 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.179 -1.045 . . . . 3.56 108.179 165.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.45 -125.37 37.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.577 -1.009 . . . . 0.58 110.577 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.5 t -98.34 9.11 43.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.54 0.736 . . . . 0.84 111.436 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -80.98 119.93 24.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.059 -1.089 . . . . 1.79 108.059 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.7 p -79.88 120.02 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.84 -0.8 . . . . 1.49 108.84 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.7 t -78.65 77.3 5.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.982 -1.118 . . . . 0.83 107.982 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.43 176.9 44.31 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.036 0.351 . . . . 1.09 113.407 -170.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -48.31 146.31 2.86 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.418 0.687 . . . . 4.65 110.77 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.58 -20.75 33.01 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.009 -0.884 . . . . 0.65 111.54 -166.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -124.52 171.2 10.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.065 1.433 . . . . 2.01 109.962 -177.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.74 137.46 29.81 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.604 1.962 . . . . 2.57 110.49 176.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.5 t -89.15 118.45 28.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.656 0.782 . . . . 0.52 109.15 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.48 130.04 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.716 -1.587 . . . . 1.35 106.716 170.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.6 mt -74.6 65.08 1.26 Allowed 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.035 0.934 . . . . 2.95 111.627 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.02 174.06 29.77 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.518 -0.764 . . . . 3.49 112.011 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.52 93.59 2.63 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.282 -1.377 . . . . 4.87 107.282 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.0 t0 38.74 67.39 0.43 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.462 1.905 . . . . 5.55 111.56 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.03 -31.42 7.68 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.511 -1.222 . . . . 2.58 113.02 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -63.96 142.95 58.22 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.707 1.753 . . . . 4.56 109.91 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -66.8 174.1 3.14 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.583 1.153 . . . . 4.03 111.127 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -43.05 138.45 2.1 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.881 2.072 . . . . 1.87 114.233 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -136.41 110.9 8.54 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.742 1.217 . . . . 3.15 109.728 -173.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.72 100.8 11.13 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.61 0.764 . . . . 0.5 109.13 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -96.55 167.01 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 C-N-CA 122.968 0.507 . . . . 0.9 109.72 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.38 159.67 14.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.649 0.78 . . . . 2.42 110.374 -171.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.04 45.07 1.31 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.646 1.117 . . . . 2.63 112.637 169.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 58.5 144.9 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 129.554 3.142 . . . . 3.15 116.602 171.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.07 -179.85 25.3 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.799 1.19 . . . . 0.69 111.647 -168.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 m -95.38 130.68 31.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.935 . . . . 2.37 110.943 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.52 135.41 42.26 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 CA-C-N 120.714 1.291 . . . . 1.09 110.327 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -64.55 131.86 95.22 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 119.066 -0.492 . . . . 2.48 111.011 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.56 171.02 18.98 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.599 2.199 . . . . 1.38 111.657 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.24 151.53 0.24 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.71 2.004 . . . . 7.7 114.251 -176.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.4 m -158.66 171.24 20.47 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.664 -1.606 . . . . 4.7 106.664 164.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 107.116 -1.438 . . . . 8.25 107.116 151.209 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 121.034 0.445 . . . . 8.38 110.452 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.5 t -111.53 82.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 106.867 -1.531 . . . . 3.24 106.867 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -143.08 178.48 7.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.05 0.94 . . . . 2.15 109.311 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.8 p -124.22 167.2 14.61 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.156 0.983 . . . . 0.91 109.913 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.47 168.19 2.94 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.316 0.647 . . . . 1.67 111.464 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.44 ' HB2' HD21 ' A' ' 30' ' ' LEU . 65.0 m -83.91 150.86 25.42 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 108.204 -1.035 . . . . 1.25 108.204 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -108.94 -20.84 12.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.656 0.783 . . . . 1.52 111.412 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -144.57 147.85 33.68 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.232 1.413 . . . . 2.6 109.225 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -68.77 159.7 31.83 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.764 0.826 . . . . 0.61 110.849 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.68 14.88 80.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.829 -0.908 . . . . 0.49 110.829 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -119.27 158.4 26.12 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 123.411 0.685 . . . . 2.34 110.125 -170.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -135.63 -176.46 4.29 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.449 0.7 . . . . 0.75 110.402 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 13' ' ' LEU . 5.4 tp 66.79 39.76 3.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.158 0.983 . . . . 2.37 109.704 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.4 p -154.61 153.45 31.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.339 1.455 . . . . 0.91 108.156 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.511 ' CD2' HG22 ' A' ' 21' ' ' VAL . 76.5 mt -76.38 108.67 9.49 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 125.396 1.478 . . . . 0.85 108.004 -174.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -107.32 -63.17 1.32 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.449 0.699 . . . . 0.54 109.41 -170.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -91.51 98.63 11.79 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.666 0.786 . . . . 2.9 109.841 168.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.8 -130.69 50.01 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.247 -1.141 . . . . 0.41 110.247 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.88 4.97 42.65 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.217 0.509 . . . . 0.61 111.039 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -79.89 120.12 23.68 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 120.922 -1.111 . . . . 1.67 108.058 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.511 HG22 ' CD2' ' A' ' 15' ' ' LEU . 4.9 t -83.78 124.85 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.315 -0.994 . . . . 2.59 108.315 -175.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.8 t -76.53 86.9 3.24 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.956 -0.757 . . . . 0.46 108.956 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.65 172.29 19.4 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 121.659 -0.651 . . . . 0.78 113.151 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.07 152.21 4.32 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.73 -0.865 . . . . 4.0 112.249 174.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.93 -5.73 83.1 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.969 0.795 . . . . 0.68 111.787 -174.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -132.36 157.64 43.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.963 2.505 . . . . 1.28 108.048 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -141.51 152.33 44.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.363 1.465 . . . . 2.31 109.042 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.4 t -99.42 130.18 45.67 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.771 2.029 . . . . 0.41 108.91 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.5 mm -102.72 107.48 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.4 -1.704 . . . . 1.28 106.4 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 6' ' ' CYS . 34.4 mt -69.73 73.91 0.41 Allowed 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.387 1.475 . . . . 2.18 110.375 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.05 146.49 2.87 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.066 -1.214 . . . . 2.8 110.066 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.44 58.13 1.39 Allowed 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 108.739 -0.838 . . . . 4.3 108.739 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 49.63 28.02 2.41 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.479 1.512 . . . . 5.85 111.832 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.88 -72.41 0.14 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.433 -1.467 . . . . 3.89 109.433 -165.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -63.5 158.16 21.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 117.967 0.884 . . . . 3.52 110.199 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -86.91 177.64 7.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.902 2.481 . . . . 4.23 109.641 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -42.0 110.13 0.16 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.365 1.866 . . . . 2.41 114.083 166.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -128.27 133.3 48.76 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.153 0.981 . . . . 2.58 110.328 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.5 t -100.85 105.02 16.27 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.636 -0.876 . . . . 0.46 108.636 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -110.3 172.82 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 109.329 -0.619 . . . . 0.78 109.329 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 t -67.16 177.99 1.61 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.272 1.034 . . . . 2.03 111.949 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.41 124.03 4.76 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.853 -2.099 . . . . 2.27 107.853 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.4 134.05 40.26 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.469 -0.567 . . . . 3.71 109.469 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.8 165.86 15.37 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 108.528 -1.829 . . . . 0.65 108.528 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -76.01 149.94 83.01 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 108.581 -0.896 . . . . 1.73 108.581 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -78.08 157.48 30.37 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.275 1.983 . . . . 0.71 111.506 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -61.55 132.51 93.01 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 119.096 -0.478 . . . . 3.22 111.069 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.1 131.81 34.03 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.49 1.46 . . . . 1.62 108.973 170.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -50.25 144.64 7.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.675 0.79 . . . . 6.15 110.838 174.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.0 m 67.48 -75.64 0.06 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.559 0.744 . . . . 4.56 109.81 -174.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 117.597 -1.192 . . . . 10.24 109.64 -177.511 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 107.233 -1.395 . . . . 4.44 107.233 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 73.3 t -85.19 114.91 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.931 -1.507 . . . . 3.47 106.931 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -124.71 161.76 25.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.425 1.09 . . . . 1.8 109.291 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 p -147.9 165.83 29.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.606 1.562 . . . . 0.78 107.652 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -64.22 160.47 18.48 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.393 0.616 . . . . 1.66 111.975 -176.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -83.2 152.66 25.12 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.501 -0.772 . . . . 1.06 112.317 165.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.7 p -132.6 23.77 4.35 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.82 1.248 . . . . 1.39 111.319 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.08 159.66 11.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.116 0.966 . . . . 3.18 109.419 175.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -85.49 146.34 26.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.909 0.484 . . . . 0.5 111.164 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.69 28.01 17.69 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.011 -0.541 . . . . 0.58 111.854 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.92 158.12 39.7 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.674 -0.679 . . . . 3.34 110.569 -165.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -138.33 -179.81 6.01 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.694 1.134 . . . . 1.02 111.822 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 62.74 36.7 13.1 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.677 0.751 . . . . 2.23 111.049 173.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.9 p -149.45 161.04 42.89 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.572 1.549 . . . . 1.14 107.605 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.78 130.94 40.97 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.177 -1.046 . . . . 0.65 108.177 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.9 t -127.64 -63.64 1.02 Allowed 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 106.938 -1.505 . . . . 0.54 106.938 -174.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.59 98.26 11.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.944 -0.761 . . . . 3.46 108.944 172.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.78 -135.26 52.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.87 -1.292 . . . . 0.51 109.87 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 t -85.52 9.99 14.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.715 0.757 . . . . 0.82 112.225 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -90.64 124.85 35.39 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.655 -0.869 . . . . 1.68 108.655 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.3 139.17 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.999 -0.371 . . . . 1.7 109.999 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.7 t -75.09 91.21 2.54 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.532 -0.914 . . . . 0.62 108.532 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.68 158.26 1.43 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.158 1.837 . . . . 1.08 113.971 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -56.99 144.72 32.93 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.77 -0.841 . . . . 3.49 111.404 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.74 -5.08 79.57 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.105 0.86 . . . . 0.74 111.967 -171.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -125.48 166.87 15.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.169 1.788 . . . . 1.48 109.238 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -145.84 153.57 41.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.02 -1.104 . . . . 2.62 108.02 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.8 t -98.55 128.89 45.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.691 1.596 . . . . 0.45 107.041 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mt -101.05 124.65 54.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.456 -1.683 . . . . 2.14 106.456 166.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.01 129.95 39.24 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 106.551 -1.648 . . . . 2.5 106.551 167.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -48.02 146.56 4.95 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 117.861 -1.522 . . . . 2.43 112.112 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.0 t -124.33 42.49 3.24 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.95 1.875 . . . . 4.25 113.826 -171.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.0 p30 152.89 28.42 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.689 0.996 . . . . 5.62 113.689 -140.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.53 14.31 77.54 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.47 -1.394 . . . . 2.22 114.127 173.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.19 169.96 12.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.736 1.215 . . . . 3.51 110.216 173.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -91.37 176.44 6.56 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.628 1.171 . . . . 3.93 109.908 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -55.82 150.41 13.06 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.613 0.765 . . . . 2.2 111.776 173.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -148.04 109.54 4.39 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.31 0.644 . . . . 3.26 111.542 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.1 t -90.05 114.44 26.32 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 124.641 1.176 . . . . 0.41 109.466 174.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.86 161.65 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.825 -0.806 . . . . 0.77 108.825 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -61.58 148.0 43.74 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.784 -0.572 . . . . 2.35 110.226 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.77 -31.85 0.27 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.151 -0.805 . . . . 2.68 113.623 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 72.06 83.51 0.13 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.293 1.437 . . . . 3.72 111.356 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.38 -178.01 52.17 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.152 -0.477 . . . . 0.93 112.184 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.0 m -87.89 147.72 41.7 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.215 1.006 . . . . 2.35 108.652 171.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.61 143.5 24.23 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.111 1.874 . . . . 1.22 111.54 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -50.52 130.22 26.36 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 123.464 0.705 . . . . 2.67 111.129 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.32 149.52 75.53 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.788 1.659 . . . . 1.22 110.342 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -59.9 153.63 20.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.998 0.428 . . . . 5.43 110.525 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.5 p -172.93 -64.77 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.617 -0.883 . . . . 4.0 108.617 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.324 0 CA-C-N 114.774 -1.103 . . . . 10.07 109.35 171.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 107.618 -1.252 . . . . 4.59 107.618 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.19 150.02 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 106.828 -1.545 . . . . 2.95 106.828 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -125.3 157.96 35.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.571 1.148 . . . . 1.96 108.106 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 p -147.03 173.44 12.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.466 1.907 . . . . 1.19 106.221 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.03 168.5 8.17 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.939 0.4 . . . . 1.95 111.034 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.3 m -82.86 156.14 23.75 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.714 0.768 . . . . 1.29 110.759 159.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -110.53 -11.05 14.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.244 -1.344 . . . . 0.84 111.259 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -147.79 136.28 21.64 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 107.171 -1.418 . . . . 3.36 107.171 -166.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -64.7 150.35 47.39 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.45 0.568 . . . . 0.49 110.021 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.04 -1.27 62.9 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.046 -0.597 . . . . 0.46 112.149 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -99.79 147.43 25.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 117.657 0.729 . . . . 2.4 112.676 -171.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -115.19 -176.13 2.84 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.485 1.114 . . . . 1.17 110.664 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 59.14 53.74 5.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 122.379 1.085 . . . . 2.36 110.361 172.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.0 p -169.33 159.43 8.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.189 -1.411 . . . . 1.16 107.189 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.64 143.81 46.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.78 -0.822 . . . . 0.74 108.78 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.8 t -138.89 -63.2 0.53 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.509 -0.922 . . . . 0.57 108.509 -172.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -93.29 97.49 10.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.696 -0.853 . . . . 2.96 108.696 169.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.94 -132.64 52.55 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.925 -1.27 . . . . 0.54 109.925 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.4 t -87.28 14.68 7.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.732 0.766 . . . . 0.66 112.168 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -88.22 124.61 34.02 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.185 0.902 . . . . 1.49 109.377 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.0 t -71.66 133.23 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.209 1.004 . . . . 2.06 109.518 175.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.5 t -74.15 91.87 2.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.992 -0.744 . . . . 0.63 108.992 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.66 152.58 1.84 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.327 1.918 . . . . 1.18 114.188 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -49.43 139.1 12.35 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.479 0.712 . . . . 4.83 110.732 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.94 -3.3 87.28 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.411 -0.661 . . . . 0.97 112.71 -174.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -123.05 167.79 13.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.965 1.306 . . . . 1.55 108.318 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HE3' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -146.04 154.99 42.47 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.357 1.063 . . . . 2.7 110.653 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.8 t -105.83 127.79 53.33 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 106.846 -1.539 . . . . 0.52 106.846 -172.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.5 mm -98.11 107.37 20.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 105.698 -1.964 . . . . 1.3 105.698 173.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -71.14 92.99 1.02 Allowed 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.849 1.259 . . . . 2.13 108.815 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.45 175.58 4.35 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.489 -1.044 . . . . 2.97 110.489 -175.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -176.38 94.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 103.898 -2.63 . . . . 3.89 103.898 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 54.77 43.19 30.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.889 0.876 . . . . 6.22 112.141 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.96 6.91 58.96 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.097 1.332 . . . . 2.41 113.734 176.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.4 173.26 11.16 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 122.791 1.281 . . . . 2.86 110.971 172.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.41 177.01 8.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.277 2.631 . . . . 4.16 109.287 171.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -63.45 125.35 23.9 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 111.968 0.358 . . . . 1.72 111.968 162.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -118.7 127.26 53.4 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 131.306 3.842 . . . . 4.19 109.359 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -101.42 111.26 23.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.692 1.587 . . . . 0.47 110.15 172.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG23 ' HE3' ' A' ' 27' ' ' LYS . 31.4 m -114.22 155.57 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.038 0.935 . . . . 0.81 111.202 -174.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.01 168.54 15.85 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.793 0.806 . . . . 2.41 111.229 -169.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.61 45.96 1.47 Allowed Glycine 0 CA--C 1.524 0.605 0 O-C-N 120.842 -1.162 . . . . 2.95 111.38 162.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 73.68 154.97 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.586 2.354 . . . . 3.48 111.108 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.77 158.27 31.09 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.129 -1.588 . . . . 0.67 109.129 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -92.56 146.91 33.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 117.544 0.672 . . . . 1.97 109.436 -174.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.41 154.56 65.06 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-N 121.035 1.405 . . . . 1.4 110.659 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 106.86 38.1 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.354 1.062 . . . . 2.61 109.592 176.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -80.48 139.63 12.97 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.743 2.296 . . . . 1.73 110.19 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -86.34 160.55 19.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.73 0.812 . . . . 7.51 109.346 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.8 m 63.64 162.15 0.11 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.196 1.798 . . . . 4.95 112.176 -172.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 . . . . . 0 N--CA 1.45 -0.442 0 C-N-CA 127.62 2.368 . . . . 10.82 105.233 174.248 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 106.427 -1.694 . . . . 4.82 106.427 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.7 t -86.03 123.42 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.783 -1.562 . . . . 3.5 106.783 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -85.82 169.49 13.29 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.181 0.992 . . . . 2.62 108.527 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.1 p -101.63 165.93 10.97 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 124.106 0.963 . . . . 1.33 109.579 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.11 156.98 38.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.907 0.776 . . . . 2.23 110.955 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.456 ' C ' HD21 ' A' ' 30' ' ' LEU . 75.7 m -84.81 150.87 24.74 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 117.855 -1.538 . . . . 1.15 109.226 178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -132.34 6.06 4.13 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.73 0.641 . . . . 1.45 112.73 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.53 136.33 18.28 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.58 1.552 . . . . 3.68 106.812 -169.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -71.83 139.4 48.89 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 118.65 0.659 . . . . 0.77 110.353 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.68 67.53 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.733 -0.547 . . . . 0.48 111.733 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -97.13 164.07 12.66 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 123.297 0.639 . . . . 2.56 109.742 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -148.41 -175.37 4.89 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.223 0.609 . . . . 0.96 109.587 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 58.61 37.03 25.4 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.516 0.674 . . . . 2.3 109.481 -174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -148.81 145.6 27.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.6 1.16 . . . . 1.07 109.269 175.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 mt -57.68 108.88 0.62 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.411 2.284 . . . . 0.69 108.637 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.1 t -99.18 -63.15 1.15 Allowed 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.443 -1.688 . . . . 0.62 106.443 -174.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -109.79 99.08 8.28 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.035 1.334 . . . . 3.83 109.452 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.82 -145.73 38.84 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.617 -1.393 . . . . 0.66 109.617 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.02 -0.7 45.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.512 0.725 . . . . 1.02 110.687 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -82.25 118.82 23.41 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.197 -1.408 . . . . 1.62 107.197 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.18 146.94 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 110.289 -0.263 . . . . 1.8 110.289 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 t -73.16 95.79 2.13 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.789 0.804 . . . . 0.51 109.285 167.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.57 157.42 2.19 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 127.632 2.539 . . . . 1.09 113.137 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.38 144.94 56.8 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.051 -0.676 . . . . 3.89 110.667 -177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.5 0.41 84.45 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.323 0.487 . . . . 0.76 112.156 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.66 161.2 30.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.063 2.145 . . . . 1.44 108.596 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -136.63 156.64 48.27 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.881 1.672 . . . . 2.71 111.49 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.5 t -103.42 119.43 38.88 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.232 -1.766 . . . . 0.5 106.232 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.537 HD13 HG22 ' A' ' 40' ' ' VAL . 1.3 mp -88.3 109.36 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 104.883 -2.266 . . . . 1.29 104.883 174.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.456 HD21 ' C ' ' A' ' 6' ' ' CYS . 1.0 OUTLIER -61.39 132.97 55.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.766 -1.198 . . . . 2.03 107.766 175.091 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.29 137.88 49.53 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.06 -0.816 . . . . 2.85 111.06 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 m -130.23 43.2 3.16 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.082 -0.485 . . . . 4.64 111.955 -174.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 164.07 49.72 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.89 1.676 . . . . 4.73 109.105 -173.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.77 0.34 13.0 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 120.306 -1.496 . . . . 2.84 113.926 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -68.18 160.23 29.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 117.525 0.662 . . . . 3.89 110.828 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.95 166.19 12.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.271 -0.64 . . . . 5.07 109.271 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -58.72 127.39 31.94 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.895 0.878 . . . . 2.17 110.003 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.44 110.21 14.82 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.471 1.108 . . . . 2.73 110.409 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.3 t -84.53 98.11 9.94 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.277 -0.638 . . . . 0.33 109.277 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.537 HG22 HD13 ' A' ' 29' ' ' ILE . 3.2 m -100.48 168.56 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.734 -0.839 . . . . 0.66 108.734 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 t -67.29 171.06 6.26 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.037 -1.039 . . . . 2.56 111.51 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.05 140.79 7.57 Favored Glycine 0 C--O 1.223 -0.581 0 N-CA-C 109.106 -1.598 . . . . 2.27 109.106 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.39 112.74 14.46 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.326 -1.102 . . . . 3.73 108.976 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.94 174.76 23.59 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.264 0.935 . . . . 0.72 111.536 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -94.5 138.08 22.45 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 109.115 -0.698 . . . . 2.3 109.115 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.72 142.11 42.92 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 121.862 1.708 . . . . 1.1 109.586 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -50.77 108.23 0.99 Allowed Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.985 -0.531 . . . . 3.29 111.737 -177.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -77.71 170.79 18.51 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.014 1.809 . . . . 1.66 110.143 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -60.68 160.66 8.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.856 1.312 . . . . 5.39 111.649 173.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 m -151.62 124.58 8.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.613 -1.995 . . . . 5.73 105.613 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 105.346 -2.094 . . . . 9.16 105.346 179.516 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 71.7 t . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 106.557 -1.645 . . . . 4.14 106.557 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.2 t -136.63 118.89 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.638 -1.986 . . . . 2.58 105.638 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -89.65 163.04 15.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.335 -0.617 . . . . 1.53 109.335 175.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 p -134.39 163.9 28.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.296 1.438 . . . . 1.16 108.719 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.64 161.49 29.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.351 0.596 . . . . 1.87 111.91 -176.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 11' ' ' GLN . 1.3 m -83.82 173.73 11.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.652 0.781 . . . . 1.65 111.765 171.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -141.35 28.0 1.87 Allowed 'General case' 0 C--N 1.345 0.404 0 CA-C-O 118.733 -0.651 . . . . 1.58 112.733 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -165.14 160.78 19.05 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.995 -1.113 . . . . 2.76 107.995 170.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.29 153.82 26.88 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.866 0.867 . . . . 0.48 111.363 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.512 ' HA2' ' CG ' ' A' ' 27' ' ' LYS . . . 75.37 15.32 81.25 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.154 0.883 . . . . 0.46 111.751 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.43 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 1.9 mt-30 -92.18 171.4 9.1 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.412 0.685 . . . . 2.42 109.158 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -154.94 179.6 8.97 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.089 0.859 . . . . 0.71 110.394 170.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 63.56 55.84 1.68 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.544 1.538 . . . . 2.13 111.103 178.326 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.4 p -173.83 163.91 4.21 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.415 1.886 . . . . 0.9 106.532 -172.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.0 mt -71.93 144.18 49.03 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.918 -0.771 . . . . 1.01 108.918 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.0 t -142.31 -64.57 0.42 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.393 -0.595 . . . . 0.64 109.393 -172.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -94.32 98.96 11.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.156 -1.424 . . . . 2.97 107.156 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.69 -128.6 32.98 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.094 -1.203 . . . . 0.62 110.094 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 t -88.32 5.98 39.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 117.134 0.467 . . . . 0.67 111.823 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -83.61 124.34 30.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.129 -0.982 . . . . 2.14 108.484 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.08 132.68 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.533 0.733 . . . . 1.53 109.26 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.7 t -87.55 92.19 9.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.486 -1.301 . . . . 0.49 107.486 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.73 -172.71 9.94 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.501 1.048 . . . . 0.81 114.797 -168.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -61.63 145.46 52.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.856 -0.791 . . . . 3.91 109.321 168.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.51 10.3 86.02 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.159 -0.776 . . . . 1.08 111.159 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -135.2 167.92 20.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.474 1.11 . . . . 2.21 108.126 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.512 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 13.9 ttmt -145.46 132.32 20.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.744 1.218 . . . . 2.22 108.205 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -92.0 123.77 35.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.215 1.006 . . . . 0.62 109.293 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.9 mm -107.71 111.56 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 106.417 -1.697 . . . . 1.7 106.417 169.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.98 166.21 16.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.771 -0.455 . . . . 2.34 109.771 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.62 134.13 4.46 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.803 0.716 . . . . 2.34 112.798 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 m -144.29 98.5 3.22 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.444 -2.058 . . . . 3.67 105.444 -175.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t0 78.05 61.76 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.907 2.083 . . . . 5.81 110.73 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.53 29.88 74.87 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.818 0.723 . . . . 2.49 113.452 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -104.53 173.87 6.12 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.653 1.981 . . . . 3.92 110.606 173.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -96.27 176.86 5.91 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.251 2.62 . . . . 3.47 109.073 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -72.62 144.21 47.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.876 -0.583 . . . . 3.3 111.371 172.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -142.11 124.18 15.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.269 1.428 . . . . 2.99 110.165 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.4 t -97.81 102.22 13.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.454 1.025 . . . . 0.37 109.881 174.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.8 m -91.47 162.7 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.195 0.598 . . . . 0.74 109.916 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 t -79.71 152.8 29.69 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.778 -0.823 . . . . 1.9 108.778 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.75 -114.58 0.76 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.706 -1.358 . . . . 2.71 109.706 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -162.8 156.84 20.72 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.335 1.454 . . . . 4.49 107.816 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.8 170.37 30.6 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.703 -0.959 . . . . 0.78 110.703 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 t -81.04 140.28 49.76 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 117.366 0.583 . . . . 2.16 109.86 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.31 154.75 56.32 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.057 1.838 . . . . 1.12 111.673 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.97 133.88 47.61 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.085 0.554 . . . . 3.45 110.054 171.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.31 153.18 35.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.741 2.294 . . . . 1.8 109.756 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -90.36 141.29 28.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.752 0.821 . . . . 6.0 109.511 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.1 m 67.86 174.46 0.27 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.302 1.441 . . . . 5.12 111.894 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 118.376 -0.821 . . . . 8.04 110.532 170.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 106.924 -1.51 . . . . 4.42 106.924 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.8 t -124.83 141.94 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 106.576 -1.639 . . . . 2.68 106.576 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -117.2 160.1 21.59 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.313 1.445 . . . . 2.55 108.504 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 79.0 p -143.31 173.22 11.79 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.679 1.192 . . . . 1.36 108.683 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.71 162.2 8.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.503 0.668 . . . . 2.1 112.391 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -83.64 165.91 18.59 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 115.65 -0.704 . . . . 1.35 111.4 169.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -126.68 9.0 6.99 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.512 0.725 . . . . 1.02 112.592 -174.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -156.98 161.89 39.59 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.514 1.125 . . . . 2.81 109.007 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -81.91 157.69 24.24 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 122.767 0.427 . . . . 0.53 110.439 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.26 21.94 69.09 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 119.696 -1.24 . . . . 0.56 110.328 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -110.64 165.92 11.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.523 0.729 . . . . 2.26 109.14 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -144.23 -179.3 6.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.745 1.157 . . . . 0.81 110.612 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 13' ' ' LEU . 1.2 mt 58.46 54.84 5.26 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.62 1.168 . . . . 2.55 111.388 175.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.6 p -165.01 164.96 20.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.427 1.091 . . . . 1.06 108.172 -175.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.552 ' CD2' HG22 ' A' ' 21' ' ' VAL . 22.2 mt -75.4 120.82 21.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.073 -1.084 . . . . 0.49 108.073 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.1 t -123.07 -63.43 1.26 Allowed 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 108.109 -1.071 . . . . 0.56 108.109 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -90.82 88.9 7.25 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.715 1.206 . . . . 3.06 109.338 168.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.32 -135.21 42.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.393 -1.483 . . . . 0.48 109.393 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -81.78 -6.06 58.73 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.046 0.923 . . . . 0.73 111.604 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -76.51 123.98 26.88 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.184 -0.948 . . . . 1.59 108.662 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.552 HG22 ' CD2' ' A' ' 15' ' ' LEU . 6.8 t -83.2 136.87 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.156 -0.683 . . . . 2.32 109.156 -176.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.5 t -77.96 94.36 4.59 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.907 -0.496 . . . . 0.65 110.869 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.24 165.66 9.18 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.239 0.923 . . . . 0.83 114.156 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -57.34 151.53 15.97 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.876 -1.367 . . . . 3.63 113.249 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.36 0.32 86.72 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.07 1.319 . . . . 0.75 111.305 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -130.91 161.47 31.79 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.072 2.549 . . . . 1.34 108.642 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 145.83 33.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.641 1.176 . . . . 2.55 108.307 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.72 126.42 40.97 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.134 2.174 . . . . 0.45 108.688 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 29' ' ' ILE . 2.3 mp -97.81 114.19 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 106.168 -1.789 . . . . 1.66 106.168 170.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -73.0 76.41 1.19 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.828 1.251 . . . . 2.23 109.038 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.27 150.18 4.61 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.119 -0.793 . . . . 3.01 111.119 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.0 p -147.88 64.22 1.11 Allowed 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.993 -0.71 . . . . 5.15 110.024 -175.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.0 t0 87.38 61.49 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.688 1.995 . . . . 6.05 109.715 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.98 -12.61 10.98 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.341 -0.849 . . . . 2.67 113.989 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -61.98 161.92 9.95 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 123.016 1.388 . . . . 3.52 110.752 164.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -86.55 177.55 7.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.681 2.392 . . . . 5.16 108.436 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -43.25 149.64 0.23 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.622 0.971 . . . . 1.76 113.622 164.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.73 105.58 1.62 Allowed 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.518 1.127 . . . . 3.21 111.78 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.2 t -80.99 100.31 8.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 125.071 1.348 . . . . 0.5 109.325 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -107.72 176.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.772 0.829 . . . . 0.81 108.879 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.04 178.38 5.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.79 -0.569 . . . . 2.31 110.286 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.83 155.4 31.77 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.826 -1.71 . . . . 2.19 108.826 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -81.3 165.67 21.19 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 117.458 0.629 . . . . 3.48 109.918 -171.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.91 -179.13 38.01 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.355 -1.498 . . . . 0.97 109.355 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -93.19 148.79 36.33 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 117.416 0.608 . . . . 1.94 110.165 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -73.66 173.3 14.14 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.552 1.501 . . . . 1.1 111.137 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 132.09 21.22 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.887 0.875 . . . . 2.23 108.95 177.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.4 149.89 57.32 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.384 1.39 . . . . 1.85 110.802 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -72.38 154.87 40.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.148 0.979 . . . . 6.06 109.938 174.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.56 158.73 17.3 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.614 1.166 . . . . 5.41 108.294 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 106.35 -1.722 . . . . 10.91 106.35 178.414 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 104.931 -2.248 . . . . 4.23 104.931 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.6 t -97.85 147.51 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.174 -1.047 . . . . 3.22 108.174 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -108.55 -176.17 2.97 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.94 1.296 . . . . 2.34 109.193 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.9 p -127.3 166.43 17.81 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.965 0.906 . . . . 0.93 108.917 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.87 164.96 25.11 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.365 0.984 . . . . 2.29 109.684 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -82.48 157.13 23.73 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.113 -1.035 . . . . 1.09 109.397 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.1 p -121.64 -18.24 7.23 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.02 0.748 . . . . 1.0 113.02 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.24 155.08 43.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.998 1.719 . . . . 2.46 107.182 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -69.79 150.65 46.65 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.305 0.957 . . . . 0.46 109.888 173.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.66 -1.13 71.35 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.741 -0.477 . . . . 0.47 112.348 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -91.72 163.3 14.13 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.292 0.637 . . . . 2.44 110.544 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -150.52 -178.96 6.85 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.553 -0.717 . . . . 1.09 109.288 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mp 62.23 38.49 13.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.512 1.125 . . . . 2.22 110.398 -167.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -149.16 152.26 35.77 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.922 0.889 . . . . 1.05 110.232 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.8 mt -66.02 135.23 54.38 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.28 1.432 . . . . 0.51 107.67 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.9 t -140.84 -63.94 0.46 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.283 -1.377 . . . . 0.69 107.283 -168.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.42 89.15 7.89 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.184 -1.043 . . . . 3.27 108.184 168.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.75 -128.92 48.11 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.532 -1.427 . . . . 0.44 109.532 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 t -84.23 9.77 12.04 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.954 0.877 . . . . 0.74 112.432 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -91.33 117.99 30.13 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.797 1.181 . . . . 1.73 107.831 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.48 128.74 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.842 -0.617 . . . . 1.56 109.453 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.0 t -72.83 85.23 1.23 Allowed 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.347 0.594 . . . . 0.49 109.913 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.27 167.62 9.58 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 126.331 1.92 . . . . 0.75 114.049 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -55.6 152.44 9.2 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.307 -1.702 . . . . 3.96 112.019 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.02 12.0 84.58 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.338 0.97 . . . . 0.89 112.827 -173.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -138.7 170.1 16.6 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.67 3.188 . . . . 2.36 108.934 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.34 136.7 14.04 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.544 1.538 . . . . 1.98 109.524 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.4 t -94.48 126.52 39.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.211 -1.403 . . . . 0.43 107.211 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.6 mm -101.43 113.53 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.925 -1.509 . . . . 1.76 106.925 170.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mt -89.07 85.69 6.74 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.503 1.521 . . . . 2.23 107.723 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.0 135.09 6.24 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.224 -0.75 . . . . 3.42 111.224 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.06 99.45 2.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 104.65 -2.352 . . . . 4.62 104.65 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 42.82 47.7 4.81 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.523 1.154 . . . . 8.05 112.745 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.72 34.31 25.25 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.487 1.518 . . . . 3.8 112.951 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -97.66 169.65 9.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 123.017 1.389 . . . . 3.97 112.405 169.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -85.11 177.99 7.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.663 2.385 . . . . 3.44 109.212 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -62.38 127.14 29.91 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.283 0.633 . . . . 2.64 110.431 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -135.08 123.77 23.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.425 1.89 . . . . 4.29 111.346 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 39.0 t -95.81 101.99 13.74 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.603 1.961 . . . . 0.37 110.246 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.83 158.7 3.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 123.927 0.891 . . . . 0.61 110.099 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.41 167.71 16.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.832 -0.543 . . . . 2.57 110.226 176.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.97 -110.8 0.83 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.691 -1.763 . . . . 2.76 108.691 170.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -156.7 165.31 36.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.067 -1.827 . . . . 2.84 106.067 171.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.62 168.32 38.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.366 -1.494 . . . . 0.66 109.366 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.9 t -82.78 132.77 50.49 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.268 -0.642 . . . . 2.16 109.268 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.77 132.22 18.29 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.273 1.315 . . . . 0.76 110.252 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -55.31 119.25 22.37 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.774 -0.632 . . . . 2.22 110.008 174.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.3 146.78 40.85 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.287 1.325 . . . . 1.61 108.851 172.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -92.69 153.1 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.316 1.046 . . . . 6.02 109.618 169.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.4 m -163.58 -41.57 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.385 1.074 . . . . 4.78 110.575 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.5 p80 . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 125.211 1.404 . . . . 9.07 112.682 -176.018 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 CA--C 1.531 0.219 0 N-CA-C 107.775 -1.195 . . . . 2.5499999999999998 107.775 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.6 p -123.7 168.47 12.64 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.995 -0.743 . . . . 0.89000000000000001 108.995 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -65.85 170.46 5.37 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.215 0.606 . . . . 2.1099999999999999 109.718 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.19 143.38 28.01 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.502 -0.749 . . . . 1.0900000000000001 111.266 171.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.484 HG23 ' HE3' ' A' ' 47' ' ' LYS . 10.2 p -97.85 -22.78 16.17 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.179 1.177 . . . . 1.29 114.179 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -133.32 160.84 36.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.343 0.974 . . . . 2.5699999999999998 109.197 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -75.89 154.81 35.78 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.5 110.292 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.54 22.77 66.44 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.313 -0.715 . . . . 0.54000000000000004 111.313 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -108.15 147.67 30.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.907 0.883 . . . . 2.1499999999999999 109.944 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -115.17 176.85 4.88 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.758 0.823 . . . . 1.04 110.979 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.57 42.93 4.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.783 0.833 . . . . 2.1699999999999999 111.316 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.4 p -148.44 155.43 41.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.666 0.786 . . . . 1.46 109.201 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.4 mt -69.98 133.81 47.67 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.723 0.809 . . . . 0.58999999999999997 109.548 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 t -143.14 -63.06 0.41 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.44 -0.948 . . . . 1.03 108.44 -168.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -85.01 87.79 7.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.544 0.688 . . . . 3.6400000000000001 109.97 161.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.64 -136.33 51.21 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.582 -1.407 . . . . 0.52000000000000002 109.582 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.7 t -77.5 4.92 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 117.95 0.875 . . . . 0.77000000000000002 112.445 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -86.21 125.35 33.49 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 119.754 1.161 . . . . 1.78 108.095 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.3 t -74.17 140.12 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.785 0.834 . . . . 2.0699999999999998 108.939 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.4 t -73.67 90.38 1.81 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.714 0.769 . . . . 0.52000000000000002 109.165 169.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.96 156.98 1.91 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.948 2.213 . . . . 1.02 113.786 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -53.78 144.38 18.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.484 -0.421 . . . . 3.3999999999999999 111.626 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.47 -2.42 72.24 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.581 -0.566 . . . . 0.93000000000000005 112.572 -174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -122.75 153.5 39.39 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.489 1.516 . . . . 1.6599999999999999 107.839 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 156.15 48.34 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.07 0.85 . . . . 2.4100000000000001 112.044 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.6 t -102.1 127.17 49.12 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.437 -2.061 . . . . 0.65000000000000002 105.437 -170.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.1 mp -94.11 114.15 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 103.678 -2.712 . . . . 1.6200000000000001 103.678 170.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 105.972 -1.862 . . . . 2.0499999999999998 105.972 165.529 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 m120 . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 109.099 -0.704 . . . . 2.0499999999999998 109.099 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -126.35 113.55 17.06 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.751 0.82 . . . . 2.6000000000000001 110.809 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -91.77 119.68 31.81 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.811 -0.811 . . . . 0.46999999999999997 108.811 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -128.41 152.35 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-N 118.275 0.489 . . . . 0.73999999999999999 109.852 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -64.48 159.41 21.57 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.798 0.439 . . . . 2.1099999999999999 110.925 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.39 -103.98 0.26 Allowed Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.099 -1.601 . . . . 2.6899999999999999 109.099 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.55 160.31 8.96 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.671 1.588 . . . . 3.8900000000000001 107.126 168.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.64 166.8 38.14 Favored Glycine 0 N--CA 1.467 0.713 0 N-CA-C 110.531 -1.027 . . . . 0.82999999999999996 110.531 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.7 m -76.44 140.8 68.93 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.948 0.899 . . . . 1.6799999999999999 110.09 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.03 131.65 13.33 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.29 1.327 . . . . 0.87 111.527 173.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HE3' HG23 ' A' ' 7' ' ' THR . 44.6 tttt . . . . . 0 CA--C 1.552 1.051 0 C-N-CA 124.117 0.967 . . . . 2.6499999999999999 111.681 177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 108.477 -0.934 . . . . 2.0600000000000001 108.477 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.9 p -140.82 162.48 35.34 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.038 1.335 . . . . 1.4299999999999999 109.382 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.56 162.39 27.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.309 1.044 . . . . 1.99 112.296 -173.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.3 m -87.28 162.04 17.63 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.357 -0.979 . . . . 0.95999999999999996 108.357 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -123.93 13.22 9.13 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.887 -0.578 . . . . 1.1000000000000001 112.443 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -176.79 163.8 2.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.516 1.526 . . . . 2.6499999999999999 109.395 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -79.28 161.28 26.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.568 0.747 . . . . 0.56999999999999995 111.306 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.85 7.77 59.6 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.282 1.896 . . . . 0.47999999999999998 113.289 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.12 -178.3 5.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.518 0.727 . . . . 2.9199999999999999 109.234 -175.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -166.53 -179.5 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 119.612 1.097 . . . . 0.91000000000000003 109.199 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tp 68.69 31.84 4.42 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.229 0.612 . . . . 2.8100000000000001 109.876 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.84 161.22 41.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.964 1.306 . . . . 1.22 108.635 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -74.27 104.68 5.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.534 -1.654 . . . . 0.68000000000000005 106.534 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -89.93 -63.92 1.21 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.993 -1.114 . . . . 1.3200000000000001 107.993 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -96.74 125.93 41.55 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.229 1.411 . . . . 4.6299999999999999 108.997 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.33 -127.76 6.76 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.714 0.673 . . . . 0.85999999999999999 112.003 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.5 t -96.42 14.32 24.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.65 0.78 . . . . 1.0900000000000001 111.281 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -88.41 113.87 24.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.764 0.793 . . . . 3.02 109.026 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.37 125.88 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.546 -0.752 . . . . 1.78 109.977 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -97.3 72.34 2.41 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.783 -0.821 . . . . 0.90000000000000002 108.783 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.78 -174.21 12.51 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 122.168 0.871 . . . . 1.3700000000000001 114.873 -171.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -50.19 143.83 7.92 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.477 -1.014 . . . . 3.4500000000000002 111.343 166.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.0 -8.16 71.5 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 123.797 0.713 . . . . 1.0700000000000001 111.673 -167.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -132.11 162.76 30.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.24 1.416 . . . . 1.6899999999999999 109.44 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.04 135.7 36.14 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 127.676 2.39 . . . . 2.6099999999999999 108.486 -174.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 t -94.45 142.81 27.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.581 1.152 . . . . 0.93999999999999995 109.058 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.9 mm -124.0 117.0 49.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.769 -1.937 . . . . 1.1899999999999999 105.769 172.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.321 0 C-N-CA 124.786 1.234 . . . . 2.5800000000000001 109.815 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m120 . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 119.467 -0.301 . . . . 2.0800000000000001 111.347 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -142.21 127.55 18.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.617 0.767 . . . . 3.29 109.217 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.9 t -96.35 105.43 17.5 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.679 0.672 . . . . 0.42999999999999999 109.544 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -95.99 174.75 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.351 1.06 . . . . 0.73999999999999999 109.577 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.1 166.76 18.44 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.842 0.857 . . . . 2.3100000000000001 111.272 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.69 121.74 3.58 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 109.87 -1.292 . . . . 2.3300000000000001 109.87 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -51.36 123.15 9.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.656 1.182 . . . . 3.21 112.68 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.43 -168.11 32.72 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.575 1.083 . . . . 1.04 112.916 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.5 m -85.15 124.19 72.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.282 1.033 . . . . 1.98 110.378 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -74.73 135.0 19.01 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-N 120.95 1.375 . . . . 0.82999999999999996 111.427 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.4 tttm . . . . . 0 CA--C 1.538 0.502 0 C-N-CA 123.488 0.715 . . . . 2.6299999999999999 111.753 178.41 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 108.695 -0.854 . . . . 2.2799999999999998 108.695 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -120.15 166.43 13.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.9 1.28 . . . . 0.98999999999999999 110.139 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.69 163.26 26.02 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.674 1.19 . . . . 1.6799999999999999 112.257 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.4 m -86.07 143.96 27.8 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.084 -0.71 . . . . 1.24 109.084 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -115.56 15.08 16.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.257 0.623 . . . . 1.45 111.815 -172.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.12 145.8 0.64 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.63 1.572 . . . . 3.5299999999999998 109.645 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -70.52 151.49 45.02 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 120.862 0.363 . . . . 0.37 110.643 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.45 0.17 89.91 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.551 -0.62 . . . . 0.60999999999999999 111.551 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -98.19 168.7 10.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.06 0.944 . . . . 2.52 109.845 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -148.15 -170.9 3.7 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.921 -0.487 . . . . 0.93000000000000005 110.606 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.448 HD22 ' HB3' ' A' ' 46' ' ' PRO . 2.3 mp 60.31 37.67 20.15 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.734 0.778 . . . . 2.1899999999999999 110.128 -176.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.4 p -150.21 147.49 27.76 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.959 1.303 . . . . 0.93000000000000005 108.845 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 mt -63.02 113.51 3.15 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 126.896 2.078 . . . . 0.68999999999999995 108.409 -176.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.5 t -109.94 -63.72 1.34 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.854 -1.536 . . . . 0.57999999999999996 106.854 -170.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -98.11 97.83 9.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.354 1.062 . . . . 3.46 108.327 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.46 -136.2 39.3 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.924 -1.271 . . . . 0.51000000000000001 109.924 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.05 -3.84 55.49 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.541 0.736 . . . . 1.1100000000000001 112.293 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -78.08 117.92 19.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.915 -0.772 . . . . 1.53 108.915 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p -73.31 139.44 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.102 0.561 . . . . 1.73 109.495 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.4 t -74.14 96.93 2.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.099 -0.704 . . . . 0.42999999999999999 109.099 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.25 169.1 8.09 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.155 0.883 . . . . 0.70999999999999996 113.69 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.08 147.1 40.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.499 -1.0 . . . . 3.5800000000000001 111.273 173.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.62 81.77 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.578 -0.609 . . . . 0.71999999999999997 111.578 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -142.58 161.52 37.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.068 2.147 . . . . 1.47 109.122 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -139.75 138.89 36.29 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.402 2.281 . . . . 2.0499999999999998 109.715 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -90.41 120.31 31.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.59 1.556 . . . . 0.48999999999999999 108.582 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.444 HD12 ' N ' ' A' ' 29' ' ' ILE . 1.9 mp -94.5 117.32 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 107.082 -1.451 . . . . 1.3500000000000001 107.082 170.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 N--CA 1.455 -0.219 0 O-C-N 123.845 0.716 . . . . 2.25 109.292 172.373 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 108.463 -0.94 . . . . 2.4300000000000002 108.463 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -126.13 123.58 38.62 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.242 0.617 . . . . 3.0299999999999998 110.53 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -92.88 88.59 6.25 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.266 0.626 . . . . 0.65000000000000002 109.536 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 m -85.55 168.08 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 C-N-CA 123.303 0.641 . . . . 0.63 109.362 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.21 171.16 14.99 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.48 -0.762 . . . . 2.3399999999999999 112.01 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.55 132.03 7.16 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 108.496 -1.842 . . . . 2.1299999999999999 108.496 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.76 142.7 55.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.011 1.406 . . . . 3.6800000000000002 110.901 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -139.5 164.28 25.99 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.569 -1.412 . . . . 1.03 109.569 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.0 m -75.63 142.61 74.14 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.509 1.124 . . . . 1.95 109.757 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.448 ' HB3' HD22 ' A' ' 13' ' ' LEU . 56.0 Cg_endo -74.48 151.83 42.78 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.541 2.16 . . . . 1.1599999999999999 111.652 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.37 0 C-N-CA 122.928 0.491 . . . . 2.8100000000000001 111.825 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 109.963 -0.384 . . . . 1.8600000000000001 109.963 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.4 p -144.95 165.99 26.56 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.146 1.379 . . . . 1.22 109.275 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.02 166.57 20.66 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.785 0.72 . . . . 2.3399999999999999 112.049 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -88.14 157.68 18.76 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 108.226 -1.028 . . . . 0.96999999999999997 108.226 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.6 p -103.4 -39.0 6.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.813 0.845 . . . . 1.3799999999999999 110.88 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.6 161.0 35.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.282 1.033 . . . . 2.5899999999999999 110.179 -175.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -70.05 150.55 46.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.932 0.872 . . . . 0.40000000000000002 110.944 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.45 10.67 85.58 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.212 1.387 . . . . 0.39000000000000001 113.249 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -77.04 179.92 5.95 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.927 0.863 . . . . 2.6499999999999999 110.213 172.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -158.05 -176.71 6.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.504 1.522 . . . . 0.72999999999999998 107.999 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp 67.43 36.1 3.99 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.052 1.341 . . . . 2.6499999999999999 111.398 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.25 159.02 38.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.504 2.722 . . . . 1.1699999999999999 107.987 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 mt -70.09 116.2 10.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.331 -1.729 . . . . 0.56000000000000005 106.331 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -95.23 -64.43 1.06 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.847 -1.168 . . . . 1.3 107.847 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -109.59 120.16 41.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.288 1.435 . . . . 2.7999999999999998 108.072 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 53.58 -128.72 39.87 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.416 -1.074 . . . . 0.81999999999999995 110.416 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 t -98.25 15.7 23.69 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.202 0.601 . . . . 1.0 111.241 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -88.28 118.13 27.68 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.226 -1.027 . . . . 2.2799999999999998 108.226 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.03 116.39 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.809 0.844 . . . . 2.0699999999999998 110.65 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.9 t -89.92 78.45 6.77 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.351 -0.981 . . . . 0.66000000000000003 108.351 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.72 -172.5 25.52 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 123.417 0.532 . . . . 1.1799999999999999 114.362 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -56.82 144.98 31.0 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 121.417 -1.049 . . . . 4.6100000000000003 111.065 168.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.97 -7.66 81.27 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.196 0.903 . . . . 1.0800000000000001 111.285 -168.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -125.82 171.2 10.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.448 1.099 . . . . 2.1499999999999999 109.227 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -142.67 139.28 31.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.639 1.175 . . . . 2.75 107.889 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.2 t -95.59 143.88 26.51 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 123.852 0.861 . . . . 0.82999999999999996 109.477 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.6 mm -118.84 118.3 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 127.206 2.202 . . . . 1.24 106.709 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 126.308 1.843 . . . . 2.1499999999999999 107.706 169.497 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 . . . . . 0 C--O 1.225 -0.223 0 N-CA-C 109.659 -0.497 . . . . 1.79 109.659 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -139.71 126.79 21.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.287 1.035 . . . . 3.3399999999999999 111.415 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.7 t -95.63 108.23 20.49 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.768 1.227 . . . . 0.46000000000000002 109.812 174.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.8 m -94.55 166.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.889 0.876 . . . . 0.78000000000000003 108.931 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.8 t -79.65 156.78 27.45 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.378 -0.826 . . . . 1.79 108.796 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.32 -113.05 0.62 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.633 -1.387 . . . . 2.8300000000000001 109.633 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -170.21 147.35 3.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.805 2.042 . . . . 4.5700000000000003 106.666 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.57 177.01 24.25 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 118.938 0.79 . . . . 0.72999999999999998 111.384 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.8 m -86.11 131.5 46.4 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.81 -0.614 . . . . 1.6899999999999999 109.404 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.36 140.87 59.8 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.266 1.311 . . . . 0.80000000000000004 110.101 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 118.673 -0.68 . . . . 3.0899999999999999 110.459 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 109.186 -0.672 . . . . 1.95 109.186 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.6 p -121.89 171.57 8.82 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.882 0.873 . . . . 0.97999999999999998 110.943 171.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.13 163.26 5.0 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.789 0.835 . . . . 2.0099999999999998 112.367 172.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.53 163.22 18.53 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.223 1.009 . . . . 1.1100000000000001 110.823 172.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.9 p -129.44 15.28 6.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.757 0.823 . . . . 1.1000000000000001 112.642 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.29 154.28 24.97 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.351 0.978 . . . . 3.2999999999999998 110.147 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -82.45 136.92 34.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.339 0.655 . . . . 0.55000000000000004 110.742 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.69 19.35 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.721 -0.551 . . . . 0.40999999999999998 111.721 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.25 145.36 47.93 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.046 0.538 . . . . 2.3999999999999999 110.717 -168.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -117.84 -178.63 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.893 0.877 . . . . 0.93000000000000005 110.471 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp 62.08 49.29 4.59 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.14 0.971 . . . . 2.0699999999999998 110.565 174.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -160.77 160.33 31.15 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.409 1.084 . . . . 1.26 108.313 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.7 mt -75.38 113.86 13.25 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.29 1.036 . . . . 0.68999999999999995 108.971 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -116.41 -64.07 1.36 Allowed 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.196 -1.038 . . . . 0.67000000000000004 108.196 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.58 91.27 6.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.248 -1.39 . . . . 3.0899999999999999 107.248 171.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.21 -132.0 52.33 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.347 -1.101 . . . . 0.41999999999999998 110.347 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.6 t -83.08 5.3 22.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.987 0.893 . . . . 0.59999999999999998 112.158 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -89.5 123.52 33.69 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.243 0.928 . . . . 2.3999999999999999 108.563 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.48 137.04 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.086 0.554 . . . . 1.49 110.19 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.7 t -75.95 92.28 3.11 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.282 -0.636 . . . . 0.63 109.282 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.24 156.73 8.33 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.752 1.168 . . . . 0.89000000000000001 112.599 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -51.86 155.28 1.8 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.743 -0.857 . . . . 3.8100000000000001 112.722 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.72 1.4 89.25 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.028 0.823 . . . . 0.76000000000000001 113.357 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -135.26 156.81 48.35 Favored 'General case' 0 N--CA 1.448 -0.571 1 C-N-CA 131.998 4.119 . . . . 2.1600000000000001 108.578 179.211 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.95 154.27 48.3 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.719 1.608 . . . . 2.5699999999999998 110.588 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.5 t -95.23 128.53 42.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.598 1.559 . . . . 0.42999999999999999 108.809 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.3 mm -101.51 114.61 41.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.772 -1.936 . . . . 1.4399999999999999 105.772 170.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 124.196 0.998 . . . . 2.0699999999999998 109.104 172.33 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 118.272 -0.87 . . . . 2.52 110.386 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -135.65 124.74 24.38 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 118.725 -0.655 . . . . 3.48 111.922 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.4 t -92.99 101.71 14.05 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.734 1.152 . . . . 0.33000000000000002 109.144 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -104.39 158.59 5.38 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 C-N-CA 123.567 0.747 . . . . 0.57999999999999996 109.065 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -71.16 176.04 4.8 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 119.864 -0.734 . . . . 1.96 111.207 -179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.3 129.48 6.31 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 108.097 -2.001 . . . . 2.1299999999999999 108.097 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.37 132.62 48.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.022 -0.733 . . . . 2.9500000000000002 109.022 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.99 -159.21 10.19 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.968 -1.653 . . . . 1.03 108.968 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.89 142.5 26.34 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.36 0.664 . . . . 1.54 110.145 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.06 138.98 31.95 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.418 2.079 . . . . 0.72999999999999998 110.696 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 tttm . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 118.794 -0.622 . . . . 2.3799999999999999 111.066 179.194 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 110.045 -0.354 . . . . 1.76 110.045 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.0 p -142.6 169.04 18.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.935 1.294 . . . . 0.96999999999999997 109.678 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.63 171.0 12.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.193 0.451 . . . . 1.79 110.469 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.4 m -85.63 153.92 22.04 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.595 -0.891 . . . . 1.23 108.595 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 p -103.11 -34.37 8.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.317 1.047 . . . . 1.49 111.632 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -133.54 162.65 31.34 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.501 1.12 . . . . 3.0499999999999998 109.549 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.61 138.06 35.4 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.843 0.457 . . . . 0.57999999999999996 110.856 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.67 26.26 13.6 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.929 -0.868 . . . . 0.40000000000000002 110.929 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.15 151.66 43.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.364 0.666 . . . . 2.48 110.679 -172.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -124.31 -179.74 4.58 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.706 0.802 . . . . 1.1000000000000001 111.08 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.3 mt 60.46 49.76 6.5 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.871 1.268 . . . . 2.1600000000000001 110.603 -171.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -157.98 147.44 19.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.118 0.567 . . . . 0.90000000000000002 110.066 174.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.1 mt -64.27 129.64 40.72 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 125.976 1.711 . . . . 0.64000000000000001 108.208 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.9 t -131.14 -63.76 0.84 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 106.462 -1.681 . . . . 0.93999999999999995 106.462 -168.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.56 92.44 6.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.39 -1.707 . . . . 3.2999999999999998 106.39 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.1 -133.53 39.81 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.28 -1.128 . . . . 0.69999999999999996 110.28 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 t -84.73 0.1 51.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.886 0.475 . . . . 0.77000000000000002 111.216 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -80.75 119.34 23.22 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.845 -1.169 . . . . 1.8600000000000001 107.845 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.46 137.15 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.712 -0.847 . . . . 1.73 108.712 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.4 t -73.63 95.84 2.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.161 -1.052 . . . . 0.51000000000000001 108.161 170.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.42 168.89 33.93 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.059 0.838 . . . . 0.68000000000000005 112.975 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -57.68 153.6 13.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.02 0.928 . . . . 3.7599999999999998 111.732 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.67 -5.91 76.16 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.844 0.735 . . . . 0.70999999999999996 112.224 -172.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.96 169.14 17.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.044 2.538 . . . . 1.51 106.732 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 pttt -151.3 148.77 28.57 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.665 1.186 . . . . 1.97 108.658 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.7 t -104.06 132.2 50.56 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.1 1.36 . . . . 0.58999999999999997 109.242 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.9 mp -102.0 128.0 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.2 -1.407 . . . . 1.3300000000000001 107.2 173.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.342 0.256 0 N-CA-C 108.908 -0.775 . . . . 2.1699999999999999 108.908 173.756 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.6 m120 . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 109.203 -0.666 . . . . 2.5800000000000001 109.203 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -133.63 113.18 12.1 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 119.215 -0.422 . . . . 3.2000000000000002 110.893 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.1 t -94.65 108.05 20.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.042 -0.725 . . . . 0.37 109.042 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.38 154.04 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.826 -0.805 . . . . 0.56999999999999995 108.826 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -69.72 163.63 25.27 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.972 -0.455 . . . . 1.8999999999999999 111.292 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.62 127.36 4.57 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.243 -1.943 . . . . 2.1299999999999999 108.243 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -47.86 146.98 2.16 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.243 1.022 . . . . 4.3799999999999999 110.729 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.49 175.09 27.01 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.501 -1.839 . . . . 0.70999999999999996 108.501 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.9 m -73.64 136.83 77.39 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.286 0.634 . . . . 1.6299999999999999 109.583 177.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.76 139.35 33.49 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.13 1.886 . . . . 0.84999999999999998 109.507 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.2 tttt . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 119.13 -0.462 . . . . 2.75 110.857 -178.788 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 109.002 -0.74 . . . . 2.0299999999999998 109.002 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 p -143.76 170.68 15.41 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.557 1.543 . . . . 1.23 107.823 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.52 163.37 27.01 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.658 0.783 . . . . 2.0299999999999998 112.295 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.54 167.33 17.47 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.89 0.476 . . . . 1.3500000000000001 111.666 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -120.01 -41.03 2.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.88 1.272 . . . . 1.3600000000000001 112.776 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -110.01 161.03 15.91 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.207 0.912 . . . . 2.7400000000000002 110.873 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.33 148.36 29.42 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 121.384 0.611 . . . . 0.41999999999999998 111.303 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.46 3.71 90.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 115.838 -0.619 . . . . 0.41999999999999998 112.154 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.54 170.07 15.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.345 -1.354 . . . . 2.4100000000000001 107.345 171.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -153.2 -171.91 4.07 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.318 -0.864 . . . . 0.71999999999999997 109.892 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tp 59.79 53.61 4.76 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.682 1.593 . . . . 2.21 110.654 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.7 p -166.83 160.82 14.9 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 126.649 1.98 . . . . 1.03 107.036 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.5 141.31 51.98 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.452 0.701 . . . . 0.66000000000000003 109.557 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.3 t -142.07 -64.15 0.43 Allowed 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 118.226 -1.39 . . . . 0.68999999999999995 108.702 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -92.83 91.73 7.59 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.597 -1.26 . . . . 3.2599999999999998 107.597 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.5 -130.48 51.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.366 -1.494 . . . . 0.57999999999999996 109.366 -175.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 t -87.13 12.15 12.25 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 117.176 0.488 . . . . 0.60999999999999999 111.867 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -87.04 125.06 33.86 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.084 -1.01 . . . . 1.8999999999999999 109.422 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.0 t -75.61 123.18 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.193 -1.04 . . . . 1.95 108.193 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.6 t -76.27 85.82 3.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.856 -0.794 . . . . 0.56999999999999995 108.856 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.02 -175.41 9.17 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 115.147 0.819 . . . . 0.83999999999999997 115.147 -170.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.5 148.71 22.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.955 -0.732 . . . . 4.3600000000000003 109.748 165.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.65 4.01 90.27 Favored Glycine 0 CA--C 1.538 1.527 0 N-CA-C 111.427 -0.669 . . . . 1.1100000000000001 111.427 -170.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -137.38 174.48 10.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.405 1.103 . . . . 1.7 109.571 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.46 133.35 18.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.953 1.301 . . . . 2.6800000000000002 109.914 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -102.82 118.09 36.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.668 -0.864 . . . . 0.56999999999999995 108.668 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.5 mp -101.76 122.35 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.146 -1.798 . . . . 1.45 106.146 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 CA--C 1.53 0.2 0 C-N-CA 123.253 0.621 . . . . 2.3900000000000001 109.623 172.173 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 118.888 -0.577 . . . . 3.0 110.086 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -134.01 120.08 19.8 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.564 -0.731 . . . . 2.98 110.685 -176.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 50.6 t -101.59 107.08 18.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.707 1.139 . . . . 0.44 110.086 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 m -102.85 162.18 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 121.66 -0.65 . . . . 0.59999999999999998 109.364 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -75.04 150.98 38.74 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.157 -0.683 . . . . 1.9099999999999999 109.157 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.15 -116.5 0.8 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.585 -1.406 . . . . 2.8399999999999999 109.585 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -167.19 142.42 4.05 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.943 1.297 . . . . 4.04 108.699 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.8 170.52 30.6 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.425 1.488 . . . . 0.60999999999999999 109.906 -169.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -98.24 138.21 20.86 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 117.684 0.742 . . . . 2.1000000000000001 110.08 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.64 143.16 61.18 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.873 1.715 . . . . 0.87 110.317 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.1 tttp . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 118.994 -0.527 . . . . 2.9900000000000002 110.83 178.563 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.613 ' CE1' HG21 ' A' ' 21' ' ' VAL . 13.4 m-85 . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 109.889 -0.412 . . . . 1.8200000000000001 109.889 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.8 p -138.17 164.68 28.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.733 1.213 . . . . 1.01 108.642 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -75.33 162.75 28.14 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.56 -0.734 . . . . 2.2599999999999998 110.917 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.4 m -83.33 140.71 32.28 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.65 1.114 . . . . 1.2 108.614 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -109.59 -11.53 14.77 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.051 0.76 . . . . 1.03 113.051 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.44 145.8 34.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.87 1.668 . . . . 3.8599999999999999 109.769 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -73.7 158.3 34.94 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.335 1.064 . . . . 0.5 111.373 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.94 15.04 81.2 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.835 -1.075 . . . . 0.56000000000000005 111.405 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -123.09 156.95 33.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.02 0.928 . . . . 2.8100000000000001 109.106 -172.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -135.94 -167.68 2.08 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.941 0.896 . . . . 1.2 110.275 -173.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 64.46 38.66 7.41 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.96 0.8 . . . . 2.0499999999999998 110.235 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -158.0 154.31 27.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.71 0.804 . . . . 1.0 109.655 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -64.95 119.55 10.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.338 -1.727 . . . . 0.54000000000000004 106.338 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.7 t -118.79 -63.62 1.38 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.261 -1.385 . . . . 0.56000000000000005 107.261 -173.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -98.51 101.62 13.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.481 1.112 . . . . 4.0099999999999998 109.01 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.81 -138.64 49.27 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.725 -0.95 . . . . 0.5 110.725 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -83.4 1.83 39.52 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 122.188 -0.596 . . . . 0.59999999999999998 111.287 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -84.19 116.7 23.07 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.059 -1.46 . . . . 1.52 107.059 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.613 HG21 ' CE1' ' A' ' 3' ' ' TYR . 8.2 p -69.86 136.77 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.906 -0.776 . . . . 1.6799999999999999 108.906 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.6 t -73.5 93.98 2.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.046 -1.094 . . . . 0.52000000000000002 108.046 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.97 171.96 16.48 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 122.071 0.817 . . . . 0.67000000000000004 113.425 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.19 138.27 57.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.459 1.104 . . . . 4.4800000000000004 112.463 172.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.93 10.3 62.94 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 110.988 -0.845 . . . . 0.78000000000000003 110.988 -172.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -140.11 163.5 32.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.537 1.935 . . . . 1.47 108.487 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.91 137.61 36.63 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.28 1.832 . . . . 2.3700000000000001 109.344 176.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -90.63 128.41 36.6 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.615 1.166 . . . . 0.41999999999999998 108.736 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.7 mm -110.08 111.2 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.469 -1.678 . . . . 1.49 106.469 172.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 N--CA 1.463 0.19 0 C-N-CA 123.846 0.858 . . . . 2.2799999999999998 110.091 177.833 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 119.279 -0.391 . . . . 2.1800000000000002 110.449 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -135.91 107.07 6.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.065 0.946 . . . . 3.1099999999999999 109.363 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.6 t -82.64 93.66 7.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.604 0.638 . . . . 0.35999999999999999 109.572 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 m -89.65 164.0 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.465 0.706 . . . . 0.72999999999999998 109.722 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 t -73.74 167.09 22.1 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.981 -0.449 . . . . 1.9299999999999999 110.783 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.79 137.47 8.33 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.551 -1.42 . . . . 2.1299999999999999 109.551 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.5 146.62 54.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.787 1.294 . . . . 3.2999999999999998 109.899 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.08 -171.41 13.48 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.535 1.064 . . . . 0.98999999999999999 111.157 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -72.42 131.55 84.69 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.907 1.683 . . . . 1.6499999999999999 112.322 168.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.9 146.43 20.61 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.763 2.976 . . . . 0.85999999999999999 110.471 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.2 tmtt? . . . . . 0 N--CA 1.449 -0.501 0 C-N-CA 123.48 0.712 . . . . 2.7799999999999998 109.813 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 109.549 -0.537 . . . . 1.6000000000000001 109.549 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.2 p -147.58 163.13 37.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.061 1.744 . . . . 0.93999999999999995 108.327 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -80.29 159.19 25.92 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.013 0.824 . . . . 2.1400000000000001 111.16 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.6 m -84.2 155.59 22.45 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.588 1.085 . . . . 0.97999999999999998 108.152 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -114.71 -15.02 11.97 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.702 1.001 . . . . 0.82999999999999996 113.702 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -144.71 152.18 40.02 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.769 0.828 . . . . 2.5099999999999998 109.282 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -76.89 144.08 39.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.094 0.473 . . . . 0.54000000000000004 109.997 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 4.36 76.75 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.931 -0.927 . . . . 0.41999999999999998 112.424 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.78 173.94 7.99 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.383 1.091 . . . . 2.5699999999999998 108.867 171.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.0 p30 -151.31 -172.61 4.26 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.814 0.846 . . . . 0.98999999999999999 109.816 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 66.56 44.16 2.36 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 122.119 0.962 . . . . 2.0099999999999998 110.037 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -161.2 152.29 18.61 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.722 2.009 . . . . 1.1200000000000001 108.603 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.5 mt -59.52 134.44 57.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.865 1.266 . . . . 0.65000000000000002 107.706 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -131.9 -68.4 0.64 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.543 -1.651 . . . . 0.55000000000000004 106.543 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -90.36 89.94 7.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.065 -1.087 . . . . 3.1299999999999999 108.065 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.47 -131.65 52.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.102 -1.599 . . . . 0.58999999999999997 109.102 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.0 t -79.59 6.35 10.76 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.441 -0.79 . . . . 0.75 112.488 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -84.33 118.72 24.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.844 -1.169 . . . . 1.6100000000000001 107.844 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.4 p -72.12 129.02 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.803 -0.814 . . . . 1.4399999999999999 108.803 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.1 t -76.44 85.79 3.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.405 -0.961 . . . . 0.41999999999999998 108.405 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.25 157.95 17.61 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.448 1.499 . . . . 0.71999999999999997 113.448 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.67 137.35 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.287 1.035 . . . . 4.3499999999999996 111.57 174.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.1 -34.34 4.73 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 110.924 -0.87 . . . . 0.98999999999999999 110.924 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -84.54 166.45 17.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.937 -0.764 . . . . 1.78 108.937 173.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -139.95 128.17 22.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.026 1.73 . . . . 2.98 107.722 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.9 t -86.95 135.45 33.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.237 -0.653 . . . . 0.59999999999999998 109.237 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.1 mm -112.19 123.18 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 104.703 -2.332 . . . . 1.3500000000000001 104.703 167.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 108.698 -0.853 . . . . 2.0800000000000001 108.698 167.546 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.3 m120 . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 119.738 -0.172 . . . . 2.1400000000000001 111.458 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -140.79 124.44 16.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.03 0.932 . . . . 2.6699999999999999 108.953 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.8 t -103.2 98.98 8.82 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.162 0.985 . . . . 0.40999999999999998 109.24 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -102.51 179.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.357 0.663 . . . . 0.56999999999999995 109.382 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.67 140.45 34.93 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.248 -0.649 . . . . 2.23 109.248 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.57 -24.6 0.18 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.167 -1.016 . . . . 2.7999999999999998 114.323 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 68.49 144.95 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.846 1.658 . . . . 2.7999999999999998 110.71 -171.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.43 -172.03 24.14 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.96 -1.256 . . . . 0.87 109.96 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 m -73.12 135.5 79.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.122 0.969 . . . . 1.6799999999999999 111.116 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.99 143.6 36.66 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.754 1.636 . . . . 0.67000000000000004 110.06 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.544 0.727 0 N-CA-C 111.814 0.301 . . . . 2.29 111.814 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.433 ' HB2' HD21 ' A' ' 15' ' ' LEU . 66.2 m-85 . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 109.478 -0.564 . . . . 1.8600000000000001 109.478 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.8 p -143.84 164.58 30.14 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.089 0.956 . . . . 0.85999999999999999 109.275 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.91 165.68 24.69 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.092 0.557 . . . . 2.1200000000000001 110.679 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.3 m -86.84 142.62 27.94 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.011 -1.107 . . . . 1.29 108.011 -175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 p -106.53 -16.27 14.57 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.664 0.386 . . . . 1.05 111.167 -172.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -147.71 153.47 39.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.485 1.514 . . . . 2.4399999999999999 109.289 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -71.14 157.8 37.54 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 121.037 0.446 . . . . 0.58999999999999997 110.968 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.71 5.24 86.19 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.538 -0.625 . . . . 0.53000000000000003 111.538 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.75 164.86 12.22 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.665 0.786 . . . . 2.3700000000000001 109.755 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -147.57 -176.98 5.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.364 -0.606 . . . . 1.2 109.364 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 13' ' ' LEU . 5.4 mt 65.51 35.18 7.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.544 1.538 . . . . 2.5 110.259 -174.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.34 151.86 37.25 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.165 -0.68 . . . . 0.92000000000000004 109.165 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 3' ' ' TYR . 28.8 mt -72.31 108.12 5.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.323 1.449 . . . . 0.93000000000000005 107.291 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.5 t -106.94 -63.36 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.034 -0.728 . . . . 0.54000000000000004 109.034 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -95.02 98.95 11.05 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.925 1.29 . . . . 3.8999999999999999 108.767 169.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.16 -134.11 52.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.67 -0.972 . . . . 0.40999999999999998 110.67 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.6 t -82.75 -3.0 55.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 117.476 0.638 . . . . 0.77000000000000002 111.073 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.08 122.43 23.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.042 -1.036 . . . . 1.77 108.34 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.7 126.61 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.563 -0.903 . . . . 2.79 108.563 -173.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.5 t -76.43 90.97 3.27 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.022 -0.423 . . . . 0.63 109.867 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.65 161.44 22.58 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 121.451 -0.781 . . . . 0.76000000000000001 113.166 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -50.71 154.13 1.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.802 0.841 . . . . 3.71 111.934 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.52 -19.32 44.89 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.123 -0.791 . . . . 1.1299999999999999 111.123 -173.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -119.62 166.49 13.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.22 2.208 . . . . 1.53 109.716 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 141.06 27.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.454 1.502 . . . . 1.96 110.313 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.6 t -88.1 122.57 31.83 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.341 2.256 . . . . 0.44 108.735 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.9 mp -100.56 123.48 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.082 -1.451 . . . . 1.47 107.082 172.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.548 0.898 0 CA-C-N 119.934 1.243 . . . . 2.0499999999999998 110.969 -179.005 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 CA--C 1.542 0.639 0 N-CA-C 113.974 1.102 . . . . 2.02 113.974 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.67 115.09 3.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.75 0.82 . . . . 3.75 112.924 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -88.02 110.98 21.02 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.938 1.295 . . . . 0.57999999999999996 110.547 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.25 155.06 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.119 0.968 . . . . 1.0800000000000001 109.586 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -64.84 148.96 50.32 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.406 0.283 . . . . 2.2200000000000002 110.487 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.44 50.41 0.06 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.464 1.03 . . . . 2.9199999999999999 111.638 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 42.11 83.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.461 2.304 . . . . 5.3399999999999999 114.829 171.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.72 174.8 44.9 Favored Glycine 0 C--N 1.338 0.673 0 O-C-N 121.477 -0.765 . . . . 0.93999999999999995 112.632 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.2 m -96.85 134.88 22.49 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.683 1.193 . . . . 2.0600000000000001 109.503 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.6 152.43 78.2 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.551 1.501 . . . . 0.88 110.836 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 118.677 -0.677 . . . . 2.5699999999999998 110.928 174.773 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CE1' HG21 ' A' ' 21' ' ' VAL . 17.4 m-85 . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 110.37 -0.233 . . . . 1.8799999999999999 110.37 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -148.42 170.85 17.08 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.505 1.522 . . . . 0.76000000000000001 108.125 -175.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -78.36 166.62 22.45 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 118.721 0.691 . . . . 2.0899999999999999 111.056 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -84.46 170.89 13.05 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 107.503 -1.295 . . . . 1.0700000000000001 107.503 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 p -134.45 -39.21 0.82 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.877 -0.602 . . . . 1.03 111.093 -170.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -116.98 147.78 42.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.556 1.143 . . . . 2.79 109.992 173.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -74.9 139.38 43.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.826 0.45 . . . . 0.60999999999999999 110.255 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.69 -2.69 58.78 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.937 -0.465 . . . . 0.65000000000000002 111.937 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -94.97 174.24 7.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.369 1.068 . . . . 2.5600000000000001 109.265 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -150.18 -173.32 4.4 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.146 -0.971 . . . . 1.1100000000000001 110.591 176.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 71.38 38.5 1.03 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.618 1.567 . . . . 2.3399999999999999 111.982 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.88 153.49 31.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.223 2.609 . . . . 1.05 109.545 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 mt -64.05 127.7 32.56 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.899 1.68 . . . . 0.48999999999999999 107.917 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.5 t -120.69 -63.98 1.29 Allowed 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.831 -1.174 . . . . 0.53000000000000003 107.831 -169.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -105.46 106.06 16.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.453 -1.249 . . . . 4.9199999999999999 107.678 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.2 -136.98 50.47 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.337 -1.105 . . . . 0.52000000000000002 110.337 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 -3.99 58.47 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.869 0.868 . . . . 1.3100000000000001 112.525 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -75.26 118.32 18.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.356 -0.979 . . . . 1.55 108.356 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' A' ' 3' ' ' TYR . 5.0 p -72.78 139.26 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.46 -0.57 . . . . 1.6399999999999999 109.46 175.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.55 97.13 4.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.954 -1.128 . . . . 0.57999999999999996 107.954 170.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.71 165.86 32.41 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.096 0.855 . . . . 0.68000000000000005 112.866 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.89 153.49 20.87 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.673 -0.898 . . . . 4.4100000000000001 111.803 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.34 -0.5 83.49 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 111.555 -0.618 . . . . 0.67000000000000004 111.555 -172.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -136.29 171.23 14.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.066 2.146 . . . . 1.4099999999999999 108.081 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -142.7 144.66 32.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.315 1.446 . . . . 2.1699999999999999 109.484 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -96.88 125.74 41.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.794 1.238 . . . . 0.5 108.211 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.5 mm -97.25 120.37 46.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.794 -2.298 . . . . 1.05 104.794 171.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 CA--C 1.517 -0.296 0 N-CA-C 109.166 -0.679 . . . . 2.1099999999999999 109.166 169.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 119.614 -0.231 . . . . 1.9399999999999999 110.73 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -143.92 132.91 22.77 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 118.891 -0.576 . . . . 2.9100000000000001 110.777 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.6 t -97.3 94.98 7.39 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 118.972 0.805 . . . . 0.45000000000000001 108.982 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 m -88.25 166.88 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 C-N-CA 123.525 0.73 . . . . 0.69999999999999996 109.353 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 t -81.23 -173.14 4.16 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.909 1.338 . . . . 1.9299999999999999 111.8 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.89 133.74 6.57 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.562 -1.815 . . . . 1.97 108.562 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -56.2 137.59 51.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 117.622 0.711 . . . . 4.2300000000000004 111.003 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.68 172.94 26.23 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.52 -1.032 . . . . 0.88 110.52 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.0 m -84.07 138.74 39.64 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 123.954 0.901 . . . . 1.75 110.559 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -74.35 147.9 37.69 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.342 2.028 . . . . 0.85999999999999999 111.392 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.5 tttt . . . . . 0 CA--C 1.534 0.351 0 C-N-CA 123.192 0.597 . . . . 2.3300000000000001 110.962 176.485 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 109.719 -0.474 . . . . 2.6099999999999999 109.719 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.9 p -146.98 169.21 19.68 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.218 -1.401 . . . . 1.03 107.218 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.99 165.85 5.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.948 0.404 . . . . 1.8500000000000001 111.589 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.16 151.72 25.58 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.231 0.539 . . . . 1.0700000000000001 111.933 163.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -117.97 -30.65 5.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.32 1.848 . . . . 1.1599999999999999 111.705 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.89 155.25 23.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.47 1.108 . . . . 3.3799999999999999 110.036 173.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -79.16 147.6 32.62 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 122.869 0.468 . . . . 0.42999999999999999 110.383 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.51 27.11 21.12 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.04 -0.824 . . . . 0.48999999999999999 111.04 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.46 144.63 51.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.137 0.575 . . . . 2.3300000000000001 110.331 -171.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -114.78 -177.31 3.1 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.066 1.346 . . . . 1.0900000000000001 109.689 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 13' ' ' LEU . 15.2 mt 52.2 57.69 6.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.121 0.968 . . . . 2.2000000000000002 111.197 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -163.53 156.57 18.62 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.52 1.128 . . . . 1.22 108.183 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -72.1 130.09 40.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.803 -1.184 . . . . 0.51000000000000001 107.803 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.7 t -127.66 -62.93 1.05 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.14 -0.689 . . . . 0.56999999999999995 109.14 -168.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -100.34 108.29 20.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.929 1.292 . . . . 4.2199999999999998 109.323 164.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.5 -143.58 47.22 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.391 -0.818 . . . . 0.66000000000000003 111.321 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 t -83.99 5.95 23.78 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.089 0.444 . . . . 0.94999999999999996 110.691 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -85.65 119.77 26.36 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.646 -1.242 . . . . 1.73 107.646 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.93 139.64 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.408 -0.59 . . . . 1.6699999999999999 109.408 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.3 t -73.22 85.8 1.41 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.089 0.947 . . . . 0.52000000000000002 109.813 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.87 157.0 1.84 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.348 1.927 . . . . 0.84999999999999998 113.141 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -58.91 151.03 22.68 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.901 0.48 . . . . 3.2999999999999998 111.187 -175.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.32 -10.99 64.51 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.608 -0.551 . . . . 0.81999999999999995 112.626 -173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -122.01 160.6 24.59 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.5 1.92 . . . . 2.0299999999999998 108.028 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.04 150.0 43.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.739 1.215 . . . . 2.0899999999999999 109.358 177.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.1 t -97.59 123.41 41.48 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 125.094 1.358 . . . . 0.5 107.895 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.4 mp -96.2 120.12 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.769 -1.567 . . . . 1.3400000000000001 106.769 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.523 -0.072 0 C-N-CA 126.784 2.034 . . . . 2.1000000000000001 110.19 178.801 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.4 m120 . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 114.649 1.352 . . . . 1.8500000000000001 114.649 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.72 121.13 7.9 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 124.067 0.947 . . . . 3.1699999999999999 111.477 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.3 t -92.31 103.3 15.76 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.27 -0.641 . . . . 0.34999999999999998 109.27 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -111.73 159.87 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.905 0.882 . . . . 0.64000000000000001 109.599 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.0 149.06 51.16 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.836 0.351 . . . . 2.2599999999999998 110.394 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.26 114.74 1.76 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.259 -1.936 . . . . 2.29 108.259 -174.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -55.94 121.81 10.16 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.313 -0.625 . . . . 3.2400000000000002 109.313 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.13 -172.96 16.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.055 1.312 . . . . 0.59999999999999998 110.214 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 t -96.94 147.36 32.81 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.108 -0.948 . . . . 2.0 109.531 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.96 141.61 24.16 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.292 1.995 . . . . 0.75 112.394 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 119.528 -0.272 . . . . 2.3500000000000001 111.294 174.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 109.22 -0.659 . . . . 1.5700000000000001 109.22 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.1 p -137.83 166.91 22.86 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.635 1.574 . . . . 1.22 108.273 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.88 162.84 21.46 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.412 0.285 . . . . 1.77 111.456 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.7 m -83.71 163.96 19.91 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.255 0.55 . . . . 1.54 111.454 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -123.08 -2.78 8.61 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.42 1.088 . . . . 1.0 112.442 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -139.59 136.17 34.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.908 0.883 . . . . 4.7000000000000002 109.89 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -60.71 141.67 56.62 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 121.63 -0.669 . . . . 0.37 110.109 174.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.54 -11.01 72.16 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.817 -0.435 . . . . 0.73999999999999999 112.02 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -72.55 168.72 17.99 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 118.057 0.928 . . . . 2.4500000000000002 111.194 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -149.29 174.58 12.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.941 0.896 . . . . 0.78000000000000003 110.249 171.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 74.73 53.36 0.08 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.732 1.213 . . . . 1.99 108.81 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -174.49 162.86 3.55 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.111 1.765 . . . . 1.02 107.173 -169.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.6 mt -79.33 145.53 33.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.716 0.806 . . . . 0.77000000000000002 109.692 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.5 t -139.21 -63.24 0.52 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.506 -0.77 . . . . 0.72999999999999998 109.756 -168.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -103.01 109.8 21.48 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.179 -1.045 . . . . 3.5600000000000001 108.179 165.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.45 -125.37 37.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.577 -1.009 . . . . 0.57999999999999996 110.577 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.5 t -98.34 9.11 43.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.54 0.736 . . . . 0.83999999999999997 111.436 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -80.98 119.93 24.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.059 -1.089 . . . . 1.79 108.059 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.7 p -79.88 120.02 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.84 -0.8 . . . . 1.49 108.84 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.7 t -78.65 77.3 5.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.982 -1.118 . . . . 0.82999999999999996 107.982 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.43 176.9 44.31 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.036 0.351 . . . . 1.0900000000000001 113.407 -170.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -48.31 146.31 2.86 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.418 0.687 . . . . 4.6500000000000004 110.77 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.58 -20.75 33.01 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.009 -0.884 . . . . 0.65000000000000002 111.54 -166.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -124.52 171.2 10.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.065 1.433 . . . . 2.0099999999999998 109.962 -177.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.74 137.46 29.81 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.604 1.962 . . . . 2.5699999999999998 110.49 176.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.5 t -89.15 118.45 28.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.656 0.782 . . . . 0.52000000000000002 109.15 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.48 130.04 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.716 -1.587 . . . . 1.3500000000000001 106.716 170.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.6 mt . . . . . 0 C--N 1.34 0.178 0 C-N-CA 124.035 0.934 . . . . 2.9500000000000002 111.627 -179.809 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 m120 . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 114.233 1.197 . . . . 1.8700000000000001 114.233 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -136.41 110.9 8.54 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.742 1.217 . . . . 3.1499999999999999 109.728 -173.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.72 100.8 11.13 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.61 0.764 . . . . 0.5 109.13 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -96.55 167.01 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 C-N-CA 122.968 0.507 . . . . 0.90000000000000002 109.72 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.38 159.67 14.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.649 0.78 . . . . 2.4199999999999999 110.374 -171.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.04 45.07 1.31 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.646 1.117 . . . . 2.6299999999999999 112.637 169.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 58.5 144.9 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 129.554 3.142 . . . . 3.1499999999999999 116.602 171.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.07 -179.85 25.3 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.799 1.19 . . . . 0.68999999999999995 111.647 -168.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 m -95.38 130.68 31.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.935 . . . . 2.3700000000000001 110.943 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.52 135.41 42.26 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 CA-C-N 120.714 1.291 . . . . 1.0900000000000001 110.327 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 tttm . . . . . 0 CA--C 1.542 0.654 0 CA-C-O 119.066 -0.492 . . . . 2.48 111.011 176.54 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 109.311 -0.625 . . . . 2.1499999999999999 109.311 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.8 p -124.22 167.2 14.61 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.156 0.983 . . . . 0.91000000000000003 109.913 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.47 168.19 2.94 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.316 0.647 . . . . 1.6699999999999999 111.464 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.44 ' HB2' HD21 ' A' ' 30' ' ' LEU . 65.0 m -83.91 150.86 25.42 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 108.204 -1.035 . . . . 1.25 108.204 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -108.94 -20.84 12.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.656 0.783 . . . . 1.52 111.412 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -144.57 147.85 33.68 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.232 1.413 . . . . 2.6000000000000001 109.225 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -68.77 159.7 31.83 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.764 0.826 . . . . 0.60999999999999999 110.849 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.68 14.88 80.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.829 -0.908 . . . . 0.48999999999999999 110.829 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -119.27 158.4 26.12 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 123.411 0.685 . . . . 2.3399999999999999 110.125 -170.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -135.63 -176.46 4.29 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.449 0.7 . . . . 0.75 110.402 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.487 ' HA ' HD12 ' A' ' 13' ' ' LEU . 5.4 tp 66.79 39.76 3.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.158 0.983 . . . . 2.3700000000000001 109.704 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.4 p -154.61 153.45 31.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.339 1.455 . . . . 0.91000000000000003 108.156 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.511 ' CD2' HG22 ' A' ' 21' ' ' VAL . 76.5 mt -76.38 108.67 9.49 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 125.396 1.478 . . . . 0.84999999999999998 108.004 -174.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -107.32 -63.17 1.32 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.449 0.699 . . . . 0.54000000000000004 109.41 -170.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -91.51 98.63 11.79 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.666 0.786 . . . . 2.8999999999999999 109.841 168.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.8 -130.69 50.01 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.247 -1.141 . . . . 0.40999999999999998 110.247 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.88 4.97 42.65 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.217 0.509 . . . . 0.60999999999999999 111.039 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -79.89 120.12 23.68 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 120.922 -1.111 . . . . 1.6699999999999999 108.058 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.511 HG22 ' CD2' ' A' ' 15' ' ' LEU . 4.9 t -83.78 124.85 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.315 -0.994 . . . . 2.5899999999999999 108.315 -175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.8 t -76.53 86.9 3.24 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.956 -0.757 . . . . 0.46000000000000002 108.956 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.65 172.29 19.4 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 121.659 -0.651 . . . . 0.78000000000000003 113.151 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.07 152.21 4.32 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.73 -0.865 . . . . 4.0 112.249 174.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.93 -5.73 83.1 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.969 0.795 . . . . 0.68000000000000005 111.787 -174.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -132.36 157.64 43.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.963 2.505 . . . . 1.28 108.048 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -141.51 152.33 44.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.363 1.465 . . . . 2.3100000000000001 109.042 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.4 t -99.42 130.18 45.67 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.771 2.029 . . . . 0.40999999999999998 108.91 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.5 mm -102.72 107.48 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.4 -1.704 . . . . 1.28 106.4 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 6' ' ' CYS . 34.4 mt . . . . . 0 C--N 1.343 0.304 0 C-N-CA 125.387 1.475 . . . . 2.1800000000000002 110.375 178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 114.083 1.142 . . . . 2.4100000000000001 114.083 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -128.27 133.3 48.76 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.153 0.981 . . . . 2.5800000000000001 110.328 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.5 t -100.85 105.02 16.27 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.636 -0.876 . . . . 0.46000000000000002 108.636 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -110.3 172.82 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 109.329 -0.619 . . . . 0.78000000000000003 109.329 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 t -67.16 177.99 1.61 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.272 1.034 . . . . 2.0299999999999998 111.949 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.41 124.03 4.76 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.853 -2.099 . . . . 2.27 107.853 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.4 134.05 40.26 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.469 -0.567 . . . . 3.71 109.469 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.8 165.86 15.37 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 108.528 -1.829 . . . . 0.65000000000000002 108.528 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -76.01 149.94 83.01 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 108.581 -0.896 . . . . 1.73 108.581 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -78.08 157.48 30.37 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.275 1.983 . . . . 0.70999999999999996 111.506 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 tttm . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 119.096 -0.478 . . . . 3.2200000000000002 111.069 175.485 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 109.291 -0.633 . . . . 1.8 109.291 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 p -147.9 165.83 29.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.606 1.562 . . . . 0.78000000000000003 107.652 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -64.22 160.47 18.48 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.393 0.616 . . . . 1.6599999999999999 111.975 -176.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -83.2 152.66 25.12 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.501 -0.772 . . . . 1.0600000000000001 112.317 165.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.7 p -132.6 23.77 4.35 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.82 1.248 . . . . 1.3899999999999999 111.319 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.08 159.66 11.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.116 0.966 . . . . 3.1800000000000002 109.419 175.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -85.49 146.34 26.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.909 0.484 . . . . 0.5 111.164 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.69 28.01 17.69 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.011 -0.541 . . . . 0.57999999999999996 111.854 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.92 158.12 39.7 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.674 -0.679 . . . . 3.3399999999999999 110.569 -165.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -138.33 -179.81 6.01 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.694 1.134 . . . . 1.02 111.822 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 62.74 36.7 13.1 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.677 0.751 . . . . 2.23 111.049 173.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.9 p -149.45 161.04 42.89 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.572 1.549 . . . . 1.1399999999999999 107.605 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.78 130.94 40.97 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.177 -1.046 . . . . 0.65000000000000002 108.177 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.9 t -127.64 -63.64 1.02 Allowed 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 106.938 -1.505 . . . . 0.54000000000000004 106.938 -174.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.59 98.26 11.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.944 -0.761 . . . . 3.46 108.944 172.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.78 -135.26 52.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.87 -1.292 . . . . 0.51000000000000001 109.87 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 t -85.52 9.99 14.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.715 0.757 . . . . 0.81999999999999995 112.225 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -90.64 124.85 35.39 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.655 -0.869 . . . . 1.6799999999999999 108.655 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.3 139.17 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.999 -0.371 . . . . 1.7 109.999 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.7 t -75.09 91.21 2.54 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.532 -0.914 . . . . 0.62 108.532 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.68 158.26 1.43 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.158 1.837 . . . . 1.0800000000000001 113.971 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -56.99 144.72 32.93 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.77 -0.841 . . . . 3.4900000000000002 111.404 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.74 -5.08 79.57 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.105 0.86 . . . . 0.73999999999999999 111.967 -171.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -125.48 166.87 15.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.169 1.788 . . . . 1.48 109.238 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -145.84 153.57 41.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.02 -1.104 . . . . 2.6200000000000001 108.02 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.8 t -98.55 128.89 45.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.691 1.596 . . . . 0.45000000000000001 107.041 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mt -101.05 124.65 54.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.456 -1.683 . . . . 2.1400000000000001 106.456 166.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 106.551 -1.648 . . . . 2.5 106.551 167.633 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.1 m120 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 111.776 0.287 . . . . 2.2000000000000002 111.776 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -148.04 109.54 4.39 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.31 0.644 . . . . 3.2599999999999998 111.542 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.1 t -90.05 114.44 26.32 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 124.641 1.176 . . . . 0.40999999999999998 109.466 174.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.86 161.65 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.825 -0.806 . . . . 0.77000000000000002 108.825 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -61.58 148.0 43.74 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.784 -0.572 . . . . 2.3500000000000001 110.226 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.77 -31.85 0.27 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.151 -0.805 . . . . 2.6800000000000002 113.623 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 72.06 83.51 0.13 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.293 1.437 . . . . 3.7200000000000002 111.356 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.38 -178.01 52.17 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.152 -0.477 . . . . 0.93000000000000005 112.184 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.0 m -87.89 147.72 41.7 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.215 1.006 . . . . 2.3500000000000001 108.652 171.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.61 143.5 24.23 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.111 1.874 . . . . 1.22 111.54 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tttm . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 123.464 0.705 . . . . 2.6699999999999999 111.129 179.067 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 108.106 -1.072 . . . . 1.96 108.106 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 p -147.03 173.44 12.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.466 1.907 . . . . 1.1899999999999999 106.221 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.03 168.5 8.17 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.939 0.4 . . . . 1.95 111.034 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.3 m -82.86 156.14 23.75 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.714 0.768 . . . . 1.29 110.759 159.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -110.53 -11.05 14.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.244 -1.344 . . . . 0.83999999999999997 111.259 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -147.79 136.28 21.64 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 107.171 -1.418 . . . . 3.3599999999999999 107.171 -166.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -64.7 150.35 47.39 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.45 0.568 . . . . 0.48999999999999999 110.021 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.04 -1.27 62.9 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.046 -0.597 . . . . 0.46000000000000002 112.149 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -99.79 147.43 25.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 117.657 0.729 . . . . 2.3999999999999999 112.676 -171.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -115.19 -176.13 2.84 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.485 1.114 . . . . 1.1699999999999999 110.664 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 59.14 53.74 5.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 122.379 1.085 . . . . 2.3599999999999999 110.361 172.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.0 p -169.33 159.43 8.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.189 -1.411 . . . . 1.1599999999999999 107.189 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.64 143.81 46.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.78 -0.822 . . . . 0.73999999999999999 108.78 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.8 t -138.89 -63.2 0.53 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.509 -0.922 . . . . 0.56999999999999995 108.509 -172.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -93.29 97.49 10.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.696 -0.853 . . . . 2.96 108.696 169.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.94 -132.64 52.55 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.925 -1.27 . . . . 0.54000000000000004 109.925 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.4 t -87.28 14.68 7.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.732 0.766 . . . . 0.66000000000000003 112.168 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -88.22 124.61 34.02 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.185 0.902 . . . . 1.49 109.377 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.0 t -71.66 133.23 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.209 1.004 . . . . 2.0600000000000001 109.518 175.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.5 t -74.15 91.87 2.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.992 -0.744 . . . . 0.63 108.992 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.66 152.58 1.84 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.327 1.918 . . . . 1.1799999999999999 114.188 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -49.43 139.1 12.35 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.479 0.712 . . . . 4.8300000000000001 110.732 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.94 -3.3 87.28 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.411 -0.661 . . . . 0.96999999999999997 112.71 -174.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -123.05 167.79 13.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.965 1.306 . . . . 1.55 108.318 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HE3' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -146.04 154.99 42.47 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.357 1.063 . . . . 2.7000000000000002 110.653 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.8 t -105.83 127.79 53.33 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 106.846 -1.539 . . . . 0.52000000000000002 106.846 -172.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.5 mm -98.11 107.37 20.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 105.698 -1.964 . . . . 1.3 105.698 173.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.231 0.129 0 C-N-CA 124.849 1.259 . . . . 2.1299999999999999 108.815 -179.259 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 111.968 0.358 . . . . 1.72 111.968 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -118.7 127.26 53.4 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 131.306 3.842 . . . . 4.1900000000000004 109.359 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -101.42 111.26 23.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.692 1.587 . . . . 0.46999999999999997 110.15 172.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.491 HG23 ' HE3' ' A' ' 27' ' ' LYS . 31.4 m -114.22 155.57 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.038 0.935 . . . . 0.81000000000000005 111.202 -174.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.01 168.54 15.85 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.793 0.806 . . . . 2.4100000000000001 111.229 -169.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.61 45.96 1.47 Allowed Glycine 0 CA--C 1.524 0.605 0 O-C-N 120.842 -1.162 . . . . 2.9500000000000002 111.38 162.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 73.68 154.97 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.586 2.354 . . . . 3.48 111.108 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.77 158.27 31.09 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.129 -1.588 . . . . 0.67000000000000004 109.129 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -92.56 146.91 33.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 117.544 0.672 . . . . 1.97 109.436 -174.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.41 154.56 65.06 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-N 121.035 1.405 . . . . 1.3999999999999999 110.659 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 124.354 1.062 . . . . 2.6099999999999999 109.592 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 CA--C 1.544 0.714 0 N-CA-C 108.527 -0.916 . . . . 2.6200000000000001 108.527 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.1 p -101.63 165.93 10.97 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 124.106 0.963 . . . . 1.3300000000000001 109.579 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.11 156.98 38.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.907 0.776 . . . . 2.23 110.955 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.456 ' C ' HD21 ' A' ' 30' ' ' LEU . 75.7 m -84.81 150.87 24.74 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 117.855 -1.538 . . . . 1.1499999999999999 109.226 178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -132.34 6.06 4.13 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.73 0.641 . . . . 1.45 112.73 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.53 136.33 18.28 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.58 1.552 . . . . 3.6800000000000002 106.812 -169.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -71.83 139.4 48.89 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 118.65 0.659 . . . . 0.77000000000000002 110.353 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.68 67.53 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.733 -0.547 . . . . 0.47999999999999998 111.733 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -97.13 164.07 12.66 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 123.297 0.639 . . . . 2.5600000000000001 109.742 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -148.41 -175.37 4.89 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.223 0.609 . . . . 0.95999999999999996 109.587 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 58.61 37.03 25.4 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.516 0.674 . . . . 2.2999999999999998 109.481 -174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -148.81 145.6 27.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.6 1.16 . . . . 1.0700000000000001 109.269 175.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 mt -57.68 108.88 0.62 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.411 2.284 . . . . 0.68999999999999995 108.637 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.1 t -99.18 -63.15 1.15 Allowed 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.443 -1.688 . . . . 0.62 106.443 -174.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -109.79 99.08 8.28 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.035 1.334 . . . . 3.8300000000000001 109.452 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.82 -145.73 38.84 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.617 -1.393 . . . . 0.66000000000000003 109.617 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.02 -0.7 45.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.512 0.725 . . . . 1.02 110.687 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -82.25 118.82 23.41 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.197 -1.408 . . . . 1.6200000000000001 107.197 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.18 146.94 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 110.289 -0.263 . . . . 1.8 110.289 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 t -73.16 95.79 2.13 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.789 0.804 . . . . 0.51000000000000001 109.285 167.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.57 157.42 2.19 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 127.632 2.539 . . . . 1.0900000000000001 113.137 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.38 144.94 56.8 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.051 -0.676 . . . . 3.8900000000000001 110.667 -177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.5 0.41 84.45 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.323 0.487 . . . . 0.76000000000000001 112.156 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.66 161.2 30.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.063 2.145 . . . . 1.4399999999999999 108.596 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -136.63 156.64 48.27 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.881 1.672 . . . . 2.71 111.49 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.5 t -103.42 119.43 38.88 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.232 -1.766 . . . . 0.5 106.232 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.537 HD13 HG22 ' A' ' 40' ' ' VAL . 1.3 mp -88.3 109.36 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 104.883 -2.266 . . . . 1.29 104.883 174.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.456 HD21 ' C ' ' A' ' 6' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.367 0 N-CA-C 107.766 -1.198 . . . . 2.0299999999999998 107.766 175.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 110.003 -0.369 . . . . 2.1699999999999999 110.003 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.44 110.21 14.82 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.471 1.108 . . . . 2.73 110.409 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.3 t -84.53 98.11 9.94 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.277 -0.638 . . . . 0.33000000000000002 109.277 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.537 HG22 HD13 ' A' ' 29' ' ' ILE . 3.2 m -100.48 168.56 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.734 -0.839 . . . . 0.66000000000000003 108.734 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 t -67.29 171.06 6.26 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.037 -1.039 . . . . 2.5600000000000001 111.51 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.05 140.79 7.57 Favored Glycine 0 C--O 1.223 -0.581 0 N-CA-C 109.106 -1.598 . . . . 2.27 109.106 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.39 112.74 14.46 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.326 -1.102 . . . . 3.73 108.976 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.94 174.76 23.59 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.264 0.935 . . . . 0.71999999999999997 111.536 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -94.5 138.08 22.45 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 109.115 -0.698 . . . . 2.2999999999999998 109.115 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.72 142.11 42.92 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 121.862 1.708 . . . . 1.1000000000000001 109.586 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 tttp . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 118.985 -0.531 . . . . 3.29 111.737 -177.945 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.335 -0.617 . . . . 1.53 109.335 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 p -134.39 163.9 28.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.296 1.438 . . . . 1.1599999999999999 108.719 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.64 161.49 29.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.351 0.596 . . . . 1.8700000000000001 111.91 -176.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 11' ' ' GLN . 1.3 m -83.82 173.73 11.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.652 0.781 . . . . 1.6499999999999999 111.765 171.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -141.35 28.0 1.87 Allowed 'General case' 0 C--N 1.345 0.404 0 CA-C-O 118.733 -0.651 . . . . 1.5800000000000001 112.733 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -165.14 160.78 19.05 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.995 -1.113 . . . . 2.7599999999999998 107.995 170.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.29 153.82 26.88 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.866 0.867 . . . . 0.47999999999999998 111.363 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.512 ' HA2' ' CG ' ' A' ' 27' ' ' LYS . . . 75.37 15.32 81.25 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.154 0.883 . . . . 0.46000000000000002 111.751 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.43 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 1.9 mt-30 -92.18 171.4 9.1 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.412 0.685 . . . . 2.4199999999999999 109.158 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -154.94 179.6 8.97 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.089 0.859 . . . . 0.70999999999999996 110.394 170.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 63.56 55.84 1.68 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.544 1.538 . . . . 2.1299999999999999 111.103 178.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.4 p -173.83 163.91 4.21 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.415 1.886 . . . . 0.90000000000000002 106.532 -172.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.0 mt -71.93 144.18 49.03 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.918 -0.771 . . . . 1.01 108.918 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.0 t -142.31 -64.57 0.42 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.393 -0.595 . . . . 0.64000000000000001 109.393 -172.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -94.32 98.96 11.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.156 -1.424 . . . . 2.9700000000000002 107.156 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.69 -128.6 32.98 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.094 -1.203 . . . . 0.62 110.094 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 t -88.32 5.98 39.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 117.134 0.467 . . . . 0.67000000000000004 111.823 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -83.61 124.34 30.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.129 -0.982 . . . . 2.1400000000000001 108.484 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.08 132.68 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.533 0.733 . . . . 1.53 109.26 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.7 t -87.55 92.19 9.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.486 -1.301 . . . . 0.48999999999999999 107.486 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.73 -172.71 9.94 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.501 1.048 . . . . 0.81000000000000005 114.797 -168.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -61.63 145.46 52.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.856 -0.791 . . . . 3.9100000000000001 109.321 168.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.51 10.3 86.02 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.159 -0.776 . . . . 1.0800000000000001 111.159 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -135.2 167.92 20.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.474 1.11 . . . . 2.21 108.126 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.512 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 13.9 ttmt -145.46 132.32 20.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.744 1.218 . . . . 2.2200000000000002 108.205 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -92.0 123.77 35.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.215 1.006 . . . . 0.62 109.293 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.9 mm -107.71 111.56 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 106.417 -1.697 . . . . 1.7 106.417 169.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.2 mt . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.771 -0.455 . . . . 2.3399999999999999 109.771 169.293 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 118.876 -0.583 . . . . 3.2999999999999998 111.371 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -142.11 124.18 15.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.269 1.428 . . . . 2.9900000000000002 110.165 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.4 t -97.81 102.22 13.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.454 1.025 . . . . 0.37 109.881 174.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.8 m -91.47 162.7 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.195 0.598 . . . . 0.73999999999999999 109.916 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 t -79.71 152.8 29.69 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.778 -0.823 . . . . 1.8999999999999999 108.778 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.75 -114.58 0.76 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.706 -1.358 . . . . 2.71 109.706 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -162.8 156.84 20.72 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.335 1.454 . . . . 4.4900000000000002 107.816 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.8 170.37 30.6 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.703 -0.959 . . . . 0.78000000000000003 110.703 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 t -81.04 140.28 49.76 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 117.366 0.583 . . . . 2.1600000000000001 109.86 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.31 154.75 56.32 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.057 1.838 . . . . 1.1200000000000001 111.673 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.539 0.545 0 C-N-CA 123.085 0.554 . . . . 3.4500000000000002 110.054 171.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 108.504 -0.924 . . . . 2.5499999999999998 108.504 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 79.0 p -143.31 173.22 11.79 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.679 1.192 . . . . 1.3600000000000001 108.683 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.71 162.2 8.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.503 0.668 . . . . 2.1000000000000001 112.391 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -83.64 165.91 18.59 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 115.65 -0.704 . . . . 1.3500000000000001 111.4 169.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -126.68 9.0 6.99 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.512 0.725 . . . . 1.02 112.592 -174.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -156.98 161.89 39.59 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.514 1.125 . . . . 2.8100000000000001 109.007 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -81.91 157.69 24.24 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 122.767 0.427 . . . . 0.53000000000000003 110.439 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.26 21.94 69.09 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 119.696 -1.24 . . . . 0.56000000000000005 110.328 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -110.64 165.92 11.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.523 0.729 . . . . 2.2599999999999998 109.14 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -144.23 -179.3 6.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.745 1.157 . . . . 0.81000000000000005 110.612 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 13' ' ' LEU . 1.2 mt 58.46 54.84 5.26 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.62 1.168 . . . . 2.5499999999999998 111.388 175.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.6 p -165.01 164.96 20.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.427 1.091 . . . . 1.0600000000000001 108.172 -175.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.552 ' CD2' HG22 ' A' ' 21' ' ' VAL . 22.2 mt -75.4 120.82 21.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.073 -1.084 . . . . 0.48999999999999999 108.073 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.1 t -123.07 -63.43 1.26 Allowed 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 108.109 -1.071 . . . . 0.56000000000000005 108.109 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -90.82 88.9 7.25 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.715 1.206 . . . . 3.0600000000000001 109.338 168.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.32 -135.21 42.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.393 -1.483 . . . . 0.47999999999999998 109.393 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -81.78 -6.06 58.73 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.046 0.923 . . . . 0.72999999999999998 111.604 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -76.51 123.98 26.88 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.184 -0.948 . . . . 1.5900000000000001 108.662 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.552 HG22 ' CD2' ' A' ' 15' ' ' LEU . 6.8 t -83.2 136.87 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.156 -0.683 . . . . 2.3199999999999998 109.156 -176.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.5 t -77.96 94.36 4.59 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.907 -0.496 . . . . 0.65000000000000002 110.869 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.24 165.66 9.18 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.239 0.923 . . . . 0.82999999999999996 114.156 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -57.34 151.53 15.97 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.876 -1.367 . . . . 3.6299999999999999 113.249 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.36 0.32 86.72 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.07 1.319 . . . . 0.75 111.305 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -130.91 161.47 31.79 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.072 2.549 . . . . 1.3400000000000001 108.642 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 145.83 33.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.641 1.176 . . . . 2.5499999999999998 108.307 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.72 126.42 40.97 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.134 2.174 . . . . 0.45000000000000001 108.688 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.3 mp -97.81 114.19 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 106.168 -1.789 . . . . 1.6599999999999999 106.168 170.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 CA--C 1.531 0.235 0 C-N-CA 124.828 1.251 . . . . 2.23 109.038 177.495 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 CA--C 1.541 0.605 0 N-CA-C 113.622 0.971 . . . . 1.76 113.622 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.73 105.58 1.62 Allowed 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.518 1.127 . . . . 3.21 111.78 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.2 t -80.99 100.31 8.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 125.071 1.348 . . . . 0.5 109.325 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -107.72 176.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.772 0.829 . . . . 0.81000000000000005 108.879 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.04 178.38 5.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.79 -0.569 . . . . 2.3100000000000001 110.286 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.83 155.4 31.77 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.826 -1.71 . . . . 2.1899999999999999 108.826 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -81.3 165.67 21.19 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 117.458 0.629 . . . . 3.48 109.918 -171.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.91 -179.13 38.01 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.355 -1.498 . . . . 0.96999999999999997 109.355 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -93.19 148.79 36.33 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 117.416 0.608 . . . . 1.9399999999999999 110.165 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -73.66 173.3 14.14 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.552 1.501 . . . . 1.1000000000000001 111.137 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 123.887 0.875 . . . . 2.23 108.95 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 . . . . . 0 CA--C 1.542 0.647 0 N-CA-C 109.193 -0.669 . . . . 2.3399999999999999 109.193 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.9 p -127.3 166.43 17.81 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.965 0.906 . . . . 0.93000000000000005 108.917 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.87 164.96 25.11 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.365 0.984 . . . . 2.29 109.684 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -82.48 157.13 23.73 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.113 -1.035 . . . . 1.0900000000000001 109.397 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.1 p -121.64 -18.24 7.23 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.02 0.748 . . . . 1.0 113.02 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.24 155.08 43.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.998 1.719 . . . . 2.46 107.182 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -69.79 150.65 46.65 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.305 0.957 . . . . 0.46000000000000002 109.888 173.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.66 -1.13 71.35 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.741 -0.477 . . . . 0.46999999999999997 112.348 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -91.72 163.3 14.13 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.292 0.637 . . . . 2.4399999999999999 110.544 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -150.52 -178.96 6.85 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.553 -0.717 . . . . 1.0900000000000001 109.288 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mp 62.23 38.49 13.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.512 1.125 . . . . 2.2200000000000002 110.398 -167.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -149.16 152.26 35.77 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.922 0.889 . . . . 1.05 110.232 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.8 mt -66.02 135.23 54.38 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.28 1.432 . . . . 0.51000000000000001 107.67 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.9 t -140.84 -63.94 0.46 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.283 -1.377 . . . . 0.68999999999999995 107.283 -168.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.42 89.15 7.89 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.184 -1.043 . . . . 3.27 108.184 168.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.75 -128.92 48.11 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.532 -1.427 . . . . 0.44 109.532 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 t -84.23 9.77 12.04 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.954 0.877 . . . . 0.73999999999999999 112.432 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -91.33 117.99 30.13 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.797 1.181 . . . . 1.73 107.831 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.48 128.74 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.842 -0.617 . . . . 1.5600000000000001 109.453 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.0 t -72.83 85.23 1.23 Allowed 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.347 0.594 . . . . 0.48999999999999999 109.913 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.27 167.62 9.58 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 126.331 1.92 . . . . 0.75 114.049 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -55.6 152.44 9.2 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.307 -1.702 . . . . 3.96 112.019 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.02 12.0 84.58 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.338 0.97 . . . . 0.89000000000000001 112.827 -173.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -138.7 170.1 16.6 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.67 3.188 . . . . 2.3599999999999999 108.934 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.34 136.7 14.04 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.544 1.538 . . . . 1.98 109.524 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.4 t -94.48 126.52 39.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.211 -1.403 . . . . 0.42999999999999999 107.211 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.6 mm -101.43 113.53 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.925 -1.509 . . . . 1.76 106.925 170.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 N--CA 1.45 -0.436 0 C-N-CA 125.503 1.521 . . . . 2.23 107.723 175.34 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 119.069 -0.491 . . . . 2.6400000000000001 110.431 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -135.08 123.77 23.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.425 1.89 . . . . 4.29 111.346 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 39.0 t -95.81 101.99 13.74 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.603 1.961 . . . . 0.37 110.246 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.83 158.7 3.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 123.927 0.891 . . . . 0.60999999999999999 110.099 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.41 167.71 16.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.832 -0.543 . . . . 2.5699999999999998 110.226 176.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.97 -110.8 0.83 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.691 -1.763 . . . . 2.7599999999999998 108.691 170.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -156.7 165.31 36.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.067 -1.827 . . . . 2.8399999999999999 106.067 171.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.62 168.32 38.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.366 -1.494 . . . . 0.66000000000000003 109.366 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.9 t -82.78 132.77 50.49 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.268 -0.642 . . . . 2.1600000000000001 109.268 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.77 132.22 18.29 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.273 1.315 . . . . 0.76000000000000001 110.252 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 tttm . . . . . 0 CA--C 1.54 0.56 0 CA-C-O 118.774 -0.632 . . . . 2.2200000000000002 110.008 174.376 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 67.4 t . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 106.058 -1.831 . . . . 3.8799999999999999 106.058 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.9 t -110.69 127.66 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.668 -1.604 . . . . 2.73 106.668 174.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -109.41 176.49 5.06 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.138 1.375 . . . . 2.5499999999999998 107.775 -173.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.6 p -123.7 168.47 12.64 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.995 -0.743 . . . . 0.89000000000000001 108.995 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -65.85 170.46 5.37 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.215 0.606 . . . . 2.1099999999999999 109.718 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -86.19 143.38 28.01 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.502 -0.749 . . . . 1.0900000000000001 111.266 171.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.484 HG23 ' HE3' ' A' ' 47' ' ' LYS . 10.2 p -97.85 -22.78 16.17 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.179 1.177 . . . . 1.29 114.179 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -133.32 160.84 36.15 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.343 0.974 . . . . 2.5699999999999998 109.197 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -75.89 154.81 35.78 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.038 0.447 . . . . 0.5 110.292 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.54 22.77 66.44 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.313 -0.715 . . . . 0.54000000000000004 111.313 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -108.15 147.67 30.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.907 0.883 . . . . 2.1499999999999999 109.944 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -115.17 176.85 4.88 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.758 0.823 . . . . 1.04 110.979 174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 64.57 42.93 4.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.783 0.833 . . . . 2.1699999999999999 111.316 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.4 p -148.44 155.43 41.19 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.666 0.786 . . . . 1.46 109.201 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.4 mt -69.98 133.81 47.67 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.723 0.809 . . . . 0.58999999999999997 109.548 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 t -143.14 -63.06 0.41 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.44 -0.948 . . . . 1.03 108.44 -168.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -85.01 87.79 7.4 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.544 0.688 . . . . 3.6400000000000001 109.97 161.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.64 -136.33 51.21 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.582 -1.407 . . . . 0.52000000000000002 109.582 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.7 t -77.5 4.92 9.97 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 117.95 0.875 . . . . 0.77000000000000002 112.445 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -86.21 125.35 33.49 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 119.754 1.161 . . . . 1.78 108.095 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.3 t -74.17 140.12 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 123.785 0.834 . . . . 2.0699999999999998 108.939 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.4 t -73.67 90.38 1.81 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.714 0.769 . . . . 0.52000000000000002 109.165 169.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.96 156.98 1.91 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.948 2.213 . . . . 1.02 113.786 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -53.78 144.38 18.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 122.484 -0.421 . . . . 3.3999999999999999 111.626 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.47 -2.42 72.24 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-O 119.581 -0.566 . . . . 0.93000000000000005 112.572 -174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -122.75 153.5 39.39 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.489 1.516 . . . . 1.6599999999999999 107.839 174.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.68 156.15 48.34 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.07 0.85 . . . . 2.4100000000000001 112.044 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.6 t -102.1 127.17 49.12 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.437 -2.061 . . . . 0.65000000000000002 105.437 -170.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.1 mp -94.11 114.15 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 103.678 -2.712 . . . . 1.6200000000000001 103.678 170.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -65.53 130.74 44.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.972 -1.862 . . . . 2.0499999999999998 105.972 165.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -53.18 151.89 8.98 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 118.958 -0.912 . . . . 2.6000000000000001 111.018 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.8 m -128.72 42.63 3.29 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.942 1.46 . . . . 4.6100000000000003 114.942 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 153.09 34.87 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.217 0.451 . . . . 5.3600000000000003 112.217 -141.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.05 -8.16 8.73 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.373 -1.455 . . . . 2.3900000000000001 113.901 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -63.46 155.61 28.66 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 118.731 1.265 . . . . 3.4199999999999999 113.065 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -95.19 167.47 11.34 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 114.535 -1.211 . . . . 4.3700000000000001 109.188 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -59.47 123.62 17.4 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.281 1.032 . . . . 2.0499999999999998 109.099 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -126.35 113.55 17.06 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.751 0.82 . . . . 2.6000000000000001 110.809 -177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -91.77 119.68 31.81 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 108.811 -0.811 . . . . 0.46999999999999997 108.811 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -128.41 152.35 36.43 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-N 118.275 0.489 . . . . 0.73999999999999999 109.852 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 t -64.48 159.41 21.57 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.798 0.439 . . . . 2.1099999999999999 110.925 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.39 -103.98 0.26 Allowed Glycine 0 CA--C 1.532 1.095 0 N-CA-C 109.099 -1.601 . . . . 2.6899999999999999 109.099 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.55 160.31 8.96 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.671 1.588 . . . . 3.8900000000000001 107.126 168.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.64 166.8 38.14 Favored Glycine 0 N--CA 1.467 0.713 0 N-CA-C 110.531 -1.027 . . . . 0.82999999999999996 110.531 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 90.7 m -76.44 140.8 68.93 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.948 0.899 . . . . 1.6799999999999999 110.09 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.03 131.65 13.33 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.29 1.327 . . . . 0.87 111.527 173.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.484 ' HE3' HG23 ' A' ' 7' ' ' THR . 44.6 tttt -58.68 118.6 29.95 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.117 0.967 . . . . 2.6499999999999999 111.681 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.6 160.61 31.51 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.293 3.329 . . . . 1.1899999999999999 112.127 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -82.45 102.83 11.57 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 120.869 -1.145 . . . . 5.4400000000000004 112.159 -166.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.7 m 61.19 144.58 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.266 0.839 . . . . 4.4800000000000004 113.266 -150.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 . . . . . 0 C--N 1.343 0.322 0 N-CA-C 106.696 -1.594 . . . . 11.9 106.696 166.275 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 108.621 -0.881 . . . . 4.6900000000000004 108.621 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 82.2 t -86.16 149.94 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.354 -1.35 . . . . 2.6200000000000001 107.354 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -138.86 163.33 32.55 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.132 1.373 . . . . 2.0600000000000001 108.477 177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.9 p -140.82 162.48 35.34 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.038 1.335 . . . . 1.4299999999999999 109.382 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.56 162.39 27.82 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.309 1.044 . . . . 1.99 112.296 -173.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.3 m -87.28 162.04 17.63 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.357 -0.979 . . . . 0.95999999999999996 108.357 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 p -123.93 13.22 9.13 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 118.887 -0.578 . . . . 1.1000000000000001 112.443 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -176.79 163.8 2.32 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.516 1.526 . . . . 2.6499999999999999 109.395 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -79.28 161.28 26.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.568 0.747 . . . . 0.56999999999999995 111.306 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.85 7.77 59.6 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.282 1.896 . . . . 0.47999999999999998 113.289 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.12 -178.3 5.64 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.518 0.727 . . . . 2.9199999999999999 109.234 -175.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -166.53 -179.5 4.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 119.612 1.097 . . . . 0.91000000000000003 109.199 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 tp 68.69 31.84 4.42 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.229 0.612 . . . . 2.8100000000000001 109.876 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.84 161.22 41.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.964 1.306 . . . . 1.22 108.635 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -74.27 104.68 5.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.534 -1.654 . . . . 0.68000000000000005 106.534 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -89.93 -63.92 1.21 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.993 -1.114 . . . . 1.3200000000000001 107.993 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -96.74 125.93 41.55 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.229 1.411 . . . . 4.6299999999999999 108.997 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 44.33 -127.76 6.76 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.714 0.673 . . . . 0.85999999999999999 112.003 176.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.5 t -96.42 14.32 24.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.65 0.78 . . . . 1.0900000000000001 111.281 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -88.41 113.87 24.44 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.764 0.793 . . . . 3.02 109.026 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.9 p -75.37 125.88 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.546 -0.752 . . . . 1.78 109.977 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -97.3 72.34 2.41 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.783 -0.821 . . . . 0.90000000000000002 108.783 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.78 -174.21 12.51 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 122.168 0.871 . . . . 1.3700000000000001 114.873 -171.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -50.19 143.83 7.92 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.477 -1.014 . . . . 3.4500000000000002 111.343 166.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.0 -8.16 71.5 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 123.797 0.713 . . . . 1.0700000000000001 111.673 -167.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -132.11 162.76 30.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.24 1.416 . . . . 1.6899999999999999 109.44 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.04 135.7 36.14 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 127.676 2.39 . . . . 2.6099999999999999 108.486 -174.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 54.0 t -94.45 142.81 27.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.581 1.152 . . . . 0.93999999999999995 109.058 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.9 mm -124.0 117.0 49.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.769 -1.937 . . . . 1.1899999999999999 105.769 172.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 63.46 1.72 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.786 1.234 . . . . 2.5800000000000001 109.815 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.24 -168.96 37.06 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 121.892 0.718 . . . . 3.2000000000000002 113.84 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.3 t -144.04 69.42 1.28 Allowed 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 105.983 -1.858 . . . . 3.79 105.983 172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 50.88 30.84 5.5 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.505 1.522 . . . . 5.4100000000000001 111.974 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 170.58 -56.19 0.19 Allowed Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.298 -0.721 . . . . 2.1699999999999999 111.298 -170.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.41 155.89 27.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 117.777 0.788 . . . . 3.4199999999999999 111.385 167.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -85.1 175.54 8.94 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 126.174 1.79 . . . . 4.7800000000000002 108.354 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -46.18 143.69 2.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.034 0.934 . . . . 2.0800000000000001 111.347 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -142.21 127.55 18.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.617 0.767 . . . . 3.29 109.217 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.9 t -96.35 105.43 17.5 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.679 0.672 . . . . 0.42999999999999999 109.544 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -95.99 174.75 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.351 1.06 . . . . 0.73999999999999999 109.577 177.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.1 166.76 18.44 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.842 0.857 . . . . 2.3100000000000001 111.272 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.69 121.74 3.58 Favored Glycine 0 C--N 1.339 0.723 0 N-CA-C 109.87 -1.292 . . . . 2.3300000000000001 109.87 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -51.36 123.15 9.07 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.656 1.182 . . . . 3.21 112.68 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -97.43 -168.11 32.72 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.575 1.083 . . . . 1.04 112.916 174.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 93.5 m -85.15 124.19 72.43 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.282 1.033 . . . . 1.98 110.378 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -74.73 135.0 19.01 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-N 120.95 1.375 . . . . 0.82999999999999996 111.427 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -46.99 111.65 1.66 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.488 0.715 . . . . 2.6299999999999999 111.753 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -72.01 115.53 4.35 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.884 1.723 . . . . 2.0600000000000001 109.959 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -79.41 121.02 24.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.119 -0.697 . . . . 5.0099999999999998 109.119 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.5 m -86.38 177.15 7.54 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.104 0.962 . . . . 5.6900000000000004 110.206 169.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 117.461 -1.257 . . . . 10.06 110.86 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 106.591 -1.633 . . . . 3.7599999999999998 106.591 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.1 122.65 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 106.79 -1.559 . . . . 3.6800000000000002 106.79 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -96.79 -173.94 2.86 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.31 1.444 . . . . 2.2799999999999998 108.695 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 p -120.15 166.43 13.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.9 1.28 . . . . 0.98999999999999999 110.139 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.69 163.26 26.02 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.674 1.19 . . . . 1.6799999999999999 112.257 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.4 m -86.07 143.96 27.8 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.084 -0.71 . . . . 1.24 109.084 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -115.56 15.08 16.66 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.257 0.623 . . . . 1.45 111.815 -172.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -176.12 145.8 0.64 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.63 1.572 . . . . 3.5299999999999998 109.645 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -70.52 151.49 45.02 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 120.862 0.363 . . . . 0.37 110.643 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.45 0.17 89.91 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.551 -0.62 . . . . 0.60999999999999999 111.551 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -98.19 168.7 10.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.06 0.944 . . . . 2.52 109.845 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -148.15 -170.9 3.7 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.921 -0.487 . . . . 0.93000000000000005 110.606 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.448 HD22 ' HB3' ' A' ' 46' ' ' PRO . 2.3 mp 60.31 37.67 20.15 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.734 0.778 . . . . 2.1899999999999999 110.128 -176.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.4 p -150.21 147.49 27.76 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.959 1.303 . . . . 0.93000000000000005 108.845 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.9 mt -63.02 113.51 3.15 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 126.896 2.078 . . . . 0.68999999999999995 108.409 -176.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.5 t -109.94 -63.72 1.34 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 106.854 -1.536 . . . . 0.57999999999999996 106.854 -170.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -98.11 97.83 9.22 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.354 1.062 . . . . 3.46 108.327 173.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.46 -136.2 39.3 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.924 -1.271 . . . . 0.51000000000000001 109.924 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.05 -3.84 55.49 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.541 0.736 . . . . 1.1100000000000001 112.293 177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -78.08 117.92 19.85 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.915 -0.772 . . . . 1.53 108.915 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.6 p -73.31 139.44 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.102 0.561 . . . . 1.73 109.495 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.4 t -74.14 96.93 2.82 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.099 -0.704 . . . . 0.42999999999999999 109.099 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.25 169.1 8.09 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.155 0.883 . . . . 0.70999999999999996 113.69 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.08 147.1 40.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.499 -1.0 . . . . 3.5800000000000001 111.273 173.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.4 11.62 81.77 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 111.578 -0.609 . . . . 0.71999999999999997 111.578 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -142.58 161.52 37.85 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 127.068 2.147 . . . . 1.47 109.122 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -139.75 138.89 36.29 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 127.402 2.281 . . . . 2.0499999999999998 109.715 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -90.41 120.31 31.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.59 1.556 . . . . 0.48999999999999999 108.582 175.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.444 HD12 ' N ' ' A' ' 29' ' ' ILE . 1.9 mp -94.5 117.32 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 107.082 -1.451 . . . . 1.3500000000000001 107.082 170.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.47 137.54 58.14 Favored 'General case' 0 N--CA 1.455 -0.219 0 O-C-N 123.845 0.716 . . . . 2.25 109.292 172.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -53.09 134.62 40.69 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.5 -0.773 . . . . 2.8799999999999999 112.741 -176.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 p -101.35 69.96 1.29 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.75 1.62 . . . . 3.7799999999999998 108.448 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 45.0 33.61 1.07 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.085 1.354 . . . . 5.0099999999999998 113.048 176.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.41 -72.48 0.05 OUTLIER Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.02 -1.632 . . . . 2.8500000000000001 109.02 -173.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -62.35 154.32 28.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.534 0.683 . . . . 3.3999999999999999 111.224 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -95.81 174.51 6.92 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.148 2.579 . . . . 5.8700000000000001 108.434 177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -52.9 121.01 6.48 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.463 -0.94 . . . . 2.4300000000000002 108.463 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -126.13 123.58 38.62 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.242 0.617 . . . . 3.0299999999999998 110.53 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.1 t -92.88 88.59 6.25 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.266 0.626 . . . . 0.65000000000000002 109.536 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.3 m -85.55 168.08 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.216 0 C-N-CA 123.303 0.641 . . . . 0.63 109.362 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.21 171.16 14.99 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.48 -0.762 . . . . 2.3399999999999999 112.01 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.55 132.03 7.16 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 108.496 -1.842 . . . . 2.1299999999999999 108.496 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -60.76 142.7 55.7 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.011 1.406 . . . . 3.6800000000000002 110.901 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -139.5 164.28 25.99 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 109.569 -1.412 . . . . 1.03 109.569 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 92.0 m -75.63 142.61 74.14 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.509 1.124 . . . . 1.95 109.757 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.448 ' HB3' HD22 ' A' ' 13' ' ' LEU . 56.0 Cg_endo -74.48 151.83 42.78 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.541 2.16 . . . . 1.1599999999999999 111.652 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.9 110.11 2.08 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 122.928 0.491 . . . . 2.8100000000000001 111.825 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -72.27 128.43 13.77 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 N-CA-C 107.282 -1.853 . . . . 1.5700000000000001 107.282 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -48.87 158.04 0.35 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.17 0.988 . . . . 5.21 111.215 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.3 m -150.28 67.11 0.96 Allowed 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.638 -0.663 . . . . 5.0199999999999996 109.743 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.248 0 C-N-CA 124.911 1.284 . . . . 8.9000000000000004 110.587 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 86.7 t . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 106.726 -1.583 . . . . 4.3600000000000003 106.726 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 73.9 t -92.12 155.99 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.432 1.093 . . . . 2.2999999999999998 108.5 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -133.26 170.54 15.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.356 1.463 . . . . 1.8600000000000001 109.963 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.4 p -144.95 165.99 26.56 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.146 1.379 . . . . 1.22 109.275 -176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.02 166.57 20.66 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.785 0.72 . . . . 2.3399999999999999 112.049 -173.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -88.14 157.68 18.76 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 108.226 -1.028 . . . . 0.96999999999999997 108.226 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.6 p -103.4 -39.0 6.96 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.813 0.845 . . . . 1.3799999999999999 110.88 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -133.6 161.0 35.81 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.282 1.033 . . . . 2.5899999999999999 110.179 -175.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -70.05 150.55 46.49 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.932 0.872 . . . . 0.40000000000000002 110.944 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.45 10.67 85.58 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.212 1.387 . . . . 0.39000000000000001 113.249 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -77.04 179.92 5.95 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.927 0.863 . . . . 2.6499999999999999 110.213 172.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -158.05 -176.71 6.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.504 1.522 . . . . 0.72999999999999998 107.999 166.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp 67.43 36.1 3.99 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.052 1.341 . . . . 2.6499999999999999 111.398 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -156.25 159.02 38.52 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.504 2.722 . . . . 1.1699999999999999 107.987 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.1 mt -70.09 116.2 10.18 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.331 -1.729 . . . . 0.56000000000000005 106.331 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.9 t -95.23 -64.43 1.06 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.847 -1.168 . . . . 1.3 107.847 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -109.59 120.16 41.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.288 1.435 . . . . 2.7999999999999998 108.072 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 53.58 -128.72 39.87 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.416 -1.074 . . . . 0.81999999999999995 110.416 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 t -98.25 15.7 23.69 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.202 0.601 . . . . 1.0 111.241 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -88.28 118.13 27.68 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.226 -1.027 . . . . 2.2799999999999998 108.226 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 p -80.03 116.39 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 123.809 0.844 . . . . 2.0699999999999998 110.65 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.9 t -89.92 78.45 6.77 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.351 -0.981 . . . . 0.66000000000000003 108.351 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.72 -172.5 25.52 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 123.417 0.532 . . . . 1.1799999999999999 114.362 -170.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -56.82 144.98 31.0 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 121.417 -1.049 . . . . 4.6100000000000003 111.065 168.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.97 -7.66 81.27 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.196 0.903 . . . . 1.0800000000000001 111.285 -168.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -125.82 171.2 10.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.448 1.099 . . . . 2.1499999999999999 109.227 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -142.67 139.28 31.13 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.639 1.175 . . . . 2.75 107.889 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 53.2 t -95.59 143.88 26.51 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 123.852 0.861 . . . . 0.82999999999999996 109.477 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.6 mm -118.84 118.3 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 127.206 2.202 . . . . 1.24 106.709 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -86.24 129.36 34.88 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.308 1.843 . . . . 2.1499999999999999 107.706 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -71.03 170.06 47.93 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.68 -0.968 . . . . 3.4199999999999999 110.68 170.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.5 m -144.34 43.22 1.41 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.41 1.105 . . . . 6.2599999999999998 112.609 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 170.27 37.04 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.34 0.591 . . . . 5.4699999999999998 112.566 -150.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.81 1.23 37.76 Favored Glycine 0 CA--C 1.539 1.544 0 O-C-N 120.828 -1.17 . . . . 4.4800000000000004 114.106 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.5 169.11 18.86 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 127.612 2.365 . . . . 5.0700000000000003 111.842 173.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -95.12 168.33 10.83 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.385 1.474 . . . . 5.0499999999999998 110.09 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -81.28 153.1 27.27 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.101 0.961 . . . . 1.79 109.659 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -139.71 126.79 21.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.287 1.035 . . . . 3.3399999999999999 111.415 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.7 t -95.63 108.23 20.49 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.768 1.227 . . . . 0.46000000000000002 109.812 174.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.8 m -94.55 166.66 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.889 0.876 . . . . 0.78000000000000003 108.931 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.8 t -79.65 156.78 27.45 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.378 -0.826 . . . . 1.79 108.796 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 147.32 -113.05 0.62 Allowed Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.633 -1.387 . . . . 2.8300000000000001 109.633 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -170.21 147.35 3.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.805 2.042 . . . . 4.5700000000000003 106.666 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.57 177.01 24.25 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 118.938 0.79 . . . . 0.72999999999999998 111.384 -175.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.8 m -86.11 131.5 46.4 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 118.81 -0.614 . . . . 1.6899999999999999 109.404 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.36 140.87 59.8 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 121.266 1.311 . . . . 0.80000000000000004 110.101 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.66 117.99 12.14 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 118.673 -0.68 . . . . 3.0899999999999999 110.459 176.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.6 149.29 84.14 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 N-CA-C 108.525 -1.375 . . . . 1.27 108.525 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -64.79 152.9 41.53 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.529 1.132 . . . . 6.1900000000000004 110.896 166.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.3 m 65.45 168.8 0.2 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.679 1.192 . . . . 4.7000000000000002 111.467 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 117.267 -1.349 . . . . 9.5800000000000001 111.821 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 75.7 t . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.55 -1.278 . . . . 3.5800000000000001 107.55 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.3 t -92.15 111.65 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.323 -1.362 . . . . 4.5700000000000003 107.323 175.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -79.63 -173.12 3.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.333 2.653 . . . . 1.95 109.186 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.6 p -121.89 171.57 8.82 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.882 0.873 . . . . 0.97999999999999998 110.943 171.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.13 163.26 5.0 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.789 0.835 . . . . 2.0099999999999998 112.367 172.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -85.53 163.22 18.53 Favored 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.223 1.009 . . . . 1.1100000000000001 110.823 172.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.9 p -129.44 15.28 6.06 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.757 0.823 . . . . 1.1000000000000001 112.642 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.29 154.28 24.97 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.351 0.978 . . . . 3.2999999999999998 110.147 173.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -82.45 136.92 34.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.339 0.655 . . . . 0.55000000000000004 110.742 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.23 17.69 19.35 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.721 -0.551 . . . . 0.40999999999999998 111.721 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.25 145.36 47.93 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.046 0.538 . . . . 2.3999999999999999 110.717 -168.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -117.84 -178.63 3.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.893 0.877 . . . . 0.93000000000000005 110.471 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 mp 62.08 49.29 4.59 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.14 0.971 . . . . 2.0699999999999998 110.565 174.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.6 p -160.77 160.33 31.15 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 124.409 1.084 . . . . 1.26 108.313 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.7 mt -75.38 113.86 13.25 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.29 1.036 . . . . 0.68999999999999995 108.971 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.7 t -116.41 -64.07 1.36 Allowed 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.196 -1.038 . . . . 0.67000000000000004 108.196 -173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.58 91.27 6.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.248 -1.39 . . . . 3.0899999999999999 107.248 171.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.21 -132.0 52.33 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 110.347 -1.101 . . . . 0.41999999999999998 110.347 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.6 t -83.08 5.3 22.91 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.987 0.893 . . . . 0.59999999999999998 112.158 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -89.5 123.52 33.69 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 119.243 0.928 . . . . 2.3999999999999999 108.563 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.48 137.04 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.086 0.554 . . . . 1.49 110.19 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.7 t -75.95 92.28 3.11 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 109.282 -0.636 . . . . 0.63 109.282 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.24 156.73 8.33 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.752 1.168 . . . . 0.89000000000000001 112.599 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -51.86 155.28 1.8 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.743 -0.857 . . . . 3.8100000000000001 112.722 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.72 1.4 89.25 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 124.028 0.823 . . . . 0.76000000000000001 113.357 -177.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 0.9 OUTLIER -135.26 156.81 48.35 Favored 'General case' 0 N--CA 1.448 -0.571 1 C-N-CA 131.998 4.119 . . . . 2.1600000000000001 108.578 179.211 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.95 154.27 48.3 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.719 1.608 . . . . 2.5699999999999998 110.588 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.5 t -95.23 128.53 42.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.598 1.559 . . . . 0.42999999999999999 108.809 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.3 mm -101.51 114.61 41.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 105.772 -1.936 . . . . 1.4399999999999999 105.772 170.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.9 mp -63.4 142.39 58.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.196 0.998 . . . . 2.0699999999999998 109.104 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.66 134.43 30.26 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.307 -0.86 . . . . 2.7200000000000002 112.762 -177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.7 t -99.83 68.52 1.52 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.722 -1.214 . . . . 3.6899999999999999 107.722 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 43.55 35.31 0.95 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.545 1.538 . . . . 5.0300000000000002 113.195 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.09 -72.6 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.419 -1.872 . . . . 2.3300000000000001 108.419 -172.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -66.83 159.99 26.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.329 0.652 . . . . 3.9500000000000002 110.003 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.5 176.37 6.06 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.011 1.324 . . . . 4.7400000000000002 108.453 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -54.17 129.86 36.36 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.272 -0.87 . . . . 2.52 110.386 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -135.65 124.74 24.38 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 118.725 -0.655 . . . . 3.48 111.922 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 10.4 t -92.99 101.71 14.05 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.734 1.152 . . . . 0.33000000000000002 109.144 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -104.39 158.59 5.38 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 C-N-CA 123.567 0.747 . . . . 0.57999999999999996 109.065 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -71.16 176.04 4.8 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 119.864 -0.734 . . . . 1.96 111.207 -179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.3 129.48 6.31 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 108.097 -2.001 . . . . 2.1299999999999999 108.097 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -55.37 132.62 48.59 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.022 -0.733 . . . . 2.9500000000000002 109.022 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.99 -159.21 10.19 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 108.968 -1.653 . . . . 1.03 108.968 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.89 142.5 26.34 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.36 0.664 . . . . 1.54 110.145 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.06 138.98 31.95 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.418 2.079 . . . . 0.72999999999999998 110.696 176.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.9 tttm -55.32 121.23 36.11 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.794 -0.622 . . . . 2.3799999999999999 111.066 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.4 124.72 13.78 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 N-CA-C 107.798 -1.654 . . . . 1.6499999999999999 107.798 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -70.33 154.78 41.52 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 124.227 1.011 . . . . 5.7999999999999998 108.29 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.7 m 67.23 91.16 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.899 0.88 . . . . 4.6600000000000001 110.13 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 104.9 -2.259 . . . . 11.109999999999999 104.9 178.294 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.967 0.413 . . . . 3.7200000000000002 110.278 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.8 t -74.86 129.72 36.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.111 -1.07 . . . . 2.52 108.111 176.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -107.7 172.16 6.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.703 1.201 . . . . 1.76 110.045 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.0 p -142.6 169.04 18.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.935 1.294 . . . . 0.96999999999999997 109.678 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.63 171.0 12.27 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.193 0.451 . . . . 1.79 110.469 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 64.4 m -85.63 153.92 22.04 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.595 -0.891 . . . . 1.23 108.595 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 p -103.11 -34.37 8.89 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.317 1.047 . . . . 1.49 111.632 -175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -133.54 162.65 31.34 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.501 1.12 . . . . 3.0499999999999998 109.549 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.61 138.06 35.4 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.843 0.457 . . . . 0.57999999999999996 110.856 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.67 26.26 13.6 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.929 -0.868 . . . . 0.40000000000000002 110.929 176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.15 151.66 43.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.364 0.666 . . . . 2.48 110.679 -172.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -124.31 -179.74 4.58 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.706 0.802 . . . . 1.1000000000000001 111.08 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.3 mt 60.46 49.76 6.5 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 124.871 1.268 . . . . 2.1600000000000001 110.603 -171.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -157.98 147.44 19.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.118 0.567 . . . . 0.90000000000000002 110.066 174.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.1 mt -64.27 129.64 40.72 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 125.976 1.711 . . . . 0.64000000000000001 108.208 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.9 t -131.14 -63.76 0.84 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 106.462 -1.681 . . . . 0.93999999999999995 106.462 -168.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.56 92.44 6.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.39 -1.707 . . . . 3.2999999999999998 106.39 172.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.1 -133.53 39.81 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.28 -1.128 . . . . 0.69999999999999996 110.28 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 t -84.73 0.1 51.73 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.886 0.475 . . . . 0.77000000000000002 111.216 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -80.75 119.34 23.22 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.845 -1.169 . . . . 1.8600000000000001 107.845 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.46 137.15 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 108.712 -0.847 . . . . 1.73 108.712 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.4 t -73.63 95.84 2.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.161 -1.052 . . . . 0.51000000000000001 108.161 170.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.42 168.89 33.93 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.059 0.838 . . . . 0.68000000000000005 112.975 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -57.68 153.6 13.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.02 0.928 . . . . 3.7599999999999998 111.732 176.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.67 -5.91 76.16 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 123.844 0.735 . . . . 0.70999999999999996 112.224 -172.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.96 169.14 17.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.044 2.538 . . . . 1.51 106.732 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.0 pttt -151.3 148.77 28.57 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.665 1.186 . . . . 1.97 108.658 175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 50.7 t -104.06 132.2 50.56 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.1 1.36 . . . . 0.58999999999999997 109.242 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.9 mp -102.0 128.0 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.2 -1.407 . . . . 1.3300000000000001 107.2 173.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.69 143.5 57.51 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.908 -0.775 . . . . 2.1699999999999999 108.908 173.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.22 133.13 37.97 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 116.014 -0.539 . . . . 3.0 112.465 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 t -83.72 65.4 8.51 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.121 0.968 . . . . 3.7999999999999998 108.444 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 43.86 41.59 3.93 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.561 1.545 . . . . 5.5099999999999998 112.155 175.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.62 -66.26 0.06 OUTLIER Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.528 -1.429 . . . . 2.4300000000000002 109.528 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.5 mp0 -63.46 159.78 17.71 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.649 0.737 . . . . 3.54 110.975 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -95.22 175.01 6.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.398 1.079 . . . . 3.73 108.758 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -50.85 133.6 26.35 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.447 1.099 . . . . 2.5800000000000001 109.203 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -133.63 113.18 12.1 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 119.215 -0.422 . . . . 3.2000000000000002 110.893 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 20.1 t -94.65 108.05 20.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.042 -0.725 . . . . 0.37 109.042 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.38 154.04 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.826 -0.805 . . . . 0.56999999999999995 108.826 -176.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.8 t -69.72 163.63 25.27 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.972 -0.455 . . . . 1.8999999999999999 111.292 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.62 127.36 4.57 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.243 -1.943 . . . . 2.1299999999999999 108.243 -174.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -47.86 146.98 2.16 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.243 1.022 . . . . 4.3799999999999999 110.729 173.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.49 175.09 27.01 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 108.501 -1.839 . . . . 0.70999999999999996 108.501 177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 51.9 m -73.64 136.83 77.39 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.286 0.634 . . . . 1.6299999999999999 109.583 177.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.76 139.35 33.49 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.13 1.886 . . . . 0.84999999999999998 109.507 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -56.66 115.14 9.31 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 119.13 -0.462 . . . . 2.75 110.857 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.44 166.66 27.06 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.355 2.037 . . . . 1.3999999999999999 109.507 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -82.09 157.8 23.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.915 0.886 . . . . 5.3499999999999996 110.265 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 p -101.33 -60.72 1.48 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.168 0.987 . . . . 4.2999999999999998 109.726 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.8 p80 . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 105.905 -1.887 . . . . 8.1799999999999997 105.905 173.192 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 106.52 -1.659 . . . . 4.5999999999999996 106.52 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 75.2 t -114.29 154.51 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 107.193 -1.41 . . . . 2.5 107.193 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -129.83 161.06 31.62 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.02 1.328 . . . . 2.0299999999999998 109.002 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 p -143.76 170.68 15.41 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.557 1.543 . . . . 1.23 107.823 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.52 163.37 27.01 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.658 0.783 . . . . 2.0299999999999998 112.295 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.7 m -83.54 167.33 17.47 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.89 0.476 . . . . 1.3500000000000001 111.666 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -120.01 -41.03 2.67 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.88 1.272 . . . . 1.3600000000000001 112.776 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -110.01 161.03 15.91 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.207 0.912 . . . . 2.7400000000000002 110.873 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.33 148.36 29.42 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 121.384 0.611 . . . . 0.41999999999999998 111.303 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.46 3.71 90.02 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 115.838 -0.619 . . . . 0.41999999999999998 112.154 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.54 170.07 15.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.345 -1.354 . . . . 2.4100000000000001 107.345 171.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -153.2 -171.91 4.07 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.318 -0.864 . . . . 0.71999999999999997 109.892 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tp 59.79 53.61 4.76 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.682 1.593 . . . . 2.21 110.654 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.7 p -166.83 160.82 14.9 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 126.649 1.98 . . . . 1.03 107.036 -172.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.8 mt -70.5 141.31 51.98 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.452 0.701 . . . . 0.66000000000000003 109.557 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.3 t -142.07 -64.15 0.43 Allowed 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 118.226 -1.39 . . . . 0.68999999999999995 108.702 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -92.83 91.73 7.59 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.597 -1.26 . . . . 3.2599999999999998 107.597 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.5 -130.48 51.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.366 -1.494 . . . . 0.57999999999999996 109.366 -175.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.0 t -87.13 12.15 12.25 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 117.176 0.488 . . . . 0.60999999999999999 111.867 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -87.04 125.06 33.86 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.084 -1.01 . . . . 1.8999999999999999 109.422 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.0 t -75.61 123.18 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.193 -1.04 . . . . 1.95 108.193 176.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.6 t -76.27 85.82 3.07 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.856 -0.794 . . . . 0.56999999999999995 108.856 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.02 -175.41 9.17 Favored Glycine 0 CA--C 1.536 1.382 0 N-CA-C 115.147 0.819 . . . . 0.83999999999999997 115.147 -170.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.5 148.71 22.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.955 -0.732 . . . . 4.3600000000000003 109.748 165.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.65 4.01 90.27 Favored Glycine 0 CA--C 1.538 1.527 0 N-CA-C 111.427 -0.669 . . . . 1.1100000000000001 111.427 -170.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -137.38 174.48 10.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.405 1.103 . . . . 1.7 109.571 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.46 133.35 18.05 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.953 1.301 . . . . 2.6800000000000002 109.914 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 44.2 t -102.82 118.09 36.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.668 -0.864 . . . . 0.56999999999999995 108.668 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.5 mp -101.76 122.35 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.146 -1.798 . . . . 1.45 106.146 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.32 146.59 53.95 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.253 0.621 . . . . 2.3900000000000001 109.623 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -64.35 169.47 23.7 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.563 0.601 . . . . 2.6699999999999999 111.873 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -142.55 93.28 2.5 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.137 -0.69 . . . . 3.6899999999999999 109.137 -174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 46.7 t0 95.75 73.44 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 128.989 2.916 . . . . 7.3300000000000001 109.897 174.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.6 58.67 9.61 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.47 -0.786 . . . . 4.4500000000000002 112.186 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -133.55 171.04 14.64 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.484 1.114 . . . . 4.4400000000000004 110.803 -177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -95.95 171.91 8.33 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.067 1.347 . . . . 4.7599999999999998 110.054 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -79.85 151.67 30.1 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.155 0.982 . . . . 3.0 110.086 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -134.01 120.08 19.8 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 118.564 -0.731 . . . . 2.98 110.685 -176.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 50.6 t -101.59 107.08 18.24 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.707 1.139 . . . . 0.44 110.086 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.5 m -102.85 162.18 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 121.66 -0.65 . . . . 0.59999999999999998 109.364 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 t -75.04 150.98 38.74 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.157 -0.683 . . . . 1.9099999999999999 109.157 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.15 -116.5 0.8 Allowed Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.585 -1.406 . . . . 2.8399999999999999 109.585 175.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -167.19 142.42 4.05 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.943 1.297 . . . . 4.04 108.699 176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.8 170.52 30.6 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.425 1.488 . . . . 0.60999999999999999 109.906 -169.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -98.24 138.21 20.86 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 117.684 0.742 . . . . 2.1000000000000001 110.08 -174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.64 143.16 61.18 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 121.873 1.715 . . . . 0.87 110.317 -177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -56.08 118.17 19.64 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 118.994 -0.527 . . . . 2.9900000000000002 110.83 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -74.75 154.03 43.5 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 C-N-CA 121.566 1.511 . . . . 1.54 109.176 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -56.63 159.88 3.6 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.916 0.886 . . . . 6.5099999999999998 111.643 171.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -81.68 -50.67 9.03 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.821 1.248 . . . . 5.5599999999999996 111.337 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 . . . . . 0 CA--C 1.53 0.179 0 C-N-CA 124.511 1.125 . . . . 8.3599999999999994 109.422 179.006 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 107.97 -1.122 . . . . 4.75 107.97 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.6 t -82.37 137.75 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.049 -1.093 . . . . 3.3999999999999999 108.049 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.613 ' CE1' HG21 ' A' ' 21' ' ' VAL . 13.4 m-85 -106.94 158.28 17.14 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.659 1.183 . . . . 1.8200000000000001 109.889 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.8 p -138.17 164.68 28.57 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.733 1.213 . . . . 1.01 108.642 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -75.33 162.75 28.14 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 118.56 -0.734 . . . . 2.2599999999999998 110.917 -175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.4 m -83.33 140.71 32.28 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.65 1.114 . . . . 1.2 108.614 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -109.59 -11.53 14.77 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.051 0.76 . . . . 1.03 113.051 -175.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.44 145.8 34.15 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.87 1.668 . . . . 3.8599999999999999 109.769 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -73.7 158.3 34.94 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 122.335 1.064 . . . . 0.5 111.373 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.94 15.04 81.2 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 114.835 -1.075 . . . . 0.56000000000000005 111.405 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -123.09 156.95 33.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.02 0.928 . . . . 2.8100000000000001 109.106 -172.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -135.94 -167.68 2.08 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.941 0.896 . . . . 1.2 110.275 -173.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 64.46 38.66 7.41 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.96 0.8 . . . . 2.0499999999999998 110.235 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -158.0 154.31 27.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.71 0.804 . . . . 1.0 109.655 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 mt -64.95 119.55 10.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.338 -1.727 . . . . 0.54000000000000004 106.338 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.7 t -118.79 -63.62 1.38 Allowed 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.261 -1.385 . . . . 0.56000000000000005 107.261 -173.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -98.51 101.62 13.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.481 1.112 . . . . 4.0099999999999998 109.01 173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.81 -138.64 49.27 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.725 -0.95 . . . . 0.5 110.725 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 t -83.4 1.83 39.52 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 122.188 -0.596 . . . . 0.59999999999999998 111.287 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -84.19 116.7 23.07 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.059 -1.46 . . . . 1.52 107.059 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.613 HG21 ' CE1' ' A' ' 3' ' ' TYR . 8.2 p -69.86 136.77 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.906 -0.776 . . . . 1.6799999999999999 108.906 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.6 t -73.5 93.98 2.06 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.046 -1.094 . . . . 0.52000000000000002 108.046 169.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.97 171.96 16.48 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 122.071 0.817 . . . . 0.67000000000000004 113.425 -178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.19 138.27 57.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.459 1.104 . . . . 4.4800000000000004 112.463 172.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.93 10.3 62.94 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 110.988 -0.845 . . . . 0.78000000000000003 110.988 -172.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -140.11 163.5 32.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.537 1.935 . . . . 1.47 108.487 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.91 137.61 36.63 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 126.28 1.832 . . . . 2.3700000000000001 109.344 176.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -90.63 128.41 36.6 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.615 1.166 . . . . 0.41999999999999998 108.736 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.7 mm -110.08 111.2 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.469 -1.678 . . . . 1.49 106.469 172.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.21 63.84 1.94 Allowed 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.846 0.858 . . . . 2.2799999999999998 110.091 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 43.85 -135.11 5.64 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.21 -0.905 . . . . 2.98 113.79 -172.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.5 m -157.45 72.31 0.67 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.15 1.38 . . . . 3.3599999999999999 107.453 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.3 t0 53.44 41.69 32.08 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.385 1.074 . . . . 7.9000000000000004 111.867 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 167.1 -49.7 0.25 Allowed Glycine 0 CA--C 1.529 0.942 0 O-C-N 121.266 -0.896 . . . . 2.9900000000000002 112.134 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -63.56 163.13 11.66 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.414 0.626 . . . . 3.8100000000000001 111.096 170.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.14 175.51 6.67 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.668 1.187 . . . . 4.4299999999999997 110.013 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.68 135.42 57.62 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.777 1.631 . . . . 2.1800000000000002 110.449 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -135.91 107.07 6.75 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.065 0.946 . . . . 3.1099999999999999 109.363 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.6 t -82.64 93.66 7.39 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 118.604 0.638 . . . . 0.35999999999999999 109.572 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.0 m -89.65 164.0 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 123.465 0.706 . . . . 0.72999999999999998 109.722 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 t -73.74 167.09 22.1 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.981 -0.449 . . . . 1.9299999999999999 110.783 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.79 137.47 8.33 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.551 -1.42 . . . . 2.1299999999999999 109.551 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.5 146.62 54.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.787 1.294 . . . . 3.2999999999999998 109.899 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.08 -171.41 13.48 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.535 1.064 . . . . 0.98999999999999999 111.157 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.4 m -72.42 131.55 84.69 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.907 1.683 . . . . 1.6499999999999999 112.322 168.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.9 146.43 20.61 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.763 2.976 . . . . 0.85999999999999999 110.471 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 7.2 tmtt? -76.19 118.81 74.0 Favored Pre-proline 0 N--CA 1.449 -0.501 0 C-N-CA 123.48 0.712 . . . . 2.7799999999999998 109.813 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.69 139.96 28.72 Favored 'Trans proline' 0 N--CA 1.443 -1.496 0 N-CA-C 107.938 -1.601 . . . . 1.5900000000000001 107.938 172.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -66.28 154.62 39.45 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 121.803 -0.561 . . . . 7.0499999999999998 109.658 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.8 t -71.52 -40.76 69.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.53 0.332 . . . . 4.5999999999999996 111.751 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 118.243 -0.884 . . . . 10.119999999999999 110.485 178.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 108.883 -0.784 . . . . 7.1200000000000001 108.883 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.06 89.82 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 107.476 -1.305 . . . . 4.8700000000000001 107.476 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -143.18 166.58 24.31 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.049 0.94 . . . . 1.6000000000000001 109.549 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 46.2 p -147.58 163.13 37.56 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.061 1.744 . . . . 0.93999999999999995 108.327 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -80.29 159.19 25.92 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.013 0.824 . . . . 2.1400000000000001 111.16 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 66.6 m -84.2 155.59 22.45 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.588 1.085 . . . . 0.97999999999999998 108.152 -171.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -114.71 -15.02 11.97 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.702 1.001 . . . . 0.82999999999999996 113.702 -176.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -144.71 152.18 40.02 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.769 0.828 . . . . 2.5099999999999998 109.282 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -76.89 144.08 39.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.094 0.473 . . . . 0.54000000000000004 109.997 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.51 4.36 76.75 Favored Glycine 0 CA--C 1.532 1.128 0 CA-C-O 118.931 -0.927 . . . . 0.41999999999999998 112.424 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.78 173.94 7.99 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.383 1.091 . . . . 2.5699999999999998 108.867 171.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.0 p30 -151.31 -172.61 4.26 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.814 0.846 . . . . 0.98999999999999999 109.816 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 66.56 44.16 2.36 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 122.119 0.962 . . . . 2.0099999999999998 110.037 -178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -161.2 152.29 18.61 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.722 2.009 . . . . 1.1200000000000001 108.603 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 39.5 mt -59.52 134.44 57.01 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.865 1.266 . . . . 0.65000000000000002 107.706 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.3 t -131.9 -68.4 0.64 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.543 -1.651 . . . . 0.55000000000000004 106.543 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -90.36 89.94 7.83 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.065 -1.087 . . . . 3.1299999999999999 108.065 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.47 -131.65 52.16 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.102 -1.599 . . . . 0.58999999999999997 109.102 -175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.0 t -79.59 6.35 10.76 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.441 -0.79 . . . . 0.75 112.488 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 33.6 m-20 -84.33 118.72 24.39 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.844 -1.169 . . . . 1.6100000000000001 107.844 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.4 p -72.12 129.02 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 108.803 -0.814 . . . . 1.4399999999999999 108.803 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.1 t -76.44 85.79 3.17 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.405 -0.961 . . . . 0.41999999999999998 108.405 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.25 157.95 17.61 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.448 1.499 . . . . 0.71999999999999997 113.448 -174.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.67 137.35 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.287 1.035 . . . . 4.3499999999999996 111.57 174.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.1 -34.34 4.73 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 110.924 -0.87 . . . . 0.98999999999999999 110.924 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -84.54 166.45 17.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.937 -0.764 . . . . 1.78 108.937 173.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.1 ttpt -139.95 128.17 22.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 126.026 1.73 . . . . 2.98 107.722 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.9 t -86.95 135.45 33.29 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.237 -0.653 . . . . 0.59999999999999998 109.237 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.1 mm -112.19 123.18 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 104.703 -2.332 . . . . 1.3500000000000001 104.703 167.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.42 149.97 43.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.698 -0.853 . . . . 2.0800000000000001 108.698 167.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.85 149.76 43.5 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 121.92 0.733 . . . . 3.25 112.163 174.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.8 p -86.28 69.91 10.48 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.431 2.693 . . . . 4.3300000000000001 108.649 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 46.89 40.3 8.89 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.836 1.255 . . . . 6.9699999999999998 112.508 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.28 -59.9 0.07 OUTLIER Glycine 0 CA--C 1.525 0.675 0 N-CA-C 109.337 -1.505 . . . . 3.4100000000000001 109.337 -177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -65.49 164.36 14.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.468 0.651 . . . . 3.0800000000000001 110.438 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -96.6 174.3 6.9 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.594 1.157 . . . . 5.04 108.318 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.87 149.06 37.34 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.358 0.663 . . . . 2.1400000000000001 111.458 173.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -140.79 124.44 16.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.03 0.932 . . . . 2.6699999999999999 108.953 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.8 t -103.2 98.98 8.82 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.162 0.985 . . . . 0.40999999999999998 109.24 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -102.51 179.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 123.357 0.663 . . . . 0.56999999999999995 109.382 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.67 140.45 34.93 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.248 -0.649 . . . . 2.23 109.248 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 164.57 -24.6 0.18 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.167 -1.016 . . . . 2.7999999999999998 114.323 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 68.49 144.95 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.846 1.658 . . . . 2.7999999999999998 110.71 -171.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.43 -172.03 24.14 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.96 -1.256 . . . . 0.87 109.96 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 m -73.12 135.5 79.85 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.122 0.969 . . . . 1.6799999999999999 111.116 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.99 143.6 36.66 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.754 1.636 . . . . 0.67000000000000004 110.06 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.442 ' HG2' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -54.12 153.37 9.38 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 111.814 0.301 . . . . 2.29 111.814 173.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD2' ' HG2' ' A' ' 47' ' ' LYS . 57.8 Cg_endo -71.74 151.56 57.77 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.21 1.94 . . . . 2.3500000000000001 108.913 174.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -93.14 122.21 35.3 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.768 1.227 . . . . 5.7300000000000004 108.633 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 t 74.09 151.56 0.12 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.733 1.613 . . . . 5.5099999999999998 110.326 -171.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 . . . . . 0 CA--C 1.541 0.623 0 C-N-CA 124.589 1.156 . . . . 7.75 110.341 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.428 HG23 ' CE2' ' A' ' 3' ' ' TYR . 4.1 p . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.815 -0.439 . . . . 6.3099999999999996 109.815 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 85.8 t -116.69 106.37 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 N-CA-C 106.56 -1.645 . . . . 2.2999999999999998 106.56 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.433 ' HB2' HD21 ' A' ' 15' ' ' LEU . 66.2 m-85 -108.71 -174.22 2.46 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.37 1.068 . . . . 1.8600000000000001 109.478 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 72.8 p -143.84 164.58 30.14 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.089 0.956 . . . . 0.85999999999999999 109.275 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.91 165.68 24.69 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 123.092 0.557 . . . . 2.1200000000000001 110.679 -175.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.3 m -86.84 142.62 27.94 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 108.011 -1.107 . . . . 1.29 108.011 -175.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.2 p -106.53 -16.27 14.57 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.664 0.386 . . . . 1.05 111.167 -172.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -147.71 153.47 39.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.485 1.514 . . . . 2.4399999999999999 109.289 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -71.14 157.8 37.54 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 121.037 0.446 . . . . 0.58999999999999997 110.968 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 77.71 5.24 86.19 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.538 -0.625 . . . . 0.53000000000000003 111.538 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.75 164.86 12.22 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 123.665 0.786 . . . . 2.3700000000000001 109.755 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -147.57 -176.98 5.46 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.364 -0.606 . . . . 1.2 109.364 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 13' ' ' LEU . 5.4 mt 65.51 35.18 7.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.544 1.538 . . . . 2.5 110.259 -174.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.34 151.86 37.25 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 109.165 -0.68 . . . . 0.92000000000000004 109.165 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 3' ' ' TYR . 28.8 mt -72.31 108.12 5.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.323 1.449 . . . . 0.93000000000000005 107.291 -174.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.5 t -106.94 -63.36 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.034 -0.728 . . . . 0.54000000000000004 109.034 -169.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -95.02 98.95 11.05 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.925 1.29 . . . . 3.8999999999999999 108.767 169.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.16 -134.11 52.28 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.67 -0.972 . . . . 0.40999999999999998 110.67 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.6 t -82.75 -3.0 55.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 117.476 0.638 . . . . 0.77000000000000002 111.073 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -75.08 122.43 23.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.042 -1.036 . . . . 1.77 108.34 -174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.7 126.61 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.563 -0.903 . . . . 2.79 108.563 -173.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.5 t -76.43 90.97 3.27 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.022 -0.423 . . . . 0.63 109.867 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.65 161.44 22.58 Favored Glycine 0 CA--C 1.538 1.515 0 O-C-N 121.451 -0.781 . . . . 0.76000000000000001 113.166 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -50.71 154.13 1.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.802 0.841 . . . . 3.71 111.934 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.52 -19.32 44.89 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.123 -0.791 . . . . 1.1299999999999999 111.123 -173.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -119.62 166.49 13.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.22 2.208 . . . . 1.53 109.716 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.73 141.06 27.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.454 1.502 . . . . 1.96 110.313 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.6 t -88.1 122.57 31.83 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 127.341 2.256 . . . . 0.44 108.735 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.9 mp -100.56 123.48 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.082 -1.451 . . . . 1.47 107.082 172.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 mp -74.71 63.28 1.13 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.934 1.243 . . . . 2.0499999999999998 110.969 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.77 162.4 0.3 Allowed Glycine 0 CA--C 1.547 2.036 0 CA-C-O 118.249 -1.306 . . . . 3.0699999999999998 113.541 -164.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.8 p -143.67 42.09 1.46 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 118.091 2.626 . . . . 4.4900000000000002 118.091 150.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.6 p30 160.09 28.38 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 CA-C-N 119.416 1.007 . . . . 8.0 113.571 -144.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.57 1.69 86.92 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 120.898 -1.126 . . . . 3.3999999999999999 113.598 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.4 172.44 8.39 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.52 1.152 . . . . 3.8100000000000001 109.529 174.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -87.69 176.89 7.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.368 2.667 . . . . 4.9800000000000004 109.561 177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -44.1 146.01 0.69 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.055 1.342 . . . . 2.02 113.974 168.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.67 115.09 3.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.75 0.82 . . . . 3.75 112.924 178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -88.02 110.98 21.02 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.938 1.295 . . . . 0.57999999999999996 110.547 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.25 155.06 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 C-N-CA 124.119 0.968 . . . . 1.0800000000000001 109.586 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -64.84 148.96 50.32 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.406 0.283 . . . . 2.2200000000000002 110.487 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 138.44 50.41 0.06 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.464 1.03 . . . . 2.9199999999999999 111.638 172.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 42.11 83.75 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.461 2.304 . . . . 5.3399999999999999 114.829 171.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.72 174.8 44.9 Favored Glycine 0 C--N 1.338 0.673 0 O-C-N 121.477 -0.765 . . . . 0.93999999999999995 112.632 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.2 m -96.85 134.88 22.49 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.683 1.193 . . . . 2.0600000000000001 109.503 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.6 152.43 78.2 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.551 1.501 . . . . 0.88 110.836 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp -78.59 112.19 24.81 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.677 -0.677 . . . . 2.5699999999999998 110.928 174.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.36 149.5 50.85 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 121.317 1.345 . . . . 1.77 109.483 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.14 164.48 22.34 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.719 0.808 . . . . 5.4400000000000004 109.306 175.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 99.8 p -102.17 159.3 15.51 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.371 1.068 . . . . 4.0700000000000003 109.199 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 127.103 2.161 . . . . 7.7199999999999998 113.434 177.798 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 77.6 t . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 107.32 -1.363 . . . . 4.6299999999999999 107.32 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.16 145.21 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 107.905 -1.146 . . . . 2.6499999999999999 107.905 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CE1' HG21 ' A' ' 21' ' ' VAL . 17.4 m-85 -118.9 164.89 14.77 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.735 1.214 . . . . 1.8799999999999999 110.37 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -148.42 170.85 17.08 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.505 1.522 . . . . 0.76000000000000001 108.125 -175.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -78.36 166.62 22.45 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-N 118.721 0.691 . . . . 2.0899999999999999 111.056 -173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.1 m -84.46 170.89 13.05 Favored 'General case' 0 C--N 1.347 0.471 0 N-CA-C 107.503 -1.295 . . . . 1.0700000000000001 107.503 -178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 p -134.45 -39.21 0.82 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.877 -0.602 . . . . 1.03 111.093 -170.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -116.98 147.78 42.01 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.556 1.143 . . . . 2.79 109.992 173.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -74.9 139.38 43.06 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.826 0.45 . . . . 0.60999999999999999 110.255 177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.69 -2.69 58.78 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.937 -0.465 . . . . 0.65000000000000002 111.937 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -94.97 174.24 7.19 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.369 1.068 . . . . 2.5600000000000001 109.265 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -150.18 -173.32 4.4 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.146 -0.971 . . . . 1.1100000000000001 110.591 176.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 71.38 38.5 1.03 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.618 1.567 . . . . 2.3399999999999999 111.982 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.88 153.49 31.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 128.223 2.609 . . . . 1.05 109.545 -178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 mt -64.05 127.7 32.56 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.899 1.68 . . . . 0.48999999999999999 107.917 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.5 t -120.69 -63.98 1.29 Allowed 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.831 -1.174 . . . . 0.53000000000000003 107.831 -169.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -105.46 106.06 16.38 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.453 -1.249 . . . . 4.9199999999999999 107.678 174.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.2 -136.98 50.47 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.337 -1.105 . . . . 0.52000000000000002 110.337 -176.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.1 -3.99 58.47 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.869 0.868 . . . . 1.3100000000000001 112.525 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -75.26 118.32 18.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.356 -0.979 . . . . 1.55 108.356 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' A' ' 3' ' ' TYR . 5.0 p -72.78 139.26 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.46 -0.57 . . . . 1.6399999999999999 109.46 175.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.55 97.13 4.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.954 -1.128 . . . . 0.57999999999999996 107.954 170.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.71 165.86 32.41 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.096 0.855 . . . . 0.68000000000000005 112.866 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.89 153.49 20.87 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.673 -0.898 . . . . 4.4100000000000001 111.803 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.34 -0.5 83.49 Favored Glycine 0 CA--C 1.534 1.278 0 N-CA-C 111.555 -0.618 . . . . 0.67000000000000004 111.555 -172.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -136.29 171.23 14.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 127.066 2.146 . . . . 1.4099999999999999 108.081 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.1 mtmm -142.7 144.66 32.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.315 1.446 . . . . 2.1699999999999999 109.484 174.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -96.88 125.74 41.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.794 1.238 . . . . 0.5 108.211 173.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.5 mm -97.25 120.37 46.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 104.794 -2.298 . . . . 1.05 104.794 171.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mp -69.47 146.36 52.0 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.166 -0.679 . . . . 2.1099999999999999 109.166 169.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.08 134.89 52.22 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.531 -1.213 . . . . 3.25 111.506 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.83 67.67 1.11 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.818 -1.179 . . . . 4.3499999999999996 107.818 -175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 45.26 35.13 1.65 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.599 1.16 . . . . 5.8399999999999999 113.601 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.41 -61.19 0.05 OUTLIER Glycine 0 C--N 1.347 1.154 0 O-C-N 120.87 -1.144 . . . . 2.23 110.956 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -69.26 154.18 42.46 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 117.488 0.644 . . . . 4.3099999999999996 110.082 165.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -94.24 174.49 7.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.203 1.801 . . . . 4.0499999999999998 109.235 174.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -57.74 140.41 51.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 119.614 -0.231 . . . . 1.9399999999999999 110.73 175.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -143.92 132.91 22.77 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 118.891 -0.576 . . . . 2.9100000000000001 110.777 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 38.6 t -97.3 94.98 7.39 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 118.972 0.805 . . . . 0.45000000000000001 108.982 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.9 m -88.25 166.88 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.144 0 C-N-CA 123.525 0.73 . . . . 0.69999999999999996 109.353 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 t -81.23 -173.14 4.16 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.909 1.338 . . . . 1.9299999999999999 111.8 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.89 133.74 6.57 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.562 -1.815 . . . . 1.97 108.562 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -56.2 137.59 51.61 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 117.622 0.711 . . . . 4.2300000000000004 111.003 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.68 172.94 26.23 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 110.52 -1.032 . . . . 0.88 110.52 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 89.0 m -84.07 138.74 39.64 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 123.954 0.901 . . . . 1.75 110.559 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -74.35 147.9 37.69 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.342 2.028 . . . . 0.85999999999999999 111.392 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -60.53 124.93 80.96 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.192 0.597 . . . . 2.3300000000000001 110.962 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -66.46 157.13 62.04 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.172 1.915 . . . . 1.24 109.486 171.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -51.16 155.41 1.33 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.039 0.535 . . . . 5.5499999999999998 111.959 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.2 t -137.96 157.63 45.99 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.473 -1.306 . . . . 4.8799999999999999 107.473 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 105.866 -1.901 . . . . 7.1200000000000001 105.866 -177.545 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 106.906 -1.516 . . . . 5.8600000000000003 106.906 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.5 t -86.01 129.49 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.221 -1.029 . . . . 3.0499999999999998 108.221 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -94.48 165.11 12.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.087 0.955 . . . . 2.6099999999999999 109.719 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.9 p -146.98 169.21 19.68 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.218 -1.401 . . . . 1.03 107.218 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -61.99 165.85 5.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.948 0.404 . . . . 1.8500000000000001 111.589 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.16 151.72 25.58 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.231 0.539 . . . . 1.0700000000000001 111.933 163.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.4 p -117.97 -30.65 5.31 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.32 1.848 . . . . 1.1599999999999999 111.705 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.89 155.25 23.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.47 1.108 . . . . 3.3799999999999999 110.036 173.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -79.16 147.6 32.62 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 122.869 0.468 . . . . 0.42999999999999999 110.383 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.51 27.11 21.12 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.04 -0.824 . . . . 0.48999999999999999 111.04 170.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.46 144.63 51.03 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.137 0.575 . . . . 2.3300000000000001 110.331 -171.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -114.78 -177.31 3.1 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.066 1.346 . . . . 1.0900000000000001 109.689 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 13' ' ' LEU . 15.2 mt 52.2 57.69 6.2 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.121 0.968 . . . . 2.2000000000000002 111.197 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -163.53 156.57 18.62 Favored 'General case' 0 CA--C 1.521 -0.161 0 C-N-CA 124.52 1.128 . . . . 1.22 108.183 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -72.1 130.09 40.06 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.803 -1.184 . . . . 0.51000000000000001 107.803 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.7 t -127.66 -62.93 1.05 Allowed 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.14 -0.689 . . . . 0.56999999999999995 109.14 -168.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -100.34 108.29 20.29 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.929 1.292 . . . . 4.2199999999999998 109.323 164.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.5 -143.58 47.22 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 121.391 -0.818 . . . . 0.66000000000000003 111.321 174.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 t -83.99 5.95 23.78 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.089 0.444 . . . . 0.94999999999999996 110.691 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -85.65 119.77 26.36 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.646 -1.242 . . . . 1.73 107.646 -175.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 10.0 p -69.93 139.64 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 109.408 -0.59 . . . . 1.6699999999999999 109.408 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.3 t -73.22 85.8 1.41 Allowed 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.089 0.947 . . . . 0.52000000000000002 109.813 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.87 157.0 1.84 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.348 1.927 . . . . 0.84999999999999998 113.141 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -58.91 151.03 22.68 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.901 0.48 . . . . 3.2999999999999998 111.187 -175.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.32 -10.99 64.51 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.608 -0.551 . . . . 0.81999999999999995 112.626 -173.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -122.01 160.6 24.59 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.5 1.92 . . . . 2.0299999999999998 108.028 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.04 150.0 43.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.739 1.215 . . . . 2.0899999999999999 109.358 177.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.1 t -97.59 123.41 41.48 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 125.094 1.358 . . . . 0.5 107.895 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 29' ' ' ILE . 1.4 mp -96.2 120.12 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 N-CA-C 106.769 -1.567 . . . . 1.3400000000000001 106.769 175.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.92 64.78 0.51 Allowed 'General case' 0 CA--C 1.523 -0.072 0 C-N-CA 126.784 2.034 . . . . 2.1000000000000001 110.19 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.17 169.54 9.56 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 114.972 -1.013 . . . . 3.0699999999999998 111.851 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.5 60.5 1.33 Allowed 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.165 -1.42 . . . . 4.0800000000000001 107.165 178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 58.11 24.68 11.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.657 1.183 . . . . 6.4900000000000002 111.62 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 172.12 -53.22 0.17 Allowed Glycine 0 CA--C 1.533 1.174 0 O-C-N 121.765 -0.585 . . . . 2.9399999999999999 111.747 -171.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -62.89 163.74 9.13 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.906 0.882 . . . . 3.4900000000000002 110.828 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -94.56 177.26 5.99 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.201 2.2 . . . . 3.79 109.084 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -42.29 130.57 3.74 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.649 1.352 . . . . 1.8500000000000001 114.649 166.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.72 121.13 7.9 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 124.067 0.947 . . . . 3.1699999999999999 111.477 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.3 t -92.31 103.3 15.76 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.27 -0.641 . . . . 0.34999999999999998 109.27 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -111.73 159.87 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.905 0.882 . . . . 0.64000000000000001 109.599 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.0 149.06 51.16 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.836 0.351 . . . . 2.2599999999999998 110.394 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.26 114.74 1.76 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.259 -1.936 . . . . 2.29 108.259 -174.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -55.94 121.81 10.16 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.313 -0.625 . . . . 3.2400000000000002 109.313 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.13 -172.96 16.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.055 1.312 . . . . 0.59999999999999998 110.214 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 t -96.94 147.36 32.81 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.108 -0.948 . . . . 2.0 109.531 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.96 141.61 24.16 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.292 1.995 . . . . 0.75 112.394 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.12 137.47 27.63 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 119.528 -0.272 . . . . 2.3500000000000001 111.294 174.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.99 132.91 31.6 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 N-CA-C 108.281 -1.469 . . . . 1.71 108.281 172.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.35 161.41 30.49 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.376 1.07 . . . . 6.0199999999999996 109.74 173.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.3 p -139.23 82.5 1.89 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.666 -1.235 . . . . 5.3099999999999996 107.666 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.3 m80 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 106.613 -1.625 . . . . 11.9 106.613 172.146 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 106.138 -1.801 . . . . 4.5199999999999996 106.138 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.8 t -134.42 126.48 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 106.231 -1.766 . . . . 2.7000000000000002 106.231 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -113.52 170.54 8.17 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.114 1.366 . . . . 1.5700000000000001 109.22 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.1 p -137.83 166.91 22.86 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.635 1.574 . . . . 1.22 108.273 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.88 162.84 21.46 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 122.412 0.285 . . . . 1.77 111.456 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.7 m -83.71 163.96 19.91 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.255 0.55 . . . . 1.54 111.454 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -123.08 -2.78 8.61 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.42 1.088 . . . . 1.0 112.442 -179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -139.59 136.17 34.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.908 0.883 . . . . 4.7000000000000002 109.89 -172.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -60.71 141.67 56.62 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 121.63 -0.669 . . . . 0.37 110.109 174.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.54 -11.01 72.16 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.817 -0.435 . . . . 0.73999999999999999 112.02 175.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -72.55 168.72 17.99 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 118.057 0.928 . . . . 2.4500000000000002 111.194 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -149.29 174.58 12.25 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.941 0.896 . . . . 0.78000000000000003 110.249 171.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 74.73 53.36 0.08 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.732 1.213 . . . . 1.99 108.81 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.7 p -174.49 162.86 3.55 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 126.111 1.765 . . . . 1.02 107.173 -169.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.6 mt -79.33 145.53 33.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.716 0.806 . . . . 0.77000000000000002 109.692 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.5 t -139.21 -63.24 0.52 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.506 -0.77 . . . . 0.72999999999999998 109.756 -168.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -103.01 109.8 21.48 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 108.179 -1.045 . . . . 3.5600000000000001 108.179 165.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.45 -125.37 37.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.577 -1.009 . . . . 0.57999999999999996 110.577 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.5 t -98.34 9.11 43.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.54 0.736 . . . . 0.83999999999999997 111.436 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -80.98 119.93 24.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.059 -1.089 . . . . 1.79 108.059 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.7 p -79.88 120.02 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.84 -0.8 . . . . 1.49 108.84 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.7 t -78.65 77.3 5.13 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.982 -1.118 . . . . 0.82999999999999996 107.982 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.43 176.9 44.31 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.036 0.351 . . . . 1.0900000000000001 113.407 -170.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -48.31 146.31 2.86 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.418 0.687 . . . . 4.6500000000000004 110.77 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.58 -20.75 33.01 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-O 119.009 -0.884 . . . . 0.65000000000000002 111.54 -166.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -124.52 171.2 10.18 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.065 1.433 . . . . 2.0099999999999998 109.962 -177.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.74 137.46 29.81 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.604 1.962 . . . . 2.5699999999999998 110.49 176.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.5 t -89.15 118.45 28.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.656 0.782 . . . . 0.52000000000000002 109.15 175.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.48 130.04 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.716 -1.587 . . . . 1.3500000000000001 106.716 170.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 88.6 mt -74.6 65.08 1.26 Allowed 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.035 0.934 . . . . 2.9500000000000002 111.627 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.02 174.06 29.77 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 115.518 -0.764 . . . . 3.4900000000000002 112.011 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.52 93.59 2.63 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.282 -1.377 . . . . 4.8700000000000001 107.282 178.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 49.0 t0 38.74 67.39 0.43 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.462 1.905 . . . . 5.5499999999999998 111.56 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.03 -31.42 7.68 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 114.511 -1.222 . . . . 2.5800000000000001 113.02 179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -63.96 142.95 58.22 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.707 1.753 . . . . 4.5599999999999996 109.91 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -66.8 174.1 3.14 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.583 1.153 . . . . 4.0300000000000002 111.127 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -43.05 138.45 2.1 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.881 2.072 . . . . 1.8700000000000001 114.233 175.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -136.41 110.9 8.54 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.742 1.217 . . . . 3.1499999999999999 109.728 -173.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.72 100.8 11.13 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.61 0.764 . . . . 0.5 109.13 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 m -96.55 167.01 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 C-N-CA 122.968 0.507 . . . . 0.90000000000000002 109.72 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -98.38 159.67 14.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.649 0.78 . . . . 2.4199999999999999 110.374 -171.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.04 45.07 1.31 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.646 1.117 . . . . 2.6299999999999999 112.637 169.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 58.5 144.9 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 129.554 3.142 . . . . 3.1499999999999999 116.602 171.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.07 -179.85 25.3 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 124.799 1.19 . . . . 0.68999999999999995 111.647 -168.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.7 m -95.38 130.68 31.54 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.036 0.935 . . . . 2.3700000000000001 110.943 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.52 135.41 42.26 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 CA-C-N 120.714 1.291 . . . . 1.0900000000000001 110.327 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -64.55 131.86 95.22 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-O 119.066 -0.492 . . . . 2.48 111.011 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.56 171.02 18.98 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.599 2.199 . . . . 1.3799999999999999 111.657 171.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.24 151.53 0.24 Allowed 'General case' 0 C--N 1.341 0.22 0 C-N-CA 126.71 2.004 . . . . 7.7000000000000002 114.251 -176.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.4 m -158.66 171.24 20.47 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.664 -1.606 . . . . 4.7000000000000002 106.664 164.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 107.116 -1.438 . . . . 8.25 107.116 151.209 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 121.034 0.445 . . . . 8.3800000000000008 110.452 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.5 t -111.53 82.82 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 106.867 -1.531 . . . . 3.2400000000000002 106.867 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -143.08 178.48 7.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.05 0.94 . . . . 2.1499999999999999 109.311 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 51.8 p -124.22 167.2 14.61 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.156 0.983 . . . . 0.91000000000000003 109.913 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.47 168.19 2.94 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.316 0.647 . . . . 1.6699999999999999 111.464 177.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.44 ' HB2' HD21 ' A' ' 30' ' ' LEU . 65.0 m -83.91 150.86 25.42 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 108.204 -1.035 . . . . 1.25 108.204 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -108.94 -20.84 12.9 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.656 0.783 . . . . 1.52 111.412 -174.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -144.57 147.85 33.68 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.232 1.413 . . . . 2.6000000000000001 109.225 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -68.77 159.7 31.83 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.764 0.826 . . . . 0.60999999999999999 110.849 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.68 14.88 80.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.829 -0.908 . . . . 0.48999999999999999 110.829 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -119.27 158.4 26.12 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 123.411 0.685 . . . . 2.3399999999999999 110.125 -170.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -135.63 -176.46 4.29 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.449 0.7 . . . . 0.75 110.402 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.487 ' HA ' HD12 ' A' ' 13' ' ' LEU . 5.4 tp 66.79 39.76 3.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.158 0.983 . . . . 2.3700000000000001 109.704 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.4 p -154.61 153.45 31.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 125.339 1.455 . . . . 0.91000000000000003 108.156 -177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.511 ' CD2' HG22 ' A' ' 21' ' ' VAL . 76.5 mt -76.38 108.67 9.49 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 125.396 1.478 . . . . 0.84999999999999998 108.004 -174.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.8 t -107.32 -63.17 1.32 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.449 0.699 . . . . 0.54000000000000004 109.41 -170.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -91.51 98.63 11.79 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.666 0.786 . . . . 2.8999999999999999 109.841 168.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.8 -130.69 50.01 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.247 -1.141 . . . . 0.40999999999999998 110.247 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.88 4.97 42.65 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 117.217 0.509 . . . . 0.60999999999999999 111.039 176.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -79.89 120.12 23.68 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 120.922 -1.111 . . . . 1.6699999999999999 108.058 -176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.511 HG22 ' CD2' ' A' ' 15' ' ' LEU . 4.9 t -83.78 124.85 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 108.315 -0.994 . . . . 2.5899999999999999 108.315 -175.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.8 t -76.53 86.9 3.24 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.956 -0.757 . . . . 0.46000000000000002 108.956 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.65 172.29 19.4 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 121.659 -0.651 . . . . 0.78000000000000003 113.151 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.07 152.21 4.32 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.73 -0.865 . . . . 4.0 112.249 174.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.93 -5.73 83.1 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 123.969 0.795 . . . . 0.68000000000000005 111.787 -174.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -132.36 157.64 43.98 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 127.963 2.505 . . . . 1.28 108.048 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -141.51 152.33 44.06 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.363 1.465 . . . . 2.3100000000000001 109.042 174.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.4 t -99.42 130.18 45.67 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.771 2.029 . . . . 0.40999999999999998 108.91 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.5 mm -102.72 107.48 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.4 -1.704 . . . . 1.28 106.4 171.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 6' ' ' CYS . 34.4 mt -69.73 73.91 0.41 Allowed 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.387 1.475 . . . . 2.1800000000000002 110.375 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.05 146.49 2.87 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.066 -1.214 . . . . 2.7999999999999998 110.066 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.44 58.13 1.39 Allowed 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 108.739 -0.838 . . . . 4.2999999999999998 108.739 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 49.63 28.02 2.41 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.479 1.512 . . . . 5.8499999999999996 111.832 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.88 -72.41 0.14 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.433 -1.467 . . . . 3.8900000000000001 109.433 -165.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -63.5 158.16 21.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 117.967 0.884 . . . . 3.52 110.199 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -86.91 177.64 7.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.902 2.481 . . . . 4.2300000000000004 109.641 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -42.0 110.13 0.16 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.365 1.866 . . . . 2.4100000000000001 114.083 166.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -128.27 133.3 48.76 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.153 0.981 . . . . 2.5800000000000001 110.328 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.5 t -100.85 105.02 16.27 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.636 -0.876 . . . . 0.46000000000000002 108.636 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -110.3 172.82 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 109.329 -0.619 . . . . 0.78000000000000003 109.329 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.1 t -67.16 177.99 1.61 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.272 1.034 . . . . 2.0299999999999998 111.949 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.41 124.03 4.76 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.853 -2.099 . . . . 2.27 107.853 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.4 134.05 40.26 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.469 -0.567 . . . . 3.71 109.469 174.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.8 165.86 15.37 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 108.528 -1.829 . . . . 0.65000000000000002 108.528 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -76.01 149.94 83.01 Favored Pre-proline 0 CA--C 1.541 0.624 0 N-CA-C 108.581 -0.896 . . . . 1.73 108.581 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -78.08 157.48 30.37 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.275 1.983 . . . . 0.70999999999999996 111.506 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -61.55 132.51 93.01 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-O 119.096 -0.478 . . . . 3.2200000000000002 111.069 175.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.1 131.81 34.03 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 121.49 1.46 . . . . 1.6200000000000001 108.973 170.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -50.25 144.64 7.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.675 0.79 . . . . 6.1500000000000004 110.838 174.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.0 m 67.48 -75.64 0.06 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.559 0.744 . . . . 4.5599999999999996 109.81 -174.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 N--CA 1.446 -0.636 0 CA-C-O 117.597 -1.192 . . . . 10.24 109.64 -177.511 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.472 0.65 0 N-CA-C 107.233 -1.395 . . . . 4.4400000000000004 107.233 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 73.3 t -85.19 114.91 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 106.931 -1.507 . . . . 3.4700000000000002 106.931 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -124.71 161.76 25.66 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.425 1.09 . . . . 1.8 109.291 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 p -147.9 165.83 29.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.606 1.562 . . . . 0.78000000000000003 107.652 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -64.22 160.47 18.48 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.393 0.616 . . . . 1.6599999999999999 111.975 -176.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -83.2 152.66 25.12 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.501 -0.772 . . . . 1.0600000000000001 112.317 165.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.7 p -132.6 23.77 4.35 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.82 1.248 . . . . 1.3899999999999999 111.319 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.08 159.66 11.29 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.116 0.966 . . . . 3.1800000000000002 109.419 175.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -85.49 146.34 26.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.909 0.484 . . . . 0.5 111.164 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.69 28.01 17.69 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 116.011 -0.541 . . . . 0.57999999999999996 111.854 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.92 158.12 39.7 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-O 118.674 -0.679 . . . . 3.3399999999999999 110.569 -165.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -138.33 -179.81 6.01 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.694 1.134 . . . . 1.02 111.822 -172.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 62.74 36.7 13.1 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.677 0.751 . . . . 2.23 111.049 173.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.9 p -149.45 161.04 42.89 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 125.572 1.549 . . . . 1.1399999999999999 107.605 -176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.4 mt -73.78 130.94 40.97 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.177 -1.046 . . . . 0.65000000000000002 108.177 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 46.9 t -127.64 -63.64 1.02 Allowed 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 106.938 -1.505 . . . . 0.54000000000000004 106.938 -174.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.59 98.26 11.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.944 -0.761 . . . . 3.46 108.944 172.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 58.78 -135.26 52.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.87 -1.292 . . . . 0.51000000000000001 109.87 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 t -85.52 9.99 14.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 117.715 0.757 . . . . 0.81999999999999995 112.225 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -90.64 124.85 35.39 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.655 -0.869 . . . . 1.6799999999999999 108.655 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.3 139.17 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 109.999 -0.371 . . . . 1.7 109.999 178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.7 t -75.09 91.21 2.54 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.532 -0.914 . . . . 0.62 108.532 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.68 158.26 1.43 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 126.158 1.837 . . . . 1.0800000000000001 113.971 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -56.99 144.72 32.93 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.77 -0.841 . . . . 3.4900000000000002 111.404 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.74 -5.08 79.57 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.105 0.86 . . . . 0.73999999999999999 111.967 -171.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -125.48 166.87 15.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.169 1.788 . . . . 1.48 109.238 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -145.84 153.57 41.02 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 108.02 -1.104 . . . . 2.6200000000000001 108.02 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.8 t -98.55 128.89 45.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.691 1.596 . . . . 0.45000000000000001 107.041 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mt -101.05 124.65 54.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 106.456 -1.683 . . . . 2.1400000000000001 106.456 166.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -73.01 129.95 39.24 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 106.551 -1.648 . . . . 2.5 106.551 167.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -48.02 146.56 4.95 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 117.861 -1.522 . . . . 2.4300000000000002 112.112 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.0 t -124.33 42.49 3.24 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.95 1.875 . . . . 4.25 113.826 -171.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.0 p30 152.89 28.42 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.689 0.996 . . . . 5.6200000000000001 113.689 -140.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.53 14.31 77.54 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.47 -1.394 . . . . 2.2200000000000002 114.127 173.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.19 169.96 12.58 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.736 1.215 . . . . 3.5099999999999998 110.216 173.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -91.37 176.44 6.56 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.628 1.171 . . . . 3.9300000000000002 109.908 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -55.82 150.41 13.06 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.613 0.765 . . . . 2.2000000000000002 111.776 173.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -148.04 109.54 4.39 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.31 0.644 . . . . 3.2599999999999998 111.542 176.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.1 t -90.05 114.44 26.32 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 124.641 1.176 . . . . 0.40999999999999998 109.466 174.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 m -126.86 161.65 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 108.825 -0.806 . . . . 0.77000000000000002 108.825 -177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -61.58 148.0 43.74 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.784 -0.572 . . . . 2.3500000000000001 110.226 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.77 -31.85 0.27 Allowed Glycine 0 CA--C 1.527 0.807 0 CA-C-O 119.151 -0.805 . . . . 2.6800000000000002 113.623 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 72.06 83.51 0.13 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.293 1.437 . . . . 3.7200000000000002 111.356 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -82.38 -178.01 52.17 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 116.152 -0.477 . . . . 0.93000000000000005 112.184 176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.0 m -87.89 147.72 41.7 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.215 1.006 . . . . 2.3500000000000001 108.652 171.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -76.61 143.5 24.23 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.111 1.874 . . . . 1.22 111.54 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -50.52 130.22 26.36 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 123.464 0.705 . . . . 2.6699999999999999 111.129 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.32 149.52 75.53 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 121.788 1.659 . . . . 1.22 110.342 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -59.9 153.63 20.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.998 0.428 . . . . 5.4299999999999997 110.525 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.5 p -172.93 -64.77 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.617 -0.883 . . . . 4.0 108.617 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.324 0 CA-C-N 114.774 -1.103 . . . . 10.07 109.35 171.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 107.618 -1.252 . . . . 4.5899999999999999 107.618 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.3 t -105.19 150.02 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 106.828 -1.545 . . . . 2.9500000000000002 106.828 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -125.3 157.96 35.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.571 1.148 . . . . 1.96 108.106 174.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 p -147.03 173.44 12.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.466 1.907 . . . . 1.1899999999999999 106.221 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.03 168.5 8.17 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.939 0.4 . . . . 1.95 111.034 -176.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.3 m -82.86 156.14 23.75 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.714 0.768 . . . . 1.29 110.759 159.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -110.53 -11.05 14.51 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.244 -1.344 . . . . 0.83999999999999997 111.259 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -147.79 136.28 21.64 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 107.171 -1.418 . . . . 3.3599999999999999 107.171 -166.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -64.7 150.35 47.39 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.45 0.568 . . . . 0.48999999999999999 110.021 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.04 -1.27 62.9 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.046 -0.597 . . . . 0.46000000000000002 112.149 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -99.79 147.43 25.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 117.657 0.729 . . . . 2.3999999999999999 112.676 -171.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -115.19 -176.13 2.84 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.485 1.114 . . . . 1.1699999999999999 110.664 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 59.14 53.74 5.28 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 122.379 1.085 . . . . 2.3599999999999999 110.361 172.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.0 p -169.33 159.43 8.76 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.189 -1.411 . . . . 1.1599999999999999 107.189 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.64 143.81 46.15 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.78 -0.822 . . . . 0.73999999999999999 108.78 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.8 t -138.89 -63.2 0.53 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.509 -0.922 . . . . 0.56999999999999995 108.509 -172.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -93.29 97.49 10.65 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.696 -0.853 . . . . 2.96 108.696 169.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.94 -132.64 52.55 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.925 -1.27 . . . . 0.54000000000000004 109.925 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.4 t -87.28 14.68 7.4 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.732 0.766 . . . . 0.66000000000000003 112.168 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -88.22 124.61 34.02 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.185 0.902 . . . . 1.49 109.377 176.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.0 t -71.66 133.23 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.209 1.004 . . . . 2.0600000000000001 109.518 175.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.5 t -74.15 91.87 2.15 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 108.992 -0.744 . . . . 0.63 108.992 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -47.66 152.58 1.84 Allowed Glycine 0 CA--C 1.531 1.061 0 C-N-CA 126.327 1.918 . . . . 1.1799999999999999 114.188 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -49.43 139.1 12.35 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.479 0.712 . . . . 4.8300000000000001 110.732 173.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.94 -3.3 87.28 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.411 -0.661 . . . . 0.96999999999999997 112.71 -174.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -123.05 167.79 13.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.965 1.306 . . . . 1.55 108.318 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.491 ' HE3' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -146.04 154.99 42.47 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 124.357 1.063 . . . . 2.7000000000000002 110.653 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 43.8 t -105.83 127.79 53.33 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 106.846 -1.539 . . . . 0.52000000000000002 106.846 -172.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.5 mm -98.11 107.37 20.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 105.698 -1.964 . . . . 1.3 105.698 173.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -71.14 92.99 1.02 Allowed 'General case' 0 C--O 1.231 0.129 0 C-N-CA 124.849 1.259 . . . . 2.1299999999999999 108.815 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.45 175.58 4.35 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.489 -1.044 . . . . 2.9700000000000002 110.489 -175.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 t -176.38 94.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 103.898 -2.63 . . . . 3.8900000000000001 103.898 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 54.77 43.19 30.46 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.889 0.876 . . . . 6.2199999999999998 112.141 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.96 6.91 58.96 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.097 1.332 . . . . 2.4100000000000001 113.734 176.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.4 173.26 11.16 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 122.791 1.281 . . . . 2.8599999999999999 110.971 172.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.41 177.01 8.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.277 2.631 . . . . 4.1600000000000001 109.287 171.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -63.45 125.35 23.9 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 111.968 0.358 . . . . 1.72 111.968 162.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -118.7 127.26 53.4 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 131.306 3.842 . . . . 4.1900000000000004 109.359 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 33.9 t -101.42 111.26 23.43 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.692 1.587 . . . . 0.46999999999999997 110.15 172.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.491 HG23 ' HE3' ' A' ' 27' ' ' LYS . 31.4 m -114.22 155.57 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 124.038 0.935 . . . . 0.81000000000000005 111.202 -174.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.01 168.54 15.85 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.793 0.806 . . . . 2.4100000000000001 111.229 -169.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.61 45.96 1.47 Allowed Glycine 0 CA--C 1.524 0.605 0 O-C-N 120.842 -1.162 . . . . 2.9500000000000002 111.38 162.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 73.68 154.97 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.586 2.354 . . . . 3.48 111.108 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.77 158.27 31.09 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 109.129 -1.588 . . . . 0.67000000000000004 109.129 -169.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -92.56 146.91 33.25 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 117.544 0.672 . . . . 1.97 109.436 -174.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.41 154.56 65.06 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-N 121.035 1.405 . . . . 1.3999999999999999 110.659 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 106.86 38.1 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 124.354 1.062 . . . . 2.6099999999999999 109.592 176.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -80.48 139.63 12.97 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.743 2.296 . . . . 1.73 110.19 -176.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -86.34 160.55 19.07 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.73 0.812 . . . . 7.5099999999999998 109.346 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.8 m 63.64 162.15 0.11 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.196 1.798 . . . . 4.9500000000000002 112.176 -172.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 . . . . . 0 N--CA 1.45 -0.442 0 C-N-CA 127.62 2.368 . . . . 10.82 105.233 174.248 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 106.427 -1.694 . . . . 4.8200000000000003 106.427 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.7 t -86.03 123.42 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.783 -1.562 . . . . 3.5 106.783 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -85.82 169.49 13.29 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.181 0.992 . . . . 2.6200000000000001 108.527 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.1 p -101.63 165.93 10.97 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 124.106 0.963 . . . . 1.3300000000000001 109.579 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.11 156.98 38.59 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.907 0.776 . . . . 2.23 110.955 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.456 ' C ' HD21 ' A' ' 30' ' ' LEU . 75.7 m -84.81 150.87 24.74 Favored 'General case' 0 C--N 1.36 1.046 0 C-N-CA 117.855 -1.538 . . . . 1.1499999999999999 109.226 178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -132.34 6.06 4.13 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.73 0.641 . . . . 1.45 112.73 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.53 136.33 18.28 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.58 1.552 . . . . 3.6800000000000002 106.812 -169.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -71.83 139.4 48.89 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 118.65 0.659 . . . . 0.77000000000000002 110.353 -177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 85.59 14.68 67.53 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 111.733 -0.547 . . . . 0.47999999999999998 111.733 177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -97.13 164.07 12.66 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 123.297 0.639 . . . . 2.5600000000000001 109.742 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 33.3 p-10 -148.41 -175.37 4.89 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.223 0.609 . . . . 0.95999999999999996 109.587 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 58.61 37.03 25.4 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.516 0.674 . . . . 2.2999999999999998 109.481 -174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -148.81 145.6 27.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.6 1.16 . . . . 1.0700000000000001 109.269 175.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 mt -57.68 108.88 0.62 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.411 2.284 . . . . 0.68999999999999995 108.637 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.1 t -99.18 -63.15 1.15 Allowed 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.443 -1.688 . . . . 0.62 106.443 -174.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -109.79 99.08 8.28 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.035 1.334 . . . . 3.8300000000000001 109.452 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.82 -145.73 38.84 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.617 -1.393 . . . . 0.66000000000000003 109.617 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.02 -0.7 45.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.512 0.725 . . . . 1.02 110.687 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -82.25 118.82 23.41 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.197 -1.408 . . . . 1.6200000000000001 107.197 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.18 146.94 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 110.289 -0.263 . . . . 1.8 110.289 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 t -73.16 95.79 2.13 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.789 0.804 . . . . 0.51000000000000001 109.285 167.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -50.57 157.42 2.19 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 127.632 2.539 . . . . 1.0900000000000001 113.137 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.38 144.94 56.8 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 122.051 -0.676 . . . . 3.8900000000000001 110.667 -177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.5 0.41 84.45 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 123.323 0.487 . . . . 0.76000000000000001 112.156 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.66 161.2 30.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.063 2.145 . . . . 1.4399999999999999 108.596 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.6 mtmt -136.63 156.64 48.27 Favored 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.881 1.672 . . . . 2.71 111.49 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.5 t -103.42 119.43 38.88 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.232 -1.766 . . . . 0.5 106.232 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.537 HD13 HG22 ' A' ' 40' ' ' VAL . 1.3 mp -88.3 109.36 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 104.883 -2.266 . . . . 1.29 104.883 174.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.456 HD21 ' C ' ' A' ' 6' ' ' CYS . 1.0 OUTLIER -61.39 132.97 55.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.766 -1.198 . . . . 2.0299999999999998 107.766 175.091 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.29 137.88 49.53 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.06 -0.816 . . . . 2.8500000000000001 111.06 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.1 m -130.23 43.2 3.16 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.082 -0.485 . . . . 4.6399999999999997 111.955 -174.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 164.07 49.72 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.89 1.676 . . . . 4.7300000000000004 109.105 -173.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.77 0.34 13.0 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 120.306 -1.496 . . . . 2.8399999999999999 113.926 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -68.18 160.23 29.51 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 117.525 0.662 . . . . 3.8900000000000001 110.828 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -92.95 166.19 12.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.271 -0.64 . . . . 5.0700000000000003 109.271 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -58.72 127.39 31.94 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.895 0.878 . . . . 2.1699999999999999 110.003 176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.44 110.21 14.82 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.471 1.108 . . . . 2.73 110.409 -176.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.3 t -84.53 98.11 9.94 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 109.277 -0.638 . . . . 0.33000000000000002 109.277 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.537 HG22 HD13 ' A' ' 29' ' ' ILE . 3.2 m -100.48 168.56 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 108.734 -0.839 . . . . 0.66000000000000003 108.734 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 t -67.29 171.06 6.26 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.037 -1.039 . . . . 2.5600000000000001 111.51 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.05 140.79 7.57 Favored Glycine 0 C--O 1.223 -0.581 0 N-CA-C 109.106 -1.598 . . . . 2.27 109.106 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.39 112.74 14.46 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.326 -1.102 . . . . 3.73 108.976 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.94 174.76 23.59 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.264 0.935 . . . . 0.71999999999999997 111.536 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 t -94.5 138.08 22.45 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 109.115 -0.698 . . . . 2.2999999999999998 109.115 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -70.72 142.11 42.92 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 121.862 1.708 . . . . 1.1000000000000001 109.586 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -50.77 108.23 0.99 Allowed Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.985 -0.531 . . . . 3.29 111.737 -177.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -77.71 170.79 18.51 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.014 1.809 . . . . 1.6599999999999999 110.143 -176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -60.68 160.66 8.91 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 122.856 1.312 . . . . 5.3899999999999997 111.649 173.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 m -151.62 124.58 8.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.613 -1.995 . . . . 5.7300000000000004 105.613 174.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 . . . . . 0 CA--C 1.534 0.356 0 N-CA-C 105.346 -2.094 . . . . 9.1600000000000001 105.346 179.516 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 71.7 t . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 106.557 -1.645 . . . . 4.1399999999999997 106.557 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.2 t -136.63 118.89 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 105.638 -1.986 . . . . 2.5800000000000001 105.638 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -89.65 163.04 15.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.335 -0.617 . . . . 1.53 109.335 175.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 p -134.39 163.9 28.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.296 1.438 . . . . 1.1599999999999999 108.719 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.64 161.49 29.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.351 0.596 . . . . 1.8700000000000001 111.91 -176.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 11' ' ' GLN . 1.3 m -83.82 173.73 11.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.652 0.781 . . . . 1.6499999999999999 111.765 171.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.4 p -141.35 28.0 1.87 Allowed 'General case' 0 C--N 1.345 0.404 0 CA-C-O 118.733 -0.651 . . . . 1.5800000000000001 112.733 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -165.14 160.78 19.05 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.995 -1.113 . . . . 2.7599999999999998 107.995 170.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -81.29 153.82 26.88 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.866 0.867 . . . . 0.47999999999999998 111.363 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.512 ' HA2' ' CG ' ' A' ' 27' ' ' LYS . . . 75.37 15.32 81.25 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.154 0.883 . . . . 0.46000000000000002 111.751 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.43 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 1.9 mt-30 -92.18 171.4 9.1 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.412 0.685 . . . . 2.4199999999999999 109.158 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -154.94 179.6 8.97 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.089 0.859 . . . . 0.70999999999999996 110.394 170.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 63.56 55.84 1.68 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.544 1.538 . . . . 2.1299999999999999 111.103 178.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.4 p -173.83 163.91 4.21 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.415 1.886 . . . . 0.90000000000000002 106.532 -172.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.0 mt -71.93 144.18 49.03 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.918 -0.771 . . . . 1.01 108.918 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.0 t -142.31 -64.57 0.42 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.393 -0.595 . . . . 0.64000000000000001 109.393 -172.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -94.32 98.96 11.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.156 -1.424 . . . . 2.9700000000000002 107.156 173.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 51.69 -128.6 32.98 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.094 -1.203 . . . . 0.62 110.094 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.2 t -88.32 5.98 39.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 117.134 0.467 . . . . 0.67000000000000004 111.823 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -83.61 124.34 30.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.129 -0.982 . . . . 2.1400000000000001 108.484 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.9 p -79.08 132.68 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 123.533 0.733 . . . . 1.53 109.26 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.7 t -87.55 92.19 9.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.486 -1.301 . . . . 0.48999999999999999 107.486 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.73 -172.71 9.94 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.501 1.048 . . . . 0.81000000000000005 114.797 -168.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -61.63 145.46 52.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.856 -0.791 . . . . 3.9100000000000001 109.321 168.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.51 10.3 86.02 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.159 -0.776 . . . . 1.0800000000000001 111.159 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -135.2 167.92 20.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.474 1.11 . . . . 2.21 108.126 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.512 ' CG ' ' HA2' ' A' ' 10' ' ' GLY . 13.9 ttmt -145.46 132.32 20.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.744 1.218 . . . . 2.2200000000000002 108.205 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.4 t -92.0 123.77 35.61 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.215 1.006 . . . . 0.62 109.293 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.9 mm -107.71 111.56 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 106.417 -1.697 . . . . 1.7 106.417 169.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.98 166.21 16.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.771 -0.455 . . . . 2.3399999999999999 109.771 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.62 134.13 4.46 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.803 0.716 . . . . 2.3399999999999999 112.798 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 m -144.29 98.5 3.22 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.444 -2.058 . . . . 3.6699999999999999 105.444 -175.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t0 78.05 61.76 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.907 2.083 . . . . 5.8099999999999996 110.73 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.53 29.88 74.87 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.818 0.723 . . . . 2.4900000000000002 113.452 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -104.53 173.87 6.12 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.653 1.981 . . . . 3.9199999999999999 110.606 173.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -96.27 176.86 5.91 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.251 2.62 . . . . 3.4700000000000002 109.073 -177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -72.62 144.21 47.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.876 -0.583 . . . . 3.2999999999999998 111.371 172.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -142.11 124.18 15.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.269 1.428 . . . . 2.9900000000000002 110.165 -175.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.4 t -97.81 102.22 13.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.454 1.025 . . . . 0.37 109.881 174.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.8 m -91.47 162.7 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 123.195 0.598 . . . . 0.73999999999999999 109.916 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 t -79.71 152.8 29.69 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.778 -0.823 . . . . 1.8999999999999999 108.778 170.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.75 -114.58 0.76 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.706 -1.358 . . . . 2.71 109.706 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -162.8 156.84 20.72 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.335 1.454 . . . . 4.4900000000000002 107.816 169.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.8 170.37 30.6 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.703 -0.959 . . . . 0.78000000000000003 110.703 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 t -81.04 140.28 49.76 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 117.366 0.583 . . . . 2.1600000000000001 109.86 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.31 154.75 56.32 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.057 1.838 . . . . 1.1200000000000001 111.673 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.97 133.88 47.61 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 123.085 0.554 . . . . 3.4500000000000002 110.054 171.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.31 153.18 35.52 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.741 2.294 . . . . 1.8 109.756 168.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -90.36 141.29 28.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.752 0.821 . . . . 6.0 109.511 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.1 m 67.86 174.46 0.27 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.302 1.441 . . . . 5.1200000000000001 111.894 -175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 118.376 -0.821 . . . . 8.0399999999999991 110.532 170.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 106.924 -1.51 . . . . 4.4199999999999999 106.924 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.8 t -124.83 141.94 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 106.576 -1.639 . . . . 2.6800000000000002 106.576 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -117.2 160.1 21.59 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.313 1.445 . . . . 2.5499999999999998 108.504 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 79.0 p -143.31 173.22 11.79 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.679 1.192 . . . . 1.3600000000000001 108.683 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.71 162.2 8.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.503 0.668 . . . . 2.1000000000000001 112.391 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.1 m -83.64 165.91 18.59 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 115.65 -0.704 . . . . 1.3500000000000001 111.4 169.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -126.68 9.0 6.99 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.512 0.725 . . . . 1.02 112.592 -174.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -156.98 161.89 39.59 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.514 1.125 . . . . 2.8100000000000001 109.007 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -81.91 157.69 24.24 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 122.767 0.427 . . . . 0.53000000000000003 110.439 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.26 21.94 69.09 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 119.696 -1.24 . . . . 0.56000000000000005 110.328 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -110.64 165.92 11.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 123.523 0.729 . . . . 2.2599999999999998 109.14 -175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -144.23 -179.3 6.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.745 1.157 . . . . 0.81000000000000005 110.612 176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 13' ' ' LEU . 1.2 mt 58.46 54.84 5.26 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.62 1.168 . . . . 2.5499999999999998 111.388 175.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.6 p -165.01 164.96 20.46 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.427 1.091 . . . . 1.0600000000000001 108.172 -175.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.552 ' CD2' HG22 ' A' ' 21' ' ' VAL . 22.2 mt -75.4 120.82 21.36 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.073 -1.084 . . . . 0.48999999999999999 108.073 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.1 t -123.07 -63.43 1.26 Allowed 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 108.109 -1.071 . . . . 0.56000000000000005 108.109 -172.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -90.82 88.9 7.25 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.715 1.206 . . . . 3.0600000000000001 109.338 168.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.32 -135.21 42.44 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.393 -1.483 . . . . 0.47999999999999998 109.393 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.2 t -81.78 -6.06 58.73 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.046 0.923 . . . . 0.72999999999999998 111.604 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -76.51 123.98 26.88 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.184 -0.948 . . . . 1.5900000000000001 108.662 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.552 HG22 ' CD2' ' A' ' 15' ' ' LEU . 6.8 t -83.2 136.87 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.156 -0.683 . . . . 2.3199999999999998 109.156 -176.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.5 t -77.96 94.36 4.59 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.907 -0.496 . . . . 0.65000000000000002 110.869 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.24 165.66 9.18 Favored Glycine 0 CA--C 1.541 1.705 0 C-N-CA 124.239 0.923 . . . . 0.82999999999999996 114.156 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -57.34 151.53 15.97 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 120.876 -1.367 . . . . 3.6299999999999999 113.249 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.36 0.32 86.72 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.07 1.319 . . . . 0.75 111.305 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -130.91 161.47 31.79 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.072 2.549 . . . . 1.3400000000000001 108.642 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 145.83 33.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.641 1.176 . . . . 2.5499999999999998 108.307 178.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 48.6 t -95.72 126.42 40.97 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 127.134 2.174 . . . . 0.45000000000000001 108.688 175.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 29' ' ' ILE . 2.3 mp -97.81 114.19 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 106.168 -1.789 . . . . 1.6599999999999999 106.168 170.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 mp -73.0 76.41 1.19 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.828 1.251 . . . . 2.23 109.038 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.27 150.18 4.61 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.119 -0.793 . . . . 3.0099999999999998 111.119 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 90.0 p -147.88 64.22 1.11 Allowed 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.993 -0.71 . . . . 5.1500000000000004 110.024 -175.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.0 t0 87.38 61.49 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.688 1.995 . . . . 6.0499999999999998 109.715 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.98 -12.61 10.98 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 121.341 -0.849 . . . . 2.6699999999999999 113.989 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -61.98 161.92 9.95 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 123.016 1.388 . . . . 3.52 110.752 164.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -86.55 177.55 7.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.681 2.392 . . . . 5.1600000000000001 108.436 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -43.25 149.64 0.23 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.622 0.971 . . . . 1.76 113.622 164.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.73 105.58 1.62 Allowed 'General case' 0 C--N 1.344 0.357 0 C-N-CA 124.518 1.127 . . . . 3.21 111.78 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.2 t -80.99 100.31 8.89 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 125.071 1.348 . . . . 0.5 109.325 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 m -107.72 176.37 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.772 0.829 . . . . 0.81000000000000005 108.879 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.04 178.38 5.04 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.79 -0.569 . . . . 2.3100000000000001 110.286 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.83 155.4 31.77 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.826 -1.71 . . . . 2.1899999999999999 108.826 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -81.3 165.67 21.19 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 117.458 0.629 . . . . 3.48 109.918 -171.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.91 -179.13 38.01 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.355 -1.498 . . . . 0.96999999999999997 109.355 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.1 t -93.19 148.79 36.33 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 117.416 0.608 . . . . 1.9399999999999999 110.165 -177.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -73.66 173.3 14.14 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 121.552 1.501 . . . . 1.1000000000000001 111.137 175.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.78 132.09 21.22 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.887 0.875 . . . . 2.23 108.95 177.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.4 149.89 57.32 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.384 1.39 . . . . 1.8500000000000001 110.802 174.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -72.38 154.87 40.68 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.148 0.979 . . . . 6.0599999999999996 109.938 174.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.56 158.73 17.3 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.614 1.166 . . . . 5.4100000000000001 108.294 177.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 106.35 -1.722 . . . . 10.91 106.35 178.414 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 104.931 -2.248 . . . . 4.2300000000000004 104.931 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.6 t -97.85 147.51 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.174 -1.047 . . . . 3.2200000000000002 108.174 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -108.55 -176.17 2.97 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.94 1.296 . . . . 2.3399999999999999 109.193 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.9 p -127.3 166.43 17.81 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.965 0.906 . . . . 0.93000000000000005 108.917 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.87 164.96 25.11 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 119.365 0.984 . . . . 2.29 109.684 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -82.48 157.13 23.73 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 119.113 -1.035 . . . . 1.0900000000000001 109.397 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.1 p -121.64 -18.24 7.23 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.02 0.748 . . . . 1.0 113.02 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -145.24 155.08 43.03 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.998 1.719 . . . . 2.46 107.182 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -69.79 150.65 46.65 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.305 0.957 . . . . 0.46000000000000002 109.888 173.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.66 -1.13 71.35 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 119.741 -0.477 . . . . 0.46999999999999997 112.348 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -91.72 163.3 14.13 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.292 0.637 . . . . 2.4399999999999999 110.544 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -150.52 -178.96 6.85 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.553 -0.717 . . . . 1.0900000000000001 109.288 172.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mp 62.23 38.49 13.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.512 1.125 . . . . 2.2200000000000002 110.398 -167.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -149.16 152.26 35.77 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.922 0.889 . . . . 1.05 110.232 177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.8 mt -66.02 135.23 54.38 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.28 1.432 . . . . 0.51000000000000001 107.67 -178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.9 t -140.84 -63.94 0.46 Allowed 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.283 -1.377 . . . . 0.68999999999999995 107.283 -168.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.42 89.15 7.89 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.184 -1.043 . . . . 3.27 108.184 168.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 56.75 -128.92 48.11 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.532 -1.427 . . . . 0.44 109.532 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 t -84.23 9.77 12.04 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.954 0.877 . . . . 0.73999999999999999 112.432 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -91.33 117.99 30.13 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.797 1.181 . . . . 1.73 107.831 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.48 128.74 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.842 -0.617 . . . . 1.5600000000000001 109.453 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.0 t -72.83 85.23 1.23 Allowed 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.347 0.594 . . . . 0.48999999999999999 109.913 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.27 167.62 9.58 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 126.331 1.92 . . . . 0.75 114.049 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -55.6 152.44 9.2 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.307 -1.702 . . . . 3.96 112.019 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.02 12.0 84.58 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 124.338 0.97 . . . . 0.89000000000000001 112.827 -173.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -138.7 170.1 16.6 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 129.67 3.188 . . . . 2.3599999999999999 108.934 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.34 136.7 14.04 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.544 1.538 . . . . 1.98 109.524 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.4 t -94.48 126.52 39.8 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.211 -1.403 . . . . 0.42999999999999999 107.211 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.6 mm -101.43 113.53 37.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.925 -1.509 . . . . 1.76 106.925 170.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mt -89.07 85.69 6.74 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.503 1.521 . . . . 2.23 107.723 175.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.0 135.09 6.24 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.224 -0.75 . . . . 3.4199999999999999 111.224 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.06 99.45 2.1 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 104.65 -2.352 . . . . 4.6200000000000001 104.65 -177.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 42.82 47.7 4.81 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 122.523 1.154 . . . . 8.0500000000000007 112.745 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.72 34.31 25.25 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.487 1.518 . . . . 3.7999999999999998 112.951 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -97.66 169.65 9.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 123.017 1.389 . . . . 3.9700000000000002 112.405 169.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -85.11 177.99 7.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.663 2.385 . . . . 3.4399999999999999 109.212 174.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -62.38 127.14 29.91 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.283 0.633 . . . . 2.6400000000000001 110.431 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -135.08 123.77 23.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.425 1.89 . . . . 4.29 111.346 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 39.0 t -95.81 101.99 13.74 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.603 1.961 . . . . 0.37 110.246 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.83 158.7 3.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 C-N-CA 123.927 0.891 . . . . 0.60999999999999999 110.099 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.41 167.71 16.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 121.832 -0.543 . . . . 2.5699999999999998 110.226 176.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 135.97 -110.8 0.83 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.691 -1.763 . . . . 2.7599999999999998 108.691 170.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -156.7 165.31 36.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.067 -1.827 . . . . 2.8399999999999999 106.067 171.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.62 168.32 38.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.366 -1.494 . . . . 0.66000000000000003 109.366 -176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.9 t -82.78 132.77 50.49 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 109.268 -0.642 . . . . 2.1600000000000001 109.268 177.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.77 132.22 18.29 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.273 1.315 . . . . 0.76000000000000001 110.252 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -55.31 119.25 22.37 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.774 -0.632 . . . . 2.2200000000000002 110.008 174.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.3 146.78 40.85 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 121.287 1.325 . . . . 1.6100000000000001 108.851 172.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -92.69 153.1 19.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.316 1.046 . . . . 6.0199999999999996 109.618 169.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.4 m -163.58 -41.57 0.03 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.385 1.074 . . . . 4.7800000000000002 110.575 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.5 p80 . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 125.211 1.404 . . . . 9.0700000000000003 112.682 -176.018 . . . . . . . . 0 0 . 1 stop_ save_